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ABSTRACT
An investigation into the design and synthesis of helical chiral ligands for
atropoenantioselective Suzuki reactions was undertaken. The chiral synthesis of 2,2'bipyrrolidine was the subject of primary investigations which focused on methods to
prepare the key intermediate alkene - (4E)-1,8-di(benzyloxy)-4-octene - in high
geometrical purity. The trans selective Wittig reaction provided the optimum
stereoselectivity (E:Z, 97:3), albeit with a low chemical yield (30%). Subsequent
Sharpless

asymmetric

dihydroxylation

afforded

(4R,5R)-1,8-di(benzyloxy)-4,5-

octanediol (73%, 97% ee) and separately, its S,S-enantiomer (77%, 87% ee). These
diols can be easily elaborated to the target enantiomers of 2,2'-bipyrrolidine with
preservation of stereochemical integrity.
The first two stereoselective syntheses of (2S,2'S)-2,2'-biindoline were concurrently
performed using (2R,2'R)-2,2'-bioxirane and (2S,2'S)-N,N'-di-tert-butoxycarbonyl-2,2'biaziridine as chiral precursors. The copper catalysed ring opening of each heterocycle
with 2-bromophenylmagnesium chloride provided two pathways to (2S,3S)-1,4-di(2bromophenyl)-2,3-butanediamine,

which

was

regioselectively

cyclised

under

microwave assisted palladium catalysis. The synthesis of (2S,2'S)-2,2'-biindoline was
thus achieved in five-steps with an overall yield of 5% (>99% ee) from the bioxirane
and in three-steps with in an overall yield of 15% from the biazidirine (>99% ee).
Crystallographic analysis of the biindoline and its corresponding palladium(II)
dichloride complex unequivocally confirmed the structure, enantiomeric purity and
absolute stereochemistry of the molecule.
The chiral bioxirane was also used in a highly stereoselective four-step synthesis of
(2S,2'S)-N,N'-di-tert-butoxycarbonyl-2,2'-bipyrrolidine

using

acetonitrile

as

the

carbanion source for the ring opening reaction. A chiral copper(II) complex was
subsequently prepared from the parent compound for application in oxidative aryl
homo-coupling reactions, however its precise structure is yet to be determined.
The preparation of the analogous phospholane and arsolane monomers was investigated
using
iv

a

one-pot

diGrignard

cyclisation

strategy.

The

reaction

of

1,4-

di(bromomagnesio)butane at 0 oC with PhPOCl2 and separately, PhAsO, provided 1phenylphospholane 1-oxide and 1-phenylarsolane in unoptimised yields of 23% and
12% respectively. The same electrophiles in combination with 1-bromomagnesio-2-(2(chloromagnesio)ethyl)benzene at -78

o

C afforded

racemic mixtures of 1-

phenylbenzophospholane 1-oxide (46%) and 1-phenylbenzoarsolane (20%). The labile
dimethylamino moiety was also accommodated as a P-substituent in the cyclisation of
the latter diGrignard, providing racemic dimethylaminobenzophospholane 1-oxide in
60% yield.

v
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CHAPTER 1
Introduction

The importance of preparing a chiral stereoisomer in optically pure form has long been
recognised in synthetic chemistry and subsequent applications. While developments in
this field of endeavour have enabled the highly enantioselective synthesis of molecules
bearing quaternary sp3 carbon atoms,1-3 a general, reliable and efficient method for
asymmetric induction in molecules which possess atropisomerism has yet to be
devised.4 The increasing importance of this chirality element, particularly within
sterically encumbered biaryls,4 highlights the growing need for methodology to make
possible the routine stereoselective synthesis of such compounds.

1.1 Atropisomerism in Biaryls
Atropisomerism occurs when steric hindrance around a covalent bond elevates the
rotational energy barrier sufficiently high to facilitate the isolation of conformational
stereoisomers.5 Molecules possessing this chemical entity can be considered to be
axially chiral,6 referring to the bond (axis) about which the conformation is locked.
Although many types of atropisomers are known,7-9 this phenomenon is manifested in
biaryl systems where, most commonly, steric interactions between ortho substituents
(including fused rings) prevent rotation about the biaryl bond.4

A rotationally

constrained biaryl with dissimilar ortho substituents on each aryl unit can be resolved
into enantiomeric atropisomers such as those represented by 1a and 1b (Figure 1.1).

A
X

*

1a

B
Y

B
Y

*

A
X

1b

Figure 1.1: Enantiomeric atropisomers 1a and 1b arising from restricted rotation about the
biaryl bond.

The conformational stability of a biaryl is usually governed by the size of the ortho
groups and the degree of substitution. In general, at least three ortho substituents are
necessary to provide a sufficient barrier to rotation at room temperature.10 At elevated
1
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temperatures, interconversion between enantiomers may become possible leading to
racemization of the chiral axis.10
The atropisomeric biaryl axis is the structurally and stereochemically decisive
component of an increasing number of biologically active natural products,11,12 chiral
auxiliaries and catalysts13-15 as well as liquid crystals,16 chiral cavities17 and
chromatographic stationary phases.18 Selected examples (Figure 1.2) include the
naturally occurring knipholone 2,19 which has been shown to exhibit good antitumoral
activity in the M-configuration,‡ the central and axially chiral mastigophorene 3,20
which stimulates nerve growth and the synthetic C2-symmetric ligand BINAP 4,21
which is ubiquitously used in asymmetric catalysis including rhodium- and rutheniumbased hydrogenation.
S

OH O

OH

OH

P *

O
HO

M *

OH

OH
OH
OH

M

*

PPh2
PPh2

S

MeO

O

knipholone
2

mastigophorene
3

BINAP
4

Figure 1.2: Selected examples of chiral biaryls with biological or synthetic applications.

1.2 Atroposelective Biaryl Synthesis
The sterically encumbered nature of atropisomeric biaryls, coupled with their thermal
lability, renders the stereoselective synthesis of such compounds a challenging goal and
it is unsurprising that a general method to accomplish this task, with a broad scope and
applicability, is still lacking. In the past two decades, reasonable advances have been
made in the development of methodology for atroposelective biaryl synthesis; the
majority of these strategies falling into one of two general approaches (Scheme 1.1).
The ‘classical’ approach involves the direct atroposelective coupling of the two

‡

The configuration of the atropisomeric biaryl axis is assigned as either M or P based on the priority of
the aryl substituents. For an explanation on the rules governing this assignment, see reference 4.

2
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aromatic portions 5 and 6, usually mediated by a transition metal, in which the biaryl
axis is formed with simultaneous asymmetric induction.22-31
1) Direct atroposelective
coupling

2) Dynamic kinetic resolution

R

R
X

X
R

A
5

R
*

B

X
Y

R'

Y

°

B

R'

R'

Y
7

6

A
5

X
Y

° configurationally labile
biaryl axis
* configurationally stable
biaryl axis

R'
6

Scheme 1.1: The two main approaches currently used for the atroposelective synthesis of
biaryls.

The second strategy is a step-wise process in which a configurationally labile biaryl 7 is
constructed before being resolved in a dynamic kinetic resolution fashion32-36 - for
example, by atropodiastereoselective cleavage (or formation34) of a bridge between the
ortho substituents X and Y.35

1.2.1 The Lactone Strategy
Among the step-wise dynamic kinetic resolution approaches, the ‘lactone’ strategy has
exhibited the broadest scope and applicability (Scheme 1.2).37-40 This approach begins
with pre-fixation of the aryl substrates 8 and 9 by formation of bromoester 10 which
facilitates facile intramolecular coupling to afford the configurationally unstable biaryl
lactone 11. Subsequent atropodiastereoselective cleavage of the lactone bridge by a
chiral oxygen or nitrogen nucleophile (Nu*)† forms the configurationally stable biaryl
12, which contains a hydroxyl group and an amide or ester as the resulting ortho
substituents. With the desired axial configuration installed, the chiral auxiliary can be
removed and further functional group manipulations carried out (if necessary) to access
the target biaryls with the required substitution patterns.‡

†

The lactone can also be reductively cleaved by a chiral hydride source to give the biaryl
atropoenantioselectively.41 In these cases a benzylic alcohol is formed as one of the substituents.
‡
The other atropisomer is also available simply by using the other enantiomer of the nucleophile (Nu*) in
the ring cleavage step.35

3

CHAPTER 1

Introduction

R
R

CO2H
pre-fixation

Br
8

O
Br

R

aryl
coupling

°

O
OH

O

O
°

O

O

R'

R'

R'

R
fast

R'
biaryl lactone 11
(configurationally unstable)

10
9
atroposelective
cleavage with a
chiral O or N
nucleophile (Nu*)
dynamic kinetic
resolution

R

Nu*
*

further
manipulations

O
OH

R'

R
*

X
Y

R'

12

Scheme 1.2: General principle of the lactone strategy.

The main advantages of the lactone strategy are the high yields of the aryl coupling step
and the consistently good atropodiastereoselectivities obtainable, regardless of the size
and position of the adjacent substituents R and R'. This concept has thus been applied to
the synthesis of a number of axially chiral natural products and ligands.37-40 A notable
drawback with this methodology however is the large number of steps required (from
the aryl precursors) to prepare the target biaryls with the desired substitution patterns in
place - if accessible from the biaryl intermediate 12 at all. The dynamic resolution is
also limited to six-membered lactones42 and the ring cleavage is not stereoselective
using chiral carbon nucleophiles.43 The stoichiometric use of the chiral nucleophile,
which is often removed after ring cleavage, is also uneconomical.

1.2.2 Direct Atroposelective Aryl Coupling
The direct aryl coupling strategy for the stereoselective synthesis of atropisomeric
biaryls has been achieved by a number of different approaches, which can be classified
as either atropodiastereo- or atropoenantioselective (Scheme 1.3). The former strategies
use a chiral auxiliary attached to one of the aryl substrates to control the
stereoselectivity of the coupling - a chiral tether,22-24 ortho substituent6,25 or planar
chiral arene.26 In contrast, the atropoenantioselective strategies, encompassing both
oxidative27-29 and redox-neutral couplings,30,31 involve catalysis by a transition metal in

4
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the presence of a chiral ligand (M/L*) to translate the required stereochemical
information.
R

diastereoselective
aryl couplings:

X
A
R

B

R

X

Y*

X

A

R'

A
B

*

B

chiral ortho substituent

Y

R'

R'

Y
MLn

*
13

chiral tether

planar chirality
R
*

X
Y

R'

enantioselective
aryl couplings:

redox-neutral

oxidative
M/L*
oxidant

M/L*
R

R

X

X

A
5
B

X
R'

Y
R'
6

Scheme 1.3: Current strategies for direct atroposelective formation of axially chiral biaryls.

Although each of the above strategies has found application (albeit limited at this stage)
in the atroposelective synthesis of selected axially chiral biaryls,22-31 including natural
products, the enantioselective redox-neutral coupling process offers a number of
advantages over the other strategies in terms of scope and efficiency, making it
potentially an ideal general method:
1. The chiral source (M/L*) is used in substoichiometric quantities, making it an
economical process.
2. It allows the regioselective cross-coupling of the two aryl substrates 5 and 6 - in
contrast to the oxidative coupling approach which is essentially restricted to homocoupling.4
5
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3. The target biaryls can be formed directly with the required substitution patterns in
place (or with suitable protecting groups) thus avoiding the need for subsequent
(wasteful) removal of an attached chiral auxiliary or extensive further functional
group manipulations.31
4. The aryl precursors are achiral (unless otherwise desired) which simplifies their
preparation - consider, for example, the tedious preparation of the enantiomerically
pure planar chiral aryl substrates 13.26
5. Both atropisomers are accessible from the same precursors simply by using the
opposite enantiomer of the chiral ligand.
1.2.2.1 Redox-Neutral Cross Coupling - The Suzuki Reaction
The general protocol for redox-neutral cross-coupling involves the reaction of an
organometallic aryl nucleophile 5 (A = MgX, ZnX, SnR2, B(OH)2, etc.) with an aryl
halide 6 (B = I, Br, Cl) in the presence of a transition metal catalyst coordinated by a
phosphorus or nitrogen ligand (M/L) (Scheme 1.4).44-47
R
X
A = MgX, ZnX, SnR2, B(OH)2, etc.
B = I, Br, Cl (or OTf)

R

A
5

M/L

B

M = Pd, Ni, etc.
Y

X
Y
R'

R'
6

Scheme 1.4: General protocol for redox-neutral aryl cross-coupling.

Among the numerous cross-coupling methods available, the Suzuki reaction is the most
versatile and widely used.45 This protocol utilises boronic acids or esters (5, A =
B(OH)2 or B(OR)2) as the organometallic components and requires a palladium catalyst
in combination with a stoichiometric quantity of a base. The ease of preparation of
boronic acids, combined with their thermal stability, inertness to air and water and
compatibility with a large range of functional groups,48 gives the Suzuki reaction a
broad scope and applicability, encompassing both homogeneous and heterogeneous
conditions.10 The reaction can also be applied on large scale in industry as there are no
toxic by-products.49
6
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The catalytic cycle of the Suzuki reaction45 proceeds via oxidative addition (a) of the
aryl halide to the palladium metal, followed by transmetallation (b), which gives a
diaryl-Pd(II) intermediate 14 (Scheme 1.5). This step requires the presence of a base to
facilitate the formation of a quaternary boronate complex 15, enhancing the
nucleophilicity of the adjacent carbon atom for transfer to palladium.49 Reductive
elimination (c) of the diaryl-Pd(II) species regenerates the Pd(0) catalyst and results in
formation of the biaryl bond.
Ar1-Ar2

(c) reductive elimination

intermediate
diaryl complex

Ar1X

Pd(0)

Ar1-Pd(II)-Ar2

(a) oxidative addition

Ar1-Pd(II)-X

14
(b) transmetallation
Ar1-Pd(II)-OH
Ar2B(OH)2

NaOH

Ar2

OH
B OH
OH
15

NaOH
NaX

(ligand not shown)

Scheme 1.5: Catalytic cycle for the Suzuki reaction with NaOH as the base.45 The usually
obligatory coordinating ligand is not shown.

Although the Suzuki reaction is ubiquitously employed in the synthesis of achiral
biaryls,45,49 the relatively low reactivity of boronic acids renders the efficiency of this
coupling protocol particularly susceptible to steric hindrance. Thus the development of
the asymmetric variant, which involves the coupling of ortho-substituted aryl substrates
(or fused aromatics), has received only limited attention.4,31 Nonetheless, with the recent
development of new chiral ligands and innovative palladium catalysts, the scope and
efficiency of the atropoenantioselective Suzuki reaction has experienced a gradual
improvement. High stereoselectivities and chemical yields are now possible under
relatively mild conditions - including temperatures low enough to avoid racemisation of
chiral biaryls with thermally labile axes.50-55
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1.2.2.2 The Atropoenantioselective Suzuki Reaction
The first enantioselective Suzuki coupling reactions were independently reported in
2000.50,51 In one account, naphthyl phosphonate 16 was coupled with several boronic
acids 17 in the presence of the axially chiral bidentate aminophosphine ligand (P)-18 to
give biaryls 19 in high yields and up to 92% ee (Scheme 1.6).51 The phosphonate
substituent can be easily converted to a dialkyl- or diarylphosphine (eg: PPh2), making
the products useful precursors to chiral monodentate phosphine ligands.

P *

NMe2
PCy2

(P)-18
(0.8-3.3 mol%)
O

P
Br (OR')2
16

+

R
B(OH)2
17

Pd2(dba)3 (1-3 mol%), K3PO4
toluene, 60-80°C, 17-48 h

O
P
* (OR')2
R

19

Yield ee [%]
[%]
(rot.)
Me OEt
93
87 (+)
Et
OEt
96
92 (+)
i-Pr OEt
89
85 (+)
Ph OEt
74
74 (+)
Me OMe
91
84 (+)
R

1
2
3
4
5

OR'

Scheme 1.6: Enantioselective Suzuki coupling of naphthyl phosphonate 16 with boronic acids
17 in the presence of aminophosphine ligand (P)-18.51 The absolute configurations of the
products were not determined.

The planar and centrally chiral aminophosphine-ferrocenyl ligand (R,Sp)-20 has
facilitated the Suzuki coupling of ortho-substituted naphthyl bromides 21 and boronic
acids 22 with moderate to high atropoenantioselectivity (Scheme 1.7).52 A modest
catalytic activity was exhibited, with reaction times of 3-4 days required to achieve
good conversions to the highly sterically hindered products. Notably, both the chemical
yields and optical purities of binaphthyls 23 were found to be dependent on the
palladium source (compare entry 1 with 2 and entry 3 with 4).
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Me2N
*
Ph2P

*
Fe

(R,Sp)-20
12-20 mol%
+

R

R'
B(OH)2

Br
21

22

Pd source 3-10 mol%
CsF, 50-65 oC, 3-4 d

*

R'
R

23

R

R'

Solvent

1 Me
Me
DME
2 Me
Me
DME
3 OBn OBn
THF
4 OBn OBn
THF
5 OMe OMe
THF
6 Me OMe
THF
7 OBn OMe
THF
a
Absolute configuration not determined.

Pd Source
[Pd2(dba)3]·CHCl3
[Pd(NCMe4)](BF4)2
Pd(OAc)2
[Pd2(dba)3]·CHCl3
Pd(OAc)2
[Pd2(dba)3]·CHCl3
[Pd2(dba)3]·CHCl3

Yield ee [%]
[%] (conf.)
85
85 (P)
55
90 (P)
95
60 (P)
50
88 (P)
95
50 (P)
80
73a
93
62a

Scheme 1.7: Enantioselective Suzuki coupling of naphthyl bromides 21 and boronic acids 22 in
the presence of aminophosphine-ferrocenyl ligand (R,Sp)-20.52

An exceptionally active chiral catalyst for sterically encumbered Suzuki reactions has
been realised through the innovative use of (P)-BINAP/Pd nanoparticles,‡ enabling the
room temperature preparation of biaryls such as (M)-25 and 26 in high yields (Scheme
1.8).53 Although the stereoselectivities induced were moderate, this promising approach
has the potential for extention to a range of chiral ligand/palladium nanocatalysts for
future application in asymmetric Suzuki couplings.

‡

The nanoparticles were prepared by the reduction of K2PdCl4 with NaBH4 in the presence of (P)BINAP.53
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B(OH)2
3h

OMe
Br

(P)-BINAP/Pd nanoparticles*
(1.6 nm), 0.1 mol%

M *

OMe

(M)-25
96%, 69% ee

Ph2P
Ph2P

P *

Ba(OH)2, DME/H2O (9:1), RT

24

(P)-BINAP (4)
24 h

B(OH)2

*

OMe

26
89%, 55% ee (absolute configuration
not determined)

Scheme 1.8: Enantioselective room temperature Suzuki coupling of naphthyl bromide 24 with
naphthyl and phenyl boronic acids catalysed by (P)-BINAP/Pd nanoparticles.53

Recently, the highly atropoenantioselective Suzuki coupling of substituted naphthyl
halides and boronic acids was achieved in water using a chiral imidazoindole phosphine
ligand 27 immobilised on a polystyrene-poly(ethyleneglycol) copolymer resin (PSPEG-L*) in the presence of 10 mol% Pd(OAc)2 and TBAF (Scheme 1.9).54 The
protocol exhibited a broad substrate tolerance and the nature of the ortho substituent had
no effect on the asymmetric induction, with consistently high ee’s returned throughout
substrate screening. Advantageously, the catalytic palladium-ligand-polymer complex
could be readily recovered and reused several times with minimal loss of activity and
stereoselectivity.
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O
PS

O

O
HN C (CH2)3

O

N

H
N
PCy2

PS PEG L*
27

Pd(OAc)2 (10 mol%)
PS PEG L* (Pd/P = 1:1)

+

R

R'
B(OH)2

X

R'
R

*

TBAF, H2O, 80 oC, 24 h

22
23

X

a

R

Yield
[%]
Me
95
Me
85
OEt
93
Me
90
OEt
90
Me
61
OMe
70
R'

1 I
Me
2 I
OMe
3 I
Me
4 I
OEt
5 I
OMe
6 Br
COOMe
7 Br P(O)(OEt)2

ee [%]
(conf.)
94 (P)
92 (M)
92 (M)
92 (M)
92 (P)
88 (M)
99a (P)

After crystallisation.

Scheme 1.9: Enantioselective Suzuki coupling of substituted naphthyl halides and boronic acids
in water using a polymer bound chiral imidazoindole phosphine ligand 27.54

This heterogeneous catalyst was also applied to the highly efficient preparation of
axially chiral phenylnaphthalenes 28 (Scheme 1.10), in which further electrophilic
functional groups were tolerated, including a cyano and a nitro group.54
R'

Pd(OAc)2 (10 mol%)
PS PEG L* (Pd/P = 1:1)

+
R
Br

*

n-Bu4NF, H2O, 80 oC, 24 h

R

B(OH)2
R'
28

R
1 Me
2 Me
3 Me
4 NO2
a
Absolute configuration not determined.

Yield ee [%]
[%] (conf.)
H
96
92a
CN
89
92a
COOMe
93
94a
H
96
92 (M)
R'

Scheme 1.10: Preparation of phenylnaphthalenes 28 via atropoenantioselective Suzuki
couplings in water using a polymer bound chiral imidazoindole phosphine ligand 27.54

The highest enantioselectivities reported for Suzuki cross-couplings have been achieved
with the chiral C2-symmetric bis-hydrazone/Pd(II) catalyst 29 (Scheme 1.11).55 Initial
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couplings were performed at 80 oC in toluene with Cs2CO3 as the base, affording
selected biaryls 30-33 in moderate to high yields (up to 99%) with good
stereoselectivities (>75% ee). Reducing the temperature to 20 oC provided an increase
in optical purities, giving complete stereocontrol in the construction of biaryls 31 and 32
(>98% ee), but came at the expense of chemical yields with significantly longer
reactions times required (7 days).
Ph

Ph

N N

N N
Pd

Ph
+

R
21

R'
B(OH)2

Br

Cl

Cl
Ph
29
5 mol%
*

toluene, Cs2CO3

R
R'

Selected Products:

P

*

OMe

M

*

M

*

30

M

*

OMe
Ph

33
31

Product
1
2
3
4
5
6
7

30
30
31
31
32
32
33

32

Temp.
(oC)
80
20
80
20
80
20
20

Time
15 h
7d
14 h
7d
14 h
7d
7d

Yield ee [%]
[%]
(conf.)
99
75 (P)
61
90 (P)
85
89 (M)
53
>98 (M)
64
88 (M)
67
>98 (M)
64
77 (M)

Scheme 1.11: Enantioselective Suzuki coupling of naphthyl bromides with aryl boronic acids
catalysed by a chiral bis-hydrazone/Pd(II) complex 29.55 Note that the top aryl components of
the biaryl products (as drawn) are derived from the arylbromides and the bottom halves from the
boronic acids.

The atropoenantioselectivity in these reactions was proposed to arise from stabilising πstacking interactions between the aryl substrates and two of the (anti) phenyl
substituents of the bis-hydrazone ligand, creating a ‘propeller shaped’ arrangement in
the penultimate diaryl-Pd(II) intermediate (see species 14 in Scheme 1.5).55
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1.2.2.2.1 Current Limitations and Outlook
Despite the clear potential of the asymmetric Suzuki reaction as a powerful and versatile
tool for the atroposelective construction of rotationally constrained biaryls, the most
effective chiral catalysts described remain limited in their application. It appears that the
current examples, which in many cases remain insufficiently enantioselective for
relevant applications, are still restricted to couplings in which at least one of the aryl
moieties is a napthyl substrate. To the best of our knowledge, no examples of the
enantioselective assembly of tetra-ortho-substituted biphenyls (or atropisomers in which
one half of the molecule is a di-ortho-substituted phenyl moiety) have been reported
using this methodology. Extension to heterocyclic biaryls and atropisomers with
structurally diverse substitution patterns has also been largely overlooked.
Furthermore, there is currently no evidence of chiral ligand design specific to the
asymmetric Suzuki reaction and no comprehensive systematic ligand screening studies
have been performed. The ligands described have been identified either by random
screening or as a result of their (previously established) ability to induce central
chirality in other types of palladium catalysed reactions. It is therefore unsurprising that
the ligands have considerable structural variability, containing both C1- and C2symmetric backbones with the elements of axial, central and/or planar chirality.50-55
Although all the ligands are bidentate, they vary from dinitrogen and diphosphine
systems to molecules containing a mixture of both coordinating heteroatoms, with
abilities to form from five- to seven-membered rings with palladium. A general set of
structural features required to control the stereoselectively of Suzuki reactions is
therefore clearly absent. In addition, with the exception of the bis-hydrazone catalyst 29,
no attempts have been made to rationalise the stereochemical outcomes from a
mechanistic perspective, which clearly inhibits further developments of these lead chiral
ligands.
It should also be noted that the coupling conditions used with each ligand (see Schemes
1.6-1.11) were in most cases established after extensive reaction optimisation studies,
including solvent, base, temperature, palladium source and ligand/palladium ratio
variations. It was also found that in some cases the optimal coupling conditions were
substrate dependent, for example with the aminophosphine-ferrocenyl ligand 20 (see
13
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Scheme 1.7). This usual requirement to perform these potentially laborious and (often)
unpredictable optimisation processes has undoubtedly contributed to the limited
application of the atropoenantioselective Suzuki reaction in the synthesis of biologically
or synthetically useful axially chiral biaryls to date.

1.3 Research Program Aims
Given the current limitations and existing drawbacks of the asymmetric Suzuki coupling
strategy, combined with the lack of insight into the current mechanisms of stereocontrol,
a strong need remains for new chiral ligands to be designed for screening in these
reactions. A rational design approach would significantly aid the development of a more
general and reliable ligand/palladium catalyst system that provides stereocontrol for the
coupling of a structurally and functionally diverse array of aryl substrates across a wide
range of conditions.
Therefore, we are interested in the following research areas:
1. The design and development of new chiral ligands for atropoenantioselective
Suzuki coupling reactions.
2. The stereoselective synthesis of new chiral ligands.
3. The synthesis and characterisation of new chiral palladium complexes.
4. The screening of these complexes as chiral catalysts for atropoenantioselective
Suzuki reactions.
5. The application of this methodology to the synthesis of biologically and
synthetically important axially chiral biaryl compounds.
6. Further screening of our chiral ligands in a range of transition metal catalysed aryl
homo- and cross-coupling protocols.
A computational modelling component of this research program is also being
undertaken in collaboration with Professor Tim Clark (University of ErlangenNuremberg, Germany), to aid the design and development of new chiral ligands.
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1.3.1 Ligand Design
Given the sterically demanding nature of the atropoenantioselective Suzuki crosscoupling, asymmetric induction in such reactions needs to be mediated by a
complementary or stabilising interaction between the aryl moieties and the chiral
catalyst, as opposed to a direct steric intrusion by the ligand, in order to avoid
compromising the chemical yield. In the catalytic cycle (see Scheme 1.5), the
penultimate intermediate 34 in which both aryl groups are bound to the palladium in a
cis arrangement with the bidentate chiral ligand (L*) is the key structure upon which
ligand design should be focused (Scheme 1.12).
B Y
A

Pd

Reductive Elimination

X

L*

A
X

*

B
Y

L* = chiral ligand
1a

34

Scheme 1.12: The diaryl-Pd(II) intermediate 34, which should be reduced to give the
atropisomer in a stereoselective fashion when a chiral ligand (L*) is bound.

A unique approach to chiral ligand design is to utilise the helicity of the atropisomeric
biaryl. Viewed from the highest priority substituent on the distal ring to that of the
proximal ring, a rotationally hindered biaryl can be considered to have a helical sense or
a twist (Figure 1.3). Accordingly, the assignment of P and M stereochemistry to the
biaryl axis4 is the same assignment as that given to helices.

*

*

Figure 1.3: The helical aspect of atropisomeric biaryls.

A pair of enantiomeric atropisomers have opposite helical senses and their steric
interactions with a fixed helical structure will thus differ. To demonstrate this, Figure
1.4 shows a cartoon representing a pair of enantiomeric biaryls A and B inserted into the
groove of a right-handed helix. Atropisomer A can be positioned with its larger ortho-
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substituted directed outward while in contrast, the substituents of atropisomer B
experience steric clashing with the helix.
Interaction of Atropisomer A

Interaction of Atropisomer B

Figure 1.4: Cartoon representation of the differing steric interactions of a pair of enantiomeric
atropisomers A and B with a right-handed helix.

It is well known that the ‘tongue in groove’ intermeshing of helices with opposite
handedness is a manifestation of chiral recognition.56 Therefore, constructing axially
chiral biaryls in optically pure form should also be possible using helical sense
discriminations. Given that all biaryls have a helical sense, this mode of chiral
discrimination should have a wide applicability without being restricted to specific
substitution patterns.
To apply this concept to the Suzuki reaction, a palladium catalyst which contains a
ligand that is helical should serve as a ‘guiding template’ for atropoenantioselective
biaryl formation. Enantioselectivity should arise through a complementary ‘tongue in
groove’ intermeshing of the aryl substrates with the chiral ligand in the key intermediate
complex 34. With this stereochemical array, the larger ortho substituents would be
directed away from the catalyst, thus minimising steric interactions. The (inverted)
helicity of the ligand will be transferred to the biaryl after reductive elimination,
forming the chiral axis in a stereoselective fashion.
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1.3.2 Ligand Structure and Targets
The following ligand structural features are expected to be required to induce selectively
in the Suzuki coupling reaction based on helical sense discrimination:†
1. The ligand should have C2-symmetry (as does a helix).
2. The ligand should be bidentate.
3. The ligand should contain two attached stereogenic carbon atoms‡ directly between
the coordinating heteroatoms to create a central helical twist in close proximity to
the palladium metal.
4. The coordinating heteroatoms should be incorporated into ring systems to minimise
steric hindrance around the palladium metal.

These structural features can be observed in our first generation of helical ligands
encompassed by 35 and 36 (Figure 1.5). Although depicted in the S,S configurations,
the R,R enantiomers will create helices of the opposite handedness when palladium
bound, enabling access to both atropisomers of a given biaryl. An additional design
feature of these structures is that the coordinated metal will be situated within the helical
ligand groove, as opposed to other commonly used ligands such as BINAP where the
chiral twist is remote from the reaction site.
Central helical twist
close to the binding site

Donor atoms
incorporated
into rings

X
X
R R
(S,S)-35
C2-symmetrical

X
X
R
R
(S,S)-36
Bidentate

Two attached
stereogenic
carbon atoms
X = N, P, As
R = H, Me, Et, Ph, Cy, etc.

Figure 1.5: Our first generation of synthetic target ligands which contain the necessary
structural features to form a helical twist when coordinated to palladium.

In accordance with current precedents, the specific target ligands to be synthesised
include the dinitrogen and diphosphine versions of each structure as well as the mixed
heteroatom systems (X = N, P or both). The preparation of each of these heterocycles
†

The chiral ligands currently used for Suzuki couplings do not adhere to all of these design principles.
Alternatively, the required helical twist could be induced by a stereogenic biaryl axis. Therefore, we are
also interested in ligands containing this element of chirality.
‡
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with a variety of alkyl or aryl substituents (R) will provide an array of compounds for
chiral ligand screening. It should also be noted that although palladium catalysts
supported by arsine ligands have proven to be efficient for promoting Suzuki
reactions,57 no attention has been given to extension of their application to asymmetric
cross-couplings. Therefore, we aim to additionally investigate the preparation and
application of the arsenic analogues of our chiral scaffolds.
The helical groove depth, degree of twist and catalytic activity of these ligands could be
further modulated by variations in the heterocyclic ring sizes and/or by aromatic
substitution - including the fusion of additional rings at various junctions. It would
therefore be ideal to identify synthetic strategies towards structures 35 and 36 that not
only fulfil the requirement of being highly stereoselective for both the desired
enantiomers but allow articulation to produce different ring sizes, fused ring structures
and an array of substituted ligands.
An additional consideration is that the phosphorus and arsenic atoms in these structures
are stereogenic and thus constitute additional elements of central chirality. Therefore,
devising stereoselective synthetic strategies toward the target molecules containing
these heteroatoms is anticipated to be more challenging than the preparation of their
(parent) nitrogen analogues 2,2'-bipyrrolidine 37 and 2,2'-biindoline 38 (Figure 1.6),
which will be the subjects of primary investigations.

N
N
H
H
(S,S)-37

N
N
H
H
(S,S)-38

Figure 1.6: The dinitrogen target ligands shown in their parent form.

1.3.2.1 Previous Results from our Laboratory
Although the 2,2'-bipyrrolidine ligand 37‡ has been prepared previously from chiral
precursors58,59 or by dimerisation/resolution,60 we require a more versatile synthetic
strategy that can accommodate the aforementioned potential modifications of the
scaffold. Therefore, a new synthetic strategy was recently developed in our laboratory61
‡

To the best of our knowledge, this ligand (or any N-substituted derivatives) has not been tested in
stereoselective Suzuki coupling reactions.
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using self-metathesis62 and Sharpless Asymmetric Dihydroxylation (AD)1 reactions as
the key steps (Scheme 1.13) - the latter being used for introduction of the stereogenic
elements.‡ This approach offered several advantages as a general strategy including the
potential to use a range of alkenes in the metathesis, thus leading towards the production
of numerous C2-symmetric systems with different ring sizes, substitutions and fused
frameworks.
(ii) metathesis

R1O

E:Z, 78:22

PMBO

OPMB

(iii) Sharpless AD

40

1

R =H
R1 = PMB 39

(i) benzylation

R1

NHBoc
OPMB

PMBO

(vii) debenzylation

RO

R1
(iv) mesylation

OR2

2

NHBoc
R1 = OH (R,R)-41
R1 = OMs

(viii) mesylation

R2 = H 42
R2 = Ms

(v) azidation
(vi) reduction/
protection

R1 = N3
R1 = NHBoc

(ix) cyclisation
N
N
Boc
Boc
(S,S)-43

Scheme 1.13: Stereoselective synthesis of the protected chiral 2,2'-bipyrrolidine 43 previously
established in our laboratory.61 Selected results for the (S,S)-enantiomer, reagents and
conditions: i. a) NaH, THF, 0 °C. b) PMBBr, 0 °C to RT, 4 h, 73%. ii. 2.5 mol% Grubbs’ 1,
CH2Cl2, reflux, 20 h, 86%, E:Z, 78:22. iii. ADmix β, CH3SO2NH2, t-BuOH:H2O (1:1), 0 °C to
RT, 65 h, 98%, 88% ee. iv. MsCl, NEt3, CH2Cl2, 0 °C to RT, 25 min, 95%. v. NaN3, DMF, 80
°C, 18 h, 76%. vi. a) H2(g), Pd/C, EtOH, RT, 2 h, 100%. b) Boc2O, NEt3, Et2O, 35 °C, 15 h,
75%. vii. H2(g), Pd/C, EtOH, RT, 5 h, 95%. viii. MsCl, NEt3, CH2Cl2, 0 °C to RT, 10 min, 76%.
ix. NaH, DMF, 0 °C to RT, 3 h, 76%, (S,S)-43 [α]23
= -43.7, Lit.58 [α]23
= -40.6.
D
D

An outstanding problem with this particular synthesis however was the insufficient
stereoselectivity of the metathesis reaction for the desired trans alkene 40 (E:Z, 78:22),
which lead to further complications due to the inseparability of the geometric isomers.61
Therefore, before application of this metathesis/Sharpless AD strategy to further ligand
targets, this problem needed to be addressed.

‡

The final steps of the sequence from diol 42 have been previously published.58
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1.3.3 Thesis Aims
A new ligand design paradigm for the control of axial chirality in sterically hindered
Suzuki reactions has been presented based on helical discrimination. In order to
investigate this concept, an array of new helical ligands will be required for screening.
Therefore, a key component of this research program is the development of efficient
synthetic strategies towards the ligands encompassed by our first generation of target
scaffolds (see Figures 1.5 and 1.6) which are not only highly stereoselective but are also
adaptable to a range of structural alterations.

Therefore, the aims of this thesis were:
1. To improve the stereochemical efficiency of our previously established synthesis of
2,2'-bipyrrolidine.‡
2. To develop a stereoselective synthesis of 2,2'-biindoline using a strategy adaptable
to other chiral ligands.
3. To investigate a synthetic strategy towards the phosphorus and arsenic analogues of
2,2'-bipyrrolidine and -biindoline.
4. To investigate the preparation and characterisation of transition metal complexes of
these ligands and access their performance as new helical catalysts for
atroposelective aryl couplings processes - primarily the Suzuki reaction.

‡

After the completion of laboratory work in this project, both enantiomers of the parent 2,2'-bipyrrolidine
became commercially available from Sigma-Aldrich - prepared via racemic dimerisation and
resolution.60
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The Investigation of Methods to Improve the Stereochemical
Efficiency of our Previously Developed Synthesis of 2,2'-Bipyrrolidine

A new synthetic strategy towards both enantiomers of the first target ligand 2,2'bipyrrolidine 37 was previously developed in our laboratory using metathesis and
Sharpless AD reactions as the key steps (see Chapter 1, Section 1.3.2.1).61 However, a
drawback of this sequence was that the metathesis reaction resulted in insufficient
selectivity for the desired trans isomer.‡ In addition, the cis and trans isomers were
inseparable, which meant that the Sharpless AD reaction had to be performed on the
geometrical mixture, resulting in contamination of the chiral compound with the (again
inseparable) meso diastereomer (~20%).
In light of these outstanding problems, methods to improve the stereochemical
efficiency of this synthetic strategy were investigated in this thesis and included:
1. The attempted optimisation of the metathesis stereoselectivity using Grubbs’ 2
catalyst in combination with 1,4-benzoquinone.
2. The removal of the meso isomer by conversion of the diastereomers into
chromatographically separable cyclic sulfites.
3. The synthesis of the trans alkene using alternative routes, including:
3a. The chain lengthening of (2E)-1,4-dibromo-2-butene.
3b. The trans selective Wittig reaction.

2.1 Attempted Optimisation of the Metathesis Stereoselectivity
Despite metathesis now being a standard synthetic method for the redistribution of
carbon-carbon double bonds, no general protocols currently exist for controlling the
stereoselectivity of intermolecular metathesis.62 Different catalysts however offer
varying degrees of selectivity based on their reactivity. In general, more active catalysts
deliver higher trans selectivity.63 For instance, Grubbs’ 2nd generation ruthenium
catalyst is generally more active than its predecessor owing to the replacement of one of
‡

The optimum E:Z ratio obtained using Grubbs’ 1 catalyst was 80:20.61
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the phosphine ligands of Grubbs’ 1 with a sterically bulky and strongly σ-donating
carbene moiety (Figure 2.1).64

PCy3 Ph
Cl
Ru
Cl
PCy3

Mes N

N Mes
Ph
Cl
Ru
Cl
PCy3

Mes =

Grubbs' 2

Grubbs' 1

Figure 2.1: Grubbs’ 1st and 2nd generation catalysts.

The enhanced reactivity of Grubbs’ 2 catalyst, coupled with its longer catalytic lifetime,
can facilitate isomerisation of the more sterically accessible cis product leading to
higher trans selectivities in intermolecular metathesis.65 However, a previous attempt in
our laboratory to synthesise alkene 40 with this catalyst resulted in a mixture of
chromatographically inseparable non-symmetrical alkenes (Scheme 2.1).61
5 mol% Grubbs' 2
CH2Cl2, reflux, 72 h
OPMB
39

X
mixture of nonsymmetrical alkenes

OPMB

PMBO
40

Scheme 2.1: Previously attempted synthesis of alkene 40 with Grubbs’ 2 catalyst performed in
our laboratory which resulted in a mixture of non-symmetrical alkenes.61

It is well documented that double bond migration/isomerisation can interfere with olefin
metathesis as an undesired side reaction giving alkenes that can themselves participate
in metathesis, leading to a range of products.66-68 Ruthenium hydride complexes, formed
from the decomposition of Grubbs’ catalysts, are believed to be responsible for
catalysing these processes.69 As such, the addition of a catalytic quantity of a hydride
scavenger such as 1,4-benzoquinone has been found to suppress this problem.69
In order to investigate the effect of a hydride scavenger in this project, a new supply of
the metathesis substrate was required. Therefore, 4-penten-1-ol was protected with a
PMB group to give the required alkene 39 in 82% yield under the established
conditions.61 Subsequent self metathesis using 5 mol% Grubbs’ 2 with 10 mol% 1,4benzoquinone69 gave octene 40 in 61% yield after column chromatography, with minor
unidentified impurities present (Scheme 2.2).
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5 mol% Grubbs' 2
10 mol% 1,4-benzoquinone
CH2Cl2, reflux, 24 h

OPMB

H3
OPMB

PMBO

61%, E:Z ~80:20

39

40

H6

Scheme 2.2: Synthesis of alkene 40 with Grubbs’ 2 catalyst and 1,4-benzoquinone as a hydride
scavenger.

In previous work in our laboratory,61 the stereochemical purity of alkene 40 was
determined by integral analysis of the 1H NMR spectrum, in which the cis and trans
signals from the methylene protons adjacent to the π bond (H3 and H6) were resolved.
In this case, this region was slightly obscured by minor impurities. Therefore, the ratio
of the geometric isomers was estimated at 80:20 (E:Z) by comparison of the heights of
analogous peaks in the 13C NMR spectrum.
The primary catalytic cycle of the ruthenium catalysed self metathesis of alkene 39 is
illustrated in Scheme 2.3.70 Entry into the cycle occurs after dissociation of the
phosphine ligand and the release of styrene (see Figure 2.1 for the structure of Grubbs’
2).71 The other ligands (not shown) remain bound and do not participate directly. In
essence, the cycle precedes via a series of reversible cycloaddition/reversion steps,
setting up a complex equilibrium which is shifted towards alkene 40 by the evolution of
ethene gas.70 Once formed, the product continues to react, changing the E:Z ratio until
thermodynamic equilibrium is reached.69
R
39

Ru

Ru
R = (CH2)3OPMB

R
R
40

Primary Cycle

R

H2C CH2

(g)

Ph
Ru
R

Ru
R

R
39

R

Ph

Ph

Ru
R

Ru
R
39

Scheme 2.3: The ruthenium catalysed self metathesis of alkene 39 to give octene 40 driven by
the evolution of ethene gas.70 The spectator ligands are emitted from ruthenium for clarity.

Clearly, the addition of 1,4-benzoquinone to the Grubbs’ 2 metathesis of alkene 39
improved the outcome to that previously observed in our laboratory with this catalyst
(see Scheme 2.1), however this modified system was still overall inferior to the result
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obtained using Grubbs’ 1 (see Chapter 1, Scheme 1.13).61 Although other hydride
scavengers in conjuction with Grubbs’ 2 could have been investigated,69 it was thought
that returning to the use of Grubbs’ 1 and establishing a method to remove the meso
isomer after the Sharpless AD reaction could be a more efficient approach.

2.2 Removal of the Meso Isomer by Conversion to Cyclic Sulfites
Self metathesis of alkene 39 using Grubbs’ 1 catalyst was thus carried out as previously
described,61 giving octene 40 in 88% yield with an E:Z ratio of 80:20 (Scheme 2.4). It
was then proposed that in order to remove the meso isomer from the desired chiral
product after subsequent Sharpless AD, converting the chiral- and meso-diols 41 into
cyclic sulfites 44 would render the diastereomers separable by column chromatography.
The pure chiral sulfites could then be hydrolysed back to the required diol enantiomers.†
Accordingly, Sharpless AD of alkene 40 was performed with both ADmixes.1
Treatment of the crude diols 41 with SOCl2/NEt3 furnished the cyclic sulfites 44 as
diastereomeric mixtures which were subjected to column chromatography, affording
sulfite (S,S)-44 in 50% yield and (R,R)-44 in 47% yield (62% and 58% yields
respectively based on the conversion of the trans isomer). In the case of sulfite (R,R)44, a 1:1 mixture (11%) of the sulfite diastereomers and a portion of the pure mesosulfite (14%) were sequentially eluted after the chiral compound, giving a 72% overall
yield.‡

†

It might appear that a shorter synthetic route to 2,2'-bipyrrolidine (that avoids hydrolysis back to the
diol) could be realised by introducing the required nitrogens by a double nucleophilic displacement of the
cyclic sulfate with the azide anion (see also Chapter 1, Scheme 1.13). However, this is unlikely to occur
due to the high pKa of the intermediate alkyl sulfate, rendering it a poor leaving group for the second
intermolecular substitution.72
‡
Fractions from the ‘S,S chromatography column’ containing the meso isomer were not concentrated.
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OPMB
39
5 mol% Grubbs' 1
CH2Cl2, reflux, 21 h
PMBO
ADmix α, CH3SO2NH2
t-BuOH:H2O (1:1)
0 oC to RT, 17 h

88%
E:Z, 80:20
OPMB
40

ADmix β, CH3SO2NH2
t-BuOH:H2O (1:1)
0 oC to RT, 17 h
OH

OH
OPMB

PMBO

OH
(R,R)- & meso-41
(crude)

OH
(S,S)- & meso-41
(crude)
(i) SOCl2, NEt3, CH2Cl2
0 oC to RT, 72 h
(ii) chromatographic
separation

meso 44
+
mixture of
(S,S)- & meso-44

O
PMBO

OPMB

PMBO

O
S

O

meso-44 (14%)
+
mixture of
(R,R)- & meso-44
(11%,1:1)

O

OPMB
(S,S)-44
50% (2 steps)

PMBO

O
S

O

OPMB
(R,R)-44
47% (2 steps)

NaOMe, MeOH
RT, 116 h
OH

OH
OPMB

PMBO
OH
(S,S)-41
69%, 96% ee

OPMB

PMBO
OH
(R,R)-41
77%, 68% ee

Scheme 2.4: Removal of the meso diastereomer via conversion of the diols 41 to their
corresponding cyclic sulfites 44, chromatographic separation of the diastereomers and
subsequent hydrolysis back to the chiral diols.

Although only a single meso isomer was isolated, there are two meso diastereomers 44a
and 44b that could be formed after introduction of the stereogenic trigonal pyramidal
sulfite moiety (Figure 2.2).73 Additionally, this stereogenic atom destroys the axial
symmetry present in chiral diol 41, which renders the methine protons inequivalent in
sulfites (S,S)- and (R,R)-44. As such, the chiral sulfites were identified by NMR
spectroscopy based on the appearance of two distinct multiplets at 4.07 ppm and 4.60
ppm assigned to the methine protons. There is no simple spectroscopic means of
discriminating between the two meso compounds and, given that this was of little
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importance, the absolute configuration of the isolated meso compound was not
determined.
O
S
O
O
H
PMBO
H
chiral-(R,R)-44

S
O
O
OPMB

H
H

O

O
OPMB
OPMB

meso-44a

S
O
O

H
H

OPMB
OPMB

meso-44b

Figure 2.2: The possible cyclic sulfite diastereomers 44 formed via reaction of diols (R,R)- and
meso-41 with SOCl2.

Finally, removal of the sulfite moiety using NaOMe in MeOH74 provided diols (R,R)-41
(77%) and (S,S)-41 (69%) in enantiomeric excesses of 68% and 96% respectively, as
determined by chiral HPLC analysis (Scheme 2.4).† Considering that this sequence was
performed on a small scale and that the remainder of the 2,2'-bipyrrolidine synthesis
from these intermediates had already been established in our laboratory,61 these diols
were not further elaborated.

2.3 Alternative Synthetic Routes to (4E)-1,8-Di(benzyloxy)-4-octene
Given that the stereochemical outcome of intermolecular metathesis is governed by the
thermodynamic equilibrium between the geometric isomers, deleterious amounts of the
unwanted cis isomer are always likely to form when preparing straight chain 1,2-dialkyl
substituted systems.61,65,69 Clearly, our chiral synthesis of 2,2'-bipyrrolidine would be
more efficient if the inseparable cis alkene was not produced in the first instance.
Therefore, alternative methods to synthesise the alkene in the trans form were
investigated.‡

2.3.1 Attempted Chain Lengthening of (2E)-1,4-Dibromo-2-butene
There is one example of the commercially available (2E)-1,4-dibromo-2-butene being
used as a building block for chain lengthening, in which its reaction with
†

This in agreement with previous results from our laboratory (diol (R,R)-41: 70% ee, diol (S,S)-41: 98%
ee).61 A more acceptable selectivity for the (R,R)-diol has been achieved with a longer reaction time (65
h), giving the diol in a higher yield (98%) and optical purity (88% ee) - see Chapter 1, Scheme 1.13.
‡
In these investigations the benzyl protecting group was used (as opposed to PMB) because the required
precursors were commercially available. The 2,2'-bipyrrolidine synthesis has also been completed
previously in our laboratory using this protecting group, in which the same (inadequate) level of trans
stereoselectivity resulted in the metathesis.61

26

CHAPTER 2

Improvement of our 2,2'-Bipyrrolidine Synthesis

allylmagnesium bromide gave (5E)-1,5,9-decatriene in 50% yield.75 As such, it was
proposed that an analogous double addition of Grignard 45 (or its cuprate derivative)
should yield the desired alkene 46 with the trans configuration preserved (Scheme 2.5).
Br

Br

+

MgBr

2 x BnO

(CuX)

OBn

BnO
46

45

Scheme 2.5: Proposed chain lengthening of (2E)-1,4-dibromo-2-butene with Grignard 45 to
give alkene (E)-46.

Therefore, a mixture of benzyl 2-bromoethyl ether and magnesium turnings in THF was
stirred at room temperature for 1 h, producing a clear, grey homogenous solution
(Scheme 2.6). After addition to a solution of (2E)-1,4-dibromo-2-butene in THF, the
mixture was stirred at room temperature for 18 h. The crude oil obtained upon work-up
was found to contain, by NMR analysis, benzyl alcohol and butane 4776 as the sole
products with relative yields of 74% and 26% respectively.
(i) Mg, THF, RT, 1 h
(ii) 0.5 eq. (2E)-1,4-dibromo-2-butene
RT, 18 h
BnO

Br

X

OBn

BnO

BnOH
74%

46
+

BnO

OBn
47
26%

Scheme 2.6: Outcome of the attempted chain lengthening of (2E)-1,4-dibromo-2-butene, giving
a mixture of Grignard decomposition products after work-up. Relative yields are shown and
were determined by 1H NMR analysis of the crude mixture.

Evidence in support of the successful formation of Grignard 45 had been provided by
complete consumption of the magnesium turnings. Therefore it was believed that the
Grignard had decomposed before addition to the electrophile. To confirm this suspicion,
a repeat experiment was performed in which the Grignard formation was allowed to
proceed at room temperature until all of the magnesium was consumed (~30 min) and
then the solution was immediately quenched with water. The crude material was again
found to contain benzyl alcohol and butane 47 as the only constituents, without any
evidence of the Grignard hydrolysis product (benzyloxyethane).
A plausible mechanism for the Grignard decomposition is shown in Scheme 2.7. After
the traditional mode of oxidative magnesium insertion via the radical intermediate 48,77
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Grignard 45 could break down to release ethene gas and benzyloxymagnesium bromide
in an analogous fashion to the activation of magnesium by entrainment with 1,2dibromoethane.77 Quenching the magnesium salt during work-up would form benzyl
alcohol.
Br Mg

BnO

Rate
Determining

BnO
48

BnOMgBr

H2O

MgBr

BnO

MgBr

45

BnOH

H2C=CH2(g)

Scheme 2.7: Proposed mechanism of the decomposition of Grignard 45 to give benzyl alcohol
accompanied by the evolution of ethene gas.

The dimerisation product observed (butane 47) could arise from either of two pathways
(Scheme 2.8). Path 1 would involve the alkylation of Grignard 45 with the starting
halide and is analogous to the traditional Würtz coupling of alkyl halides with sodium
metal.78 This pathway would also produce MgBr2 which can act as an activator for
further Grignard formation.77 Alternatively, path 2 would involve the radical homocoupling of the Grignard intermediate 48. In general, for alkyl halides, this path is
unlikely to be a significant contributor to dimerisation given that the radical
intermediates formed after the rate determining step in Grignard formation are
insufficiently stable to survive long enough to depart (to any significant extent) from the
magnesium surface.77

1)

Br

BnO
MgBr

BnO

- MgBr2

45
BnO

OBn
47

OBn

2) BnO
48

48

Scheme 2.8: Possible pathways leading to butane 47 involving 1) alkylation of Grignard 45
with the starting halide or 2) radical homo-coupling of the Grignard intermediate 48.

Therefore, if path 1 is viable, the half life of Grignard 45 must be sufficient for
intermolecular reaction with an electrophile to be a competing process to
decomposition. One way to test this hypothesis would be to substitute the alkyl bromide
precursor for its corresponding chloride, thus minimising consumption of the Grignard
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through path 1 leading to a reduced yield of butane 47. Nonetheless, regardless of the
halide precursor, for Grignard 45 to have any practical value, a large excess would be
required to account for decomposition and most importantly, the required electrophile
would need to be present from the onset of Grignard formation to allow for a potential
reaction to occur. Inherently, this brings about a severe limitation in that the electrophile
must be compatible with magnesium. As such, this would not be a remedy for the
proposed chain lengthening as the alkene contains allylic bromines which have a high
reduction potential.77

2.3.2 The Trans Selective Wittig Reaction
With the Schlosser modification of the traditional Wittig reaction, the synthesis of 1,2disubstitued alkenes can be achieved with exceptional trans selectivity (>99.5% E).79,80
As such, the synthesis of alkene (E)-46 was proposed using this methodology via the
route shown in Scheme 2.9.
O

BnO

E selective
Wittig

49
BnO

OH

OBn

BnO
46
R

BnO
R = Br 50

R = PPh3Br 51

Scheme 2.9: Proposed synthesis of alkene (E)-46 using trans selective Wittig chemistry.

2.3.2.1 Synthesis of 4-Benzyloxybutanal
The oxidation of 4-benzyloxy-1-butanol to aldehyde 49 has been reported using
standard reagents including PCC81 and DMP.82 In our hands, the reaction with PCC
(Scheme 2.10) gave similar conversions to that reported (~60%) but with
chromatographically difficult to separate side products which lowered the isolated yield
of the pure material (47%). A much cleaner and efficient oxidation was achieved using
DMP, giving aldehyde 49 in 86% yield.
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PCC, CH2Cl2
RT, 4h
47%
BnO

OH
DMP, CH2Cl2
RT, 15 min
86%

O

BnO
49

Scheme 2.10: The oxidation of 4-benzyloxy-1-butanol to aldehyde 49 using PCC81 and DMP.82

2.3.2.2 Synthesis of 4-Benzyloxybutyltriphenylphosphonium Halides
Although bromide 50 is commercially available, analysis of the NMR spectra of a
sample obtained from Sigma-Aldrich indicated a number of impurities. Therefore,
spectrochemically pure material was obtained in good yield (82%) by mesylation of 4benzyloxy-1-butanol and subsequent nucleophilic bromination with LiBr (Scheme
2.11). The synthesis of phosphonium bromide 51 was subsequently attempted under the
reported conditions.83 The reaction was monitored by TLC analysis and proved to be
extremely slow, requiring 100 h for a significant amount of the starting materials to be
consumed. After cooling the mixture, the resulting white precipitate was found to be a
mixture of the desired butylphosphonium bromide 51 (36%) and benzylphosphonium
bromide 52 (46%).

BnO

(i) MsCl, NEt3
CH2Cl2
0 oC to RT, 30 min
(ii) LiBr, THF
RT, 72 h
OH
82%

PPh3
xylenes
reflux
Br 100 h

BnO

PPh3Br

BnO

51, 36%
+

(mixture)

50
BnPPh3Br
52, 46%

Scheme 2.11: The attempted synthesis of butylphosphonium bromide 51 under the reported
conditions,83 giving unexpectedly a mixture of the desired product and benzylphosphonium
bromide 52. The percentages refer to chemical yields, not to mixture composition.

The synthesis of butylphosphonium bromide 51 has been reported in 87% yield under
these conditions without the formation of benzylphosphonium bromide 52 as a side
product.83 Therefore, the outcome of this reaction was unexpected.
A suggested mechanism for the formation of the benzyl salt is shown in Scheme 2.12.
Direct SN2 attack by PPh3 at the benzylic position of bromide 50 would form
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phosphonium oxide 53 which could rearrange to displace the bromide ion via an SN2
cyclisation, giving the observed major product 52 and a molecule of THF.
PPh3
Br

O

Br

PPh3 O

-THF
PPh3Br

53

50

52

Scheme 2.12: Suggested mechanism for the formation of benzylphosphonium bromide 52
during the reaction of PPh3 with bromide 50.

The poor regioselectivity of SN2 PPh3 attack is presumably due to the fact that benzylic
carbons can undergo SN2 reactions at faster rates than primary alkyl (non-methyl)
substrates,84 although the butoxide appendage would be a poorer leaving group than the
bromide ion produced if attack occurred at the terminal carbon. These opposing factors
may have lead to similar transition state energies for both positions of attack,
consequently producing the mixture of products observed.
In the

13

C NMR spectrum of the desired phosphonium bromide 51, the carbon-

phosphorus coupling constant experienced by the peak assigned to C3 (29.6 ppm, 3JC-P =
17.0 Hz), was unexpectedly larger than that assigned to C2 (18.8 ppm, 2JC-P = 4.0 Hz)
(Figure 2.3).‡ The assignment of C3 was based on its correlation in the gHSQC
spectrum to a pentet at 1.75 ppm assigned to H3 (3JH-H = 6.0 Hz). The assignment of H3
was inturn confirmed by the gCOSY spectrum, which showed a correlation to a triplet
at 3.48 ppm assigned to H4 (3JH-H = 6.0 Hz).
1

3 2 1 PPh3Br
BnO 4
51

JC-P = 50.2 Hz
JC-P = 4.0 Hz
3
JC-P = 17.0 Hz
4
JC-P = 0.0 Hz
2

Figure 2.3: The carbon-phosphorus coupling constants for the alkyl chain of phosphonium
bromide 51 in which 3JC-P (17.0 Hz) was unexpectedly larger than 2JC-P (4.0 Hz).

Due to the competing formation of benzylphosphonium bromide 52, an insufficient
quantity of the desired salt 51 had been obtained. Therefore, attempts were made to
optimise the reaction conditions to favour the formation of the butyl salt and ideally
eliminate the side product. In addition, iodide 54 was prepared from 4-benzyloxy-1‡

No spectral data has been reported for phosphonium bromide 51.83,85,86 The same coupling pattern was
also observed for the corresponding phosphonium iodide (synthesised later) for which again no 13C NMR
data has been reported.87-89
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butanol as previously described (Scheme 2.13),90 in order to determine the effect of a
better leaving group on the regioselectivity.
OH

BnO

PPh3 imidazole, I2
toluene, 0 oC to RT, 2h
94%

I

BnO
54

Scheme 2.13: The synthesis of iodide 54 from 4-benzyloxy-1-butanol as previously described.90

The results from the reactions of bromide 50 and iodide 54 with PPh3 under various
conditions are presented in Scheme 2.14.

BnO

X

1 eq. PPh3

55

PPh3X

BnO

+

56

BnPPh3X
57

Time
Yield (%)a
Temp.
(h)
56
57
1b Br 50 51 52 xylenes 100 reflux 36
46
2 Br
toluene
6
reflux 21
5
3 Br
CH3CN 164 reflux 71
20
4c I 54 58 - benzene
21
reflux 44
5
I
toluene 158 80 °C 74
a
1
b
Yields determined by H NMR analysis of the salt mixture. This reaction was presented
previously in Scheme 2.11. cReported conditions: 1.0 eq. PPh3, benzene, reflux, 4 h, 88%.87
X

55 56 57

Solvent

Scheme 2.14: Results of the reactions of PPh3 with bromide 50 and iodide 54 under various
conditions.

Decreasing the reflux temperature from the reported conditions (xylenes, entry 1)83 by
using toluene as the solvent (entry 2) had the desired effect on the regioselectivity,
giving the butylphosphonium bromide 51 as the major product. The reaction was still
slow however with only 21% of the desired product isolated after 6 h. Deleterious
quantities of the benzyl by-product 57 also persisted (5%). A further decrease of the
reaction temperature in a polar solvent (CH3CN, entry 3) gave a similar product
distribution and resulted in a good conversion to butylphosphonium bromide 51 (71%)
provided a long reaction time was used (164 h).
The synthesis of butylphosphonium iodide 58 was attempted as previously described
(entry 4).87 After the reported 4 h,‡ only a small quantity of precipitate was observed
and TLC analysis confirmed the reaction was incomplete. The reaction was thus
allowed to proceed for 21 h after which time 44% of the product was isolated with none

‡

An 88% yield of phosphonium iodide 58 was reported after this reaction time.87
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of the benzylphosphonium salt 57 detected by NMR analysis. Given that no
regioselectivity problems had been encountered, the reaction was repeated (entry 5) for
an extended period (158 h) in a less noxious solvent (toluene) to give 74% of the desired
salt.
2.3.2.2.1 Separation of 4-Benzyloxybutyl- and Benzyltriphenylphosphonium
Bromide
While a batch of phosphonium iodide 58 was now available, the corresponding bromide
salt 51 still remained to be separated from benzylphosphonium bromide 52. An earlier
attempt to selectively crystallise either salt from acetonitrile had been unsuccessful.
Therefore, attention was turned towards separating the salts by selective hydrolysis.91-94
The mixture obtained from the reaction with acetonitrile (Scheme 2.14, entry 3) was
utilised for this investigation and the results of this overall sequence are given in
Scheme 2.15.

BnO

PPh3
CH3CN
reflux
Br 164 h

BnO

PPh3Br
51, 71%
+

(mixture)

50
BnPPh3Br
52, 20%

(i) KOH(aq), THF
RT, 3.5 h
(ii) HBr(aq)
47% overall
(67% recovery)

PPh3Br
51
+
(PPh3O + toluene)

BnO

Scheme 2.15: The overall synthesis of butylphosphonium bromide 51 involving separation
from benzylphosphonium bromide 52 by selective alkaline hydrolysis.

The salt mixture was suspended in THF and treated with two equivalents of aqueous
KOH based on the moles of benzylphosphonium bromide 52 present. The consumption
of the benzyl salt and subsequent production of PPh3O was monitored by ES+ MS.
After 1 h, although the relative intensity of the peak at m/z 353 assigned to benzyl salt
52 had significantly decreased, it was still evident. Therefore, an additional aliquot of
aqueous KOH was added, resulting in complete consumption of the benzyl salt within a
further 2.5 h. After work-up, 67% of phosphonium bromide 51 was recovered in an
overall yield of 47%.
The alkaline hydrolysis pathway for the separation of phosphonium bromide 51 from 52
is presented in Scheme 2.16. The addition of KOH forms phosphonium hydroxides 59
and 60 which equilibrate to the pentacovalent hydroxyphosphoranes 61 and 62.92 The
coloured benzyl ylide 63 and butyl ylide (not shown) can also be reversibly formed.
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Further basic action of hydroxide on the hydroxyphosphoranes, this time in a catalytic
fashion, produces the conjugate bases 64 and 65. Finally, in the rate determining step,
irreversible formation of a phosphine oxide occurs with simultaneous loss of a
carbanion which is rapidly quenched to give a hydrocarbon and regenerate hydroxide.91
As such, the stability of the carbanion generated governs the rate of the hydrolysis. That
is, the lower the pKa of the hydrocarbon produced, the faster its corresponding anion
will dissociate. Therefore, with a controlled stoichiometric quantity of hydroxide,
selective hydrolysis can be achieved due to the greater stability of the benzyl anion
compared to the phenyl anion, which would be the leaving group from butyl salt 51 (k1
< k2).94
PPh3Br

BnO

PhH2C PPh3Br
52

51
Br

FAST

OH

Br

PPh3OH

BnO

FAST

BnO
61

OH
P Ph
Ph
Ph

OH

H2O

BnO
64

O
Ph
P
Ph
Ph
SLOW, k1

O
PPh2

-H2O
PhHC PPh3 63

HO
Ph
PhH2C P
Ph
Ph
62

H2O

FAST

66

FAST

PhH2C PPh3OH
60

59
FAST

BnO

OH

H2O

FAST

O
Ph
PhH2C P
Ph
Ph
65
PhH2C

Ph
H2O

H2O

FAST

SLOW, k2

FAST

benzene + OH + toluene

O
PPh3

k1 < k2

Scheme 2.16: The alkaline hydrolysis pathways of phosphonium bromides 51 and 52. With a
limiting amount of hydroxide, the benzyl salt 52 is selectively hydrolysed due to the greater
stability of the benzyl anion compared to the phenyl anion in the final rate determining step (k1
< k2).91-94

In the ideal case, a completely selective hydrolysis would be possible with only a slight
excess of one equivalent of hydroxide based on the moles of benzylphosphonium
bromide 52 present. This would however require the rate of equilibrium regeneration of
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any hydroxide originally consumed by butyl hydroxyphosphorane 61 to be much faster
than its competing hydrolysis. Experimentally this was not the case and even with the
initial two equivalents of hydroxide (with respect to benzylphosphonium bromide 52)
the selective hydrolysis was incomplete. Although no peak matching the mass of the
hydrolysis product 66 of butylphosphonium bromide 51 was observed when monitoring
the reaction by MS, only 67% of the butyl salt was recovered, suggesting some
decomposition had occurred.
The work-up of the hydrolysis reaction involved neutralisation with HBr to convert
hydroxyphosphorane 61 and phosphonium hydroxide 59 back to the desired bromide
salt 51. It is important to note that neutralisation had to be carried out with HBr (i.e. the
conjugate base had to be bromide) otherwise a mixture of phosphonium halide salts
would have been returned.
2.3.2.3 Synthesis of (4E)-1,8-Di(benzyloxy)-4-octene
The multistep one-pot trans selective Wittig reaction for the synthesis of alkene (E)-46
was investigated using the standard protocol.80 Results from the reactions of the
phosphonium halides 56 with aldehyde 49 are summarised in Scheme 2.17.‡

‡

No remaining aldehyde was observed by TLC or NMR analysis of the crude mixtures in any case.
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PPh3X

(i) LiBr (2.2 eq.)
PhLi (1.1 eq.)
THF, -78 oC to RT
30 min

(ii) 0.9 - 1 eq. 49
-78 oC, 10 min

(iii) PhLi (1.1 eq.)
-78 to -40 oC
45 min

56

(iv) HCl in Et2O (1.1 eq.)
then KOt-Bu
-78 oC to RT, 12 h

OBn

BnO
46

BnO

Ph
67 OH

Yield (%)a

Recovered Consumed
56 (%)
56 (%)a
(E:Z)
46
67
1 Br 51
None
30 (97:3)b 25
2 Br
Stringent Salt Drying 41 (~87:13)c 27
35
66
3 I 58
None
30 (~94:6)c 38
72
32
a
Based on aldehyde 49. bHPLC analysis of the diol derivative showed 3% of the minor
diastereomer was present (see Section 2.4 and Appendix 1). cApproximate ratio estimated using
the relative heights of analogous peaks in the 13C NMR spectrum.
X

56

Method
Modification

+

Scheme 2.17: Results of the multistep one-pot trans selective Wittig protocol for the synthesis
of alkene 46 using phosphonium halide 56 and aldehyde 49. Alcohol 67 was also formed as a
side product.

The first reaction with phosphonium bromide 51 (entry 1) gave alkene 46 highly
enriched in the trans configuration (E:Z, 97:3) with a relatively low yield (30%).
Alcohol 67 was also isolated as a side product (25%) as a result of nucleophilic attack
by PhLi on aldehyde 49. It was suspected that residual moisture in the LiBr (extremely
hygroscopic) had partially quenched the first aliquot of PhLi, leaving some of the
aldehyde to react with the second PhLi aliquot. Therefore, prior to a second attempt at
the Wittig reaction, the lithium and phosphonium bromide salts were more carefully
dried by heating at 100 oC under high vacuum for 2.5 h (entry 2). This resulted in a
marginal improvement in the yield of alkene 46 (41%) however the stereoselectivity
was somewhat lower (E:Z, 87:13) for reasons unknown. Alcohol 67 was again produced
(27%) and a moderate quantity of phosphonium bromide 51 was recovered (35%).
A similar outcome (to that of entry 1) was obtained from the reaction using
phosphonium iodide 58 (entry 3) in which alkene 46 was afforded in a relatively low
yield (30%) but with a good trans selectivity (E:Z, 94:6), in addition to alcohol 67
(38%) and the recovered phosphonium salt (72%).
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The trans selective Wittig reaction requires the presence of a THF soluble lithium salt
and PhLi as the base.80 In general, the reaction is performed with two equivalents of
LiBr as an additive. Initially, reaction of phosphonium halide 56 with PhLi leads to an
α-lithiated ylide 68 (Scheme 2.18). Subsequent nucleophilic attack on aldehyde 49 gives
predominantly the cis precursive erythro betaine 69a95 to which a second aliquot of
PhLi is added, producing the erythro α-lithiated betaine ylide 70a which undergoes
spontaneous pyramidal inversion96 to the threo form 70b.‡ A high concentration of LiBr
ensures that the metal does not dissociate from the alpha carbon, avoiding the
production of a stereochemically undefined α-lithium free betaine ylide 71.97 An
equivalent of ethereal HCl then quenches the betaine ylide forming the
configurationally stable trans precursive threo betaine 69b. Finally, the addition of
KOt-Bu cleaves the Li-betaine complex, enabling the formation of oxaphosphatane 72,
which collapses to give alkene (E)-46 and PPh3O.80
O
XPh3 P

H
R

H

XPh3P

PhLi
-C6H6

56

H

H

Li
R

OLi
R

XPh3P H

49

68

H

OLi

OLi

R

R

R
69a

PhLi -C6H6

threo

XPh3P H

HCl
-LiCl

XPh3 P H
R * Li
70b

H
69b

KOt-Bu

erythro

OLi

R

XPh3P H

inversion

X

-LiBr

H

R

Li * R
70a

OLi
R

R
R = (CH2)3OBn

PPh3
O
Ph3P H
R

R

H

X = Br, I

71
R

Ph3P O
R
H
H

72

R

R
46

R + PPh3O

Scheme 2.18: Mechanism of the trans selective Wittig reaction between phosphonium halide 56
and aldehyde 49 using PhLi as the base and LiBr as an additive.80,95-97

The relatively low chemical yields of alkene 46 obtained throughout (30-41%) could be
attributed to an incomplete generation of phosphonium ylide 68 at the beginning of the

‡

For 1,2-disubstituted straight chain hydroalkenes, the threo configuration is typically favoured to the
extent of ≥99.5% at equilibrium.96
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process. Evidence for this was provided by the reaction using phosphonium iodide 58 in
which 72% of the salt was recovered after work-up (entry 3).†
One report of phosphonium iodide 58 in a traditional Wittig reaction87 stated that two
equivalents of PhLi were required to generate the ylide.‡ This was presumed to be due
to the similar acidity of the benzylic protons and the alpha hydrogens (Figure 2.4),
although no experimental evidence was given to support this hypothesis. Nevertheless,
this competing acidity could explain the failure of one equivalent of PhLi to produce
ylide 68 successfully in our hands, although it is difficult to rationalise why no products
arising from addition of aldehyde 49 to the benzylic position were observed if this is the
case.
H
Ph

PPh3X

O
H

X = Br, I

Figure 2.4: Hydrogens possibly having similar acidity that could lead to an incomplete
generation of ylide 68 with one equivalent of PhLi.87

Despite the low yields, high trans selectivities were obtained throughout (87-97% E),
indicating that lithiation of betaine 69a was more facile than that of the starting salt.
Otherwise, the second PhLi aliquot would have been partially consumed by the
remaining phosphonium halide 56 (and unreacted aldehyde 49), leading to incomplete
formation of betaine ylide 70b and lower E:Z ratios. It has been noted that the general
acidity of phosphorus betaines of type 69 (where R = alkyl group) approximate that of
their corresponding phosphonium salts,98 however the results obtained strongly suggest
that the pKa (arising from the alpha proton) of betaine 69a (R = (CH2)3OBn) is
significantly lower than that of phosphonium halide 56. In all reactions the expected red
colour80 of betaine ylide 70b was observed, suggesting that the second deprotonation
had occurred.
Although the yields were lower, the trans selectivity of these Wittig reactions was
superior to that obtained previously in our laboratory using metathesis (E:Z, 80:20)61

†

If the ylide had formed and reacted incompletely with aldehyde 49, quenching would have returned a
mixture of phosphonium salts with all possible anions; i.e. Cl−, Br−, I− and OH−, in addition to
hydroxyphosphorane 61.
‡
Reaction with a 3,5-disubstituted benzaldehyde produced a modest 38% yield of the desired alkene.87
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and thus this pathway represents a more stereochemically efficient route to alkene (E)46.

2.4 Synthesis of (4S,5S)- and (4R,5R)-1,8-Di(benzyloxy)-4,5-octanediol
The remaining key step of our previously developed synthesis of chiral 2,2'bipyrrolidine was the introduction of the stereogenic elements to the alkene using
Sharpless AD (see Chapter 1, Scheme 1.13). In previous work in our laboratory this
reaction was performed on samples of the alkene obtained via metathesis which
contained a significant amount of the inseparable cis isomer.61 Subsequent production of
the (again inseparable) meso isomer somewhat detracted from the validity of the HPLC
traces used in the determination of the enantioselectivity of the oxidations. Therefore,
Sharpless AD1 was performed on a highly trans enriched sample of alkene 46 (E:Z,
97:3) obtained from the Wittig reaction, affording diols (S,S)-73 (77%) and (R,R)-73
(73%) in enantiomeric excesses of 87% and 97% respectively (Scheme 2.19, see
Appendix 1 for HPLC traces).‡ Both diols also contained 3% of the meso diastereomer
arising from the corresponding oxidation of the cis impurity in the alkene.
ADmix α, CH3SO2NH2
t-BuOH:H2O (1:1)
0 oC to RT, 23 h
77%, 87% ee

BnO

OH
OBn

BnO

OH
(S,S)-73 + meso-73 (3%)

OBn
46
(E:Z, 97:3)

ADmix β, CH3SO2NH2
t-BuOH:H2O (1:1)
0 oC to RT, 23 h
73%, 97% ee

OH
BnO

OBn
OH
(R,R)-73 + meso-73 (3%)

Scheme 2.19: The Sharpless AD of alkene (E)-46 with ADmix α and β to give diols (S,S)- and
(R,R)-73 respectively.

As the representative example, the biphasic Sharpless AD of alkene (E)-46 with ADmix
β proceeds through the catalytic cycle demonstrated in Scheme 2.20. In the organic
layer, the chiral dihydroquinidine ligand (L*) coordinates to OsO4 creating a rigid Ushaped binding pocket composed of two parallel methoxyquinoline units (the walls) and
‡

These stereoselectivities are in reasonable agreement with results obtained previously from our
laboratory; diol (S,S)-73: 80% ee, diol (R,R)-73: 98% ee.61
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a phthalazine linker (the base).99 The olefin approaches regioselectively to enable
coordination to the equatorial oxygen adjacent to the binding pocket, establishing two
possible diastereomic transition states.100 In transition state 74a, the R group is
positioned within the binding pocket, providing stabilising hydrophobic, aromatic πstacking and van der Waals interactions.101 The disfavoured orientation in transition
state 74b has the R group directed away from the binding pocket and unfavourable
steric interactions with the PHAL linker. Therefore, after a [3 + 2] cycloaddition, the
osmium(VI) ester 75 is formed diastereoselectively through the lower energy pathway.
Subsequent hydrolysis, which is accelerated in the presence of CH3SO2NH2,102 releases
diol (R,R)-73 and the chiral ligand to the organic layer and the osmium(VI) complex 76
to the aqueous layer. There, stoichiometric reoxidation by K3Fe(CN)6 to complex 77
regenerates the osmium(VIII) oxidation state required for further catalytic activity.1 The
advantage of biphasic conditions is that contact between the organic osmium(VI) ester
75 and the cooxidant is minimised, avoiding entry into the less enantioselective second
cycle (not shown).103

directed
away from
binding
pocket

R
O
O
Os
O
L* O
74b

O
O
Os
O
L* O
74a

R

R
steric hindrance
from PHAL linker
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R

O
O
Os O
O
L*
75

hydrolysis
CH3SO2NH2
O
HO
OH
Os
HO
OH
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R

R
R 46
L*

R = (CH2)3OBn
L* = (DHQD)2-PHAL
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R

R
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2K3Fe(CN)6
K2CO3

Organic
2- Aqueous
O
HO
O
Os
HO
O
O
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Scheme 2.20: The catatytic cycle of the enantioselective Sharpless AD of alkene (E)-46 using
ADmix β to form diol (R,R)-73.1,99-103

In conclusion, alkene (E)-46 was dihydroxylated under the Sharpless protocol to afford
diols (R,R)- and (S,S)-73 in good yield and high enantioselectivity. These key
intermediates are easily elaborated to the enantiomers of 2,2'-bipyrrolidine with
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preservation of stereochemical integrity, as previously demonstrated in our laboratory61
and by others.58

2.5 Summary and Outlook
This chapter presented the results obtained in attempts to improve the stereochemical
efficiency of our previously established synthesis of 2,2'-bipyrrolidine. Firstly, an
attempt to improve the trans stereoselectivity of the metathesis reaction was carried out
using Grubbs’ 2 catalyst in combination with 1,4-benzoquinone. This system minimised
earlier problems encountered with double bond migration, but was inferior to the
previous performance of Grubbs’ 1 catalyst overall for the reaction.61
A method to remove the undesired meso isomer was established which involved
conversion of the crude diastereomers of diol 41 into cyclic sulfites 44, followed by
their chromatographic separation and subsequent hydrolysis of the chiral isomers back
to the diol enantiomers. Nearly complete separation of the sulfite diastereomers 44 was
achieved through a single silica gel chromatography column and the modest overall
yields of the diastereomerically pure diols (R,R)-41 and (S,S)-41 each represent a single
progression through the sequence. A disadvantage with this modified sequence however
is that two extra steps are introduced to the synthesis of 2,2'-bipyrrolidine.
Alternative methods to synthesise alkene 46 in the trans form were investigated
including the chain lengthening of (2E)-1,4-dibromo-2-butene. Here, the choice of
precursors proved to be detrimental as the required carbon nucleophile Grignard 45 was
found to be unstable. A suggested alternative chain lengthening reaction is given below
in Scheme 2.21.
2 x BnO

MgCl
78

+

(CuX)

Br
79

Br

BnO

OBn
46

Scheme 2.21: Suggested alternative chain lengthening reaction to prepare alkene (E)-46 which
avoids the use of the unstable Grignard 45.

This reaction would utilise the known methylene Grignard 78,104 which is accessible
from a commercially available chloride. In an analogous fashion to previously
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proposed, dialkylation with hexene 79, which is commercially available in the trans
form, should produce the desired alkene (E)-46.
The trans selective Wittig protocol was also attempted for the preparation of the alkene.
Consistently poor yields were obtained due to the incomplete generation of
phosphonium ylide 68, which could have been a result of the competing acidity of the
benzylic protons. Therefore, as reported,87 any further attempts at the reaction should be
performed using two equivalents of PhLi for ylide generation. Despite the low yields,
the E:Z ratios afforded were superior to that obtained using metathesis,61 particularly in
one case, where alkene (E)-46 was furnished with 97% geometrical purity. This sample
was subjected to Sharpless AD to afford the key bipyrrolidine synthons, diols (R,R)-73
and (S,S)-73, in good yield and high enantioselectivity.105
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A proposed modification of the 2,2'-bipyrrolidine ligand was the fusion of an aromatic
ring to the 4,5- and 4',5'-positions to give 2,2'-biindoline 80 as the second target
structure (Figure 3.1). This ligand would presumably form a more defined helical twist
when coordinated to a metal and, when utilised as a catalyst in aryl coupling reactions,
could potentially induce favourable π-stacking interactions with the aryl substrates.

N
N
R
R
(S,S)-80

N
N
R
R
(R,R)-80

Figure 3.1: The second target ligand 2,2'-biindoline 80, shown in both enantiomer forms.

There has only been one report of this structure106 in which the parent compound (80, R
= H) was prepared in a non-stereoselective fashion by radical dimerisation of indoline.†
The parent compound has also been synthesised previously in our laboratory107 using an
analogous strategy to that established for the 2,2'-bipyrrolidine ligand with metathesis
and Sharpless AD reactions as the key steps (Scheme 3.1). The anilino nitrogen atom
was incorporated from the beginning, enabling a regioselective SN2 cyclisation to form
the target scaffold. This sequence provided biindoline (S,S)-38 with a low optical purity
due to the poor enantioselectivity of the Sharpless AD reaction (56% ee, ADmix β),‡
which was unable to be optimised.

†

No information was provided regarding the stereochemical outcome in terms of the ratio of
diastereomers produced and no spectral data was reported.106
‡
The enantioselectivity was similarly poor for diol (S,S)-81 (50% ee, ADmix α).107
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NHR1

HN

NHBoc
(iii) metathesis

(i) isomerization

NHBoc
1

(ii) protection

(iv) Sharpless AD

NHBoc

R =H
R1 = Boc
OR2

(vi) cyclisation
N
R3

56% ee
OR2
(v) mesylation

NHBoc

R2 = H (R,R)-81
R2 = Ms

(vii) deprotection

N
R3

R3 = Boc (S,S)-82
R3 = H (S,S)-38

Scheme 3.1: The poorly enantioselective synthesis of biindoline (S,S)-38 previously performed
in our laboratory.107 Reagents and conditions: i. BF3·Et2O, xylenes, reflux, 47 h, 75%. ii. Boc2O,
NEt3, Et2O, RT, 4 h, 88%. iii. 10 mol% Grubbs’ 1, CH2Cl2, reflux, 3 h, 76%, E:Z 3:2 or 10
mol% Grubbs’ 2, CH2Cl2, reflux, 7 h, 61%, E:Z 9:1. iv. ADmix β, CH3SO2NH2, t-BuOH:H2O
(1:1), 0 °C to RT, 90 h, 31%, 56% ee. v. MsCl, NEt3, CH2Cl2, 0 °C to RT, 20 min, 92%. vi.
NaH, THF, 0 °C to RT, 42 h, 74%. vii. TFA, CH2Cl2, 0 °C to RT, 16 h, 82%.

A modified approach was also previously investigated in our laboratory in which the
nitrogen atom was to be introduced midway through the sequence with metal catalysed
amination conditions needed to achieve the final cyclisation (Scheme 3.2).61 This mode
of cyclisation would require a halogen or triflate moiety at the ortho position ‘R’,
although this sequence offers the possibility of using any oxygen protecting group at ‘R’
until the later stages.‡ Thus a number of alkenes 83 were screened in the Sharpless AD
reaction (with both ADmixes) to give diols 84. In all cases however the
enantioselectivity was insufficient to continue the intended chiral synthesis of biindoline
38.61

‡

In these cases deprotection and triflation would be required, presumably after the azidation step, in
order to facilitate the metal catalysed cyclisation.
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R

R

R

OH

Sharpless AD

metathesis
83

OH
(R,R)-84

R

R

R1

R
mesylation

cyclisation
R1

azidation
reduction

R

R1 = OMs (R,R)-85

N
N
H
H
(S,S)-38

R1 = N3 (S,S)-86
R1 = NH2

Scheme 3.2: Previously attempted enantioselective synthesis of biindoline 38 in which the
nitrogen was to be introduced as the azide nucleophile.

Further experimental studies revealed that the steric imposition of the obligatory ortho
substituent was responsible for the consistently poor outcomes.61 Therefore, a new
synthetic strategy to chiral diol 84, which avoided the Sharpless AD of ortho allylic
systems, needed to be developed in this project. The same functional group
manipulations to those shown in Schemes 3.1 and 3.2 could then be carried out to make
possible the first stereoselective synthesis of 2,2'-biindoline 38 (Scheme 3.3).
R

OH

OH
(R,R)-84

R

N
N
H
H
(S,S)-38

Scheme 3.3: Elaboration of the enantiomerically pure diol (R,R)-84 to biindoline (S,S)-38.

3.1 New Strategy to Chiral Di(ortho-substitutedphenyl)-2,3-butanediols
The copper catalysed ring opening of enantiomerically pure 2,2'-bioxirane with
Grignard reagents is known to yield chiral diols.108,109 Therefore, the reaction of orthosubstituted phenyl Grignard 88 with chiral bioxirane 87 should provide an efficient
alternative route to diol 84 (Scheme 3.4). For example, the cleavage of bioxirane (S,S)87 with 2-methoxyphenylmagnesium bromide (88, R = OMe, X = Br) has been reported
to afford optically pure diol (S,S)-89 in 68% yield.109
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O
R
MgX

10 mol% CuI

O
(R,R)-87

R

OH

OH
(R,R)-84

88

R

eg:109 (S,S)-89 R = OMe, 68%

Scheme 3.4: Alternative route to enantiomerically pure diol 84, shown in the R,R-configuration,
via the CuI catalysed ring opening of a chiral bioxirane with an ortho-substituted phenyl
Grignard 88.

Although there are no reports of the ring opening of bioxirane 87 using the
corresponding ortho-substituted aryllithium reagents, such nucleophiles would
presumably also be capable of performing this task, if required.
The major advantages of this new route to chiral diol 84 are:
1. Both required enantiomers of the optically pure bioxirane 87 are easily accessible
from L- and D-tartaric acid.108,110
2. No reaction occurs at the stereogenic carbon atoms therefore the enantiomeric
purity of the bioxirane is preserved in diol 84.
3. The strategy is adaptable to the synthesis of other chiral ligands† by changing the
structure of the carbon nucleophile used for the ring opening.

3.2 Ring Opening of Racemic 2,2'-Bioxirane
Prior to preparing bioxirane 87 in optically pure form in the laboratory, a series of trial
ring opening reactions were conducted with Grignards 90-92 (Figure 3.2)‡ using the
commercially available racemic bioxirane.
OMe

Br
MgBr

90

NO2
MgCl

MgCl

91

92

Figure 3.2: Known Grignard reagents 90-92 screened in the ring opening of bioxirane 87. The
reaction has been reported with Grignard 90.109
†

Chiral bioxirane 87 has been used previously as a precursor to C2-symmetric bidentate ligands, for
example, the phosphine ligand DIOP.111
‡
To the best of our knowledge, there are no reports of the ring opening of epoxides with Grignards 91
and 92.
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These Grignard reagents are known to be easily accessible from commercially available
precursors112-114 and each has an appropriate ortho-substituent to facilitate the synthesis
of biindoline 38 from their ring opening products. For instance, the methyl group of
Grignard 90 could be cleaved and replaced by a triflate moiety to facilitate a metal
catalysed cyclisation - as would the bromine of Grignard 91 (see Scheme 3.2).
Conversely, the nitro group of Grignard 92 could be reduced to enable an SN2
cyclisation to the target scaffold (see Scheme 3.1).

3.2.1 Ring Opening with 2-Methoxyphenylmagnesium Bromide
The ring opening of bioxirane 87 with Grignard 90 has been reported (see Scheme 3.4).
Therefore, as described,109,112 o-bromoanisole was reacted with magnesium turnings in
THF, producing a dark brown solution of the Grignard which was transferred to a
suspension of catalytic CuI before addition of bioxirane 87 (Scheme 3.5, entry 1). The
crude mixture was subjected to column chromatography affording biphenyl 93 (7%),†
followed by the ring opening products 94, 95 and 89 in yields of 13%, 15% and 68%
respectively.‡ The previously unreported diols 94 and 95 were obtained primarily as a
mixture but were able to be fully characterised with the aid of a small sample eluted that
contained solely diol 94.

†

This was presumably a result of undesired radical coupling during Grignard formation. In all
subsequent reactions using this Grignard, which was freshly prepared each time, this compound was
observed by TLC analysis but no further attempts were made to isolate it.
‡
The yield of diol 89 was the same as that reported (see Scheme 3.4).109
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OMe
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Mg, THF, 30 oC, 30 min
OMe
MgBr
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o

(i) 10 mol% Cu, THF, -40 C, 20 min
(ii) 0.29 eq. 87, -40 oC to RT, 14 h

OMe
OMe
OMe

OMe

OH
X

+
OH

93

94 X = I (mixture)
95 X = Br

OH

+
OH
89

OMe

Yield (%)
93a,b 94b,c 95b,c,d 89c
1 CuI
7
13
15
68e
f
f
f
2 CuI·2LiCl 62
a
b
Yield based on o-bromoanisole. Product not reported in the literature.109 cYield based on
bioxirane 87. dObtained in a mixture with diol 94. eLiterature yield was also 68%.109 fObserved
by NMR analysis but not isolated.
Cu source

Scheme 3.5: Results of the CuI catalysed ring opening of bioxirane 87 with Grignard 90.109 The
mole percentage of CuI and the equivalents (eq.) of the bioxirane are with respect to obromoanisole which was used in excess.

The reaction was also attempted with the THF soluble CuI·2LiCl complex115 as the
catalyst which gave a slightly lower yield of diol 89 (62%, entry 2). Again, diols 94 and
95 were observed by analysis of the crude NMR spectra, as well as small quantities of
additional unknown compounds, but no attempts were made to isolate any of these side
products in this case. It should be noted that there was no evidence of chloride addition
to the epoxide.
The active species in the ring opening is cuprate 96 which is generated by the
combination

of CuI with two equivalents of Grignard 97

or with the

diorganomagnesium species 98 formed via the Schlenk equilibrium (Scheme 3.6).116,117
The higher reduction potential of copper(I) renders the R-Cu bond more covalent, and
thus less carbanionic, in character than the R-Mg bond in the Grignard reagent.118
Therefore, transmetallation to cuprate 96 is thermodynamically favoured. It is also
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evident that MgX2 salts are generated by transmetallation of Grignard 97 and the
Schlenk equilibrium. Although Grignard 97 initially has a bromide anion, the addition
of CuI can lead to either halide being present in any of the species shown, thus the
halides are simply represented by X.
OMe
MgX

2

Transmetallation
CuX

OMe
Cu·MgX
2

+ MgX2

96

97

X = Br, I

OMe
MgX2
Schlenk
equilibrium

Mg
2

CuX
Transmetallation

98

Scheme 3.6: Key equilibria established after transmetallation of Grignard 97 with CuI. The
resulting cuprate 96 is the active nucleophile in the ring opening of bioxirane 87.

A suggested mechanism for the ring opening of bioxirane 87 (depicted in the R,R
configuration) is shown in Scheme 3.7. Terminal nucleophilic attack of cuprate 96
(R2Cu·MgX) on bioxirane (R,R)-87 leads to the first ring opening through a complex
pathway involving activation by magnesium coordination and subsequent delivery of
the carbanion from copper.116 This expels the inactive organocopper species (RCu)
which can combine with another molecule of Grignard 97 to regenerate the active
complex 96. The intermediate terminal epoxide (R,R)-99 can equilibrate with the
secondary epoxide (R,S)-100 via intramolecular SN2 attack of the adjacent magnesium
alkoxide. This reversible process involves two inversions of the electrophilic carbon and
the R-configuration is restored before a second attack by cuprate 96, which is much
faster on the terminal epoxide (R,R)-99, driving the equilibrium to the desired
regioisomer. Finally, quenching the magnesium alkoxide salt (R,R)-101 forms diol
(R,R)-89.
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Scheme 3.7: Suggested mechanism for the ring opening of bioxirane (R,R)-87 with cuprate 96
to give diol (R,R)-89. The cuprate is regenerated by combination of the organocopper byproduct (RCu) with another molecule of Grignard 97.116

As demonstrated in Scheme 3.6, the reaction mixture also contains magnesium halide
salts. These Lewis acids can coordinate to bioxirane 87, activating the ring to
nucleophilic attack by the halide of a free magnesium salt (Scheme 3.8).119,120 Although
the iodide anion was only present in a catalytic quantity compared to the bromide
Grignard counterion, a similar yield of the iodide addition product was isolated (see
Scheme 3.5), presumably due to its greater nucleophilicity.123 The competing addition of
halides in the ring opening of epoxides with Grignard reagents to form halohydrins has
been observed previously,120-122 however in this particular reaction the halide addition
products 94 and 95 were not reported in the literature.109
MgX2
O
O

87

OMgX
X

O

MgX2

O

O

+ MgX2

R = o-OMePh
X = Br, I

MgX2

Scheme 3.8: The activation of bioxirane 87 by coordination of MgX2 leading to an undesired
ring opening by a halide ion.119,120

It should also be noted that treatment of the halohydrin by-products 102 with excess
base should affect their ‘recycling’ to a thermodynamic mixture of epoxides 103 and
104, which could be subjected to the standard ring opening conditions to give the
desired diol 89 (Scheme 3.9). Although this sequence is viable, it was not considered
worthwhile to perform these reactions with the racemic samples.
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R

R
OH
X

R

KOH(aq)
Et2O

R

R
OMgX
99

OH
103
+

OH

O

O

2 eq. RMgX
10 mol% CuX

OH
89

OH

OH
102

100
R

O
104

R

X

OMgX

O X

R = o-OMePh
X = Br, I

R2Cu·MgX
96

Scheme 3.9: The plausible ‘recycling’ of the halohydrin by-products 102 to epoxides 103 and
104 which could be subjected to the standard ring opening conditions to afford the desired diol
89.

3.2.2 Ring Opening with 2-Bromophenylmagnesium Chloride
Grignard 91 was prepared in situ via the Mg/I exchange of i-PrMgCl with 2bromoiodobenzene at -25 oC (Scheme 3.10).113 Subsequent reaction with bioxirane 87
used the same procedure as the previous ring opening with Grignard 90, affording a
mixture of diols 105, 106 and 107 after column chromatography.‡

‡

The mass of the mixture obtained indicated that bioxirane 87 had reacted quantitatively. The molar ratio
of diols 105:106:107 could be roughly estimated at 7:4:2 (respectively) by comparing the heights of the
peaks assigned to C4 of each diol in the 13C NMR spectrum. The C2 symmetry of diol 105 was taken into
account in this analysis.
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Br
I

i-PrMgCl, THF, -40 to -25 oC, 1 h
Br
MgCl + i-PrI
91
(i) 10 mol% CuI, THF, -40 oC, 10 min
(ii) 0.32 eq. 87, -40 oC to RT, 18 h
Br

Br

OH
4

OH
105

+
Br

40.6 ppm

[M+Cl] = 435

OH
4

Br
I

OH
4

+

OH
9.9 ppm
106
[M+Cl] = 407

Cl

OH
107 46.7 ppm
[M+Cl] = 315

(mixture)

Scheme 3.10: The CuI catalysed ring opening of bioxirane 87 with Grignard 91 to give a
mixture of diols 105, 106 and 107 after column chromatography.

Analysis of the mixture by ES− MS showed three sets of isotopic peaks at m/z 435, 407
and 315 assigned to the chloride adducts of diols 105, 106 and 107 respectively (the
ES− mass spectrum is given in Appendix 2). Further key evidence of the formation of
the products was provided by the 13C NMR spectrum, in which peaks at 40.6, 9.9 and
46.7 ppm were assigned to C4 of diols 105, 106 and 107 respectively.
The failure to chromatographically separate diol 105 from the halohydrin side products,
in contrast to diol 89, was presumably due to the lower polarity of the bromo substituent
compared to the methoxy group. As such, it proved necessary to repeat the ring opening
of bioxirane 87 with Grignard 91 a number of times in order to identify an efficient
method to isolate diol 105 from the crude reaction mixture (Table 3.1).‡

‡

In all cases the conditions shown in Scheme 3.10 were used and the crude mixture obtained was an offwhite solid that contained diols 105, 106 and 107 as the major constituents.
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Table 3.1: Results of methods attempted to isolate diol 105 from the crude mixture obtained
after the ring opening of bioxirane 87 with Grignard 91.

Separation Method

Result

1 Column chromatography.c

Mixture of diols
obtained.

2 Washing crude (solid) mixture with hexanes.

Partial dissolution of
diol 105.

Yield Purity
(%)a (%)b
28

~90

3 Crude solid dissolved in hexanes/CH2Cl2 then Incomplete precipitation

30

~90

4 Conversion of the crude diols to dimesylates

8d

~100

CH2Cl2 evaporated to induce precipitation.
followed by column chromatography.

of diol 105.

Only partial separation
achieved.

5 Treatment of the mixture obtained from entry

Diol 105 selectively
35
~100
1 with KOH to convert the halohydrins to the crystallised from EtOH.
potentially separable epoxide 108.
a
Isolated overall yield of diol 105 based on bioxirane 87. bProduct purity estimated by NMR
analysis. cThis attempt was previously presented in Scheme 3.10. dIsolated overall yield of the
dimesylate derivative based on bioxirane 87.

Given that column chromatography (entry 1) had been unsuccessful, the effect of
simply washing the crude (solid) mixture with hexanes was investigated (entry 2). This
was found to selectively dissolve diols 106 and 107, enabling diol 105 to be obtained in
28% yield with reasonable purity (~90%), albeit with some product loss due to partial
dissolution. The inverse approach gave essentially the same outcome (entry 3), in which
diol 105 was selectively precipitated from hexanes.
The diols were also converted to their dimesylate derivatives (entry 4) by subjecting the
crude mixture to the standard mesylation protocol (MsCl/NEt3 in CH2Cl2). Attempted
chromatographic separation afforded a small quantity of the desired derivative in pure
form (8% overall), but the majority of the product was eluted in a mixture with the
dimesylate derivatives of diols 106 and 107.
As a final investigation (entry 5), the mixture of diols obtained after column
chromatography (see entry 1 and Scheme 3.10) was treated with KOH in order to
convert the halohydrins to the ‘recyclable’ epoxide 108, which was anticipated to be
separable from diol 105 (Scheme 3.11). Although the constituents of the crude mixture
could not be resolved by TLC analysis, the diol was able to be selectively crystallised
from EtOH in an overall yield of 35% from bioxirane 87. Subsequent concentration of
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the filtrate gave a partially pure compound tentatively assigned by NMR analysis as
epoxide 108 (26% overall yield).
diols
105 + 106 + 107
(mixture)

KOH(aq), Et2O
RT, 12 h

Br

O
OH
108

+ diol 105

crystallisation
from EtOH

pure diol 105
35% overall

(mixture)
filtrate

partially pure
epoxide 108
26% overall

Scheme 3.11: Treatment of the mixture of diols 105-107 with KOH to convert the halohydrins
to epoxide 108 and subsequent crystallisation of diol 105. Overall yields are based on bioxirane
87.

Overall, this method was the most successful of those summarised in Table 3.1 as diol
105 was able to be quantitatively crystallised and obtained in spectrochemically pure
form. The only disadvantage was that an extra reaction needed to be performed,
although the chemistry involved was relatively simple.†
The thermodynamically favoured Mg/I exchange reaction for the preparation of
Grignard 91 is shown in Scheme 3.12.113 Due to the much greater stability (or lower
basicity) of the phenyl carbanion compared to the secondary carbanion of i-PrMgCl, the
equilibrium lies almost exclusively to the right and the exchange essentially proceeds to
completion.‡ This process significantly increases the electron density of the aromatic
ring and thus a second exchange to give a diGrignard reagent cannot occur. The
exchange is chemoselective for the more labile iodine, forming i-PrI as a by-product.
Br

Br
I

MgCl
+

THF, -40 to -25 oC, 1 h

MgCl

+

I

91

Scheme 3.12: The Mg/I exchange reaction of i-PrMgCl with 2-bromoiodobenzene to afford
Grignard 91.113

Aryl nucleophiles with halogens in the ortho position are known to be unstable.124-126
Although the half-life of Grignard 91 has not been reported, the half-life of its LiCl
complex (i.e. Grignard 91.LiCl) has been measured to be 24 h at -10 oC in THF.124 The
†

It was later found during the chiral synthesis of the biindoline that diol 105 could be selectively
crystallised from the halohydrin side products 106 and 107 in EtOH without the need to first convert them
to epoxide 108 (see Section 3.4).
‡
No unreacted 2-bromoiodobenzene was detected by analysis of the crude NMR spectra.
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low temperature in which the above exchange reaction precedes (-25 oC) ensures that
Grignard 91 is formed in a high yield.
Given that the ring opening reaction was allowed to warm to room temperature over 18
h, decomposition of Grignard 91 could have occurred according to the pathways shown
in Scheme 3.13.125,126 The 1,2-elimination of the magnesium halide (MgBrCl) would
form benzyne as a reactive intermediate which would rapidly combine with a molecule
of the remaining Grignard to form biphenyl Grignard 109. This Grignard could also
react with benzyne to produce triphenyl Grignard 110 and so forth, leading to a range of
decomposition products.
Br
MgCl
Br
MgCl

Br
MgCl

-MgBrCl

Br

MgCl
91
H2O

110

109

H2O

H2O
Br
Br

Br

111

Scheme 3.13: Possible pathways of decomposition of Grignard 91 through benzyne as a
reactive intermediate.125,126

Spectral analysis of the low polarity fractions obtained during the attempted
chromatographic separation of diol 105 (see Scheme 3.10) indicated the presence of
biaryl 111127 with no other significant by-products.‡ The yield was <15% (based on 2bromoiodobenzene) which indicated minimal decomposition of Grignard 91 had
occurred.
Therefore, the poorer outcome of the ring opening reaction with Grignard 91 compared
to Grignard 90 (35% yield compared to 68% yield) was presumably a result of the
electron withdrawing ability of the bromo substituent, rendering the Grignard and its
‡

Although Grignard 91 was used in excess of bioxirane 87, its non-polar hydrolysis product
(bromobenzene) is semi-volatile and could be removed from the crude mixture under vacuum.

55

CHAPTER 3

Synthesis of 2,2'-Biindoline from 2,2'-Bioxirane

cuprate derivative less nucleophilic than the electron rich methoxy analogue, leading to
greater yields of the competing halide addition products. The reaction with the nitrosubstituted Grignard 92 was therefore approached with a degree of sceptism.

3.2.3 Ring Opening with 2-Nitrophenylmagnesium Chloride
Grignard 92 was prepared in situ via the Mg/I exchange of PhMgCl with 2iodonitrobenzene at -40 oC (Scheme 3.14).114 Prior to attempting the ring opening
reaction, the known nucleophilic addition to benzaldehyde114 was performed, affording
alcohol 112 in 94% yield.
NO2
I

PhMgCl, THF
-40 oC, 5 min

NO2
MgCl

92

+ PhI

benzaldehyde
-40 oC, 30 min
then to RT, 16 h
94%

NO2 OH

112

Scheme 3.14: Preparation of Grignard 92 by the Mg/I exchange reaction of PhMgCl with 2iodonitrobenzene and subsequent nucleophilic addition to benzaldehyde, as previously
described.114

Encouraged by this result, the reaction of Grignard 92 with bioxirane 87 was
investigated in the presence and absence of copper(I) salts (Scheme 3.15). The multiple
products shown below were obtained after silica gel column chromatography.
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NO2
I

PhMgCl, THF, -40 oC, 10 min
NO2
MgCl + PhI
92
(i) (Cu source), THF, -40 oC, 15 min
(ii) 0.25 eq. 87, -40 oC to RT, 13 h

NO2
NO2

NO
NO

+

115

114

113

NO2

OH
116 X1 = I, X2 = I
117 X1 = Cl, X2 = I
118 X1 = Cl, X2 = Cl

X2

X1
OH
119

N
NO

+

OH
X

+
OH
120

121 X = I
122 X = Cl

Yield (%)
113a 114a 115a 118b 119c 120c
1
None
13
75
2
10 mol% CuI
18
8
<1d
~38 <20e
3 1 eq. CuCN·2LiCl 43
<1
12f
31f
a
b
c
Yield based on 2-iodonitrobenzene. Yield based on bioxirane 87. Approximate yield of
halohydrin mixture based on bioxirane 87, calculated using the average molecular weight of the
halohydrins present. dObserved as a trace impurity in the NMR spectra of 119. eProduct
contained minor impurities. fA mixture of 115 and 118 was obtained.
Cu Source

Scheme 3.15: Results of the attempted ring opening of bioxirane 87 with Grignard 92 in the
presence and absence of copper(I) salts. Yields represented with a dash indicate that the
compound was not formed.

In the absence of copper (entry 1), ring opening by chloride occurred to give diol 118
(75%) with biphenyl 113 as a by-product (13%). Under standard CuI catalysis (entry 2),
halide ring opening also predominated to give diol 119 (~38%) as a mixture of the
diiodo (116), mixed-halo (117) and dichloro (118) diols. A small quantity of the
Grignard/halide addition product 120 was also obtained (<20%) as a mixture of the iodo
(121) and chloro (122) diols, with minor impurities present. Additional products from
this reaction included biphenyl 113 (18%) and heterocycles 114 (8%) and 115 (<1%).
The diol mixtures (119 and 120) were characterised by ES− MS analysis in which peaks
assigned to the chloride adduct of each product were observed (the ES− mass spectra
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are provided in Appendix 2). The assigned structures were also supported by NMR
analysis. For example, the 1H NMR spectrum of diol 120 displayed a multiplet between
7.3 and 8.0 ppm, indicating addition of the aryl Grignard.
The cyanocuprate derivative of Grignard 92, which readily adds to allyl halides,114 was
unreactive to the bioxirane (entry 3). In this case, chloride addition took place producing
diol 118 (31%), which was eluted in a mixture with heterocycle 115 (12%). Biphenyl
113 was also formed (43%) in addition to a small quanitity of heterocycle 114 (<1%).
In all cases a number of constituents were observed by analysis of the crude NMR
spectra prior to column chromatography, which we did not attempt to isolate. These
included the by-product of Mg/I exchange (iodobenzene), the hydrolysis product of the
excess Grignard reagent (nitrobenzene) and a small quantity of unreacted 2iodonitrobenzene.
Nitroarenes have been used as oxidants to induce the coupling of organic metal-bound
ligands.128-130 A small quantity of 2-iodonitrobenzene, which remained after the Mg/I
exchange, presumably has the same potential. Therefore, a proposed mechanism for the
formation of biphenyl 113 under the transitional metal free conditions (entry 1) is
shown in Scheme 3.16. A single electron transfer (SET) from the diorganomagnesium
complex 123 (formed via the Schlenk equilibrium) to 2-iodonitrobenzene would form
radical anion 124, which is known to readily eliminate iodide to give aryl radical
125.†131 A second SET from magnesium radical cation 126 would result in coupling of
the aryl ligands to form biphenyl 113.‡ Re-oxidation of the resulting radical anion 127
upon exposure to molecular oxygen during work-up would give nitrobenzene without
significant reduction of the nitro group evident.128,131

†

The coupling of two molecules of radical 124 would also produce biphenyl 113.
This mechanism is based on that reported for the transition metal-free homocoupling of Grignard
reagents with a substituted diphenoquinone as the sequential two-electron acceptor in which magnesium
maintains its oxidation state (II) throughout the process.132
‡
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2

2

NO2

NO2
124

123
I

NO2
Mg
125

NO2

I

NO2

2

126

SET2
oxidative
coupling

NO2

Mg2 I

NO2
NO2

+

127
O2(g)

113

nitrobenzene

Scheme 3.16: Proposed mechanism for the oxidation of diorganomagnesium complex 123 by
unreacted 2-iodonitrobenzene to give biphenyl 113 after two single electron transfers
(SET’s).131,132

Biphenyl 113 was not observed as a by-product of the reaction of Grignard 92 with
benzaldehyde (see Scheme 3.14) in which there was also unreacted 2-iodonitrobenzene
and excess Grignard present. As such, the occurrence of undesired homo-coupling
during the attempted ring opening could possibly be explained by the consumption of
MgCl2 in delivering chloride to the epoxide, which would shift the Schlenk equilibrium
toward the required diorganomagnesium complex 123.
In the presence of CuI (Scheme 3.15, entry 2) an additional mode of oxidative coupling
was possible (Scheme 3.17). The Cu(I) cuprate 128 could reduce 2-iodonitrobenzene (or
newly formed biphenyl 113), via a SET from copper. Subsequent reductive elimination
of the aryl ligands from Cu(II) complex 129 would form biphenyl 113 and generate
copper metal.‡ Given that the quantity of CuI was catalytic and no stoichiometric cooxidants were present, the contribution to homocoupling via this pathway was
presumably limited.

‡

An efficient method to access symmetrical biaryls has recently been reported using a 1,3-dinitrobenzene
derivative to oxidise cuprates derived from Grignard reagents and CuBr·SMe2.130
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[oxidant]
oxidant
NO2
CuI·MgCl

MgCl

+
SET

2

NO2 O2N

reductive
elimination

CuII

128

NO2
NO2

Cuo +

129
(oxidant = 2-iodonitrobenzene or biphenyl 113)

113

Scheme 3.17: An additional pathway to biphenyl 113 involving the oxidation of cuprate 128 by
2-iodonitrobenzene (or newly formed biphenyl 113).130

The formation of heterocycles 114 and 115 (Scheme 3.15, entries 2 and 3) provided
evidence that biphenyl 113 took the role of the oxidant as these compounds are the
products of multiple electron transfers to biphenyl 113, resulting in reductive
cyclisation.133-136 Consequently, it appears that only trace quantities of 2iodonitrobenzene would be required to initiate the homo-coupling processes shown in
Schemes 3.16 and 3.17.
Transmetallation of Grignard 92 with CuCN·LiCl (Scheme 3.15, entry 3) would have
formed the R(CN)Cu·MgCl complex (R = 2-nitrophenyl).137 This cuprate is structurally
analogous to the R2Cu·MgX complex 128 and has the cyanide bound to copper acting as
a ‘dummy’ ligand, unable to add to electrophiles.116 Equilibration with the R2Cu·
(MgCl)2CN complex,138 in which two aryl groups are bound to copper, facilitates
formation of biphenyl 113 through the redox processes demonstrated in Scheme 3.17. In
this case a stoichiometric quantity of the copper salt was used which resulted in a large
quantity of the available Grignard (55%) being consumed by redox processes. There
was however no evidence of cross coupling of the aryl nucleophile with the cyanide
ligand, as has been observed with certain lithium cyanocuprates.138
These results indicated that Grignard 92 and its cuprate derivatives were insufficiently
nucleophilic to compete with chloride and iodide for addition to the bioxirane. Only in
the presence of catalytic CuI was any attack by the carbanion observed, albeit a small
extent of mono-addition. The low reactivity towards bioxirane 87 allowed side reactions
associated with the Grignard reagent to transpire, most notably oxidative homocoupling to biphenyl 113, which was promoted by copper salts.
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3.3 Towards the Synthesis of Racemic 2,2'-Biindoline
In order to establish the synthetic route to the 2,2'-biindoline scaffold, the remainder of
the synthesis was attempted with racemic diols 89 and 105 as precursors, following the
sequence of reactions from diol (R,R)-84 presented in Scheme 3.2.‡

3.3.1 Mesylation
The diols 89 and 105 were first subjected to standard mesylation conditions, affording
dimesylates 130 and 131 in 100% and 89% yields respectively (Scheme 3.18).
R

MsCl, NEt3, CH2Cl2
0 oC to RT, 1 h

OH

OH

R

89 R = OMe
105 R = Br

R

OMs

OMs

R

130 R = OMe 100%
131 R = Br
89%

Scheme 3.18: The mesylation of diols 89 and 105 under standard conditions.

3.3.2 Azidation
Subsequent introduction of the nitrogen atom via an SN2 displacement of the mesylate
groups with the azide nucleophile under standard conditions proved to be extremely
slow and resulted in the formation of side products (Scheme 3.19). The reaction with
dimesylate 130 (entry 1) afforded alkene 134 (7%) and the desired diazide 135 (35%) in
addition to the mono-addition product 136 (20%) and some recovered starting material
(23%). The corresponding alkene 137 and diazide 138 derived from dimesylate 131
(entry 2) were unable to be separated by column chromatography and were obtained as
a mixture in 15% and 46% yields respectively. An additional product of intermediate
polarity was also detected by TLC analysis, presumably azide 139, however no attempt
was made to isolate this compound.

‡

With the methoxy group in the ortho position, the molecule would also have to be demethylated and
triflated, presumably after the azidation step, in order to facilitate the metal catalysed cyclisation.
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R

OMs

OMs
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R

NaN3, DMF, 80 oC
R

R

N3

N3

R

+

N3

+
N3
86

R
132

R

OMs
133

R

Yield (%)
Time
(h) 132 86 133
7 35 20
1 OMea 130 134 135 136 109
2
Br
15 46
131 137 138 139 120
a
23% of dimesylate 130 was also recovered.
R

85

132

86

133

Scheme 3.19: Results of the reactions of dimesylate 85 with the azide nucleophile under
standard conditions to give diazide 86 and alkene 132 as an undesired side product.

An ‘elimination (E1)/carbocation shift’ mechanism to rationalise the formation of
alkene 132 is proposed in Scheme 3.20. The mesylate group dissociates from azide 133
to give the secondary carbocation 140, which rearranges to the more stable benzylic
carbocation 141. The presence of the carbocation renders the adjacent proton
sufficiently acidic to be extracted by the weakly basic azide anion,‡ giving alkene 132.
The driving force for the deprotonation, over a possible SN1 attack on the carbocation, is
the establishment of conjugation between the resulting alkene and the aromatic ring.
The configuration of alkene 132 was assigned as trans based on the coupling constant of
15.6 Hz between H1 and H2.140
R

H

R

N3

H

N3
R = OMe, Br

OMs
133
carbocation
shift

R

R
140
R

N3

H1

R

N3
+ N3H

H

R

H2
132

141 N3

R

3

JH1-H2 = 15.6 Hz

Scheme 3.20: Proposed mechanism for the formation of alkene 132 during the azidation
reaction.

‡

The much higher pKa of N3H compared with MsOH would presumably render the azide anion a more
effective base for the deprotonation than the newly dissociated mesylate anion.139
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Given the steric and electronic dissimilarity of bromo and methoxy groups, it is
reasonable to conclude from these results that dimesylate 85 is not a suitable substrate
for an efficient introduction of the azide nucleophile under standard conditions,
regardless of the ortho substituent R.
3.3.2.1 Attempted Synthesis of Racemic 1,4-Di(2-methoxyphenyl)-2,3-butanediol
2,3-Di(trifluoromethanesulfonate)
A possible way to accelerate the desired SN2 azidation reaction and minimise the extent
of elimination would be to use a ditriflate as the electrophile. The presence of the highly
electron withdrawing trifluoromethyl moiety makes the triflate an exceptional leaving
group and renders the carbon atom to which it is attached highly susceptible to
nucleophilic attack.141 Aliphatic triflates however, are not as widely used as their
corresponding mesylates because they are usually unstable and can be difficult to
isolate.‡142-144
The triflation of diol 89 was first attempted using Tf2O and pyridine at low temperature,
analogous to a procedure reported for the preparation of an aliphatic 1,2-ditriflate
(Scheme 3.21).143 Analysis of the crude mixture by NMR after work-up indicated
complete consumption of the diol and showed a complex mixture of products, none of
which contained the triflate functionality as established by the absence of a
characteristic quartet (CF3) downfield in the 13C NMR spectrum.
1) Tf2O, pyridine
CH2Cl2
-78 to -10 oC, 6 h

X
OMe

OMe

OH

OH
89

OMe

2) Tf2O, 2,6-lutidine
CH2Cl2, -78 oC
30 min

X

OTf

OTf
142

OMe

Scheme 3.21: Attempted conditions for the triflation of diol 89. Both procedures resulted in
complete consumption of the starting material and a complex mixture of products.

‡

Another alternative is the nosylate moiety (p-NO2PhSO2) which has a leaving group ability intermediate
to that of a mesylate and a triflate.145
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To prevent potential complications occurring through nucleophilic attack on the product
by excess pyridine, a second attempt at the triflation was performed with the sterically
encumbered 2,6-lutidine as the base. In an effort to avoid the possible decomposition of
ditriflate 142 during work-up, the reaction was quenched with ice water at -78 oC and
the organic layer, after washing with sat. NaHCO3 and 5% CuSO4, was concentrated at
20 oC as opposed to the usual 40 oC. Despite these measures, the crude NMR spectra
again showed a complex mixture with no evidence of a triflate group present. No further
attempts were made to synthesise the ditriflate.
3.3.2.2 Separation of Racemic 1,4-Di(2-bromophenyl)-2,3-butanediazide and (1E)3-Azido-1,4-di(2-bromophenyl)-1-butene
Given the poor outcomes of the azidation reactions and the failure to isolate ditriflate
142, the remainder of the synthesis was only pursued with the bromo-substituted diazide
138, from which two synthetic operations (reduction and cyclisation) would provide the
target compound. Before progressing however, the diazide needed to be separated from
the elimination product alkene 137. This was achieved through the selective oxidation
of the alkene with KMnO4 to polar material that was able to be removed during
filtration through silica gel, recovering 91% of the pure diazide (Scheme 3.22).
Br

Br

N3

KMnO4(aq)
THF
RT, 30 h

N3

+
137

Br

N3
138

Br

extraction,
filtration
through silica

pure 138
91% recovery

Scheme 3.22: Separation of diazide 138 from alkene 137 by oxidation of the olefin and
subsequent removal of the polar by-products by filtration through silica gel.

3.3.3 Reduction
Reduction of diazide 138 using bromine compatible Staudinger conditions146 afforded a
quantitative mixture of diamine 143 and the accompanying PPh3O by-product (Scheme
3.23). The diamine was found to degrade when subjected to silica gel chromatography
and attempts to purify the product by acid-base extraction or crystallisation as its
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dihydrochloride salt were unsuccessful. In the latter cases the diamine could not be
obtained free from PPh3O.‡

Br

PPh3, THF
RT, 2 h
then H2O
reflux, 13 h
quantitative

N3
N3
138

Br

NH2
+

Br

NH2
143

PPh3O

Br
(mixture)

Scheme 3.23: Staudinger reduction of diazide 138 affording a mixture of diamine 143 and the
accompanying PPh3O by-product.

Therefore, the reaction was attempted with polymer supported PPh3,149 enabling the
PPh3O by-product to be removed by filtration (Scheme 3.24). Analysis of the crude
NMR spectra indicated a number of impurities not observed in the previous reaction,
however due to the absence of PPh3O in the sample, diamine 143 was able to be
purified by acid-base extraction (72%).

Br

PPh3
THF, RT, 4 h
then H2O
reflux, 14 h

N3
N3

Br

acid/base
extraction

Br

72%

138

NH2
NH2

Br

143

Scheme 3.24: Staudinger reduction of diazide 138 using polymer-bound PPh3, which enabled
the PPh3O by-product to be removed by filtration.

The Staudinger reduction begins with nucleophilic attack by PPh3 on the external
nitrogen of resonance azide hybrid 144, giving cis-phosphoazide 145 which cyclises to
intermediate 146 (Scheme 3.25).150 Subsequent liberation of nitrogen gas is
accompanied by the formation of the stable phosphazene 147, which upon the addition
of water is hydrolysed to the amine and the PPh3O by-product.

‡

Alternative reagents for azide reduction that are compatible with bromine and produce easily removed
by-products include BHCl2·SMe2147 and FeCl3/NaI.148
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Scheme 3.25: Mechanism of the Staudinger reduction which affords phosphazene 147 as a
stable intermediate. This is hydrolysed to the amine and PPh3O after the addition of H2O.150

3.3.4 Cyclisation
The metal catalysed cyclisation was initially attempted on the monomeric analogue 148
as a model system (Scheme 3.26). Both CuI/L-proline151 and Pd(OAc)2/BINAP152
catalytic systems gave quantitative conversion to indoline.
10 mol% CuI
20 mol% L-proline
K3PO4, DMSO
60 oC, 72 h
quantitative
NH2

148

Br

5 mol% Pd(OAc)2
10 mol% ±-BINAP
NaOt-Bu, toluene
100 oC, 14 h
quantitative

N
H

Scheme 3.26: The metal catalysed cyclisation of amine 148 to indoline, which was examined as
a model system.

Extension of the copper protocol to diamine 143 afforded a complex mixture that did
not contain the starting material or the desired product (Scheme 3.27). In contrast, the
reaction with the palladium system was extremely slow and work-up after 60 h returned
predominantly starting material, however the ES+ MS of the crude sample provided
evidence of partial cyclisation. Isotopic peaks at m/z 317 and 319 (1:1), characteristic of
the presence of one bromine atom, were assigned to the M+H ion of indoline 149 and a
small peak at m/z 237 was assigned to the M+H ion of biindoline 38.
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20 mol% CuI
40 mol% L-proline
K3PO4, DMSO
60 oC, 72 h

X
Br

NH2
NH2
143

5 mol% Pd(OAc)2
10 mol% ±-BINAP
NaOt-Bu, toluene
100 oC, 60 h

Br

N
H

38

N
H
NH2

M+H = 237

mostly recovered 143
some 149
trace of 38

N
H

Br

149

M+H = 317, 319

Scheme 3.27: Results of the attempted metal catalysed cyclisation of diamine 143 to biindoline
38. The copper system resulted in a complex product mixture while the palladium protocol
returned mostly starting material.

The inefficiency of both systems to catalyse the desired cyclisation was presumed to be
a result of diamine 143 binding strongly to the metal in a bidentate fashion, thus
inhibiting the amination cycle (Scheme 3.28). Evidence of this was provided by ES+
MS analysis of the crude mixture obtained from the reaction with copper, in which an
isotopic set of peaks at m/z 575, 577 and 579 was assigned to the Cu complex ion 150.
Br
Br

Br

M

NH2

L

L
H2N

Br

NH2
143

L

L

X

NH2

N
H

M
L

Br

38

N
H

Br

M = Cu, Pd
L = bidentate ligand
H2N

NH2
Cu+

NH O
150

ES+ MS:
m/z: 575, 577, 579

O

Scheme 3.28: Proposed catalyst inhibition during the attempted cyclisation reactions resulting
from the strong binding of diamine 143 to the metal. Evidence to support this was provided by
ES+ MS analysis.

Given that microwave irradiation has been demonstrated to promote palladium
catalysed amination,153 the cyclisation was next attempted in a microwave reactor,
affording biindoline 38 in 45% yield‡ after column chromatography (Scheme 3.29). A
‡

This yield represents a single attempt at the microwave cyclisation with the racemic diamine and was
optimised later (79%, see Chapter 4, Section 4.4).
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number of other minor products were observed by TLC analysis of the crude sample
although no attempt was made to isolate and characterise these compounds due to the
small scale of the reaction. Key evidence of the cyclised product included the loss of the
peak at 124.6 ppm in the 13C NMR spectrum of the diamine assigned to aryl C2 and the
appearance of a peak at 150.7 ppm assigned to C9 of biindoline 38. Additionally, the
base peak at m/z 237 in the ES+ MS was assigned to the M+H ion.

124.6 ppm

Br

23 mol% Pd(OAc)2,
46 mol% ±-BINAP
NaOt-Bu, toluene
120 oC, microwave, 4 h
45%

NH2

C2

NH2
143

Br

C9 N

H

38

N
H

150.7 ppm

Scheme 3.29: Synthesis of biindoline 38 via palladium catalysed cyclisation of diamine 143
under microwave irradiation.

Although a single product was isolated, the cyclisation could have occurred via a second
pathway to give naphthyridine 151 (Scheme 3.30). This previously unreported
heterocycle would not be readily distinguishable from biindoline 38 by NMR
spectroscopy. Therefore, the product was assigned as the biindoline by EI+ MS analysis
in which the base peak at m/z 118 was assigned to the indoline radical cation 152.‡ This
mode of fragmentation would not be possible for naphthyridine 151.

‡

An X-ray crystal structure obtained later unequivocally confirmed that the product was biindoline 38
(see Chapter 4, Section 4.4).
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1)

Br

2)

H2N

Br

Br

H2N
143

Br

NH2
143

NH2

H
N
N
H

38

N
H

N
H 151

EI+ MS

EI+ MS

X

m/z = 118
N
H

152
m/z = 118

Scheme 3.30: The two possible pathways by which cyclisation can occur leading to biindoline
38 and naphthyridine 151 respectively. The product was confirmed as the biindoline by EI+ MS
analysis.

The regioselectivity can be rationalised by considering the catalytic amination cycle
(Scheme 3.31).151 Oxidative addition of the substrate to the Pd(0)/BINAP complex
gives Pd(II) complex 153 which cyclises to intermediate 154. Subsequent reductive
elimination of the biindoline regenerates the active Pd(0) catalyst. The formation of
naphthyridine 151 in this sequence would require intramolecular nucleophilic attack on
the palladium atom of complex 153 to occur from the adjacent nitrogen to that shown,
producing a seven-membered palladocycle. This would clearly be a higher energy
pathway than that required to form the six-membered ring in Pd(II) complex 154, which
leads to the production of the biindoline.
Br

NH2
L = ±-BINAP

Pd(L)

(L)Pd

Br

oxidative addition
153

reductive
elimination
(L)Pd

H
N

NH2

intramolecular
nucleophilic
attack
NaOt-Bu

N
H
154

HOt-Bu + NaBr

Scheme 3.31: The catalytic amination cycle involving oxidative addition, intramolecular
nucleophilic attack and reductive elimination, resulting in the formation of 2,2'-biindoline.151
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3.4 Synthesis of (2S,2'S)-2,2'-Biindoline
In order to use the established route to facilitate the first chiral synthesis of biindoline
38, bioxirane (R,R)-87 was prepared from D-tartaric acid as previously described
(Scheme 3.32).108,110 An acid catalysed esterification/protection furnished diester (S,S)155 (92%) which was reduced to diol (R,R)-156 (69%).† Conversion to dimesylate
(R,R)-157 (61%) followed by acid catalysed deprotection afforded diol (R,R)-158 (86%)
which was cyclised to bioxirane (R,R)-87 with aqueous base (76%).
O
HO

OH
OH

HO

TsOH, Me2C(OMe)2
MeOH, cyclohexane
70 oC, 48 h
92%

O
O

OMe
OMe

NaBH4, MeOH
0 oC to RT, 2 h
then reflux, 18 h
69%

O
(S,S)-155

O
MsCl, NEt3
CH2Cl2
0 oC to RT, 2 h
61%

O

O
O

OMs
OMs
(R,R)-157

MsOH
95% EtOH
reflux, 20 h
86%

O

OH
OH

O

(R,R)-156

OH
OMs

MsO
OH
(R,R)-158

KOH(aq)
Et2O
RT, 2 h
76%

O
O
(R,R)-87

Scheme 3.32: Synthesis of bioxirane (R,R)-87 from D-tartaric acid as previously
108,110
described.

The ring opening of bioxirane (R,R)-87 was subsequently performed with Grignard 91
giving diol (R,R)-105 (31%) after crystallisation directly from the crude mixture
(Scheme 3.33).‡ This was converted to dimesylate (R,R)-131 (84%) which was
subjected to standard azidation conditions, requiring an overtly long reaction time (264
h) to be completely consumed. The chromatographically inseparable elimination
product (alkene (S)-137, ~25% yield) was removed by oxidation affording diazide (S,S)138 in 47% yield. Subsequent Staudinger reduction provided complete conversion to
diamine (S,S)-143 which was isolated by crystallisation as its dihydrochloride salt
before liberation with hydroxide (71%). A small quantity of the Staudinger PPh3O byproduct was carried through as an impurity to the palladium catalysed microwave
cyclisation, which afforded biindoline (S,S)-38 in 57% yield.

†

Both diester (S,S)-155 and diol (R,R)-156 are commercially available from Sigma-Aldrich.
In this case 5 mol% CuI was used (based on the excess Grignard) in an attempt to minimise the addition
of iodide to the bioxirane. However this did not improve the outcome and provided a slightly lower
conversion to the desired product (compare to the results in Section 3.2.2).
‡
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(i) 5 mol% CuI
THF, -40 oC, 10 min
(ii) 0.38 eq. (R,R)-87
-40 to -10 oC, 5 h
MgCl
31%

Br

i-PrMgCl, THF
-40 to -25 oC, 2 h

Br

OH
(R,R)-105

91
MsCl, NEt3,
CH2Cl2
0 oC to RT, 3 h
84%

Br

(i) NaN3, DMF
80 oC, 264 h
(ii) KMnO4(aq)
THF, RT, 12 h
47%

OMs

OMs
(R,R)-131
PPh3, THF
RT, 2 h
then H2O
reflux, 13 h
71%

Br

Boc2O, NEt3
THF, RT, 144 h
76%

Br

Br

N3
N3

Br

Br

(S,S)-138
20 mol% Pd(OAc)2
40 mol% ±-BINAP
NaOt-Bu, toluene
120 oC, microwave, 4 h
57%

NH2
NH2
(S,S)-143

OH

Br

N
N
H
H
(S,S)-38
>99% ee

N
N
Boc Boc
(S,S)-82

Scheme 3.33: Synthesis of diol (R,R)-105 from bioxirane (R,R)-87 and subsequent elaboration
to enantiomerically pure biindoline (S,S)-38 using conditions previously established with
racemic samples (see Section 3.3).

The enantiomeric purity of biindoline (S,S)-38 (>99% ee) was determined by preparing
the Boc derivative (S,S)-82 (76%, Scheme 3.33) and performing HPLC analysis relative
to a sample enriched in the R,R-enantiomer which was previously synthesised in our
laboratory (see Scheme 3.1).107 Selected HPLC traces are given in Figure 3.3 showing
(1) the result of an injection of biindoline (S,S)-82 with a retention time of ~10 min and
(2) an injection of the same sample spiked with the R,R-enantiomer in which an
additional peak was observed with a retention time of ~13 min.
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1) Biindoline (S,S)-82
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2) Biindoline (S,S)-82 + (R,R)-82

Figure 3.3: HPLC traces of 1) Biindoline (S,S)-82 and 2) Biindoline (S,S)-82 + (R,R)-82. Traces
were obtained using a Daicel Chiralcel OD-H column with a UV detector (254 nm) and 2.5% iPrOH:hexane as the eluent (flow rate 0.5 mL/min).

An unidentified impurity (~2%) was also eluted prior to the chiral compound at 9.7 min.
This impurity was not previously detected by NMR analysis and was neither the meso
isomer, for which the NMR data was known from previous work in our laboratory,107 or
the R,R-enantiomer which clearly had a longer retention time.

3.5 Alternative Synthesis of 2,2'-Biindoline
Although the synthesis of biindoline (S,S)-38 from bioxirane (R,R)-87 provided the
target compound in enantiomerically pure form, the strategy ideally needed to be
modified in order to avoid the low yielding ring opening with Grignard 91 and the
extremely inefficient azidation reaction for introduction of the nitrogen atoms.
A potential remedy would be to use the known dilithiated aryl nucleophile 159 for the
ring opening of bioxirane (R,R)-87 which would afford diol (R,R)-81 with the required
nitrogen atoms installed (Scheme 3.34). This reagent can be generated in situ via the
treatment of N-Boc aniline with two equivalents of t-BuLi.154-156 A major advantage of
this approach is that diol (R,R)-81 can be elaborated to biindoline (S,S)-38 in three steps
established previously in our laboratory (see Scheme 3.1).‡

‡

Diol 81 was synthesised previously in our laboratory in low optical purity using Sharpless AD (see
Scheme 3.1).107
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NLiBoc (i) (Cu salt)
Li (ii) (R,R)-87

NHBoc

OH
(R,R)-81

159

(i) mesylation
(ii) cyclisation
(iii) deprotection

OH

N
N
H
H
(S,S)-38

NHBoc

Scheme 3.34: Proposed alternative synthetic route to biindoline (S,S)-38 via the ring opening of
bioxirane (R,R)-87 with aryllithium 159. Diol (R,R)-81 can be elaborated to the target
compound in three steps established previously in our laboratory.107

Although there are no reports of the addition of aryllithium 159 to epoxides, there is an
example of its use to ring open an aziridine 161 after transmetallation to the higher
order cyanocuprate157 derivative 160, leading to the core structure 162 of the drug
sumanirole (Scheme 3.35).154 It is also known to react directly with a range of
electrophiles including, for example, S2Me2.155
SES = trimethylsilylethanesulfonyl
0.5 eq.
CuCN·LiCl

161

2

NLiBoc
Li

159

NLiBoc
Cu·Li2CN Cl

SES
N

160
S2Me2
89%

NHBoc
SMe

NHBoc
Cl
NHSES
69%
overall
NHSES
N
H
162

Scheme 3.35: Selected reactions of aryllithium 159 previously reported.154,155 The ring opening
of aziridine 161 was performed after transmetallation to the cyanocuprate derivative 160.

3.5.1 Ring Opening of Racemic 2,2'-Bioxirane with Lithium tert-Butoxy
carbonyl(2-lithiophenyl)amide
Therefore, a series of trial reactions of aryllithium 159 were carried out with the racemic
bioxirane 87 under various conditions in the presence and absence of CuCN (Scheme
3.36). In all cases a plethora of products were detected by TLC analysis and the crude
mixtures were subjected to column chromatography to enable the isolation and
characterisation of the major products, shown below.
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NHBoc

163
dilithiation: 2 eq. t-BuLi
NLiBoc
Li

159
o

(i) (0.5 eq. Cu source, -50 C, 20 min)
(ii) 0.15 eq. 87
BocHN

BocHN

O

BocHN
NH

+

N
H
164

O
O

O

NH2

+
N
H

166

165
BocHN

O
NHBoc

+

NH

O

NH2

OH
81
(in mixture)

167

Dilithiation
Conditions

Cu
Source

OH

+

Reaction
Conditions (ii)

NHBoc

Yield (%)
a

b

163 164 165b 166b 167b 81
1 THF, -20 oC, 2 h CuCN·LiCl -50 to -10 oC, 2 h 42
19
5
mc
o
o
2 Et2O, -10 C, 3 h CuCN
-78 to 0 C, 1 h
19
32
6
mc
o
o
d
3 Et2O, -10 C, 3 h None
-78 to 25 C, 10 h 31
5
m
18
1
a
Recovered N-Boc aniline. bYield based on N-Boc aniline. cDiol 81 was eluted in a mixture (m)
of unknown polar compounds. dObserved in a mixture (m) with aniline 167 and an unidentified
compound.
Scheme 3.36: Results of the attempted ring opening of bioxirane 87 with aryllithium 159 in the
presence and absence of CuCN. Yields represented with a dash indicate that the compound was
not observed.

The reaction of bioxirane 87 with cyanocuprate 160, generated as described,154 gave
amide 164 (19%) and diamide 165 (5%) as side products (entry 1). A mixture of polar
compounds was also obtained which contained diol 81 as determined by comparison of
NMR spectra with that of an authentic sample.107 Although the yield could not be
quantified, the mass of the mixture indicated a low conversion to the desired product
(<25%). The structures of other constituents were unable to be elucidated, however
evidence of an undesired cyclisation of the mono ring opened intermediate 168, through
nucleophilic attack of the N-Boc anion on the second epoxide, was provided by ES+ MS
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analysis (Scheme 3.37).‡ Peaks at m/z 280, 302 and 318 were respectively assigned to
the M+H, M+Na and M+K adducts of diol 169a and/or the isomer 169b.
1) NLiBoc

2)

O

NLiBoc
O

OLi
168

OLi
168

OH
OH

BocN

OH
ES+ MS:
m/z
280 M+H
302 M+Na
318 M+K

BocN

OH

169b

169a

Scheme 3.37: The undesired intramolecular addition of the N-Boc anion to the second epoxide
unit giving 1) a six-membered heterocycle 169a and/or 2) a seven-membered heterocycle 169b.

In order to unequivocally prove that diol 81 had been produced, the mixture was
subjected to the established mesylation and cyclisation conditions107 giving
spectrochemically pure biindoline 82 after column chromatography, in an overall yield
of 9% from bioxirane 87 (Scheme 3.38).

NHBoc

(i) MsCl, NEt3, CH2Cl2
0 oC to RT, 48 h
(ii) NaH, THF
0 oC to RT, 43 h
9% overall

OH

O
O

87

OH
81
(in mixture)

NHBoc

N
N
Boc Boc
82

Scheme 3.38: The conversion of diol 81 within a mixture of unknown compounds to biindoline
82 using reactions previously established in our laboratory.107 The overall yield is based on
bioxirane 87.

Although used in excess of the bioxirane, a considerable quantity of N-Boc aniline 163
was also recovered from the attempted ring opening reaction (42%). Therefore it was
not clear whether the poor outcome was due to a low reactivity of cyanocuprate 160
towards the bioxirane or an incomplete initial dilithiation. It has been reported that the
use of Et2O as the solvent (as opposed to THF) for the reaction of N-Boc aniline with tBuLi enables a significant increase in the extent of ortho-lithiation (from ~60% to

‡

N-Boc anions are capable of ring opening epoxides in the intramolecular mode.158
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~90%)156 due to the much greater stability of t-BuLi in Et2O.† Therefore, the dilithiation
and ring opening protocol was repeated using Et2O as the solvent (Scheme 3.36, entry
2). It should also be noted that in this case cyanocuprate 160 was prepared by
transferring the solution of aryllithium 159 to a suspension of CuCN in order to avoid
the use of LiCl as a solubilising additive115 and the possibility of competing epoxide
ring opening by chloride.119 In comparision to the first attempt, this reaction afforded
amides 164 (32%) and 165 (6%) in higher yields and resulted in a greater consumption
of N-Boc aniline 163 (19% recovery) however the yield of diol 81 (within a mixture of
the same unknown compounds) appeared to be lower.
The final attempt at the ring opening was performed in the absence of CuCN using a
general procedure reported for the reaction of aryllithium 159 with electrophiles
(Scheme 3.36, entry 3).156 Under these conditions, amide 164 (5%) was formed along
with additional side products including anilines 166 (18%) and 167 (1%). Further eluent
fractions also contained aniline 167 in a mixture with a small quantity of diamide 165
and an additional unidentified compound. No spectral evidence of the desired ring
opened product or diol isomers 169 was observed.
The dimetallated nucleophile used in these reactions has two resonance contributors,
170a and 170b (Scheme 3.39). A small percentage of isocyanoate 171, formed by
dissociation of tert-butoxide from the N-Boc anion,159 would also be in equilibrium with
these structures.‡ This functional group is highly susceptible to attack by nucleophiles
such as organolithiums,156,160 cuprates161 and amines.159
susceptible to
nucleophilic
attack

M = Li or (o-NLiBocPh)Cu·Li2CN

Ot-Bu

Ot-Bu
N

170a

OLi
M

LiN

170b

O
M

-t-BuOLi

N

C

O
M

171

Scheme 3.39: Resonance contributors 170a and 170b of the dimetallated nucleophile. The
reversible dissociation of t-BuOLi from these structures gives the highly electrophilic
isocyanate 171.
†

The half life of t-BuLi at -20 oC is 483 min in Et2O and 42 min in THF.156
Equilibration of the N-Boc anion with an isocyanate has been proven by exchange of t-BuO- with
deuterium labelled t-BuO- (d9).159

‡
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A plausible set of pathways to explain the formation of the side products isolated is
therefore proposed in Scheme 3.40. Attack of aryl nucleophile 170 on isocyanoate 171
would give the key intermediate 172 which would be converted to amide 164 upon
work-up.‡ Preceding this, the N-Boc anion of intermediate 172 could also expel tertbutoxide to give an isocyanoate which could be attacked by a second molecule of the
aryl nucleophile leading to diamide 165. It is also feasible that further reactions
occurred in this fashion to give tetraaryl and larger molecules although the quantities of
these products would presumably be minimal.
The increased yields of the amides 164 and 165 and reduced recovery of N-Boc aniline
163 when using Et2O as the solvent instead of THF (Scheme 3.36, compare entries 1
and 2) could be explained by a more efficient dilithiation156 leading to a greater
concentration of intermediate 172.

‡

This is consistent with the proven pathway in which amines add to the Boc anion via isocyanates to give
ureas.159 There is also a report of aryllithium 159 being quenched with an isocyanate to give an amide.156

77

CHAPTER 3

Synthesis of 2,2'-Biindoline from 2,2'-Bioxirane

BocLiN

OLi

BocHN

N LiO

M

O
NH

H2O

N

N
H
165

NLiBoc
M
O

170

NLiBoc
M

C

O

N

-t-BuOLi
170

N

C

O
BocLiN LiO
M

M

BocHN

O

H2O

N

N
H

172

164

171
(warm to RT) LiO

M
N

M = Li or Cu(o-NLiBocPh)·Li2CN
BocLiN
NLi
OLi

H2O

BocHN

173

-t-BuOLi

NH2

O

166

NLiBoc
M

170
BocLiN

O

C

N

OLi

BocHN

N
NLi
OLi

H2O

O
NH

O

NH2

167

Scheme 3.40: Proposed set of pathways to rationalise the formation of side products 164-167
during the attempted ring opening of bioxirane 87 with dimetallated nucleophile 170.

The reaction performed without copper (Scheme 3.36, entry 3) was allowed to warm to
room temperature and most of intermediate 172 was presumably consumed by
cyclisation to azetidine 173, resulting in a favourable migration of the carbanion to the
adjacent nitrogen. Hydrolysis of azetidine 173 would generate the ketone and aniline
functionalities of side product 166. In the same fashion as described for intermediate
172, azetidine 173 could also be attacked by aryl nucleophile 170 after isocyanoate
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equilibration to furnish aniline 167 upon work-up. Given that the attempted ring
openings with cyanocuprate 160 were quenched at or below 0 oC and shorter reaction
times were used (Scheme 3.36, entries 1 and 2), it is not clear whether cyclisation of
intermediate 172 (where M = Cu(o-LiBocPh)·Li2CN)157 would also occur at ambient
temperature. However, it appears reasonable to presume that the rate of this process
would be faster with the aryllithium analogue (172, M = Li) due to its higher basicity
and lesser degree of steric encumbrance.
Considering that the desired ring opening of bioxirane 87 with aryllithium 159 (and its
cyanocuprate derivate 160) had been relatively unsuccessful, no attempt was made to
perform a chiral synthesis of biindoline 38 using this methodology.

3.6 Summary and Outlook
This chapter presented our new synthetic strategy to the second target parent ligand 2,2'biindoline 38, which utilised the ring opening of a chiral bioxirane 87 with orthosubstituted phenyl nucleophiles as the key step.
Attempts to ring open the racemic bioxirane with Grignards 88 gave undesired diols 174
and/or 119 in all cases, arising from addition of the halide anions (Scheme 3.41). The
resulting product distributions were governed by the electron donating capacity of the
ortho substituent (OMe > Br > NO2). Consequently, the methoxy derivative gave the
highest yield of diol 84 while only mono aryl addition was observed using the nitrosubstituted Grignard. Significant aryl homo-coupling also occurred in the latter case as
an additional undesired side reaction, indicative of single electron transfer redox
processes.
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(i) 10 mol% CuI
(ii)
O
R
MgX

O

R

R

OH

87

OH

OH
X +
X

+
OH
84

88

OH
174

R

X
OH
119

R = OMe 68% (89)
Br 35% (105)
NO2 0%

X = I, Br, Cl

R = OMe

Br

NO2
electron
withdrawing

electron
donating
aryl addition
predominates

halide addition
predominates

Scheme 3.41: Summary of the results obtained during the ring opening of bioxirane 87 with
ortho-substituted phenyl Grignard reagents 88.

A general approach to potentially increasing the extent of aryl addition to the bioxirane
would be to use the diarylmagnesium reagents (R2Mg) instead of the corresponding
Grignards (RMgX). These reagents could be prepared using dioxane-precipitation
methodology162 and would bring the advantage of eliminating the halide competing in
stoichiometric quantities† with the aryl nucleophile for addition to the bioxirane.
Alternatively, a route to the chiral diol (R,R)-84 which circumvents the ring opening
reaction could be realised through the copper catalysed alkylation of Grignard 88 (or the
corresponding aryllithium) with dimesylate (R,R)-157‡ (Scheme 3.42).163
(i) CuX
(ii)
O
R

MsO
MgX

88

O

(R,R)-157

O

OMs

O

R

OH

deprotection

R

R

OH
(R,R)-84

R

Scheme 3.42: Alternate synthetic route to diol (R,R)-84 which avoids the ring opening reaction.

The chiral bromo-substituted diol (R,R)-105 was accessed via the ring opening of
bioxirane (R,R)-87 with Grignard 91 and was subsequently used to perform the first
synthesis of enantiomerically pure biindoline (S,S)-38 in four steps, the most notable of
†

Iodide would still be present in a catalytic quantity - CuI is required in 10 mol% quantities next to the
organomagnesium reagent for catalytic efficiency.
‡
Accessible from D-tartaric acid in three steps (see Scheme 3.32).
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which was a palladium catalysed regioselective cyclisation which proceeded under
microwave irradiation. A considerable drawback of this synthesis however was the need
to introduce the nitrogen atom by an extremely slow azidation reaction in which a
significant quantity of an undesired elimination product was produced.
Therefore, we revisited the ring opening of racemic bioxirane 87 using aryllithium 159,
which would afford diol 81 with the required nitrogen atoms installed. In the event,
aryllithium 159 was found to be unreactive towards the bioxirane, however the use of
the cyanocuprate derivative 160 provided the desired product, albeit in a mixture of
chromatographically inseparable compounds and in a low yield. Despite these results,
this strategy remains of interest due to the ease in which diol 81 can be converted to the
biindoline scaffold, as demonstrated in this project and previously in our laboratory.107
The outcome of this ring opening could potentially be improved with Lewis acid
catalysts (eg: BF3)164 or by using the Gilman cuprate derivative of the aryllithium.‡
Considering that the N-Boc anion is a strongly electron donating substituent, it is also
feasible that transmetallation of aryllithium 159 with a magnesium halide salt165 to the
corresponding Grignard 175 could provide a more reactive species under the standard
CuI catalysed protocol (Scheme 3.43).
(i) 10 mol% CuI
(ii)
O
NLiBoc
Li

159

MgX2

NLiBoc
MgX

175

+ LiX

O
(R,R)-87

NHBoc

OH

OH
(R,R)-81

NHBoc

Scheme 3.43: Proposed transmetallation of aryllithium 159 to Grignard 175 and subsequent CuI
catalysed ring opening of bioxirane (R,R)-87.

Four new polyaryl compounds 164-167 were also isolated from these trial reactions, all
of which were proposed to arise from an initial nucleophilic attack of aryl nucleophile
170 on the isocyanate intermediate 171 generated from the N-Boc anion. With the aim
of eliminating these undesired side reactions and inturn, potentially improving the
desired ring opening, it is suggested to protect the aniline as the pivalyl amide instead of
the Boc carbamate. This moiety retains the tert-butyl appendage to shield the carbonyl
‡

A Gilman cuprate (R2CuLi) is formed by the combination of two equivalents of an organolithium reagent
with one equivalent of a Cu(I) halide salt, generating LiX as a by-product.116 Therefore, this reagent
should be used with caution due to the introduction of a stoichiometric competing halide.
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group from nucleophilic attack during dilithiation but does not have the ability to
equilibrate with an isocyanate after N-deprotonation, which would require expulsion of
the highly unstable tert-butyl anion (Figure 3.4).
O
HN

O
Ot-Bu leaving
group

HN

t-Bu

cannot
leave

Figure 3.4: Suggested modification of the nitrogen protecting group from the Boc carbamate to
the pivalyl amide to avoid side reactions associated with dissociation of tert-butoxide.

Another potential nucleophile for the ring opening is the previously unreported
Grignard 176 (Scheme 3.44). This reagent should be accessible by Mg/I exchange
methodology‡ and has the required anilino nitrogen protected as an electron donating
imine moiety.
Ph

Ph
N

i-PrMgCl

N

I

MgCl

176

Scheme 3.44: Alternative Grignard reagent 176 for the ring opening of bioxirane 87 which
should be accessible by Mg/I exchange.166

Overall, bioxirane 87 was demonstrated to be a suitable chiral precursor to the target
ligand 2,2'-biindoline 38. However, for an efficient synthesis, the ortho-substituent of
the aryl nucleophile used for the ring cleavage should be a (protected) nitrogen atom in
order to avoid the need for subsequent introduction of the heteroatom as the azide
nucleophile. Accordingly, a recent result from our laboratory using the pivalyl amide
protecting group is shown in Scheme 3.45. Aryllithium 177 was prepared as previously
described167 and used to ring open racemic bioxirane 87 in a promising yield (62%)
without the formation of side products.168 The synthesis of 2,2'-biindoline from diol 178
is currently under investigation.

‡

A range of structurally similar Grignard reagents have been prepared by Mg/I exchange and reacted
with various electrophiles without interference by the imine moiety.166
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O
2 eq. n-BuLi
NHPiv Et2O/THF
0 oC to RT, 18 h

O

NLiPiv
87
Li 0 oC to RT, 5 h
62%
177

O
NHPiv

OH

OH
178

Piv =

t-Bu

NHPiv

Scheme 3.45: The dilithiation of N-pivalyl aniline167 and subsequent ring opening of bioxirane
87 recently performed in our laboratory.168
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CHAPTER 4
The Synthesis of 2,2'-Biindoline from N,N'-Di-tert-butoxycarbonyl-2,2'biaziridine

An alternative approach to the synthesis of biindoline (S,S)-38 was concurrently
investigated using biaziridine (S,S)-179 as the chiral building block, such that copper
catalysed ring opening with Grignard 91 would directly install the required nitrogen
atoms (Scheme 4.1). Subsequent deprotection would furnish the penultimate diamine
(S,S)-143 to be cyclised using the established palladium catalysed microwave
conditions.
Cu catalysed ring
opening with
NR Grignard 91
RN
(S,S)-179

Br

NHX
cyclisation

Br

NHX
MgCl
deprotection

Br

X=R
X = H (S,S)-143

N
N
H
H
(S,S)-38

91

Scheme 4.1: Proposed alternative synthesis of biindoline (S,S)-38 using the ring opening of
biaziridine (S,S)-179 as the key step.

Both the Boc (179, R = Boc) and tosyl (179, R = Ts) derivatives of the biaziridine are
known.169-171 Although there are no reports of the ring opening of either molecule with
carbon nucleophiles, there are numerous examples of the cleavage of Boc- and tosylsubstituted mono-aziridines by organocuprates.172-174 Therefore, either derivative of
biaziridine 179 should be suitable for the intended ring opening reaction. However,
given that strong reducing conditions are required to remove the tosyl group in good
yield,175,176 the acid labile Boc carbamate was selected as the protecting group for the
sequence.

4.1 Synthesis of (2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biaziridine
Biaziridine (S,S)-183 was prepared as previously described (Scheme 4.2)171 by firstly
treating dimesylate (R,R)-158‡ with NaN3 to give diol (R,R)-180 (85%).177 Reduction
with catalytic palladium on carbon under a hydrogen atmosphere followed by Boc
‡

This compound was prepared from D-tartaric acid as described in Chapter 3, Section 3.4.
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protection of the resulting diamine gave diol (R,R)-181 (83%), which was converted to
dimesylate (R,R)-182 (95%). Subsequent deprotonation with NaH facilitated SN2
cyclisation to biaziridine (S,S)-183 (94%).†

OH
MsO

NaN3, DMF
o
OMs 80 C, 48 h
85%

OH
N3

(i) 10 mol% Pd/C, H2(g)
EtOH, RT, 23 h
(ii) Boc2O
RT, 28 h
N3
BocHN
83%

OH
NHBoc
OH

OH

OH

(R,R)-181

(R,R)-180

(R,R)-158

MsCl, NEt3, CH2Cl2
0 oC to RT, 24 h
95%

OMs
BocHN
OMs
(R,R)-182

NaH, THF
o
NHBoc 0 C to RT, 14 h
94%

NBoc
BocN
(S,S)-183

[α]23
D -145
20

Lit. (R,R)-183171 [α]D +175

Scheme 4.2: Synthesis of biaziridine (S,S)-183 from dimesylate (R,R)-158 as previously
171,177
described.

In contrast to that reported,171 analysis of the 13C NMR spectrum of the biaziridine did
not indicate the presence of rotamers - a single peak was observed for each (nonequivalent) carbon atom. The specific rotation of biaziridine (S,S)-183 in MeOH ( [α]23
D 145) was also significantly lower than expected based on the reported rotation of the
‡171
(R,R)-enantiomer ( [α]20
D +175).

4.2

Ring

Opening

of

(2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-

biaziridine
The ring opening of biaziridine (S,S)-183 was performed using a procedure analogous to
that reported for the CuBr·SMe2 catalysed cleavage of a Boc-protected mono-aziridine
with phenyl Grignard reagents.174 Trial reactions were performed with i-PrMgCl and 2methoxyphenylmagnesium bromide 90 before attempting the desired ring opening with
2-bromophenylmagnesium chloride 91 (Scheme 4.3). The biaziridine was completely
consumed in all cases providing a good overall yield of the desired dicarbamate (S,S)†

Biaziridine (R,R)-183 was also synthesised in one-pot from diol (S,S)-180 using a Staudinger
reduction/cyclisation (71%).171 Attempts to repeat this procedure in our laboratory resulted in
consistently poor yields (20-25%). The specific rotation of the S,S enantiomer was not reported.
‡
Subsequent chiral HPLC analysis of the target biindoline prepared from this sample of (S,S)-183
confirmed that the biaziridine was enantiomerically pure (see Figure 4.3).
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185 and the unforeseen imidazolidinone (S,S)-186 after chromatographic purification.
No side products arising from the addition of halides were observed.

RMgX
184

15 mol% CuBr·SMe2
0.13-0.20 eq. (S,S)-183
THF, -40 to -10 oC

NHBoc
R

R

R
+

NHBoc

R

X

HN

NBoc

R
+

O
(S,S)-186

(S,S)-185

184

R

R
HN

NH

O
(S,S)-187

Yield (%)a
Time
(h) 185 186 187
3
22 63
190
2
17 50
9c
193
6
24 42
196
described in Chapter 3, Section 3.2.1
silica gel chromatography. dPrepared as

185 186 187

1
i-Pr
Cl 188 189
2 90b 2-methoxyphenyl Br 191 192
3 91d
2-bromophenyl Cl 194 195
a
Yield based on biaziridine (S,S)-183. bPrepared as
c
Believed to be a result of degradation of 192 during
described in Chapter 3, Section 3.2.2.

Scheme 4.3: Results of the CuBr·SMe2 catalysed ring opening of biaziridine (S,S)-183 with
alkyl and aryl Grignard reagents 184. Yields represented with a dash indicate that the compound
was not observed.

The ring opening of biaziridine (S,S)-183 with i-PrMgCl (entry 1) afforded dicarbamate
(S,S)-188 (22%) and imidazolidinone (S,S)-189 as the major product (63%). A similar
product distribution was observed using Grignard 90 (entry 2), which gave dicarbamate
(S,S)-191 (17%) and imidazolidinone (S,S)-192 (50%). The Boc-deprotected
imidazolidinone (S,S)-193 (9%) was also isolated from this reaction after column
chromatography. This compound however was not detected by analysis of the crude
NMR spectrum and was believed to be a result of degradation of imidazolidinone (S,S)-

192 on silica gel. The final attempt with Grignard 91 (entry 3) proceeded in a similar
fashion to provide dicarbamate (S,S)-194 (24%) and imidazolidinone (S,S)-195 (42%).
The 13C NMR spectrum of dicarbamate (S,S)-188 showed two peaks upfield at 21.9 and
23.4 ppm assigned to the diastereotopic methyl carbon atoms (Figure 4.1).
21.9 ppm

23.4 ppm

BocHN

NHBoc
(S,S)-188

Figure 4.1: Chemical shifts of the diastereotopic methyl carbon atoms of dicarbamate (S,S)188.
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In the spectrum of the corresponding imidazolidinone (S,S)-189, the diastereotopic
methyl carbons were also resolved, however in this case four signals were observed
(21.4, 21.9, 22.8 and 23.8 ppm) due to the loss of C2 symmetry.

4.2.1 Mechanism of N-Boc-2-Imidazolidinone Formation
Two feasible pathways for the formation of imidazolidinone (S,S)-186 are proposed in
Scheme 4.4. Firstly, the desired double ring opening would give dianion (S,S)-197,
which could equilibrate with mono-isocyanate (S,S)-198‡ facilitating intramolecular
nucleophilic attack by the adjacent nitrogen anion to give the observed imidazolidinone
upon work-up. Alternatively, the first ring opening would give anion (S,S)-199, which
could attack the Boc carbonyl group in an intramolecular fashion expelling tertbutoxide and forming fused aziridine (S,S)-200. Further ring opening and subsequent
hydrolysis would complete the second pathway to imidazolidinone (S,S)-186.
1)

BocN

double
NBoc ring opening
R

BocN
(S,S)-183

BocN
R -t-BuO

R

R

NBoc

N

C

(S,S)-198

(S,S)-197

R = i-Pr
2-methoxyphenyl
2-bromophenyl

O

R

R
NBoc H2O

N

R

R
HN

O
(S,S)-186

O

2)

NBoc

BocN
(S,S)-183

1st ring
opening

2nd ring
opening

BocN

R

R -t-BuO
N
t-BuO
O
(S,S)-199

NBoc

N

NBoc

O
(S,S)-200

Scheme 4.4: Two proposed pathways for the formation of imidazolidinone (S,S)-186 during the
ring opening of biaziridine (S,S)-183.

Presumably if the first pathway is predominant, providing the Grignard reagent,
concentration and temperature are kept constant, a longer reaction time would correlate
to a decrease in the product ratio of dicarbamate (S,S)-185 to imidazolidinone (S,S)-186
indicating that the latter is formed primarily through dianion (S,S)-197. Conversely, if

‡

See Chapter 3, Section 3.5.1, for a discussion on this mode of reactivity of the N-Boc anion.
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the second pathway is predominant, the reaction time should have minimal effect on the
product ratio. Although efforts could be directed towards investigating this further, the
product ratio should have no consequence on the intended synthesis of 2,2'-biindoline
given that both dicarbamate (S,S)-194 and imidazolidinone (S,S)-195 should be able to
be hydrolysed/deprotected to the penultimate diamine (S,S)-143 (Scheme 4.5).
Br
Br

Br

BocHN
+
NHBoc

Br

deprotection/
hydrolysis
HN

Br

(S,S)-194

NH2

NBoc

NH2

Br

(S,S)-143

O
(S,S)-195

Scheme 4.5: Proposed global deprotection/hydrolysis of dicarbamate (S,S)-194 and
imidazolidinone (S,S)-195 to give diamine (S,S)-143.

4.3 Hydrolysis/Deprotection of N-Boc-2-Imidazolidinones
Given that dicarbamate (S,S)-194 should be easily hydrolysed to diamine (S,S)-143 with
acid,178 we first investigated conditions to affect this transformation from the
imidazolidinone. Treatment of imidazolidinone (S,S)-195 with concentrated HCl at
room temperature resulted in isolation of the Boc-deprotected imidazolidinone (S,S)-196
(97%) without any cleavage of the urea unit evident (Scheme 4.6). An attempt to
hydrolyse this intermediate under more forcing conditions (2 M HCl/AcOH at reflux)179
was also unsuccessful and returned only starting material.
Br

Br

HN

NBoc

32% HCl, Et2O
RT, 75 h

Br

NH2

X
NH2
(S,S)-143

O
(S,S)-195

Br

2 M HCl, AcOH

X reflux, 24 h
Br

Br

97%
HN

NH

O
(S,S)-196

Scheme 4.6: Attempted conditions for the deprotection/hydrolysis of imidazolidinone (S,S)-195
to diamine (S,S)-143.
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Further investigations were performed using imidazolidinone (S,S)-189 as a model
system (Scheme 4.7). Under alkaline conditions, previously reported to cleave a tosylsubstituted cyclic imidazolidinone,180 only the Boc group was removed, affording
imidazolidinone (S,S)-190 in 98% yield. Treatment of imidazolidinone (S,S)-189 with
concentrated HCl/MeOH at reflux181 also gave predominantly the deprotected product
(S,S)-190, however analysis of the ES+ MS of the crude sample showed a small peak at

m/z 173 assigned to the M+H ion of diamine (S,S)-201, indicating that partial urea
cleavage had occurred and that harsher conditions may be more effective. Accordingly,
imidazolidinone (S,S)-190 was suspended in concentrated HCl and heated under
microwave irradiation at 110 oC for 10 h.182 This resulted in complete consumption of
the imidazolidinone and gave a product assigned as diamine (S,S)-201 (72%) by ES+
MS analysis, in which the base peak at m/z 173 was assigned to the M+H ion.‡
Ba(OH)2·8H2O
80% EtOH,
reflux, 36 h
98%
HN

NBoc

HN
32% HCl/MeOH
(8:1), reflux
18 h, then NaOH

O
(S,S)-189

NH

32% HCl
microwave, 110 oC
10 h, then NaOH
72%

NH2
NH2

O
(S,S)-190

(S,S)-201
M+H = 173

mostly 190 (NMR)
evidence of 201 (ES+ MS)

Scheme 4.7: Attempted conditions for the deprotection/hydrolysis of imidazolidinone (S,S)-189
to diamine (S,S)-201.

The acid hydrolysis of a small sample (20 mg) of imidazolidinone (S,S)-195 was
subsequently attempted under microwave irradiation resulting in the desired
simultaneous Boc-deprotection/urea cleavage to afford diamine (S,S)-143 in 89% yield
(Scheme 4.8).
Br

Br

HN

NBoc

O
(S,S)-195

32% HCl
microwave
110 oC
12 h, then NaOH
89%

Br

NH2
NH2

Br

(S,S)-143

Scheme 4.8: Acid hydrolysis of imidazolidinone (S,S)-195 to diamine (S,S)-143 under
microwave irradiation.

‡

This compound degraded before further spectral characterisation could be performed.
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4.4 Synthesis of (2S,2'S)-2,2'-Biindoline
Given that the synthesis of the penultimate diamine (S,S)-143 from biaziridine (S,S)-183
was now established, the ring opening with Grignard 91 was repeated on a larger scale
with

the

aim

of

combining

the

expected

products

for

a

global

acid

hydrolysis/deprotection under microwave irradiation (Scheme 4.9). Work-up and
subsequent column chromatography afforded dicarbamate (S,S)-194 (~5%) with minor
impurities and imidazolidinone (S,S)-195 (49%). The overall conversion of the
biaziridine (54%) was comparable to the previous ring opening reaction (66%, see
Scheme 4.3, entry 3),‡ however considering the low yield of (S,S)-194 and the
impurities present, this dicarbamate was not elaborated further.
Therefore, imidazolidinone (S,S)-195 was subjected to the established microwave
hydrolysis conditions. The resulting insoluble dihydrochloride salt of diamine (S,S)-143
was vigorously stirred in CH2Cl2/Et2O before being collected by vacuum filtration.
Sequential treatment with hydroxide and organic extraction furnished a mixture of the
desired diamine (40%) and the Boc-deprotected imidazolidinone (S,S)-196 (19%). This
was unexpected as it was anticipated that the latter, if present, would have dissolved in
the organic solvent prior to filtration.

‡

Although the previous ring opening used a shorter reaction time (6 h), it was performed at half the
concentration. Therefore, no conclusions can be drawn from the differing product ratios regarding the
predominant pathway by which the imidazolidinone is formed.
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15 mol% CuBr·SMe2
0.20 eq. (S,S)-183
o
MgCl THF,-40 to -10 C, 9 h
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O
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18 h, NaOH
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(S,S)-196, 19%
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15 mol% ±-BINAP
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+
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H
(S,S)-151, 3%
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H
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>99% ee

N
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+
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+

N
H

N
N
H
H
(S)-203
mixture, <5% combined

Scheme 4.9: Synthesis of biindoline (S,S)-38 from biaziridine (S,S)-183 using conditions
previously established on a smaller scale.

The solubility of imidazolidinone (S,S)-195 in water was extremely low even at high
temperatures with EtOH as a co-solvent. Therefore, the failure of the hydrolysis to go to
completion was attributed to the need to significantly increase the substrate
concentration from that used in the previous reaction (see Scheme 4.8) in order to
satisfy the volume restrictions of the microwave vessel.
No further attempts were made to separate the diamine from imidazolidinone (S,S)-196
as the latter was inert to the cyclisation conditions, which afforded, after column
chromatography, the naphthyridine isomer (S,S)-151 (3%), a mixture tentatively
assigned by ES MS analysis as biindole 202 and indoline (S)-203 (<5% combined), and
the desired biindoline (S,S)-38 (79%) {see Appendix 3 for NMR spectra of (S,S)-38}.‡

‡

These yields are based on the quantity of diamine (S,S)-143 in the mixture used for the reaction.
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The 1H NMR spectra of structural isomers biindoline (S,S)-38 and naphthyridine (S,S)-

151 showed very similar chemical shifts for all proton signals. For example, the methine
(H2) and diastereotopic methylene protons (H3a and H3b) of biindoline (S,S)-38 were
assigned to peaks at 3.87, 2.71 and 3.17 ppm respectively while the corresponding
protons of naphthyridine (S,S)-151 resonated at 3.79, 2.75 and 3.16 ppm (Figure 4.2).
The magnitude of the geminal coupling between the methylene protons of the two
isomers was also similar [(S,S)-38: 2JH3a-H3b = 15.6 Hz, (S,S)-151: 2JH3a-H3b = 16.8 Hz].
However, due to the differing geometry and rigidity of the structures, the vicinal
coupling was significantly different. For example, the coupling between H2 and H3a in
biindoline (S,S)-38 was 8.1 Hz whereas the corresponding coupling in the naphthyridine
was 3.6 Hz.
3.16 ppm
2.71 ppm

3.17 ppm
2

JH3a-H3b = 15.6 Hz

3

JH2-H3a = 8.1 Hz

3

JH2-H3b = 8.7 Hz

H3b

H3a

2.75 ppm

3.79 ppm
H3b
H3a
H2 H
N

2

JH3a-H3b = 16.8 Hz

3

N H2 N
H
H
3.87 ppm
(S,S)-38

N
H
(S,S)-151

JH2-H3a = 3.6 Hz

3

JH2-H3b = 4.2 Hz

Figure 4.2: Chemical shifts and coupling constants of the methine and diastereotopic methylene
protons of biindoline (S,S)-38 and naphthyridine (S,S)-151.

Naphthyridine (S,S)-151 is structurally related to the commercially available chiral
diamine ligand (4aS,8aS)-decahydro-1,5-naphthyridine,† which is used in copper
catalysed enantioselective aryl homo-coupling reactions.28 Therefore, it is of interest to
us to investigate a method to reverse the regioselectivity of the cyclisation‡ in order to
obtain larger quantities of naphthyridine (S,S)-151 for its testing as a new chiral ligand.
Again, the enantiomeric purity of biindoline (S,S)-38 (>99% ee)
N
N
Boc Boc
(S,S)-82

was determined by preparing the Boc derivative (S,S)-82 (74% see Chapter 3, Scheme 3.33 for conditions) and performing

HPLC analysis relative to a sample enriched in the R,R-enantiomer. Selected HPLC
traces are given in Figure 4.3 showing (1) the result of an injection of biindoline (S,S)-

82 which had a retention time of ~11 min and (2) an injection of the same sample

†
‡

For the structure of this ligand and an example of its use, see Chapter 7, Section 7.1.
For a discussion on the regioselectivity of the cyclisation, see Chapter 3, Section 3.3.4.
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spiked with the R,R-enantiomer in which an additional peak was observed with
retention time of ~13 min.†
1) Biindoline (S,S)-82

2) Biindoline (S,S)-82 + (R,R)-82

Figure 4.3: HPLC traces of 1) Biindoline (S,S)-82 and 2) Biindoline (S,S)-82 + (R,R)-82. Traces
were obtained using a Daicel Chiralcel OD-H column with a UV detector (254 nm) and 2.5% iPrOH:hexane as the eluent (flow rate 0.5 mL/min).

The sample of biindoline (S,S)-82 was also spiked with the enantiomerically pure
product synthesised from bioxirane (R,R)-87 giving a single peak, as expected. Further
support of the HPLC results was provided by the specific rotation measurement ( [α]22
D -

88.6) which was essentially the same as that of the product prepared from the bioxirane
( [α]21
D -91.4).

The structure and relative stereochemistry of biindoline (S,S)-38 was confirmed by Xray analysis of a crystal grown from MeOH:CH2Cl2, shown from two perspectives in
Figure 4.4 (see Appendix 4 for complete crystal data).‡ The molecule was found to be
enantiomerically pure, however the absolute configuration could not be determined and
was assigned as S,S based on the configuration of the synthetic precursor (D-tartaric
acid).Within the crystal the free ligand adopts an essentially flat conformation enabling
H2 to be staggered with H2' (see H2 in Figure 4.2).

†

An unknown impurity (~1%) was also eluted prior to the chiral compound. For a brief discussion on this,
see Chapter 3, Section 3.4
‡
X-ray crystallography studies were performed by Dr Anthony Willis at the Australian National
University, Canberra. The absolute configuration was later confirmed as S,S by crystallographic analysis
of the corresponding PdCl2 complex (see Chapter 7, Section 7.2 and Appendix 5).
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1) Front View

2) Top View

Figure 4.4: The X-ray crystal structure of biindoline (S,S)-38 as viewed from the 1) front and 2)
top of the molecule.

4.5 Summary and Outlook
This chapter presented an alternative synthetic strategy for the synthesis of the second
target ligand 2,2'-biindoline 38 which utilised the ring opening of the known biaziridine
(S,S)-183 with 2-bromophenylmagnesium chloride 91 as the key step.

The biaziridine (S,S)-183 was prepared in four steps from dimesylate (R,R)-158 as
previously described.171 Ring opening with alkyl and aryl Grignard reagents gave the
desired dicarbamate (S,S)-185 but produced imidazolidinone (S,S)-186 as the major
product, arising from intramolecular nucleophilic attack by the nitrogen anion
(generated after ring opening) on the adjacent Boc group. Although the N-Boc
substituent of the imidazolidinone was easily removed, the urea unit proved to be highly
resilient to cleavage, requiring prolonged heating with concentrated HCl under
microwave irradiation for hydrolysis. Under these forcing conditions, the penultimate
diamine (S,S)-143 was able to be prepared on a small scale from imidazolidinone (S,S)195 in high yield.

The synthesis of biindoline (S,S)-38 from biaziridine (S,S)-183 was subsequently
attempted using a larger scale ring opening with Grignard 91, affording imidazolidinone
(S,S)-195 in moderate yield. Subsequent treatment with concentrated acid under
microwave irradiation resulted in incomplete hydrolysis due to the poor solubility of the
substrate. Consequently, the desired diamine (S,S)-143 was obtained in a mixture with
the Boc-deprotected imidazolidinone (S,S)-196 which was carried through as an
impurity to the final palladium catalysed microwave cyclisation, affording the
enantiomerically pure biindoline (S,S)-38 in good yield in addition to a small quantity of
naphthyridine (S,S)-151.
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Overall, biaziridine (S,S)-183 was demonstrated to be a suitable precursor to the target
ligand. However, to avoid the production of the imidazolidinone during ring opening
and the harsh conditions required for its hydrolysis to the penultimate diamine, it is
proposed that the biaziridine be protected as the pivalyl amide instead of the Boc
carbamate.‡ The amended synthesis of biindoline (S,S)-38 via the novel pivalylsubstituted biaziridine (S,S)-204 is currently under investigation in our laboratory
(Scheme 4.10).
OH
MsO

azidation

R1

R1

OH
(R,R)-158

mesylation
OMs

R1 = N3 (R,R)-180
R1 = NH2

protection

NPiv
PivN
(S,S)-204

NHPiv

PivHN

OH
reduction

cyclisation

OMs

OH
OMs

R1 = NHPiv

Cu catalysed ring
opening with
Grignard 91

Br

Br

NHR2
NHR2

MgCl

Br

2

deprotection

R = Piv
R2 = H (S,S)-143

91
cyclisation
N
N
H
H
(S,S)-38

Scheme 4.10: Proposed amended synthesis of biindoline (S,S)-38 using the pivalyl-substituted
biaziridine (S,S)-204 as the key intermediate.

‡

For a discussion on the virtues of this protecting group, see Chapter 3, Section 3.6.
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Given that 2,2'-bioxirane 87 and the analogous biaziridine 183 were demonstrated to be
suitable precursors to the 2,2'-biindoline target ligand 38 (Chapters 3 and 4), it was
envisioned that these molecules could be used as building blocks for a range of other
chiral ligands by modifying the structure of the carbon nucleophile used for their ring
opening.

5.1 New Synthetic Strategy Towards 2,2'-Bipyrrolidine
As a starting point for these investigations, a new synthetic route to the protected
bipyrrolidine ligand (S,S)-43 was proposed (Scheme 5.1). The ring opening of bioxirane
(R,R)-87 with lithioacetonitrile183 as the carbon nucleophile would give dinitrile (R,R)205. Subsequent reduction of the cyano groups and protection of the resulting diamine
(R,R)-206 would afford diol (R,R)-207, which could be converted to dimesylate (R,R)208 and cyclised to bipyrrolidine (S,S)-43.‡
O
O
(R,R)-87

ring
opening

OH

N

N
Li

OH
reduction

OH
(R,R)-205

N

NHR

RHN
OH
protection

R = H (R,R)-206
R = Boc (R,R)-207

OMs
mesylation

NHBoc

BocHN
OMs
(R,R)-208

cyclisation
N
N
Boc
Boc
(S,S)-43

Scheme 5.1: Proposed novel synthesis of bipyrrolidine (S,S)-43 using bioxirane (R,R)-87 as the
chiral precursor.

This sequence uses the cheap and readily available acetonitrile as the source of the
nitrogen and the carbon nucleophile and should avoid the previous problems
encountered with stereoselectivity in our alternative metathesis/Sharpless AD
‡

This mode of ring closure to form bipyrrolidine (S,S)-43 is the inverse to that previously performed in
our laboratory in which the nitrogen atoms at the 4 and 5 positions displaced mesylate groups at the
terminal carbon atoms (see Chapter 1, Scheme 1.13).61,105
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strategy.61,105,107 It is also signficantly shorter, requiring just four steps from the
bioxirane to access the desired scaffold.
Although this synthesis was anticipated to be relatively straightforward, prior to
attempting the sequence from the chiral bioxirane precursor (R,R)-87, the ring opening
and reduction reactions were investigated using racemic samples.

5.2 Ring Opening of Racemic 2,2'-Bioxirane with Lithioacetonitrile
The nucleophile required for the ring opening was generated by the treatment of
acetonitrile with LDA‡ as described.183,184 Results of the subsequent reaction with
bioxirane 87 are shown in Scheme 5.2.
O
N

LDA, THF
-78 oC, 45 min

Li
N

O

87
Conditions X

N

OH

OH
205

N

Eq. Lithioacetonitrilea
Conditions X
Yield (%)b
1
6.0
-78 oC to RT, 26 h
40
2
6.0
-78 oC to 0 oC, 3 h
54
3
2.2
-78 oC to 0 oC, 2.5 h
54
a
Equivalents of lithioacetonitrile with respect to bioxirane 87, based on the assumption that the
initial deprotonation was quantitative. bIsolated yield after column chromatography based on
bioxirane 87.
Scheme 5.2: Results of the ring opening of bioxirane 87 with lithioacetonitrile under various
conditions.

Addition of bioxirane 87 to an excess of lithioacetonitrile (6.0 eq.) and allowing the
mixture to warm to room temperature over 26 h gave dinitrile 205 in 40% yield (entry
1). A shorter reaction time (3 h) maintained below 0 oC increased the yield to 54%
(entry 2). The same yield was also obtained under these conditions with the equivalents
of lithioacetonitrile reduced to a slight excess of the stoichiometric requirement (2.2 eq.)
(entry 3).

‡

LDA was freshly prepared by treatment of i-Pr2NH with n-BuLi in THF at -78 oC. The use of this
sterically encumbered base avoids a possible competing nucleophilic addition to the nitrile group.
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5.3 Reduction of Racemic 4,5-Dihydroxyoctanedinitrile
The reduction of dinitrile 205 was attempted with a number of protocols (Scheme 5.3).
When possible, the product was Boc protected before work-up to avoid complications
arising from the high polarity and potential water solubility of diamine 206 during
purification. In all cases, excluding the reaction with LiAlH4, the diamine or protected
derivative 207 was obtained after work-up as the sole product.
OH

N

OH
205

OH
N

NHR

RHN
OH
206 R = H
207 R = Boc

Conditions
R Yield (%)
1185 (i) BH3·SMe2, reflux/distillation of SMe2, 8 h; (ii) HCl
H
28
2190 (i) LiAlH4, 0 oC to RT, 22 h; (ii) H2O then Boc2O, 8 h
Boc
mixa
3191 NiCl2 (20 mol%), NaBH4, Boc2O, MeOH, RT, 72 h x 2b Boc
62c
194
4
(i) Raney Ni, KBH4, EtOH, RT, 3 h; (ii) Boc2O, 17 h
Boc
97c
a
b
The desired product was observed in a mixture of compounds. The substrate was subjected to
the reaction conditions twice to achieve complete reduction. cPeak broadening in the NMR
spectra was observed, presumably due to the presence of residual nickel.
Scheme 5.3: Results of the reduction of dinitrile 205 using selected literature
protocols.185,190,191,194

The first reaction (entry 1) was performed with the BH3·SMe2 complex.185 This reagent
can reduce hydroxy nitriles providing excess hydride is used to account for partial
quenching by the alcohol moieties.186 Treatment with concentrated acid† during workup liberates the product from the robust amine-borane intermediates185 and thus, Bocprotection was not performed. After alkalification and saturation of the aqueous solution
with K2CO3, diamine 206 was extracted with CH2Cl2 and isolated in 28% yield.‡
The ubiquitously used LiAlH4 is also incompatible with alcohols but can reduce
hydroxy nitriles when used in excess.189 Therefore, the reduction of dinitrile 205 with
LiAlH4, followed by neutral quenching and in situ Boc protection was performed (entry
2).190 In the crude

13

C NMR spectrum, the absence of a peak at ~120 ppm, previously

assigned to the sp hybridised carbons of dinitrile 205 (119.8 ppm), indicated complete
†

Neutral methods for amine-borane cleavage are available such as methanolysis187 or ligand exchange188
but these can be time-consuming and inefficient.
‡
Further partitioning with 2-butanol failed to increase the yield of the product indicating that the
extraction with CH2Cl2 had been quantitative.
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reduction. Further NMR analysis confirmed the presence of the desired product, albeit
in a low yield and within a mixture of unknown compounds. No further purification was
attempted.
Excess NaBH4 in combination with catalytic NiCl2 has been found to be an efficient
system for nitrile reduction in protic solvents.191 These reactions must however be
carried out in the presence of an anhydride electrophile (eg: Boc2O, Ac2O) in order to
‘trap’ the desired product by in situ protection, thus preventing the formation of
secondary amines via cross-coupling.†192 Using this protocol (entry 3), reduction of
dinitrile 205 was incomplete after 72 h, giving a ~1:1 molar mixture of the partially
reduced nitrile 209 and the desired product 207, which had identical RF values. The

mixture was thus re-subjected to the reduction conditions, giving the desired product in
62% yield.‡ The failure of the reduction to reach

OH

completion

BocHN
OH
209

N

initially

is

most

likely

a

result

of

decomposition of the available NaBH4 by MeOH.193

The Raney Ni/KBH4/EtOH system has recently been reported to rapidly reduce
aliphatic nitriles at room temperature without the requirement of in situ ‘trapping’.194
Application of this protocol to dinitrile 205 (entry 4) lead to complete reduction within 3
h as monitored by TLC and ES+ MS analysis. Subsequent treatment with Boc2O
afforded diol 207 in 97% yield,‡ clearly demonstrating the superiority of this system to
affect the desired reduction.

5.4 Synthesis of (2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-bipyrrolidine
5.4.1 Ring Opening/Reduction
The chiral bioxirane (R,R)-87 was ring opened under the established conditions to give
dinitrile (R,R)-205 in 48% yield (Scheme 5.4). Subsequent reduction with the Raney
Ni/KBH4/EtOH system, followed by Boc protection, work-up and column

†

Under these milder conditions, even with a stoichiometric quantity of nickel, nucleophilic addition of the
newly formed free amine to the intermediate imine is faster than hydride attack.192
‡
Peak broadening in the NMR spectra was observed, presumably due to the presence of residual nickel.
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chromatography furnished diol (R,R)-207 in 53% yield.‡ Although representing a single
attempt at the reduction of the optically pure sample, this isolated yield was surprisingly
lower than the previous reaction (97%, Scheme 5.3, entry 4) given that in both cases the
reduction had proceeded to completion and no other products were detected.

N

LDA, THF
-78 oC, 45 min

0.4 eq. (R,R)-87
-78 to 0 oC, 2.5 h
48%

Li
N

N

OH

OH
(R,R)-205
(i) Raney Ni, KBH4
EtOH, RT, 8 h
(ii) Boc2O,17 h

OH
NHBoc

BocHN

53%

N

OH
(R,R)-207

Scheme 5.4: The synthesis of diol (R,R)-207 from bioxirane (R,R)-87 using conditions
previously established with racemic samples.

5.4.2 Mesylation
The mesylation of diol (R,R)-207 was attempted using standard conditions (Scheme
5.5). Although these reactions are typically facile, TLC and ES+ MS analysis after 1 h
indicated only a small extent of mono- and dimesylation. Additional aliquots of MsCl
and NEt3 were introduced and stirring continued at room temperature for 48 h, however
TLC analysis indicated no further reaction.
OH
NHBoc

BocHN
OH
NHBoc

BocHN
OH
(R,R)-207

OMs
(R,R)-210

MsCl, NEt3, CH2Cl2
0 oC to RT, 48 h
low conversion

+
OMs
NHBoc

BocHN
OMs
(R,R)-208

Scheme 5.5: Attempted mesylation of diol (R,R)-207 under standard conditions giving only
small amounts of the mono- and dimesylated products (R,R)-210 and (R,R)-208 respectively.

‡

A nine-step synthesis of diol (R,R)-207 from D-tartaric acid via an octadienedioate intermediate has
been reported.195,196 This is a longer route overall than required to access this compound from D-tartaric
acid via bioxirane (R,R)-87 (seven steps).
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The reaction was repeated numerous times using the racemic diol. In all cases the same
result occurred - partial mesylation was observed within the first hour and no further
conversion could be achieved thereafter by introducing additional aliquots of MsCl and
NEt3. Attempts to promote the reaction by sonicating or heating the mixture at reflux
were also unsuccessful. It was thus proposed that intra- or intermolecular hydrogen
bonding between the hydroxyl group and NH proton could be inhibiting the reaction.
Therefore, with the aim of cleaving or reducing the strength of these possible hydrogen
bonds, the mesylation was attempted using DMF as the solvent. In this case no reaction
of diol 207 was observed.
In order to identify a potential solution, the general mechanism of mesylation was
considered (Scheme 5.6). The NEt3 mediated elimination of HCl from MsCl leads to the
generation of a highly electrophilic sulfene intermediate 211, which is susceptible to
nucleophilic attack by an alcohol to produce the desired methanesulfonate ester 212.197

O H
NEt3
Cl S C H
O H

R
OH

O
S CH2
O
211

-NEt3.HCl

(MsCl)

O
O

S

CH3
OR

212

Scheme 5.6: Established mechanism of the mesylation of alcohols using MsCl and NEt3.197

Given the requirement for generation of the sulfene intermediate, the mesylation was
attempted with a modified procedure in which MsCl and NEt3 were pre-mixed before
addition of the diol (Scheme 5.7). TLC analysis after 30 min showed a low conversion,
however in this case, additional aliquots of MsCl and NEt3 were found to drive the
reaction to completion within 20 min. The dimesylate (R,R)-208 was thus obtained in
68% yield after chromatographic purification.

2.2 eq. MsCl
CH2Cl2

(i) 2.5 eq. NEt3
0 oC, 5 min
(ii) diol (R,R)-207
0 oC to RT, 30 min

low
conversion
(TLC)

2.2 eq. MsCl
2.5 eq. NEt3
RT, 20 min

OMs
NHBoc

BocHN
OMs
(R,R)-208, 68%

Scheme 5.7: Synthesis of dimesylate (R,R)-208 using a procedure in which MsCl and NEt3
were pre-mixed before addition of diol (R,R)-207. Further aliquots of the reagents were required
to complete the reaction.
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Although we cannot, as yet, explain these results, the outcome of this modified
mesylation method for diol 207 is consistently repeatable with additional aliquots of
MsCl and NEt3 always being required to complete the initially sluggish reaction.168

5.4.3 Cyclisation
The final cyclisation to bipyrrolidine (S,S)-43 was attempted under the conditions
previously established for the inverse ring closure,† however TLC analysis after 22 h
indicated no reaction had occurred (Scheme 5.8). The mixture was thus transferred to
fresh NaH and heated at reflux for 22 h resulting in complete consumption of the
dimesylate. Although NMR analysis of the crude sample confirmed bipyrrolidine (S,S)43 as the sole product, column chromatography was required to remove residual mineral
oil (arising from the commercially obtained NaH), giving the bipyrrolidine in 19%
yield.
OMs
NHBoc

BocHN

NaH, THF
0 oC to RT
22 h

OMs

no reaction
(TLC)

fresh NaH
THF, reflux
22 h
N
Boc

N
Boc

(S,S)-43, 19%

(R,R)-208

[α]21
D -52.1
27

Lit.58 [α]D -40.6
23

Our previous strategy105 [α]D -43.7

Scheme 5.8: Cyclisation of dimesylate (R,R)-208 to bipyrrolidine (S,S)-43. The product was
determined to be enantiomerically pure by comparison of the specific rotation to those
previously reported.58,105

The biyrrolidine was determined to be enantiomerically pure by comparison of the
specific rotation in CHCl3 ( [α]21
-52.1) with that reported for optically pure
D
bipyrrolidine

(S,S)-43

( [α]27
D

-40.6)58

and

the

product

prepared

by

our

‡105
metathesis/Sharpless AD strategy ( [α]23
D -43.7).

†

See Chapter 1, Scheme 1.13.
The discrepancy in the rotations could be explained by the fact that at room temperature the
bipyrrolidine exists as a mixture of rotamers,61,198 rendering its physical properties highly temperature
dependent.
‡
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Given that dimesylate (R,R)-208 was completely consumed and bipyrrolidine (S,S)-43
was the only product observed, the low isolated yield was surprising. This result
however represents a single attempt at the cyclisation. The need to heat the mixture to
induce cyclisation, in contrast to the inverse direction of ring closure,105 could be a
result of the slower rate of SN2 substitution at the secondary carbon atoms. In both
modes of ring closure, there was no evidence of the formation of structural isomer
naphthyridine
Boc
N

(S,S)-213

by

the

alternative

cyclisation

pathway.

Computational modelling studies are currently in progress in collaboration
with Professor Tim Clark (University of Erlangen-Nuremberg, Germany) to

N
Boc
(S,S)-213

determine the origin of the observed regioselectivity through transition state
analysis.

5.5 Alternative Synthesis of 2,2'-Bipyrrolidine
The reductive cyclisation of nitriles such as 214 has been reported as an efficient
method for construction of the pyrrolidine core (Scheme 5.9).199
OMs N

(i) LiAlH4
(ii) Boc2O

BnO
O

Boc
N
BnO

69%

O

O

O

214

Scheme 5.9: Previously reported reductive cyclisation of nitrile 214.199

Therefore, it was proposed that mesylation of dinitrile (R,R)-205‡ and subsequent
reductive cyclisation would provide a direct route to the parent bipyrrolidine (S,S)-37
(Scheme 5.10).
N

OH
mesylation
OH
(R,R)-205

N

N

reductive
cyclisation

OMs

OMs
(R,R)-215

N

N
N
H
H
(S,S)-37

Scheme 5.10: Proposed alternative synthetic route to the parent bipyrrolidine (S,S)-37 using a
reductive cyclisation as the key step.

‡

This is the product of the ring opening of bioxirane (R,R)-87 with lithioacetonitrile (see Scheme 5.4).
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5.5.1 Attempted Reductive Cyclisation using LiAlH4
In order to investigate the alternative synthesis, the required dimesylate 215 was
prepared in 99% yield from the racemic dinitrile 205 (Scheme 5.11).
OH

N

N

OH
205

NEt3, MsCl, CH2Cl2
0 oC to RT, 30 min
99%

OMs

N

N

OMs
215

Scheme 5.11: Preparation of dimesylate 215 using standard conditions.

Reductive cyclisation was subsequently attempted using LiAlH4 (Scheme 5.12).199 After
quenching, the mixture was treated with Boc2O to avoid potential complications with
the volatility and air sensitivity of the parent diamine 37.60 During work-up a pungent
odour was detected, suggesting reduction of the sulfonate groups had occurred.‡ A low
mass was returned in the crude mixture, which did not contain either starting material or
the desired bipyrrolidine 43. The major constituent was identified as dimesylate 208
(23%) after chromatographic separation.

N

(i) LiAlH4, THF
0 oC to RT, 2 h
(ii) sat. Na2SO4, Boc2O
0 oC to RT, 10 h

OMs

OMs
215

N

X

N
Boc

N
Boc
43
OMs

23%

NHBoc

BocHN
OMs
208

Scheme 5.12: Outcome of the attempted reductive cyclisation of dimesylate 215 with LiAlH4.

Although complete reduction of the nitrile groups had occurred, the outcome suggested
that LiAlH4 was too strong a reducing agent to achieve adequate chemoselectivity.
Evidence of some resilience of the sulfonate groups to reduction had been provided by
the isolation of a small quantity of dimesylate 208, which confirmed that the desired
cyclisation had not transpired prior to Boc protection.

‡

The reductive cleavage of sulfonate esters with LiAlH4 to give alcohols has been reported.200
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5.5.2 Attempted Reductive Cyclisation using Raney Ni/KBH4
The cyclisation was also attempted using the Raney Ni/KBH4/EtOH reduction protocol
(Scheme 5.13).194 In contrast to the previous substrate (see Scheme 5.3, entry 4),
dimesylate 215 was found to be sparingly soluble in EtOH which significantly reduced
the rate of nitrile reduction. After stirring the mixture for 17 h at room temperature, ES+
MS analysis showed a base peak at m/z 141 assigned to the M+H ion of the desired
parent diamine 37. Therefore, the suspension was filtered and the resulting solution
containing the diamine was treated with Boc2O. Spectral analysis
N

NH2
216

of the crude sample indicated a mixture of an unknown compound
and a small quantity of dimesylate 208, but the expected

bipyrrolidine 43 was not detected. Subsequent chromatographic purification afforded
dimesylate 208 (6%) and a compound identified as bicyclic amine 217 (33%).
Therefore, the base peak previously observed by ES+ MS analysis (m/z 141), originally
thought to be evidence of the desired cyclisation, was reassigned to the M+H ion of the
isomeric diamine 216.

N

(i) Raney Ni, KBH4
EtOH, RT, 17 h
(ii) Boc2O, 20 h

OMs

OMs
215

N

X
[recovered 215]
31%

N
Boc

43

N
Boc

dimesylate 208
6%

+

N

NHBoc
217
33%

Scheme 5.13: Outcome of the attempted reductive cyclisation of dimesylate 215 using the
Raney Ni/KBH4/EtOH protocol.

A reasonable quantity of dimesylate 215 (31%) was also recovered after rinsing the
filter cake with CH2Cl2, highlighting the poor solubility of the substrate in EtOH.
Although this reduction system is ineffective in aprotic solvents,194 the procedure was
repeated using a 1:1 mixture of CH2Cl2 and EtOH, however no reaction occurred under
these conditions.
The formation of the bicyclic amine 217 can be explained by the set of events illustrated
in Scheme 5.14. Mono-reduction to amine 218 enables the first SN2 cyclisation to
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proceed as desired to give pyrrolidine 219.† The free amine can then perform a second
nucleophilic attack to displace the adjacent mesylate group, forming a fused aziridine

220. Reduction of the remaining nitrile group and subsequent Boc protection affords the
observed product 217. It is also possible that the product resulted from the initial
formation of a six-membered (piperidine) ring, followed by aziridine construction.
However, this is less likely given the regioselectivity previously observed in the SN2
cyclisation of these systems.
OMs

N

H2N

N

OMs
215
cyclisation

OMs

mono
reduction

H
N

N

aziridine
formation

N
N

OMs
219
reduction

N

220

NH2
216

N

OMs
218

protection

N

NHBoc
217

Scheme 5.14: Proposed sequence of events leading to the formation of bicyclic amine 217
during the reduction of dimesylate 215.

The failure to observe the mono-cyclised product 221 indicated
NHBoc
N
Boc

OMs
221

that the formation of aziridine 220 from pyrrolidine 219 was
quantitative. This result, when considered alongside the fact that

a small quantity of dimesylate 208 was isolated, suggested that cyclisation to aziridine

220 was faster than the formation of the pyrrolidine ring. Therefore, even if a rapid
reduction of both nitrile groups had occurred leading to pyrrolidine 222 as an
intermediate (Scheme 5.15),‡ the competing formation of aziridine 216 could be faster
than the desired cyclisation to bipyrrolidine 37, which would render the reductive
cyclisation of dimesylate 215 an unfeasible route to the target ligand.

†

Due to the slow rate of reduction, it is reasonable to assume that pyrrolidine 219 was formed before
reduction of the second nitrile moiety.
‡
It is highly unlikely that both cyclisations to form the five-membered rings would occur simultaneously.
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N
OMs

N

216

NH2
N
H

N

OMs
215

NH2

or

OMs
222
N
H

N
H

37

Scheme 5.15: The two possible cyclisation pathways of intermediate 222 producing either the
bicyclic amine 216 or the desired bipyrrolidine 37.

Although the aziridine nitrogen atom of bicycle 217 is not activated by an electronwithdrawing substituent, it is conceivable that deprotonation of this molecule to
generate the N-Boc anion 223 could promote intramolecular ring opening to give the
bipyrrolidine scaffold 43 (Scheme 5.16).‡ However, closer inspection reveals that this
sequence would be of little practical value as the meso isomer would be produced due to
two stereochemical inversions having taken place at C5 of the starting dimesylate.
C5

N

OMs

R

N
R

deprotonation

S

N

OMs
215

NHBoc

S

217

N

NBoc

S

S

223

aziridine
opening

protection

S

R

N
N
Boc
Boc
meso-143

Scheme 5.16: Potential ring opening of chiral bicyclic amine 217 to give bipyrrolidine 43 in the
meso configuration as a result of two stereochemical inversions at C5 of dimesylate 215.

5.6 Summary and Outlook
This chapter demonstrated the further utility of bioxirane 87 as a building block for
chiral bidentate ligands through the successful completion of a new and concise fourstep synthesis of enantiomerically pure bipyrrolidine (S,S)-43. The results of this
synthesis are summarised in Scheme 5.17 and represent a single progression through the
sequence.

‡

A meso-imidazolidinone could also arise through attack of the nitrogen anion generated after ring
opening on the adjacent Boc moiety (see Chapter 4, Section 4.2).
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Li
N
O ring opening
48%

O
(R,R)-87

OH

N

OH
(R,R)-205

reduction/
protection
53%
N

OH
NHR

RHN
OH
(R,R)-207

OMs
mesylation
68%

NHBoc

BocHN
OMs
(R,R)-208

cyclisation
19%

N
Boc

N
Boc

(S,S)-43

Scheme 5.17: Results of the novel synthesis of bipyrrolidine (S,S)-43 from bioxirane (R,R)-87.

An alternative route to the bipyrrolidine was also attempted via the reductive cyclisation
of dimesylate 215, however this failed to yield the desired product. Although only two
reduction protocols were investigated, the results obtained indicated that the strategy
may not be viable given the potential to form bicyclic amine 216 (or its protected
derivative 217) as a competing process.
The chemical yields of each step in the established bipyrrolidine synthesis are currently
being optimised‡ and further application of the 2,2'-bioxirane and -biaziridine precursors
to the synthesis of a range of novel chiral ligands is under investigation.

‡

For example, the investigation of the bioxirane ring opening in the presence of Lewis acid catalysts, such
as Cu(OTf)3 and Yb(OTf)3, which have been shown to provide a dramatic increase in the reactivity of
nitrile enolates with epoxides.119
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CHAPTER 6
Towards the Synthesis of the Phosphorus and Arsenic Analogues of
2,2'-Bipyrrolidine and 2,2'-Biindoline

6.1 Target Ligands
The phosphorus and arsenic analogues of 2,2'-bipyrrolidine and -biindoline are also
desired for screening as chiral ligands in metal catalysed aryl coupling reactions. This
set of synthetic targets includes the 2,2'-biphospholane 224 and -biarsolane 225
scaffolds as well as the 2,2'-bibenzophospholane 226 and -bibenzoarsolane 227 systems
(Figure 6.1).
H2

H2'

HH

HH
*
P

*
P

*
P

*
P

R
R
(PR,S,S,PR)-224

R
R
(PS,R,R,PS)-224
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*
As

*
As

*
As

*
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R
R
(AsR,S,S,AsR)-225

R
R
(AsS,R,R,AsS)-225

H H

H H

*
*
P
P
R R
(PR,S,S,PR)-226

*
*
P
P
R R
(AsS,R,R,AsS)-226

H H

H H

*
*
As
As
R R
(AsR,S,S,AsR)-227

*
*
As
As
R R
(AsS,R,R,AsS)-227

Figure 6.1: The target enantiomers of the phosphorus and arsenic analogues of 2,2'bipyrrolidine and -biindoline. The configurations of the heteroatoms in these structures are
arbitrary and were assigned based on R = Ph.

In contrast to their nitrogen analogues, the heteroatoms in these ligands are stereogenic
as they are unable to undergo pyramidal inversion at ambient temperature.201,202
Although theoretically there would be ten possible stereoisomers for each structure,‡

‡

Theoretically there are two meso isomers and eight chiral isomers - including four sets of enantiomers.
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only the enantiomers in which both ‘R’ substituents are cis to their adjacent bridgehead
hydrogen (H2 and H2') are desirable ligands, as depicted in Figure 6.1. This
arrangement minimises steric interactions between the two heterocycles and enables H2
to be staggered with H2'.

6.1.1 General Synthetic Strategy
Given the large number of possible stereoisomers of each ligand in Figure 6.1,
establishing a synthesis of each target that is both diastereo- and enantioselective is
anticipated to be difficult regardless of whether the configuration of the stereogenic
carbon atoms is controlled with a chiral precursor, for instance, bioxirane 87. As a
representative example, ring opening of bioxirane (R,R)-87 with aryllithium 228,†
would produce diol 229 containing (up to) four diastereomers‡ (Scheme 6.1). These
would each need to be separated and structurally elucidated in order to elaborate the
correct isomer to the target ligand (PR,S,S,PR)-230.
*
PhPONMe2
Li
O
O
(R,R)-87

*
Ph PONMe2 OH
±-228
Ph PONMe2
OH
*
229
mixture of diastereomers

H H
*
*
P
P
Ph Ph
(PR,S,S,PR)-230

Scheme 6.1: Ring opening of bioxirane (R,R)-87 with aryllithium 228 providing a potential
pathway to the target ligand (PR,S,S,PR)-230. The intermediate diol 229 would be produced as a
mixture of diastereomers due to the stereogenicity of the phosphorus atom.

Given these foreseeable complications, our initial synthetic approach is to investigate
the dimerisation of the corresponding monomers, which is the most commonly reported
method to access 2,2'-linked chiral C2-symmetric phosphines.204,205 It should be noted
that the tert-butyl substituted analogue of 2,2'-biphospholane (224, R = t-Bu), has been
prepared by dimerisation206 and is now commercially available, although this ligand is
likely to be too sterically intrusive to efficiently catalyse the coupling of orthosubstituted aryl substrates. Other chiral biphospholane ligands with various P†

This compound should be able to be prepared by ortho-lithiation in the same fashion as its structurally
similar methylbenzylamino analogue.203
‡
Although there are four stereogenic atoms in diol 229, only four diastereomers can be formed because
the configurations of the carbon atoms are fixed.
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substituents, including a phenyl group, have also been patented,207 however only
synthetic details for the tert-butyl derivative were given in this account.
Phosphine oxides can be dimerised because protons adjacent to this functionality are
slightly acidic and as such, α-lithiation becomes possible (Scheme 6.2).205,208,209
Subsequent transmetallation with a stoichiometric quantity of a copper(II) salt followed
by reductive elimination furnishes the corresponding dimer. This process is also
possible using phosphine sulfides206 and borane protected substrates.204,210

*
P
O

α−lithiation

*
P

R

O

reductive
elimination

*
P
O

Li

transmetallation
with Cu(II)

R

*
P
O

Cu
R

R

*
P
O

*
P
R R

O

Scheme 6.2: General strategy for the dimerisation of phosphine oxides.

Although these reactions produce two new stereogenic carbon atoms and each of the ten
possible stereoisomers could result, the α-lithiation occurs trans to the ‘R’ substituent
(in cyclic systems) to facilitate intramolecular coordination between the oxygen and
lithium atoms. Therefore only three stereoisomers are produced - one meso compound
and the desired pair of enantiomers.‡205,208,209 These diastereomers can be separated by
silica gel chromatography209 or fractional crystallisation210 and the required enantiomers
can be resolved, for example, by chiral HPLC209 or chelation to a chiral palladium
complex.211
Given that arsine oxides are also known to undergo α-lithiation,212 the target ligands 225
and 227 should also be accessible by oxidative dimerisation. As such, our strategy
towards the arsine and phosphine ligands is demonstrated in Scheme 6.3. Oxidative
homo-coupling of the racemic (or achiral) monomer 231 should produce a mixture of
the two desired enantiomers ±-232 and an easily separated diasteromer meso-232.
Reduction of the racemic dimer and resolution of the resulting enantiomers would
afford the optically pure ligands (XS,R,R,XS)-233 and (XR,S,S,XR)-233. This pathway also
provides the possibility of classical resolution of the oxide enantiomers ±-232 which
‡

The configuration of the α-carbon is retained after transmetallation with copper(II) and reductive
elimination.
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should be weakly basic and may form separable salts with tartaric acid and/or
derivatives thereof.208,209
H H

dimerisation
*
X

O

*
X

R
231

O

H H
+

*
X

*
X

O

R R
±-232

O

*
X

R R O
meso-232

reduction
H H

X = As or P
*
X

*
X

R R
±-233
resolution
H H
*
X

H H
*
X

*
X

*
X

RR
(XR,S,S,XR)-233

R R
(XS,R,R,XS)-233

Scheme 6.3: Synthetic strategy towards the arsine and phosphine target ligands. The
configurations of the heteroatom ‘X’ in these structures are arbitrary and were assigned based
on R = Ph.

Although a range of derivatives of each ligand with various ‘R’ groups are required for
screening, the phenyl substituted derivatives (233, R = Ph) comprise the initial targets.
With a phenyl group, favourable π-stacking interactions with the substrates in aryl
coupling reactions could arise55 and from a synthetic perspective, the free arsines and
phosphines would be stabilised, making their purification, isolation and handling easier.

6.2 Synthetic Strategy Towards Monomers
In order to investigate the proposed synthetic strategy, the phenyl substituted phosphine
and arsine oxide monomers 234-237 need to be synthesised (Figure 6.2).

P

Ph
O
234

*
P
O
235

Ph

As
O
236

Ph

*
As
O

Ph
237

Figure 6.2: The phosphine and arsine oxide precursors to the target ligands.

Although all of these compounds are known,213-219 their reported syntheses have at least
one of the following drawbacks:
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1. Multi-step procedures are involved.213-217,219
2. The purification of reactive intermediates is required (eg: chlorophosphines).217
3. A highly toxic source of the heteroatom is used (i.e. PhAsCl2).218,219
Therefore, synthetic methodology that enables these structures to be prepared in one-pot
from less noxious starting materials needs to be developed. The strategy should also
allow for extension to monomers with different substituents and ring sizes, including
fused structures, in order to facilitate further access to a range of bidentate ligands.

6.2.1 Previously Reported Syntheses of Phosphine-Borane Analogues
A one-pot synthesis of phospholane-borane 239 has been reported by the reaction of
diGrignard 238, derived from 1,4-dibromobutane, with PhPCl2 (Scheme 6.4) - the
resulting heterocycle was α-lithiated and reacted with various electrophiles but was not
oxidatively dimerised.220

Br

Br

Mg, THF
0 oC to RT, 4 h

MgBr

BrMg
238

(i) PhPCl2, THF
0 oC to RT, 12 h
(ii) BH3·THF
0 oC to RT, 13 h
40%

P

H3B

Ph
239

Scheme 6.4: Previously reported synthesis of phospholane-borane 239.220

The benzophospholane scaffold has also been prepared from a diGrignard reagent. The
desired ring closure was accomplished by the action of diGrignard 241 upon lMen*PCl2 (Scheme 6.5). Borane protection before work-up provided a mixture of
diastereomers 242 which could be separated by fractional crystallisation.221

Cl Mg, THF
reflux, 5 h
Cl
240

MgCl
241

(i) l-Men*PCl2, THF
0 oC to RT, 1.5 h
(ii) BH3·THF
MgCl
0 oC to RT
51% overall

O
l-Men* =

P
BH3
l-Men*
242

Scheme 6.5: Previously reported synthesis of benzophospholane-borane 242.221
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6.2.2 Synthetic Strategy Towards Phosphine Oxide Monomers
Given that Grignard reagents are also known to react with dichlorophosphine oxides,222
we proposed that the reaction of diGrignards 243 and 244 with the commercially
available PhPOCl2 should yield phospholane 234 and benzophospholane 235
respectively (Scheme 6.6).
X

MgX

Mg

X

PhPOCl2
P
Ph
O
234 (without aryl ring)
235 (with aryl ring)

MgX
243 (without aryl ring)
244 (with aryl ring)

X = Br, Cl

Scheme 6.6: Synthetic strategy towards phospholane 234 and benzophospholane 235.

This single-pot process also offers the potential to vary the chain length and structure of
the diGrignard reagent as well as the P-substituent of the dichloride electrophile,
enabling access to a range of substituted heterocycles, and inturn, an array of bidentate
ligands after subsequent dimerisation.

6.3 Synthesis of 1-Phenylphospholane 1-Oxide
A solution of diGrignard 238, prepared from magnesium turnings and 1,4dibromobutane,220 was added to a solution of PhPOCl2 at 0 oC, affording phospholane
234 in 23% yield after chromatographic purification (Scheme 6.7). An attempt to
improve the outcome by carrying out the reaction at reflux also gave a low yield (27%).‡

Br

Br

Mg, THF
30 oC, 1 h

MgBr

BrMg
238

PhPOCl2, THF
0 oC to RT, 24 h
23%

P

O

Ph
234

Scheme 6.7: Synthesis of phospholane 234 using diGrignard 238.

‡

More recently in our laboratory the yield has been increased to 51% by performing the addition of the
diGrignard to PhPOCl2 at -78 oC (see Section 6.6).223
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6.4 Synthesis of Racemic Benzophospholane Derivatives
6.4.1 Attempted Synthesis using 1-Bromomagnesio-2-(2-(bromomagnesio)
ethyl)benzene
Although the dichloride Grignard 241 was used in the reported synthesis of
benzophospholane 242 (see Scheme 6.5), it has been found in other studies to be
difficult

to

form.224

Therefore,

our

investigations

into

the

synthesis

of

benzophospholane 235 commenced using the more easily reduced dibromide analogue
as the Grignard precursor.225
The required dibromide 245 was prepared from the commercially available 2-(2bromophenyl)ethanol as previously described (Scheme 6.8).226 Subsequent combination
with excess magnesium turnings under the reported conditions225 failed to produce
diGrignard 246, with minimal consumption of magnesium evident.
OH

Br

o

PBr3, 80 C, 40 h
62%

Br

5 eq. Mg, THF
RT, 12 h

MgBr

X

Br
245

MgBr
246

Scheme 6.8: Attempted preparation of diGrignard 246 under previously described conditions.225

Attempts to activate the magnesium with an iodine crystal or 1,2-dibromoethane were
also unsuccessful.77 Therefore, the reaction was attempted with excess magnesium at
reflux (Scheme 6.9). Subsequent hydrolysis gave a mixture of ethylbenzene and 1,4diphenylbutane,227 with relative yields of 41% and 59% respectively as determined by
1

H NMR analysis.‡

Br

(i) 6 eq. Mg, THF
reflux, 17 h
(ii) H2O

+

Br
245

41%

59%

Scheme 6.9: Result of the reaction of dihalide 245 with magnesium in THF at reflux. Relative
yields are shown and were determined by 1H NMR analysis.

‡

During work-up, the ethereal extracts were carefully concentrated at ≥200 mbar (40 oC) in order to
avoid the loss of the semi-volatile hydrolysis product of diGrignard 246 (ethylbenzene).
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As such, it was apparent that at reflux, the coupling of newly formed alkyl Grignard 247
with unreacted dibromide 245 was predominating over magnesium insertion into the
remaining alkyl-Br bonds (Scheme 6.10). Further reaction of dibromide 248 with
magnesium would give diGrignard 249 which would be hydrolysed upon work-up to
1,4-diphenylbutane.
Br
Br
Br

MgBr

Mg

Br
245

Br

245

Br
247

Br 248

BrMg
H2O

2Mg
MgBr
249

Scheme 6.10: Proposed mechanism of the formation of 1,4-diphenylbutane during the reaction
of dihalide 245 with magnesium in THF at reflux.

Despite the undesired dimerisation predominating, the presence of ethylbenzene after
work-up indicated diGrignard 246 had partially formed. Therefore, the reaction of
dibromide 245 with magnesium at reflux was repeated and the resulting solution,
expected to contain the desired diGrignard 246 and diarylGrignard 249, was added to a
limiting amount of PhPOCl2 in THF at 0 oC (Scheme 6.11).‡ After work-up, 1H NMR
analysis of the crude material indicated that none of the desired benzophospholane had
been formed and that 1,4-diphenylbutane was the major constituent.

Br
Br
245

(i) 6 eq. Mg, THF
reflux, 16 h
(ii) 0.25 eq. PhPOCl2
0 oC to RT, 18 h

X

P
Ph
O
235

Scheme 6.11: Attempted synthesis of benzophospholane 235 from dibromide 245 via the
diGrignard reagent formed at reflux.

‡

DiGrignard 246 should be more reactive than diGrignard 249 as it has an alkyl carbanion. Therefore it
is feasible that some selectivity could be achieved in the reaction of the mixture with 0.25 equivalents of
PhPOCl2.
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6.4.1.1 Attempted Model Reaction with Methyl Benzoate
The addition of mixed-halide Grignard 251 to methyl benzoate has been reported to
yield indanol 252 (Scheme 6.12).224

Cl

Mg, Br(CH2)2Br
THF, RT
overnight

MgCl
MgBr
251

Br
250

PhCOOMe, THF
-78 oC to RT, 20 h
45%
252

OH
Ph

224

Scheme 6.12: Previously reported synthesis of indanol 252 from diGrignard 251.

Therefore, we aimed to attempt the preparation of indanol 252 from dibromide Grignard
246 as a model reaction. Accordingly, the diGrignard was formed at reflux and added to
methyl benzoate under the reported conditions (Scheme 6.13).224 Analysis of the crude
NMR spectra indicated the presence of unreacted methyl benzoate and 1,4diphenylbutane as the sole constituents. The latter was isolated in 29% yield after
column chromatography.

Br
Br
245

(i) 6 eq. Mg, THF
reflux, 22 h
(ii) 0.5 eq. PhCOOMe
-78 oC to RT, 18 h

X

OH
252 Ph

29%

Scheme 6.13: Attempted synthesis of indanol 252 via diGrignard 246 formed at relux. The
isolated yield of 1,4-diphenylbutane is based on dibromide 245.

6.4.2 Synthesis using 1-Bromomagnesio-2-(2-(chloromagnesio)ethyl)benzene
Due to the failure to achieve either of the desired ring closures using dibromide 245 as
the Grignard precursor, attention was turned towards replacing the alkyl bromine with a
chlorine with the aim of reducing (or eliminating) the extent of undesired coupling
during reaction with magnesium. As such, the mixed dihalide 250 was prepared from 2(2-bromophenyl)ethanol as previously described (Scheme 6.14).224
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PCl5, CHCl3
reflux, 40 h
65%

OH
Br

Cl
Br
250

Scheme 6.14: Synthesis of dihalide 250 as previously described.224

An investigation was subsequently carried out into the optimum conditions for
preparation of the corresponding diGrignard 251 (Scheme 6.15).
Cl

Cl

Mg, Br(CH2)2Br
THF, 12 h

Cl

H2O

MgBr

253

or

Br
250

MgCl
MgBr
251

H2O
254

Eq. Mga Eq. Br(CH2)2Bra Temp.
Productsb
1c
4
0.25
RT
Only 253
2
4
0.25
40 oC Mostly 254, small quantity of 253
3
4
0.25
reflux
Only 254
4
2
0.00
reflux
Only 254
a
Equivalents with respect to dihalide 250. bDihalide 250 was completely consumed in all cases
and the products were determined by 1H NMR analysis of the crude sample after work-up.
c
Reported conditions which produced only 254 after quenching, indicating complete diGrignard
formation.224
Scheme 6.15: Results from the reaction of dihalide 250 with magnesium turnings under various
conditions.

The reaction was first attempted as previously described (entry 1),224 producing 2(chloroethyl)benzene 253 as the sole product after quenching and indicating that only
magnesium insertion into the aryl-Br bond had occurred. Increasing the temperature to
40 oC (entry 2) promoted the insertion of magnesium into both halide bonds giving
ethylbenzene 254 as the major product after hydrolysis, with only a small quantity of 2(chloroethyl)benzene present. Heating the mixture at reflux provided complete
conversion to diGrignard 251, with no evidence of coupling to form 1,4-diphenylbutane
(entry 3). It was also found that in the absence of an initiator and with just two
equivalents of magnesium at reflux, the desired diGrignard could be formed exclusively
(entry 4).‡

‡

This protocol was utilised in all subsequent preparations of diGrignard 251 and was convenient as the
completion of the reaction could be gauged by the complete dissolution of magnesium turnings.
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Therefore, the preparation of benzophospholane 235 was attempted via the addition of
diGrignard 251 to PhPOCl2 at 0 oC (Scheme 6.16). This protocol failed to produce the
desired heterocycle after multiple attempts.
Cl

Mg, THF
reflux, 12 h

Br
250

MgCl
MgBr
251

PhPOCl2, THF
0 oC to RT, 26 h

X

P
O
235

Ph

Scheme 6.16: Attempted synthesis of benzophospholane 235 by performing the addition of
diGrignard 251 to PhPOCl2 at 0 oC.

A subsequent attempt to repeat the reported reaction with methyl benzoate (see Scheme
6.12) afforded indanol 252224,228 in 26% yield (Scheme 6.17). This prompted us to
perform the diGrignard addition to PhPOCl2 at -78 oC, which gave benzophospholane
235 in 46% yield after column chromatography.
1) PhCOOMe, THF
-78 oC to RT, 24 h
26%
Cl Mg, THF
reflux, 12 h
Br
250

MgCl
MgBr
251

252
2) PhPOCl2, THF
-78 oC to RT, 26 h
46%

OH
Ph

P
O
235

Ph

Scheme 6.17: Synthesis of 1) indanol 252 and 2) benzophospholane 235 by performing the
addition of diGrignard 251 to the electrophile at -78 oC.

The outcome of this reaction was found to be consistently repeatable, indicating that at
the higher temperature previously used (0 oC), competing polymerisation was inhibiting
the desired cyclisation.222 Therefore, providing the low temperature is used in the
diGrignard addition, this method is clearly more efficient than the previously reported
syntheses of benzophospholane 235, which involve lower overall yielding multi-step
procedures.215-217
A sample of benzophospholane 235 was subjected to reduction with PhSiH3201 and the
resulting phosphine 255 was protected as its borane complex 256 as previously
described (Scheme 6.18).229 This adduct is known to undergo α-lithiation cis to the
boron229 and is therefore another potential precursor to the 2,2'-bibenzophospholane
target ligand.
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P
O
235

PhSiH3, toluene
reflux, 15 h
94%

BH3·SMe2, THF
0 oC to RT, 20 min
91%

P

Ph

255

Ph

P
Ph
H3B
256

Scheme 6.18: Synthesis of benzophospholane-borane 256 by the reduction of
benzophospholane 235 to phosphine 255 and subsequent reaction with BH3·SMe2 as previously
described.229

To demonstrate the utility of diGrignard 251 to provide access to additional substituted
monomers, the reaction was also performed with NMe2POCl2 as the electrophile,
yielding benzophospholane 257 in 60% yield (Scheme 6.19). This compound
hydrolysed upon standing in air quantitatively to the corresponding phosphinic acid 258
and should therefore be stored under an inert atmosphere to prevent decomposition.
MgCl
MgBr
251

NMe2POCl2, THF
-78 oC to RT, 50 h
60%

P
NMe2
O
257

atmospheric
hydrolysis
~100%

P
O OH
258

Scheme 6.19: The synthesis of benzophospholane 257 from diGrignard 251. The product was
found to decompose quantitatively to phosphinic acid 258 upon standing in air.

6.5 Synthesis of 1-Phenylarsolane and Racemic 1-Phenylbenzoarsolane
The diGrignard reagents used to prepare the phospholane monomers could presumably
be applied in the same fashion to produce the target arsine oxides, however the required
electrophile PhAsOCl2 is not readily available commercially in sufficient quantities.
Although the corresponding arsenic(III) source (PhAsCl2) has been used to prepare
arsolane 259 from diGrignard 238 and the product is known to be easily oxidised to the
target monomer (Scheme 6.20),218,230 we aimed to avoid the use of PhAsCl2 due to its
extreme toxicity and the fact that it has been used as a chemical warfare agent.231

BrMg

MgBr
238

PhAsCl2, THF
-10 oC to RT, 3 h
66%

As
Ph
259

30% H2O2
acetone, RT, 2 h
96%

As
O

Ph

236

Scheme 6.20: Previously reported synthesis of arsolane 259 from diGrignard 238 and its
subsequent oxidation to the target monomer with H2O2.218,230
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The reaction of dithiols such as 260 with the significantly less noxious PhAsO has been
reported to give arsadithiolanes with preservation of the arsenic(III) oxidation state
(Scheme 6.21).232
PhAsO, dioxane
RT, 5 h
HS

SH

S

260

S
As
Ph
261

Scheme 6.21: Previously reported synthesis of arsadithiolane 261 using PhAsO as the arsenic
source.232 The yield was not reported.

Given this precedent, it was anticipated that PhAsO would react with diGrignard
reagents in the same fashion. Therefore, diGrignard 238 was added to a solution of
PhAsO in THF at 0 oC, affording arsolane 259 in 12% yield after chromatographic
purification (Scheme 6.22).‡
Br

Br

Mg, THF
30 oC, 1 h
BrMg

MgBr
238

PhAsO, THF
0 oC to RT, 20 h
12%

As
Ph
259

Scheme 6.22: Synthesis of arsolane 259 from diGrignard 238 using PhAsO as the arsenic
source.

In this reaction, the formation of arsolane 259 presumably occurs through nucleophilic
addition of diGrignard 238 to PhAsO giving intermediate 262, which cyclises to expel
O(MgBr)2 (Scheme 6.23).

MgBr

BrMg

O
AsPh

OMgBr
AsPh

BrMg

238
262

As
Ph
259

+ O(MgBr)2

Scheme 6.23: Proposed mechanism of the reaction of diGrignard 238 with PhAsO to form
arsolane 259.

Benzoarsolane 263 was subsequently prepared in 20% yield by the treatment of PhAsO
with diGrignard 251 at -78 oC (Scheme 6.24). This one-pot operation is thus safer and
more efficient than the previously reported three-step synthesis which utilised the toxic
PhAsCl2 as the arsenic source and gave the benzoarsolane in 25% overall yield.219
‡

Oxidation during work-up with H2O2218 was not performed in order to confirm that the arsenic(III)
oxidation state had been maintained.
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Cl

Mg, THF
reflux, 12 h

Br
250

MgCl

PhAsO, THF
-78 oC to RT, 22 h
20%

MgBr
251

As
Ph
263

Scheme 6.24: Synthesis of benzoarsolane 263 via the reaction of diGrignard 251 with PhAsO.

6.6 Summary and Outlook
This chapter presented our synthetic strategy towards the phosphine and arsine target
ligands 224-227 based on the dimerisation of their corresponding monomeric oxides as
the key step.
Armed with the knowledge that cyclic phosphines can be prepared from diGrignard
reagents,220-222 a versatile and convenient one-pot synthesis of each of the required
phenyl-substituted phosphine oxides was realised. Although phospholane 234 could be
produced (23%) by combining diGrignard 238 and PhPOCl2 at ambient temperature, the
successful formation of the benzophospholane derivative required the use of the mixedhalide Grignard 251 and its addition to the electrophile at -78 oC, giving the desired
product in a reasonable 48% yield. Encouraged by these results, the preparation of
phospholane 234 has subsequently been attempted at this reduced temperature,
increasing the yield from that obtained here to an acceptable 51%.223 Therefore, both
phospholane systems have been produced using the expedient diGrignard strategy in
higher yields than possible with the previously published multi-step procedures.213-217

The labile dimethylamino group (NMe2) was also accommodated as a P-substituent in
the cyclisation of diGrignard 251. Although this moiety is unlikely to be useful on the
final ligand, its ease of removal provides a handle for further manipulations at the
phosphorus centre. In this way, benzophospholane 257 could provide a more convergent
route to substituted bidentate P-ligands by facilitating a synthetic pathway to dichloride
264 (Scheme 6.25). This compound represents an important intermediate due to the
possibility of its substitution with any aryl or alkyl group (R), as opposed to performing
the synthesis of each new ligand from a different P-substituted monomer.‡

‡

This approach would also be applicable to derivatives of the biphospholane target ligand 224 and
potentially even to the arsine targets by using NMe2AsO as the electrophile in the diGrignard reactions.
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Scheme 6.25: Proposed convergent synthesis of substituted phosphine dimers from
benzophospholane 257 via the key intermediate 264.

The diGrignard strategy was also extended to the synthesis of the corresponding
arsolanes using PhAsO as the electrophile, which avoided the need for the extremely
toxic PhAsCl2 as the arsenic source. Although the yields were low, they represent a
single attempt at each reaction. Future efforts should thus be directed towards
optimising these outcomes, for instance by attempting the preparation of arsolane 259 at
-78 oC (as proven to be successful for the analogous phosphines) or using Lewis acid
catalysts. Oxidation of the arsines during work-up should also be carried out to provide
the required substrates for dimerisation.
More recently in our laboratory, the dimerisation of benzophospholane 235 has been
performed to provide the racemic diphosphine oxide 265, which was separated from the
meso diastereomer by crystallisation (Scheme 6.26).223 Subsequent reduction and
resolution of these enantiomers, as well as dimerisation of the remaining phospholane
and arsolane monomers, is currently being investigated in order to access to our first set
of (phenyl substituted) phosphine and arsine targets 224-227 for chiral ligand screening.
H H

dimerisation
*
P
O
±-235

Ph

*
P

*
P
O Ph Ph O
±-265, 31%

H H
+

*
*
P
P
O Ph Ph O
meso-265, 19%

Scheme 6.26: Result of the dimerisation of benzophospholane 235 recently performed in our
laboratory.223
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Preliminary Investigations into the Synthesis of New Catalysts for
Stereoselective Aryl Coupling Reactions

7.1 Copper(II) Complexes for Oxidative Aryl Homo-Coupling
Within the area of atropisomeric biaryl synthesis, chiral dinitrogen ligands are
commonly utilised in copper(II) catalysed oxidative homo-coupling reactions.28,233,234
Among the ligands screened in these reactions is C2-symmetric secondary diamine
(S,S)-266 (Scheme 7.1). This compound reacts with CuI under aerobic conditions to
form a trimeric square planar Cu(II) complex ([Cu.(S,S)-266.OH]3I3) which catalyses
the stereoselective homo-coupling of naphthols such as 267 with molecular oxygen as
the co-oxidant.28,233
H
N

CuI, CH3CN
air, RT, 20 min

[Cu.(S,S)-266.OH]3I3

N
H
(S,S)-266

CO2Me
OH

10 mol%
[Cu.(S,S)-266.OH]3I3
(CH2Cl)2, O2(g)
40 oC, 48 h
85%, 92% ee

CO2Me

*

OH
OH

267
CO2Me
(M)-268

Scheme 7.1: Previously reported synthesis of the Cu(II) complex of diamine (S,S)-266 and its
use to catalyse the enantioselective homo-coupling of naphthol 267 with oxygen as the cooxidant.28,233

Given that a stereoselective synthesis of the initial target dinitrogen ligands (2,2'bipyrrolidine and 2,2'-biindoline) had been achieved, we aimed to investigate the
preparation of their corresponding copper(II) complexes in order to access their ability
to catalyse the asymmetric homo-coupling of aryl substrates such as naphthol 267.‡

‡

In general, ligands with secondary amine donor atoms give superior results to tertiary amines.28
Therefore, we initially desired to investigate these reactions using the parent ligands without Nsubstitution.
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7.1.1 Synthesis of Di-μ-hydroxo-bis[(N,N,N',N'-tetramethylethylenediamine)
copper(II)] Iodide
Prior to attempting the reaction of our chiral dinitrogen ligands with CuI, the
TMEDA/Cu(II) complex 269† was prepared as previously described (Scheme 7.2).235

Me2N

NMe2

CuI, O2(g)
95% EtOH
RT, 16 h
93%

(TMEDA)

Me2N

NMe2
Cu

OH 2I
Cu
Me2N
NMe2
HO

[Cu.TMEDA.OH]2I2

269

Scheme 7.2: Synthesis of the TMEDA/Cu(II) complex 269 as previously described.235

Although this complex has not been previously characterised,235 it was assumed to have
the same dimeric structure as its perchlorate analogue, which has been established by
EPR spectroscopy.236 Analysis of the ES+ mass spectrum showed peaks at m/z 147 and
145 assigned to the 65Cu+.(CH3CN)2 and 63Cu+.(CH3CN)2 isotopic adducts respectively,
in addition to a base peak at m/z 117 assigned to the M+H ion of TMEDA. This
indicated that the bidentate ligand had been displaced in the spectrometer by two
acetonitrile donor molecules.‡

7.1.2 Synthesis of μ-Hydroxo-[{(2S,2'S)-2,2'-bipyrrolidine}copper(II)] Iodide
In order to prepare the analogous bipyrrolidine complex, deprotection of dicarbamate
(S,S)-43 was carried out with TFA (Scheme 7.3).58 After alkalification, the volatile and
air sensitive bipyrrolidine (S,S)-3760 was extracted and added directly to a suspension of
CuI in 95% EtOH affording a blue powder assumed to be Cu(II) complex (S,S)-270 in
99% overall yield. The ES+ mass spectrum was directly analogous to that of the
TMEDA/Cu(II) complex with peaks at m/z 147 and 145 assigned to the Cu+.(CH3CN)2
isotopes and a base peak at m/z 141 assigned to the M+H ion of bipyrrolidine (S,S)-37.
An attempt to grow crystals of the complex from CH2Cl2 of sufficient quality for X-ray
analysis was unsuccessful.

†

This achiral catalyst would be useful to establish reaction conditions and obtain racemic samples of any
atropisomeric biaryls synthesised at a later stage using our chiral complexes.
‡
ES MS analysis was performed using an acetonitrile/water (1:1) solvent system.
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TFA, CH2Cl2
RT, 33 h
NaOH
N
N
H
H
(S,S)-37

N
N
Boc
Boc
(S,S)-43

CuI, air
95% EtOH
RT, 60 h
99%
overall

N
N
H Cu H
HO

nI
n

[Cu.(S,S)-37.OH]nIn
(n = 2 or 3)

(S,S)-270

Scheme 7.3: Synthesis of the chiral bipyrrolidine/Cu(II) complex (S,S)-270. The structure of the
complex was not able to be confirmed with an X-ray structure and was assumed to be [Cu.(S,S)37.OH]nIn where n = 2 (dimer) and/or 3 (trimer).

Although diamine/Cu(II) complexes prepared in this fashion are most commonly
dimeric,233,235 smaller secondary diamines such as 266 can form trimeric species (see
Scheme 7.1).233 Therefore, given the similar size of the bipyrrolidine ligand and diamine
266, the product ([Cu.(S,S)-37.OH]nIn) could have formed as a dimer (n=2), trimer
(n=3) or a mixture of both structures. Whether the molecule exists in the solid state as a
dimer or trimer however has no effect on the reactivity of the complex as equilibration
with the active monomeric species occurs in solution.233

7.1.3 Attempted Synthesis of Di-μ-Hydroxo-bis[{(2S,2'S)-2,2'-biindoline}
copper(II)] Iodide
Due to the larger size of biindoline (S,S)-38, this ligand was expected to form dimeric
Cu(II) complex (S,S,S,S)-271 upon treatment with CuI, however the desired product was
not formed when the reaction was performed in air or under an atmosphere of molecular
oxygen (Scheme 7.4). In the former case, biindoline (S,S)-38 was recovered unchanged.
In the latter, complete consumption of the ligand occurred to give a mixture of
compounds with all resonance signals in the 1H NMR spectrum at >6.5 ppm, suggesting
oxidation of the indoline units. An attempt to form the complex from CuCl235 with
stirring in air over one week also resulted in (apparent) oxidation.
CuI, CH3CN
air, RT, 16 h

X
N
N
H
H
(S,S)-38

CuI, O2(g)
95% EtOH
RT, 200 h

X

N
N
H Cu H
HO
OH
H Cu H
N
N

2I

(S,S,S,S)-271

Scheme 7.4: Attempted conditions for the preparation of chiral biindoline/Cu(II) complex
(S,S,S,S)-271.
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Although biindoline (S,S)-38 is a weaker nucleophile, base and donor ligand than
bipyrrolidine (S,S)-37, the failure to form the desired complex was difficult to
rationalise given that other dianilino compounds have been reported to form these types
of complexes from copper(I) salts,235 for example ligand 272 (Scheme 7.5).†
CuCl, O2(g)
95% EtOH
RT, 12 h
Me2N
NMe2
272

Me2N

2Cl

NMe2
Cu

HO

2

Scheme 7.5: Previously reported synthesis of the Cu(II) complex of dianilino ligand 272 from
CuCl.235 The yield was not given.

7.1.4 Oxidative Homo-Coupling of Methyl 3-Hydroxy-2-naphthoate
Despite not having obtained an X-ray structure of the product isolated from the reaction
of bipyrrolidine (S,S)-37 with CuI (see Scheme 7.3), the homo-coupling of naphthol 267
(see Scheme 7.1) was attempted as a model reaction for the screening of the complex as
a chiral catalyst. Firstly, a sample of the racemic binaphthol 268 was prepared using the
TMEDA/Cu(II) catalyst ([Cu.TMEDA.OH]2I2) (Scheme 7.6).28 Enantioselective
catalysis was then attempted using the chiral bipyrrolidine/copper complex {which was
assumed to be [Cu.(S,S)-37.OH]nIn}, however TLC analysis after 24 h indicated that no
reaction had occurred. After continued stirring for 216 h, TLC analysis revealed the
presence of a small quantity of the desired product, which was isolated in 28% yield as
a racemic mixture.‡

†

Dinitrogen ligands form complexes more readily with copper(II) salts,237 however catalysts prepared in
this fashion have been found to give lower enantioselectivity in oxidative homo-coupling reactions.28
‡
The measured specific rotation of +3.5 (c 0.40, THF) was considered to be negligible in comparison to
the reported rotation of the (M)-enantiomer of +170.5 (c 1.1, THF).238
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10 mol%
[Cu.TMEDA.OH]2I2
(CH2Cl)2, O2(g)
40 oC, 22 h
66%
CO2Me
CO2Me

OH
OH

10 mol%
[Cu.(S,S)-37.OH]nIn
(CH2Cl)2, O2(g)
40 oC

OH
267

CO2Me
±-268

0% after 24 h (TLC)
28% after 216 h

Scheme 7.6: Results of the oxidative homo-coupling of naphthol 267 using the TMEDA/Cu(II)
catalyst ([Cu.TMEDA.OH]2I2) and the chiral bipyrrolidine/Cu(II) complex ([Cu.(S,S)37.OH]nIn).

Given the poor outcome, it is possible that the bipyrrolidine complex originally isolated
and used in this reaction was actually the 2:1 diamine:copper species (S,S,S,S)-273,
which may be thermodynamically favoured at equilibrium over the desired catalyst
(S,S)-270 (Scheme 7.7).233 This 2:1 ligand:metal complex would be catalytically inactive
because it has no available sites for coordination of the naphthol substrate,233 explaining
the failure to observe the product after 24 h.‡

N
N
H Cu H
HO

nI

N 2
H Cu
H
N

N
H
H
N

2I

n

(S,S)-270
(S,S,S,S)-273

Scheme 7.7: Proposed equilibration of the desired bipyrrolidine/Cu(II) complex (S,S)-270 with
the catalytically inactive complex (S,S,S,S)-273.233

Although a small quantity of the desired product was eventually detected and isolated,
its formation required an exceedingly long reaction time and we believe that a nonstereoselective coupling was mediated by residual CuI or other bipyrrolidine-free
copper species formed after degradation of the chiral complex. Therefore, this result is
inconclusive and further investigation is clearly required.

Complexes of type 270 are active catalysts because the bridging hydroxo ligands are readily
displaced.28,233
‡
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7.2 Synthesis of (2S,2'S)-2,2'-Biindolinepalladium(II) Dichloride
Chiral palladium catalysts supported by bidentate nitrogen ligands have been found to
be effective in enantioselective Suzuki coupling reactions.55 Therefore, the preparation
and application of palladium complexes of our chiral dinitrogen ligands also needs to be
investigated.

As a starting point, Pd(II) dichloride complex (S,S)-274 was prepared in 95% yield from
the parent biindoline (S,S)-38 and Pd(CH3CN)2Cl2 (Scheme 7.8).239 The product
precipitated immediately from the reaction as a yellow/orange powder, which was
sparingly soluble in all solvents.

N
N
H
H
(S,S)-38

Pd(CH3CN)2Cl2
CH2Cl2, RT, 2 h
95%

N
N
H Pd H
Cl
Cl
(S,S)-274

Scheme 7.8: Synthesis of the chiral biindoline/Pd(II) complex (S,S)-274.

Analysis of the NMR spectra of the complex indicated preservation of C2 symmetry,
with a single set of peaks for the equivalent indoline units observed. All resonance
signals in the 1H and

13

C NMR spectra had experienced a downfield shift due to the

presence of the electron withdrawing palladium(II) atom. Most significantly, in the 1H
NMR spectrum, the broad singlet assigned to the NH proton appeared at 7.46 ppm in
contrast to 4.20 ppm in the spectrum of the free biindoline.

An X-ray structure was also obtained of a crystal grown from acetonitrile, shown from
two perspectives in Figure 7.1 (see Appendix 5 for complete crystal data).‡ The
molecule was found to be enantiomerically pure and the absolute configuration of the
ligand was confirmed as S,S by refinement of the Flack parameter.240 In the crystal
lattice the complex is not strictly C2 symmetrical, with slight variations in the bond
lengths and angles in each indoline unit. As expected, the geometry about the palladium
atom is essentially square planar, with N-Pd-N and Cl-Pd-Cl bond angles of 84o and 91o
respectively.
‡

X-ray crystallography studies were performed by Dr Anthony Willis at the Australian National
University, Canberra.
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1) Front View

2) Side View

Figure 7.1: The X-ray crystal structure of the chiral biindoline/Pd(II) complex (S,S)-274 as
viewed from the 1) front and 2) side of the molecule.

It can also be seen from these models that the helical groove depth of the complex could
be further increased by, for example, fusing an additional aromatic ring to the 7,8 and
7',8' junctions of the biindoline to give ligand (S,S)-275 (Figure 7.2). Accordingly, the
synthesis of this modified scaffold is the subject of further projects within our research
program.

X
X
R
R
(S,S)-275

X = N, P, As

Figure 7.2: Chiral ligand scaffold (S,S)-275 which would have an increased helical groove
depth in comparison to the biindoline ligand when bound to a metal such as palladium.

7.3 Summary and Outlook
Preliminary investigations into the synthesis, characterisation and application of
selected copper(II) and palladium(II) complexes of the parent dinitrogen ligands 2,2'bipyrrolidine and -biindoline were undertaken.
A single attempt to prepare the bipyrrolidine (S,S)-37/Cu(II) complex [Cu.(S,S)37.OH]nIn using a literature based procedure resulted in an inactive catalyst for the
homo-coupling of napththol 267. Therefore, further attempts to access the desired
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complex, as well as elucidate the structure of the original product, need to be carried
out.
Attempts to prepare the corresponding biindoline (S,S)-38/Cu(II) complex were
unsuccessful and in most cases appeared to result in oxidation of the ligand. The
appropriate conditions for the generation of this catalyst thus remain to be established.
In contrast, the biindoline/Pd(II) complex (S,S)-274 was easily prepared and
conformation of its structure and absolute stereochemistry was provided by X-ray
analysis. The preparation of the analogous bipyrrolidine/Pd(II) complex and a range of
N-substituted derivatives of each parent structure will also be examined in the near
future to generate an array of chiral palladium catalysts for screening in aryl crosscoupling reactions.
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An investigation into the design and synthesis of helical chiral ligands for
atropoenantioselective Suzuki reactions was undertaken. The chiral synthesis of 2,2'bipyrrolidine was the subject of primary investigations which focused on new methods
to prepare the key intermediate alkene 46 in higher geometrical purity than previously
possible with Grubbs’ 1 metathesis.61 Among the multiple methods examined, the trans
selective Wittig reaction provided the optimum level of stereoselectivity (E:Z, 97:3).
Subsequent Sharpless AD of alkene (E)-46 afforded diols (R,R)-73 (97% ee) and (S,S)73 (87% ee), which are easily elaborated to the enantiomers of 2,2'-bipyrrolidine with
preservation of stereochemical integrity.58,105

The first two stereoselective syntheses of biindoline (S,S)-38 were concurrently
performed using bioxirane (R,R)-87 and biazirdine (S,S)-183 as chiral precursors - both
of which were prepared from D-tartaric acid through the common intermediate
dimesylate (R,R)-158 (Scheme 8.1). The key step of both routes was the copper
catalysed ring opening of the heterocycle with 2-bromophenylmagnesium chloride,
providing two paths of entry to the penultimate diamine (S,S)-143, which was
regioselectively

cyclised

under

microwave

assisted

palladium

catalysis.

Crystallographic analysis of the product and its corresponding Pd(II) dichloride
complex 274 unequivocally confirmed the structure, enantiomeric purity and absolute
stereochemistry of the molecule. The R,R-enantiomer should thus be accessible in the
same fashion from the bioxirane and biazirdine building blocks derived from L-tartaric
acid.
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(S,S)-183
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Br
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NH2
NH2
(S,S)-143
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Br

N
N
Boc
Boc
(S,S)-43
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N
N
H
H
(S,S)-38

Scheme 8.1: Summary of the pathways used to synthesise the target dinitrogen ligands
biindoline (S,S)-38 and bipyrrolidine (S,S)-43.

Although both pathways provided the biindoline target in enantiomerically pure form
(>99% ee), the overall yields were low and the efficiency of each sequence could be
improved with some suggested strategy alterations. Most notably, the ortho substituent
of the nucleophile used to cleave the bioxirane should be changed to a (protected)
nitrogen atom, primarily to avoid the highly inefficient introduction of the heteroatom to
the alkyl chain as the azide nucleophile. Accordingly, a modified sequence is being
investigated with aryllithium 177 as the nitrogen source, which contains a pivalyl amide
group ortho to the carbanion. During the ring opening of biaziridine (S,S)-183,
complications arose due to an undesired intramolecular nucleophilic addition to the Boc
protecting group. Therefore, the pivalyl moiety is also being examined as an alternative
activator for the biaziridine, which is anticipated to be inert to this mode of attack.

To further demonstrate the utility of the bioxirane as a chiral ligand precursor, a concise
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synthesis of enantiomerically pure bipyrrolidine (S,S)-43 was established using the
cheap and readily available acetonitrile as the source of the nitrogen and the carbon
nucleophile for the ring opening reaction. A chiral copper(II) complex was subsequently
prepared from the parent compound for application in oxidative aryl homo-coupling
reactions, however its precise structure is yet to be determined.

Overall, the 2,2'-bioxirane and -biaziridine heterocycles represent versatile building
blocks for chiral ligand synthesis and their use avoids potential (and previously
encountered) problems with stereoselectivity using our alternative metathesis/Sharpless
AD strategy. Accordingly, further application of these precursors to the synthesis of a
range of new C2-symmetric chiral diamine ligands is currently under investigation. For
example, ring opening of the heterocycles with benzylic Grignard 276 would provide
alternate pathways to diamine (S,S)-277 which could be cyclised to the biquinoline
ligand (S,S)-278† (Scheme 8.2). The synthesis of non-C2-symmetrical ligands could also
be made possible from these molecules by the sequential stoichiometric addition of
different carbon nucleophiles.
Br
NR
RN
(S,S)-179
2 steps

O

MgX

O
(R,R)-87

276
Br

4 steps

NH2
NH2
(S,S)-277

Br

(1 step)

N
N
H
H
(S,S)-278

Scheme 8.2: Proposed synthetic route to biquinoline (S,S)-278 using benzylic Grignard 276 for
the ring opening of the chiral precursors.

Although the phosphorus- and arsenic-stereogenic analogues of the 2,2'-bipyrrolidine
and -biindoline ligands could also be potentially accessed from the chiral bioxirane,‡
foreseeable complications with stereoselectivity prompted us to employ a dimerisation
†
‡

No stereoselective syntheses of this compound have been reported.
Use of the biaziridine is restricted to the synthesis of chiral diamine ligands.
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and resolution strategy for their synthesis. A one-pot synthesis of the four required
monomers was subsequently realised by the reaction of diGrignard reagents with phenyl
substituted phosphine and arsine oxides. The labile dimethylamino group was also
accommodated as a P-substituent, which provides the possibility of aryl or alkyl Psubstitution after dimerisation - a highly convergent route to bidentate phosphine
ligands.

More recently, the diGrignard strategy developed here has been extended to the
synthesis of a number of additional cyclic phosphines, including the four-, five- and sixmembered ring structures 279-282 shown in Figure 8.1.241,242 This further highlights the
versatility of this approach to heterocyclic synthesis and its potential to facilitate the
synthesis of an array of new chiral phosphine and arsine dimers, including our first set
of target ligands 224-227.

*P Ph
O
279

*
P
O
280

Ph

*
P
O Ph
281

P
O Ph
282

Figure 8.1: The cyclic phosphine oxides 279-282 recently synthesised in our laboratory from
diGrignard reagents.241,242

Therefore, efficient synthetic strategies to our first generation of target ligands
encompassed by scaffolds 35 and 36 were developed which can be extended to
accommodate a range of structurally modified diamine, diphosphine and diarsine
compounds. The application of these principles to the synthesis of a diverse range of
mixed-heteroatom ligands will also be the subjects of future projects in this research
program.

Continued investigation into the preparation and characterisation of ligand-transition
metal complexes, including a range of hetero-substituted derivatives of each compound,
will provide an array of new helical structures to be screened as potential chiral catalysts
for enantioselective aryl homo- and cross-coupling protocols, including the increasingly
important Suzuki reaction. This methodology could then find application in the
synthesis of biologically and synthetically valuable atropisomeric biaryl compounds.
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9.1 Reagents and Solvents
Dry THF, Et2O and CH2Cl2 were obtained from a Pure Solv MD-5 solvent purification
system. Alternatively, under N2, THF was distilled from Na/benzophenone and CH2Cl2
was distilled from CaH. Anhydrous DMF, DMSO, toluene, EtOH, MeOH and CH3CN
were purchased and used without further purification. CH2Cl2 and hexanes for general
use (extractions, column chromatography, etc) were distilled in air. H2O was obtained
from a Millipore purification system. N2 was dried by passing through a CaCl2 tube.
Grignard reagents were prepared with Mg turnings that were washed with 2 M HCl and
Et2O before being dried under high vacuum. Na was purchased as lumps in oil and was
washed with hexanes before use. NaH was weighed and used as a 60% suspension in
mineral oil. 1,4-Benzoquinone was purified by sublimation with gentle heating under
high vacuum. LiBr and LiCl were dried in a 110 oC oven for at least 24 h and cooled
under N2 before use. CuCN (light green) was purified by stirring a suspension in boiling
H2O for 1 h, vacuum filtering and washing sequentially with H2O, EtOH, EtOAc, THF,
Et2O and hexanes.243 Drying under high vacuum at 80 oC for 24 h gave a light
brown/white powder which was stored under N2 in a dessicator. CuI (tan) was purified
by dissolving in a boiling sat. NaI aq. solution, cooling to RT and precipitating by
dilution with H2O.243 After vacuum filtration, the white CuI was washed and dried as
described for CuCN. Raney Ni was purchased as a suspension in H2O and was washed
with EtOH before use. In order to protect the pyrophoric alloy from the atmosphere, it
was necessary to be weighed as an EtOH slurry. The quantities of Raney Ni noted
within are expressed as dry mass and are a guide only. It is sufficient to use an excess of
the metal as the reductions described herein are stoichiometric in Ni (1 eq. per nitrile
moiety). All other reagents and solvents were purchased reagent grade and used without
further purification or drying.
The concentrations of fresh batches of commercially available organolithium and
Grignard reagents were assumed to be as stated by the manufacturer. Otherwise,
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concentrations marked with an asterix (*) were determined by titration.244 Reagents
were added directly to a few mg of 1,10-phenanthroline as indicator under N2 at RT.
Butyllithiums produced rust red solutions, PhLi gave a burgundy colour and Grignards
formed deep violet complexes. Titrations were carried out to the sharp colourless/pale
yellow end point with a standard solution of 2-butanol in toluene (~1 M).
All reagents stated with a percentage are dissolved in H2O and refer to g/100 mL (eg:
10% Na2SO3 = 10 g/100 mL). Aq. solvents are stated with a percentage which refers to
volume to volume (v:v) proportions (eg: 95% EtOH). All organic solvent mixtures
stated are also in v:v proportions.

9.2 Reactions and Purification
All reactions were performed in acetone washed and oven dried glassware with
magnetic stirring under a positive pressure of N2 unless specified that the reaction was
carried out in air. Anhydrous and/or air sensitive liquids were introduced into the
reaction vessel through a rubber septum with a syringe. The majority of other liquid
reagents were weighed analytically and mixed with the appropriate solvent before being
added to the reaction vessel. Air sensitive and/or hygroscopic solid reagents were
handled under N2 and weighed either directly into the reaction vessel or transferred as a
solution in the appropriate solvent.
All reactions performed at -40 and -78 oC used liquid N2/CH3CN and liquid N2/EtOAc
slush baths, respectively. Thermal heating of reactions was carried out with paraffin or
silicon oil baths. Microwave reactions were performed using a Discover CEM Focused
Microwave Synthesis System in 10 mL closed vessels under N2 (unless stated
otherwise) with a power setting of 100 W.
Reactions heated either thermally or under microwave irradiation were cooled to RT
before quenching and work-up, or crystallisation/precipitation at lower temperatures
than ambient. Freezer storage/cooling was perfomed at -20 oC. All organic extracts were
dried with anhydrous MgSO4 and gravity filtered. All solvents were evaporated under
reduced pressure on a rotary evaporator and products dried under high vacuum (~1
mbar) at RT unless otherwise stated.
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Purification by column chromatography was performed using Flash Merck Silica Gel 60
(63-200 mesh) under a positive pressure of air from a hand pump. Exceptions using
Gravity Merck Silica Gel (230-400 mesh) under atmospheric pressure are noted within.

9.3 Analysis and Characterisation
Melting points (m.p.) were determined using a Gallenkamp (Griffin) melting point
apparatus. Temperatures are expressed in degrees Celsius (oC) and are uncorrected.
Thin Layer Chromatography (TLC) was performed using Merck Silica Gel F254 precoated aluminium plates. Visualisation was accomplished using UV light and/or a
phosphomolybdic acid stain. High Performance Liquid Chromatography (HPLC) was
performed using a Waters 1515 pump and a Daicel Chiralcel OD-H column with a flow
rate of 0.5 mL/min and a detection wavelength of 254 nm. Enantiomeric excesses (ee’s)
and diastereomeric excesses (de’s) were determined by analysis of analyte peak area.
Proton (1H) and carbon (13C) nuclear magnetic resonance (NMR) spectra were recorded
at 300 and 75 MHz respectively on a Varian Mercury 300 MHz spectrometer.
Alternatively, where stated, 1H and

13

C NMR spectra were recorded at 500 and 125

MHz on a Varian Inova 500 MHz spectrometer. NMR spectra were aquired in CDCl3
with chemical shifts (δ) reported in parts per million (ppm) relative to TMS (1H: δ = 0
ppm) and CDCl3 (13C: δ = 77.0 ppm). Alternatively, where stated, spectra were aquired
in (CD3)2SO with δ values reported relative to (CH3)2SO (1H: δ = 2.50 ppm) and
(CD3)2SO (13C: δ = 39.5), or in CD3OD with δ values relative to (CH3)OH (1H: δ = 3.31
ppm) and (CD3)OD (13C: δ = 49.0 ppm), or in (CD3)2CO with δ values relative to
(CH3)2CO (1H: δ = 2.05 ppm) and (CD3)2CO (13C: δ = 29.8 ppm). Coupling constants
(J) are reported in Hertz (Hz). J values listed in 1H NMR spectral data refer to coupling
between hydrogen nuclei. J values listed in

13

C NMR spectral data refer to coupling

between carbon and phosphorus nuclei. Multiplicities are reported as singlet (s), broad
singlet (bs), doublet (d), doublet of doublets (dd), triplet (t), quartet (q), pentet (p) or
multiplet (m).
Electrospray (ES) mass spectra were obtained on a Micromass Platform LCZ
spectrometer. Samples were injected as a solution in 50% CH3CN. In some cases 1%
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aq. HCOOH was added to suppress dimerisation and/or aid in protonation; this is noted
within by: (ES+, HCOOH). High Resolution (HR) ES mass spectrometry (MS) was
performed on a Micromass QTOF2 Ultima Spectrometer. Electron Impact (EI) mass
spectra were performed using a Shimadzu QP-5050 spectrometer. HR EI mass spectra
were obtained using a Fison/VG Autospec-TOF spectrometer at 70 eV with a source
temperature of 250 °C. Ion mass to charge (m/z) values of molecular ions (M), fragment
peaks and adducts are stated with their relative abundances in parentheses. For
compounds with more than one major isotope (eg: compounds containing bromine) all
significant isotopic peaks are reported. For product mixtures characterised by ES MS,
the relative intensity of each ion/adduct is reported but should not be interpreted as a
quantitative measure of the mixture composition. In these cases ions are denoted with
the appropriate compound number (eg: 207+H) rather than ‘M’ (i.e.: M+H).
Infrared (IR) spectra were recorded with neat samples using a Nicolet Avatar 360 FT-IR
spectrometer fitted with a Smart Omni-Sampler germanium crystal accessory. IR data is
reported in nanometres (nm) with peak intensity assigned as weak (w), medium (m) or
strong (s). Optical rotations were measured using a Jasco DIP-370 digital polarimeter
with a 0.1 dm path length and a wavelength of 589 nm. Concentrations (c) are given in
g/100 mL. X-ray crystallography studies were performed by Dr Anthony Willis at the
Australian National University, Canberra (see Appendices 4 and 5).

9.4 Other Considerations
All compounds prepared as racemic mixtures are drawn flat without showing the
stereogenic atoms/axes and are denoted as racemates using the plus/minus symbol (±).
A number of these compounds were synthesised from the commercially available
racemate of 2,2'-bioxirane 87. All compounds prepared with this precursor which retain
rotational symmetry are assumed to be racemic mixtures of the R,R and S,S enantiomers
and are denoted as racemates (±). Compounds synthesised in which rotational symmetry
is broken have two possible racemic forms (as there is no longer a meso diastereromer)
and therefore the configuration of the racemate is specified in the name; i.e.: ±(R,R)/(S,S) as opposed to ±-(R,S)/(S,R) or visa versa. The only exceptions to this are the
elimination products from the azidations (Section 9.6.4) which have only one
enantiomeric pair due to the loss of a stereogenic carbon atom.
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The relative ratios of inseparable cis and trans diastereomers were calculated using 1H
NMR integral analysis. In cases where peaks were not resolved by 1H NMR,
approximate ratios were estimated using the relative heights of analogous peaks in the
13

C NMR spectra. For mixtures of two compounds with different molecular weights -

often obtained after column chromatography - the relative amounts (by mass) were
calculated by solving a simultaneous equation incorporating the mol% ratio‡ and the
total mass. Percentages stated next to each compound refer to chemical yields, not to
mixture composition.
Previously reported specific rotation data for chiral compounds is stated for comparison,
however some manuscripts did not specify the temperature and the units of
concentration - the latter were assumed to be g/100 mL. When following published
syntheses commencing from D- or L-tartaric acid or derivatives thereof, optical rotations
were only recorded on the final product and/or key intermediate/s.
The majority of known compounds were prepared according to literature procedures. In
these cases references are given next to the title compound name. Where a known
compound was prepared by multiple methods, references are given next to the method
number. Where a known compound was prepared by a new or modified method (or was
an undesired side product) references appear next to the compound number in the text.
The 1H and

13

C NMR spectral data of known compounds is included within and is in

agreement with that previously reported unless otherwise noted. Some manuscripts
however did not contain complete (or any) physical and spectral data and/or were
published before modern characterisation techniques were available. Therefore, the
additional data is included herein and noted where appropriate.
All new compounds, including enantiomerically pure products previously only reported
as racemic mixtures, are underlined.

‡

Determined by integral analysis of the 1H NMR spectra.
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9.5 Improvement of our 2,2'-Bipyrrolidine Synthesis
9.5.1 Methathesis with Grubbs’ 2 / Removal of the Meso Isomer
5-(4-Methoxybenzyloxy)-1-pentene (39)61,105,245
OPMB

A mixture of 4-methoxybenzyl alcohol (3.32 g, 24.06 mmol) and
HBr (6.26 mL, 45% in AcOH, 34.80 mmol) was stirred in air for 30

min. The mixture was diluted with Et2O (30 mL) before being washed with sat.
NaHCO3 (3 x 20 mL) and H2O (3 x 20 mL). The organic layer was dried and
concentrated to yield crude 4-methoxybenzyl bromide as a brown oil.
To a suspension of NaH (1.00 g, 60% suspension, 25.00 mmol) in THF (8 mL) at 0 oC
was added dropwise 4-penten-1-ol (2.40 mL, 23.21 mmol) and the mixture was
maintained at 0 oC for 30 min. A solution of the crude benzyl bromide in THF (5 mL)
was added and the mixture was allowed to warm to RT and stirred for 11.5 h. H2O (10
mL) was slowly added and the mixture was extracted with CH2Cl2 (3 x 15 mL). The
combined extracts were dried, concentrated and subjected to column chromatography
(0.75% to 10% EtOAc:hexanes) yielding pentene 39 (3.94 g, 82%) as a colourless oil.
1

H NMR: δ 1.69 (p, J = 6.5 Hz, 2H, H4), 2.12 (q, J = 6.7 Hz, 2H, H3), 3.45 (t, J = 6.5

Hz, 2H, H5), 3.79 (s, 3H, CH3), 4.42 (s, 2H, PhCH2), 4.91-5.07 (m, 2H, H1), 5.75-5.87
(m, 1H, H2), 6.87 (d, J = 8.7 Hz, 2H, ArH3, ArH5), 7.27 (d, J = 8.7 Hz, 2H, ArH2,
ArH6); 13C NMR: δ 28.9 (C4), 30.3 (C3), 55.2 (CH3), 69.4 (C5), 72.5 (PhCH2), 113.7
(ArC3, ArC5), 114.6 (C1), 129.2 (ArC2, ArC6), 130.6 (ArC1), 138.3 (C2), 159.0
(ArC4).

1,8-Di(4-methoxybenzyloxy)-4-octene (40)
PMBO

OPMB

Method 1 using Grubbs’ 1:61,105 To a solution of
pentene 39 (1.50 g, 7.27 mmol) in CH2Cl2 (20 mL)

was added Grubbs’ 1 catalyst (300 mg, 0.36 mmol) and the mixture was heated at reflux
for 21 h. The solvent was evaporated and the residue subjected to column
chromatography (6% to 8% EtOAc:hexanes) yielding octene 40 (1.23 g, 88%, E:Z
80:20) as a colourless oil. 1H NMR (500 MHz): δ 1.59-1.68 (m, 4H, H2, H7), 2.03-2.07
(m, 4H, H3, H6), 3.42 (t, J = 6.5 Hz, 4H, H1, H8), 3.79 (s, 6H, 2xCH3), 4.41 (s, 4H,
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2xPhCH2), 5.38-5.40 (m, 2H, H4, H5), 6.87 (d, 4H, J = 8.5 Hz, 2xArH3, 2xArH5), 7.25
(d, J = 8.5 Hz, 4H, 2xArH2, 2xArH6); 13C NMR: δ 29.1 (C3, C6), 29.5 (C2, C7), 55.2
(2xCH3), 69.4 (C1, C8), 72.5 (2xPhCH2), 113.7 (2xArC3, 2xArC5), 129.2 (2xArC2,
2xArC6), 130.0 (C4, C5), 130.7 (2xArC1), 159.0 (2xArC4).
Method 2 using Grubbs’ 2: To a solution of pentene 39 (340 mg, 1.65 mmol) and 1,4benzoquinone (18 mg, 0.17 mmol) in CH2Cl2 (20 mL) was added Grubbs’ 2 catalyst (70
mg, 82 μmol) and the mixture was heated at reflux for 24 h. The solvent was evaporated
and the residue subjected to column chromatography (6% to 8% EtOAc:hexanes)
yielding octene 40 (193 mg, 61%, E:Z ~80:20) as a colourless oil with minor impurities.

(4R,5R)-4,5-Di(3-(4-methoxybenzyloxy)propyl)[1,3,2]dioxathiolane-2-oxide (44)
and meso-4,5-Di(3-(4-methoxybenzyloxy)propyl)[1,3,2]dioxathiolane-2-oxide (44)

O

CH3SO2NH2 (209 mg, 2.20 mmol) in H2O (11 mL) and

O

4 5

2'

PMB'O

To an orange slurry of ADmix β (3.09 g) and

O
S

1'

2''
1''
3''

3'

OPMB''

t-BuOH (11 mL) at 0 oC was added octene 40 (848 mg,
2.21 mmol, E:Z 80:20) and the mixture was allowed to

warm to RT and stirred in air for 17 h. The mixture was cooled to 0 oC and Na2SO3
(3.31 g, 26.25 mmol) was added. After stirring for 30 min and allowing to warm to RT,
the mixture was extracted with EtOAc (3 x 15 mL) and the combined extracts were
dried and concentrated to give the crude diol as a mixture of diastereomers. The mixture
was dissolved in a solution of NEt3 (535 mg, 5.29 mmol) in CH2Cl2 (15 mL) at 0 oC and
SOCl2 (0.19 mL, 2.64 mmol) was slowly added. After warming to RT and stirring for
72 h, H2O (5 mL) was added dropwise and the mixture was extracted with CH2Cl2 (3 x
10 mL). The combined extracts were dried, concentrated and subjected to column
chromatography (15% to 50% EtOAc:hexanes) affording sulfite (R,R)-4461 (479 mg,
47%, 58% based on trans isomer content) as a viscous pale yellow oil. [α]23
D +46.8 (c
7.90, CH2Cl2).‡ 1H NMR: δ 1.67-1.95 (m, 8H, H1', H1'', H2', H2''), 3.42-3.56 (m, 4H,
H3', H3''), 3.80 (s, 6H, CH3', CH3''), 4.04-4.10 (m, 1H, H4 or H5), 4.425 (s, 2H, PhCH2'
or PhCH2''), 4.430 (s, 2H, PhCH2' or PhCH2''), 4.57-4.64 (m, 1H, H4 or H5), 6.88 (d, J =
8.7 Hz, 4H, ArH3', ArH3'', ArH5', ArH5''), 7.25 (d, J = 8.6 Hz, 4H, ArH2', ArH2'',
ArH6', ArH6'');
‡

13

C NMR: δ 26.0 (C1' or C1''), 26.1 (C1' or C1''), 28.5 (C2' or C2''),

Specific rotation not reported in reference 61.
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30.5 (C2' or C2''), 55.3 (CH3', CH3''), 68.9 (C3' or C3''), 69.0 (C3' or C3''), 72.6 (PhCH2',
PhCH2''), 83.2 (C4 or C5), 87.7 (C4 or C5), 113.8 (ArC3', ArC3'', ArC5', ArC5''), 129.3
(ArC2', ArC2'', ArC6', ArC6''), 130.4 (ArC1', ArC1''), 159.2 (ArC4', ArC4'').
Further elution gave a mixture of sulfites (R,R)-44 and meso-4461 (117 mg, 11%,
chiral:meso 46:54) to give a total yield of sulfite (R,R)-44 of 533 mg, 52% (65% based
on trans isomer content).

O

meso-44 (145 mg, 14%, 57% based on cis isomer

O

4 5

2'

PMBO

Further elution afforded a second portion of sulfite

O
S

1'

OPMB

3'

content) as a viscous pale yellow oil, to give a total
yield of sulfite meso-44 of 208 mg, 20% (82% based on

1

cis isomer content). H NMR: δ 1.62-1.93 (m, 8H, 2xH1', 2xH2'), 3.42-3.54 (m, 4H,
2xH3'), 3.80 (s, 6H, 2xCH3), 4.43 (s, 4H, 2xPhCH2), 4.81-4.88 (m, 2H, H4, H5), 6.88
(d, J = 8.7 Hz, 4H, 2xArH3, 2xArH5), 7.25 (d, J = 8.6 Hz, 4H, 2xArH2, 2xArH6); 13C
NMR: δ 25.4 (2xC1'), 28.9 (2xC2'), 55.2 (2xCH3), 68.4 (2xC3'), 72.7 (2xPhCH2), 87.3
(C4, C5), 113.8 (2xArC3, 2xArC5), 129.3 (2xArC2, 2xArC6), 130.1 (2xArC1), 159.2
(2xArC4).

(4S,5S)-4,5-Di(3-(4-methoxybenzyloxy)propyl)[1,3,2]dioxathiolane-2-oxide (44)

O

O
S

This reaction followed the procedure for the synthesis
of sulfite (R,R)-44 using ADmix α (3.09 g) and the

O

same quantities of all other reagents and solvents.
PMBO

OPMB

Purification by column chromatography afforded sulfite

(S,S)-44 (512 mg, 50%, 62% based on trans isomer content) as a viscous pale yellow
oil.‡ [α]23
D -43.0 (c 8.06, CH2Cl2).

(4R,5R)-1,8-Di(4-methoxybenzyloxy)-4,5-octanediol (41)
To a fresh solution of NaOMe in MeOH, prepared by

OH
OPMB

PMBO
OH

‡

the addition of Na (283 mg, 12.32 mmol) portion-wise
to MeOH (3 mL), was added a solution of sulfite

This compound was spectroscopically identical to sulfite (R,R)-44 which has been prepared previously in
our laboratory.61
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(R,R)-44 (479 mg, 1.03 mmol) in MeOH (10 mL) and the mixture was stirred for 96 h.
Additional Na (200 mg, 8.70 mmol) was added portion-wise and the mixture was stirred
for a further 20 h. The solvent was evaporated and the residue partitioned between H2O
(10 mL) and EtOAc (15 mL). The organic layer was separated and the aq. solution
extracted with EtOAc (2 x 15 mL). The combined organic layers were dried,
concentrated and subjected to column chromatography (50% to 80% EtOAc:hexanes) to
‡
give diol (R,R)-4161,105 (333 mg, 77%) as a white solid. [α]23
D +9.9 (CH2Cl2, c 8.06);

HPLC analysis {20% to 60% i-PrOH:hexane, retention times - diol (R,R)-41: 19.4 min
(major), diol (S,S)-41: 24.3 min (minor)} showed the ee of diol (R,R)-41 was 68%; 1H
NMR (500 MHz): δ 1.45-1.53 (m, 2H, H3a, H6a), 1.63-1.68 (m, 2H, H3b, H6b), 1.721.78 (m, 4H, H2, H7), 3.10 (bs, 2H, 2xOH), 3.39 (d, J = 5.8 Hz, 2H, H4, H5), 3.49 (t,
4H, J = 5.9 Hz, H1, H8), 3.80 (s, 6H, 2xCH3), 4.44 (s, 4H, 2xPhCH2), 6.87 (d, J = 8.5
Hz, 4H, 2xArH3, 2xArH5), 7.25 (d, J = 8.5 Hz, 4H, 2xArH2, 2xArH6); 13C NMR (125
MHz): δ 26.1 (C2, C7), 30.9 (C3, C6), 55.2 (2xCH3), 70.2 (C1, C8), 72.7 (2xPhCH2),
74.2 (C4, C5), 113.8 (2xArC3, 2xArC5), 129.3 (2xArC2, 2xArC6), 130.2 (2xArC1),
159.2 (2xArC4).

(4S,5S)-1,8-Di(4-methoxybenzyloxy)-4,5-octanediol (41)
This reaction followed the procedure for the synthesis

OH
OPMB

PMBO
OH

of diol (R,R)-41 using sulfite (S,S)-44 (512 mg, 1.10
mmol) and the same quantities of all other reagents

and solvents affording diol (S,S)-4161,105 (318 mg, 69%) as a white solid
‡
spectroscopically identical to diol (R,R)-41. [α]23
D -14.2 (CH2Cl2, c 7.96); HPLC

analysis {20% to 60% i-PrOH:hexane, retention times - diol (R,R)-41: 19.8 min (minor),
diol (S,S)-41: 23.2 min (major)} showed the ee of diol (S,S)-41 was 96%.

9.5.2 Trans Selective Wittig / Sharpless AD
4-Benzyloxybutanal (49)
BnO

O

Method 1 using PCC:81 To a solution of 4-benzyloxy-1-butanol (579
mg, 3.21 mmol) in CH2Cl2 (8 mL) was added PCC (800 mg, 3.71

mmol) and the dark brown mixture was stirred for 4 h. The mixture was diluted with
‡

Specific rotation not reported in reference 61 or 105.
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CH2Cl2 (20 mL) and stirred for 5 min before the supernatant liquid was decanted from
the sticky brown residue. The solution was concentrated and subjected to gravity silica
gel column chromatography (5% to 9% EtOAc:hexanes) giving aldehyde 49 (277 mg,
47%) as a colourless oil. 1H NMR: δ 1.94 (p, J = 6.6 Hz, 2H, H3), 2.54 (t, J = 6.9 Hz,
2H, H2), 3.50 (t, J = 6.3 Hz, 2H, H4), 4.48 (s, 2H, PhCH2), 7.25-7.37 (m, 5H, ArH2ArH6), 9.77 (s, 1H, H1);

13

C NMR: δ 22.5 (C3), 40.9 (C2), 69.1 (C4), 72.9 (PhCH2),

127.6 (ArC2, ArC4, ArC6), 128.3 (ArC3, ArC5), 138.2 (ArC1), 202.2 (C1).

Method 2 using DMP:82 To a solution of DMP (1.48 g, 3.50 mmol) in CH2Cl2 (15 mL)
was added a solution of 4-benzyloxy-1-butanol (600 mg, 3.33 mmol) in CH2Cl2 (10
mL) and the cloudy white mixture was stirred for 15 min. The mixture was treated with
5% NaOH (15 mL) and stirred for 15 min to dissolve the white precipitate. The organic
layer was separated, washed with 5% NaOH (2 x 10 mL) and H2O (15 mL), then dried
and concentrated to give aldehyde 49 (509 mg, 86%) as a colourless oil.

1-Benzyloxy-4-bromobutane (50)‡
Br

BnO

To a solution of 4-benzyloxy-1-butanol (1.00 g, 5.55 mmol) and NEt3
(730 mg, 7.21 mmol) in CH2Cl2 (10 mL) at 0 oC was added dropwise

a solution of MsCl (699 mg, 6.10 mmol) in CH2Cl2 (2 mL) and the mixture was allowed
to warm to RT and stirred in air for 30 min. The mixture was diluted with CH2Cl2 (10
mL), then washed with sat. NaHCO3 (20 mL) and brine (20 mL). The organic layer was
dried and concentrated to give the crude mesylate (1.33 g, 93%) as a colourless cloudy
oil. This was mixed with THF (2 mL) and a solution of LiBr (723 mg, 8.32 mmol) in
THF (6 mL) was added and the mixture was stirred in air for 72 h. H2O (10 mL) was
added and the mixture was extracted with CH2Cl2 (20 mL). The organic layer was dried
and concentrated to give bromide 50246 (1.11 g, 82% overall) as a colourless oil. 1H
NMR: δ 1.75 (p, J = 6.6 Hz, 2H, H2), 1.97 (p, J = 6.6 Hz, 2H, H3), 3.43 (t, J = 6.6 Hz,
2H, H4), 3.50 (t, J = 6.3 Hz, 2H, H1), 4.50 (s, 2H, PhCH2), 7.27-7.35 (m, 5H, ArH2ArH6);

13

C NMR: δ 28.3 (C2), 29.6 (C3), 33.7 (C4), 69.2 (C1), 72.9 (PhCH2), 127.5

(ArC4), 127.6 (ArC2, ArC6), 128.3 (ArC3, ArC5), 138.4 (ArC1).

‡

A sample of bromide 50 obtained from Sigma-Aldrich contained impurities and was therefore not
utilised.
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1-Benzyloxy-4-iodobutane (54)90
To a solution of 4-benzyloxy-1-butanol (1.00 g, 5.55 mmol) in toluene
I

BnO

(20 mL) at 0 oC was added sequentially PPh3 (1.89 g, 7.21 mmol),

imidazole (1.13 g, 16.60 mmol) and I2 (1.83 g, 7.21 mmol) and the dark brown slurry
was allowed to warm to RT and stirred for 2 h. A solution of Na2S2O3·5H2O (993 mg,
4.00 mmol) in H2O (10 mL) was added dropwise and stirring continued for 5 min. The
organic layer was separated, dried, concentrated and subjected to column
chromatography (hexanes to 8% EtOAc:hexanes) affording iodide 54 (1.51 g, 94%) as a
colourless oil. 1H NMR: δ 1.72 (p, J = 6.6 Hz, 2H, H2), 1.94 (p, J = 6.9 Hz, 2H, H3),
3.21 (t, J = 6.9 Hz, 2H, H4), 3.49 (t, J = 6.3 Hz, 2H, H1), 4.50 (s, 2H, PhCH2), 7.307.35 (m, 5H, ArH2-ArH6); 13C NMR: δ 6.8 (C4), 30.4 (C3), 30.6 (C2), 69.0 (C1), 72.9
(PhCH2), 127.6 (ArC2, ArC4, ArC6), 128.4 (ArC3, ArC5), 138.4 (ArC1).

4-Benzyloxybutyltriphenylphosphonium Bromide (51)83,85,86 and Benzyltriphenyl
phosphonium Bromide (52)
Method 1 using xylenes:83 A solution of bromide 50
5'

6'
2''
3''

7''
1''
6''

4''

P

O

4'

1'
2'

Br

5''

BnPPh3Br

3'

(494 mg, 2.03 mmol) and PPh3 (534 mg, 2.04 mmol)
in xylenes (10 mL) was heated at reflux for 100 h.
After standing in a freezer for 12 h, the mixture was
vacuum filtered and the white precipitate washed

with hexanes (10 mL) affording a mixture of butylphosphonium bromide 51‡ (366 mg,
36%) and benzylphosphonium bromide 52 (404 mg, 46%) assigned by MS and NMR
analysis. MS (ES+): 425 (76, P cation of 51), 353 (100%, P cation of 52).
Data for 51: m.p. 156 oC; Lit.83 m.p. 159-160 oC; 1H NMR [(CD3)2SO]: δ 1.58-1.69 (m,
2H, H2), 1.75 (p, J = 6.0 Hz, 2H, H3), 3.48 (t, J = 6.0 Hz, 2H, H4), 3.55-3.65 (m, 2H,
H1), 4.42 (s, 2H, H7''), 7.21-7.35 (m, 5H, H2''-H6''), 7.77-7.93 (m, 15H, 3x(H2'-H6'));
13

C NMR [(CD3)2SO]: δ 18.8 (d, J = 4.0 Hz, C2), 19.8 (d, J = 50.2 Hz, C1), 29.6 (d, J =

17.0 Hz, C3), 68.1 (C4), 71.7 (C7''), 118.5 (d, J = 85.5 Hz, 3xC1'), 127.4 (C2'', C4'',
C6''), 128.2 (C3'', C5''), 130.2 (d, J = 12.4 Hz, 3xC3', 3xC5'), 133.6 (d, J = 10.1 Hz,
3xC2', 3xC6'), 134.9 (d, J = 2.6 Hz, 3xC4'), 138.5 (C1''); FTIR v 2861 (w), 1438 (m),
‡

Subsequent to this work, this salt has become commercially available from Epsilon Chimie France.
However, no spectral data is available online from the company or reported in reference 83,85 or 86.
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1113 (m), 991 (w), 753 (s), 742 (m), 694 (s); MS (ES+): 425 (P cation, 100%); HRMS
(ES+): calcd for C29H30OP 425.2034, found 425.2043.

Method 2 using toluene: A solution of bromide 50 (539 mg, 2.22 mmol) and PPh3 (581
mg, 2.22 mmol) in toluene (3 mL) was heated at reflux for 6 h. After standing in a
freezer for 12 h, the mixture was vacuum filtered and the white precipitate washed with
hexanes (10 mL) affording a mixture of butylphosphonium bromide 51 (231 mg, 21%)
and benzylphosphonium bromide 52 (46 mg, 5%).

Method 3 using CH3CN followed by selective hydrolysis: A solution of bromide 50
(700 mg, 2.88 mmol) and PPh3 (755 mg, 2.88 mmol) in CH3CN (5 mL) was heated at
reflux for 164 h. The solvent was evaporated to leave a white solid to which hexanes
(20 mL) were added. The mixture was vacuum filtered and the solid washed with
hexanes (4 x 15 mL) affording a mixture of butylphosphonium bromide 51 (1.03 g,
71%) and benzylphosphonium bromide 52 (251 mg, 20%). The salts were suspended in
THF (10 mL) and treated with a solution of KOH (67 mg, 1.19 mmol) in H2O (3 mL)
and the pale yellow solution was stirred in air for 1 h. A further aliquot of KOH (20 mg,
0.36 mmol) in H2O (1 mL) was added and the mixture was stirred for 2.5 h. The mixture
was acidified to pH 3 with 48% HBr, diluted with H2O (2 mL) and CH2Cl2 (10 mL),
then stirred for 10 min. The organic layer was separated and the aq. solution extracted
with CH2Cl2 (4 x 15 mL). The combined organic layers were dried and concentrated,
then the solid was treated with Et2O (20 mL) and the suspension vacuum filtered. The
white solid was washed with Et2O (20 mL) to give phosphonium bromide 51 (686 mg,
47% overall, 67% recovery).

4-Benzyloxybutyltriphenylphosphonium Iodide (58)87-89
Method 1 using benzene:87 A solution of iodide 54
5'

6'
2''
3''

7''
1''
6''

4''
5''

P

O

4'

1'
2'

I

3'

(616 mg, 2.12 mmol) and PPh3 (557 mg, 2.12 mmol)
in benzene (10 mL) was heated at reflux for 21 h.
After standing in an ice bath for 20 min, the mixture
was vacuum filtered and the precipitate washed with

hexanes (3 x 15 mL) affording phosphonium iodide 58 (521 mg, 44%) as a white solid,‡
‡

Only the m.p. and 1H NMR data is reported in reference 87. No physical or spectral data is reported in
reference 88 or 89.
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m.p. 165-166 oC; Lit.87 m.p. 171-173 oC; 1H NMR: δ 1.69-1.84 (m, 2H, H2), 2.02 (p, J
= 5.7 Hz, 2H, H3), 3.63 (t, J = 5.7 Hz, 2H, H4), 3.68-3.75 (m, 2H, H1), 4.48 (s, 2H,
H7''), 7.22-7.31 (m, 5H, H2''-H6''), 7.63-7.69 (m, 6H, 3xH3', 3xH5'), 7.75-7.82 (m, 9H,
3xH2', 3xH4', 3xH6');

13

C NMR: δ 19.5 (C2), 22.3 (d, J = 50.4 Hz, C1), 29.4 (d, J =

16.3 Hz, C3), 68.7 (C4), 72.7 (C7''), 118.0 (d, J = 85.9 Hz, 3xC1'), 127.5 (C4''), 127.6
(C2'', C6''), 128.2 (C3'', C5''), 130.4 (d, J = 12.4 Hz, 3xC3', 3xC5'), 133.6 (d, J = 10.1
Hz, 3xC2', 3xC6'), 135.0 (d, J = 2.9 Hz, 3xC4'), 138.3 (C1''); FTIR v 2898 (w), 2874
(w), 1431 (m), 1107 (m), 1090 (m), 991 (w), 749 (s), 720 (s); MS (ES+): 425 (P cation,
100%).

Method 2 using toluene: A solution of iodide 54 (818 mg, 2.82 mmol) and PPh3 (740
mg, 2.82 mmol) in toluene (12 mL) was heated at 80 oC for 158 h. After standing at ~4
o

C for 2 h, the mixture was vacuum filtered and the precipitate washed with Et2O (2 x

20 mL) affording phosphonium iodide 58 (1.15 g, 74%) as a white solid.

1,8-Di(benzyloxy)-4-octene (46) and ±-4-Benzyloxy-1-phenyl-1-butanol (67)

BnO

OBn

Method 1 using the bromide salt (General Procedure 1
for trans selective Wittig): To a suspension of

phosphonium bromide 51 (400 mg, 0.79 mmol) and LiBr (151 mg, 1.74 mmol) in THF
(5 mL) at -78 oC was added PhLi (0.46 mL, 1.9 M* in Bu2O, 0.87 mmol) and the
mixture was allowed to warm to RT and stirred for 30 min to give a bright orange
suspension. After cooling to -78 oC, a solution of aldehyde 49 (141 mg, 0.79 mmol) in
THF (1.5 mL) was added, producing a colourless solution. After 10 min, PhLi (0.46
mL, 1.9 M* in Bu2O, 0.87 mmol) was added and the mixture was maintained below -40
o

C for 45 min and turned red. After cooling to -78 oC, HCl (0.44 mL, 2.0 M in Et2O,

0.88 mmol) was added and the solution decolourised. KOt-Bu (107 mg, 0.95 mmol) was
added and the mixture was allowed to warm to RT and stirred for 12 h. H2O (5 mL) was
added and the mixture was extracted with CH2Cl2 (3 x 10 mL). The combined extracts
were dried, concentrated and subjected to column chromatography (5% to 10%
EtOAc:hexanes) affording octene 4661,105,247 (78 mg, 30%, E:Z‡ 97:3) as a colourless oil.
1

H NMR: δ 1.66 (p, J = 6.7 Hz, 4H, H2, H7), 2.04-2.10 (m, 4H, H3, H6), 3.45 (t, J = 6.5

Hz, 4H, H1, H8), 4.48 (s, 4H, 2xPhCH2), 5.38-5.41 (m, 2H, H4, H5), 7.28-7.41 (m,
‡

Determined by HPLC analysis of the diol derivative 73.

151

CHAPTER 9

Experimental

10H, 2x(ArH1-ArH6)); 13C NMR: δ 29.0 (C3, C6), 29.5 (C2, C7), 69.7 (C1, C8), 72.8
(2xPhCH2), 127.4 (2xArC4), 127.5 (2xArC2, 2xArC6), 128.3 (2xArC3, 2xArC5), 130.0
(C4, C5), 138.6 (2xArC1).
Further elution with 15% to 25% EtOAc:hexanes gave

5'
6'
2''
3''
4''

1''
6''

4'

7''
1'

O

OH

5''

3'
2'

butanol ±-67248,249 (50 mg, 25%) as a viscous colourless
oil.‡ 1H NMR: δ 1.62-1.79 (m, 2H, H3), 1.84 (q, J = 6.3
Hz, 2H, H2), 2.75 (bs, 1H, OH), 3.49 (t, J = 6.0 Hz, 2H,

H4), 4.49 (s, 2H, H7'') 4.64-4.70 (m, 1H, H1), 7.22-7.33 (m, 10H, H2'-H6', H2''-H6'');
13

C NMR: δ 26.2 (C3), 36.4 (C2), 70.3 (C4), 73.0 (C7''), 74.1 (C1), 125.8 (C2', C6'),

127.3 (C4'), 127.6 (C4''), 127.7 (C2'', C6''), 128.3 (C3'', C5''), 128.4 (C3', C5'), 138.1
(C1''), 144.8 (C1'); FTIR v 3392 (w), 1456 (w), 1094 (m), 1033 (m), 737 (m), 704 (s);
MS (ES+, HCOOH): 279 (18, M+Na), 257 (16, M+H), 239 (100%, M+H-H2O); HRMS
(ES+) calcd for C17H21O2 257.1542, found 257.1544.

Method 2 using the bromide salt: This reaction followed General Procedure 1 with a
more stringent drying process. The reaction vessel was charged with phosphonium
bromide 51 (404 mg, 0.80 mmol) and LiBr (153 mg, 1.76 mmol), then dried under high
vacuum (1 mbar) at 100 oC for 2.5 h. The vacuum was released with N2(g) and the
reaction was performed as previously described using THF (5 mL), two aliquots of PhLi
(0.53 mL, 1.67 M* in Bu2O, 0.89 mmol), a solution of aldehyde 49 (140 mg, 0.79
mmol) in THF (1.5 mL), HCl (0.45 mL, 2.0 M in Et2O, 0.90 mmol) and KOt-Bu (108
mg, 0.96 mmol). After quenching with H2O (10 mL), the mixture was extracted with
CH2Cl2 (2 x 25 mL). The organic layers were combined and concentrated to give a
brown solid. Hexanes (50 mL) were added and the suspension was stirred for 10 min
before vacuum filtration to recover phosphonium bromide 51 (142 mg, 35%, 66%
consumed based on aldehyde 49) with a trace of PPh3O.
The filtrate was concentrated and subjected to column chromatography (1% to 8%
EtOAc:hexanes) affording octene 46 (104 mg, 41%, E:Z ~87:13) as a colourless oil.
Further elution with 12% to 20% EtOAc:hexanes gave butanol ±-67 (54 mg, 27%) as a
viscous colourless oil.

‡

No physical or spectral data reported in reference 248 or 249.
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Method 3 using the iodide salt: This reaction followed General Procedure 1 using
phosphonium iodide 58 (552 mg, 1.00 mmol), LiBr (191 mg, 2.20 mmol), THF (5 mL),
two aliquots of PhLi (0.58 mL, 1.9 M* in Bu2O, 1.10 mmol), a solution of aldehyde 49
(158 mg, 0.89 mmol) in THF (2 mL), HCl (0.55 mL, 2.0 M in Et2O, 1.10 mmol) and
KOt-Bu (135 mg, 1.20 mmol). After quenching with H2O (10 mL), the mixture was
diluted with CH2Cl2 (20 mL) and the white solids dissolved. The organic layer was
separated and the aq. solution extracted with CH2Cl2 (20 mL). The organic layers were
combined and concentrated to give a white solid. Hexanes (50 mL) were added and the
suspension was stirred for 10 min before vacuum filtration to recover phosphonium
iodide 58 (395 mg, 72%, 32% consumed based on aldehyde 49) with a trace of PPh3O.
The filtrate was concentrated and subjected to column chromatography (1% to 10%
EtOAc:hexanes) affording octene 46 (85 mg, 30%, E:Z ~94:6) as a colourless oil.
Further elution with 15% to 25% EtOAc:hexanes gave butanol ±-67 (86 mg, 38%) as a
viscous colourless oil.

(4S,5S)-1,8-Di(benzyloxy)-4,5-octanediol (73)61,105
To an orange slurry of ADmix α (118 mg) and

OH
OBn

BnO
OH

CH3SO2NH2 (8.0 mg, 84.4 µmol) in H2O (0.5 mL) and tBuOH (0.25 mL) at 0 oC was added a solution of octene

46 (25.6 mg, 78.9 µmol, E:Z 97:3) in t-BuOH (0.25 mL) and the mixture was
maintained below 10 oC for 6 h before being allowed to warm to RT and stirred in air
for 17 h. The mixture was cooled to 0 oC, then Na2SO3 (140 mg, 1.11 mmol) was added
and stirring continued for 30 min. The mixture was diluted with H2O (5 mL) and
extracted with CH2Cl2 (20 mL). The combined extracts were washed with 5 M NaOH
(20 mL), dried, concentrated and subjected to column chromatography (30%
EtOAc:hexanes to 100% EtOAc) affording diol (S,S)-73 (with a small quantity of meso-

73) as a viscous colourless oil (21.7 mg, 77% combined yield of diastereomers). [α]26
D 15.6 (c 1.09, CHCl3,); Lit.58 [α]26
D -16.8 (c 1.31, CHCl3); HPLC analysis {10% to 40% i-

PrOH:hexane, retention times - diol (R,R)-73: 31.2 min (minor), diol meso-73: 33.2 min
(minor), diol (S,S)-73: 34.8 min (major)} showed the ee of diol (S,S)-73 was 87% and
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the de was 94%;‡ 1H NMR: δ 1.44-1.56 (m, 2H, H3a, H6a), 1.60-1.73 (m, 2H, H3b, H6b),
1.75-1.82 (m, 4H, H2, H7), 3.07 (bs, 2H, 2xOH), 3.40 (d, J = 5.7 Hz, 2H, H4, H5), 3.51
(t, J = 5.9 Hz, 4H, H1, H8), 4.51 (s, 4H, 2xPhCH2), 7.25-7.35 (m, 10H, 2x(ArH1ArH6)); 13C NMR: δ 26.0 (C2, C7), 30.8 (C3, C6), 70.4 (C1, C8), 73.0 (2xPhCH2), 74.1
(C4, C5), 127.6 (2xArC4), 127.7 (2xArC2, 2xArC6), 128.4 (2xArC3, 2xArC5), 138.1
(2xArC1).
(4R,5R)-1,8-Di(benzyloxy)-4,5-octanediol (73)61,105

This reaction followed the procedure for the synthesis of

OH
OBn

BnO
OH

diol (S,S)-73 using ADmix β (130 mg), CH3SO2NH2 (8.9
mg, 93.1 µmol), octene 46 (27.0 mg, 83.2 µmol, E:Z 97:3)

and the same quantities of all other reagents and solvents. Purification by column
chromatography afforded diol (R,R)-73 (with a small quantity of meso-73) as a viscous
colourless oil (21.8 mg, 73% combined yield of diastereomers) spectroscopically
58
identical to diol (S,S)-73. [α]26
[α]27
D +15.4 (c 1.09, CHCl3); Lit.
D +16.6 (c 1.22,

CHCl3); HPLC analysis {10% to 40% i-PrOH:hexane, retention times - diol (R,R)-73:
29.8 min (major), diol meso-73: 34.0 min (minor), diol (S,S)-73: 37.1 min (minor)}
showed the ee of diol (R,R)-73 was 97% and the de was 94%.‡

9.6 Synthesis of 2,2'-Biindoline from 2,2'-Bioxirane
9.6.1 Ring Opening with 2-Methoxyphenylmagnesium Bromide
2,2'-Dimethoxybiphenyl (93), ±-(2R,3S)/(2S,3R)-4-Iodo-1-(2-methoxyphenyl)-2,3butanediol (94), ±-(2R,3S)/(2S,3R)-4-Bromo-1-(2-methoxyphenyl)-2,3-butanediol
(95) and ±-1,4-Di(2-methoxyphenyl)-2,3-butanediol (89)
Method 1 using CuI (General Procedure 2 for ring opening of bioxirane 87 with oOMePhMgBr):109 To a suspension of Mg (72 mg, 2.96 mmol) in THF (3 mL) was

added o-bromoanisole (432 mg, 2.31 mmol) and the mixture was stirred at 30 oC for 30
min. The dark brown solution was cooled to RT and added to a suspension of CuI (44
mg, 0.23 mmol) in THF (2 mL) at -40 oC. After 20 min, a solution of bioxirane ±-87 (57
mg, 0.66 mmol) in THF (2.5 mL) was added dropwise and the suspension was allowed
‡

The HPLC trace is provided in Appendix 1.
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to warm to RT and stirred for 14 h. H2O (5 mL) was added slowly and the mixture was
extracted with CH2Cl2 (2 x 25 mL). The combined extracts were dried, concentrated and
subjected to column chromatography (3% to 4.5% EtOAc:hexanes) yielding biphenyl
93250 (17 mg, 7% based on o-bromoanisole) as a white solid. 1H NMR: δ

3.70 (s, 6H, 2xCH3), 6.88-6.96 (m, 4H, H3, H3', H5, H5'), 7.15-7.19 (m,
2H, H6, H6'), 7.22-7.29 (m, 2H, H4, H4');

OMe
OMe

13

C NMR: δ 55.7 (2xCH3),

111.1 (C3, C3'), 120.3 (C5, C5'), 127.8 (C1, C1'), 128.6 (C4, C4'), 131.5
(C6, C6'), 157.0 (C2, C2').

OMe

Further elution with 25% EtOAc:hexanes afforded diol ±-94 (10 mg,

OH
I
OH

5%) as a white solid, m.p. 72-74 oC. 1H NMR: δ 2.90 (d, J = 6.6 Hz,
2H, H1), 3.32-3.36 (m, 2H, H4), 3.50-3.58 (m, 1H, H3), 3.86 (s, 3H,

CH3), 3.94-4.00 (m, 1H, H2), 6.88-6.96 (m, 2H, ArH3, ArH5), 7.17-7.27 (m, 2H, ArH4,
ArH6);

13

C NMR: δ 9.6 (C4), 35.5 (C1), 55.5 (CH3), 72.9 (C2), 73.2 (C3), 110.6

(ArC3), 121.1 (ArC5), 125.8 (ArC1), 128.2 (ArC4), 131.5 (ArC6), 157.3 (ArC2); FTIR
v 3268 (m), 2923 (w), 1495 (m), 1435 (w), 1239 (s), 1117 (m), 1033 (s), 901 (w), 749

(s); MS (ES+): 667 (100%, 2M+Na), 323 (82, M+H); HRMS (EI+): calcd for C11H15IO3
322.0066, found 322.0057.

OMe

Further elution gave diol ±-95 (28 mg, 15%) in a mixture with a

OH
Br
OH

second portion of diol ±-94 (17 mg, 8%) to give a total yield of diol
±-94 of 27 mg, 13%. Data for ±-95: 1H NMR: δ 2.92 (d, J = 6.3 Hz,

2H, H1), 3.51-3.53 (m, 2H, H4), 3.67-3.71 (m, 1H, H3), 3.86 (s, 3H, CH3), 3.95-4.00
(m, 1H, H2), 6.88-6.96 (m, 2H, ArH3, ArH5), 7.17-7.28 (m, 2H, ArH4, ArH6);

13

C

NMR: δ 35.3 (C4), 35.4 (C1), 55.5 (CH3), 72.1 (C2), 72.9 (C3), 110.6 (ArC3), 121.1
(ArC5), 125.8 (ArC1), 128.2 (ArC4), 131.5 (ArC6), 157.3 (ArC2); MS (ES+): 277 (98,
M+H,

81

Br), 275 (100%, M+H, 79Br); HRMS (EI+): calcd for C11H1581BrO3 276.0184,

found 276.0183.

OMe

Further elution afforded diol ±-89 (135 mg, 68%) as a white

OH

solid spectroscopically identical to that reported for diol (S,S)OH

OMe

89.109 1H NMR: δ 2.56 (bs, 2H, 2xOH), 2.88-2.94 (m, 4H, H1,

H4), 3.69-3.77 (m, 2H, H2, H3), 3.78 (s, 6H, 2xCH3), 6.83-6.92 (m, 4H, 2xArH3,
2xArH5), 7.15-7.21 (m, 4H, 2xArH4, 2xArH6);

13

C NMR: δ 34.9 (C1, C4), 55.3
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(2xCH3), 73.4 (C2, C3), 110.4 (2xArC3), 120.8 (2xArC5), 126.9 (2xArC1), 127.7
(2xArC4), 131.3 (2xArC6), 157.4 (2xArC2).
Method 2 using CuI·2LiCl: This reaction followed General Procedure 2 using THF

soluble CuI·2LiCl as the catalyst. The same quantities of all other reagents and solvents
were used. Therefore, a solution of CuI (44 mg, 0.23 mmol) and LiCl (20 mg, 0.46
mmol) in THF (2 mL) was cooled to -40 oC before addition of the Grignard and
bioxirane ±-87,

respectively. Purification by

column

chromatography

(25%

EtOAc:hexanes) afforded diol ±-89 (123 mg, 62%).

9.6.2 Ring Opening with 2-Bromophenylmagnesium Chloride
±-1,4-Di(2-bromophenyl)-2,3-butanediol
phenyl)-4-iodo-2,3-butanediol

(106),

(105),

±-(2R,3S)/(2S,3R)-1-(2-Bromo

±-(2R,3S)/(2S,3R)-1-(2-Bromophenyl)-4-

chloro-2,3-butanediol (107) and ±-(2R,3R)/(2S,3S)-1-(2-Bromophenyl)-3,4-epoxy-2butanol (108)
Br

To a solution of 2-bromoiodobenzene (654 mg, 2.31 mmol) in

OH

THF (6 mL) at -40 oC was added i-PrMgCl (2.10 mL, 1.10 M*

OH
Br

Br

OH
I

o

OH
Cl
OH

-25 oC over 1 h. The solution was cooled to -40 oC and added to
a suspension of CuI (44 mg, 0.23 mmol) in THF (2 mL) at -40

OH
Br

in THF, 2.31 mmol) and the mixture was allowed to warm to

C. After 10 min, a solution of bioxirane ±-87 (63 mg, 0.73

mmol) in THF (2.5 mL) was added dropwise and the suspension
was allowed to warm to RT and stirred for 18 h. H2O (10 mL)

was added slowly and the mixture was extracted with CH2Cl2 (3 x 20 mL). The
combined extracts were dried, concentrated and subjected to column chromatography
(20% to 40% EtOAc:hexanes) affording a white solid (248 mg) as a mixture of products
assigned by MS analysis as diols ±-105, ±-106 and ±-107. MS (ES−):‡ 437 (52,
105+Cl), 407 (100%, 106+Cl), 315 (25, 107+Cl).

‡

All three anions exhibited the expected isotopic pattern however only the highest intensity peak of each
isotope set is reported. The mass spectrum is provided in Appendix 2.
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Separation of ±-105 after ‘recycling’ halohydrins: The above mixture was suspended in

Et2O (10 mL) then a solution of KOH (82 mg, 1.46 mmol) in H2O (2 mL) was added
and the solution was stirred in air for 12 h. H2O (10 mL) was added and the mixture was
extracted with CH2Cl2 (3 x 15 mL). The combined extracts were dried and concentrated
to give a white solid (192 mg). Successive crystallisations from EtOH provided three
precipitate crops which were combined to give diol ±-105 (102 mg, 35% based on
bioxirane ±-87) as a white solid, m.p. 154 oC. 1H NMR: δ 2.11 (d, J = 4.5 Hz, 2H,
2xOH), 2.97 (dd, J = 8.9, 13.7 Hz, 2H, H1a, H4a), 3.14 (dd, J = 3.8, 13.7 Hz, 2H, H1b,
H4b), 3.86-3.94 (m, 2H, H2, H3), 7.10 (t, J = 8.1 Hz, 2H, 2xArH4), 7.22-7.32 (m, 4H,
2xArH5, 2xArH6), 7.55 (d, J = 8.1 Hz, 2H, 2xArH3); 13C NMR: δ 40.6 (C1, C4), 72.8
(C2, C3), 124.8 (2xArC2), 127.5 (2xArC5), 128.3 (2xArC4), 131.8 (2xArC6), 132.9
(2xArC3), 137.7 (2xArC1); FTIR v 3219 (w), 2923 (w), 1471 (w), 1440 (w), 1089 (m),
1023 (s), 917 (w), 754 (s), 739 (s); MS (ES+): 466 (45, M+Na+CH3CN, 81Br, 81Br), 464
(100%, M+Na+CH3CN,
M+Na,

81

Br,

81

81

Br,

79

Br), 462 (46, M+Na+CH3CN,

Br), 423 (30, M+Na,

81

Br,

79

79

Br), 421 (14, M+Na,

Br,
79

79

Br,

Br), 425 (15,
79

Br); HRMS

(ES+) calcd for C16H1681Br79BrO2+Na 422.9394, found 422.9398.

Br

O
OH

Subsequent concentration of the filtrate afforded a partially pure
compound assigned by NMR analysis as epoxide ±-108 (47 mg, 26%
based on bioxirane ±-87). 1H NMR: δ 2.29 (d, J = 5.7 Hz, 1H, OH),

2.62-2.65 (m, 1H, H4a), 2.75-2.78 (m, 1H, H4b), 2.96-3.09 (m, 3H, H1, H3), 3.76-3.82
(m, 1H, H2), 7.10 (t, J = 7.5 Hz, 1H, ArH4), 7.24-7.32 (m, 2H, ArH5, ArH6), 7.55 (d, J
= 7.5 Hz, 1H, ArH3);

13

C NMR: δ 41.0 (C1), 45.0 (C4), 54.7 (C3), 71.0 (C2), 124.7

(ArC2), 127.4 (ArC5), 128.4 (ArC4), 131.8 (ArC6), 132.9 (ArC3), 136.8 (ArC1).
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9.6.3 Ring Opening with 2-Nitrophenylmagnesium Chloride
2,2'-Dinitrobiphenyl (113), ±-1,4-Diiodo-2,3-butanediol (116), ±-(2R,3R)/(2S,3S)-4Chloro-1-iodo-2,3-butanediol (117), ±-1,4-Dichloro-2,3-butanediol (118), Benzo[c]
cinnoline N-Oxide (115), ±-(2R,3S)/(2S,3R)-4-Iodo-1-(2-nitrophenyl)-2,3-butanediol
(121),

±-(2R,3S)/(2S,3R)-4-Chloro-1-(2-nitrophenyl)-2,3-butanediol

(122)

and

Benzo[c]cinnoline N,N'-Dioxide (114)
Method 1 using CuI (General Procedure 3 for ring opening of bioxirane 87 with oNO2PhMgCl): To a solution of 2-iodonitrobenzene (436 mg, 1.75 mmol) in THF (8

mL) at -40 oC was added PhMgCl (0.90 mL, 2.0 M in THF, 1.80 mmol) and the
solution was stirred for 10 min then added to a suspension of CuI (33 mg, 0.17 mmol) in
THF (2 mL) at -40 oC. After 15 min, a solution of bioxirane ±-87 (36 mg, 0.42 mmol) in
THF (2 mL) was added dropwise and the mixture was stirred at -40 oC for 1.5 h, then
allowed to warm to RT and stirred for 11 h. H2O (10 mL) was added slowly and the
mixture was extracted with CH2Cl2 (2 x 20 mL). The combined extracts were dried,
concentrated and subjected to column chromatography (10% EtOAc:hexanes) affording
biphenyl 113250 (38 mg, 18% based on 2-iodonitrobenzene) as a brown
solid. 1H NMR: δ 7.22 (d, J = 7.5 Hz, 2H, 2xArH), 7.52 (t, J = 7.8 Hz, 2H,
NO2
NO2

2xArH), (t, J = 7.2 Hz, 2H, 2xArH), (d, J = 7.8 Hz, 2H, 2xArH); 13C NMR:
δ 124.8 (2xArCH), 129.1 (2xArCH), 130.9 (2xArCH), 133.4 (2xArCH),
134.2 (C1, C1'), 147.2 (C2, C2').

OH
I

I
OH

I

Cl

Further elution with 20% to 25%

OH

OH

Cl

Cl

OH

OH

EtOAc:hexanes gave a mixture of
products (40 mg) assigned by MS

analysis as diols ±-116142, ±-117251 and ±-118.111 MS (ES−):‡ 377 (38, 116+Cl), 285
(26, 117+Cl), 193 (12, 118+Cl).
This mixture also contained a trace quantity of heterocycle 115134 (<1%). 1H
N
NO

NMR: δ 7.68-7.84 (m, 3H, 3xArH), 7.92-8.02 (m, 2H, 2xArH), 8.38 (dd, J =
1.5, 8.1 Hz, 1H, ArH), 8.51 (dd, J = 0.9, 8.4 Hz, 1H, ArH), 8.84 (dd, J = 1.1,

‡

The iodide anion (m/z 127) was observed as the base peak. All three diol anions exhibited the expected
isotopic pattern however only the highest intensity peak of each isotope set is reported. The mass
spectrum is provided in Appendix 2.
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8.9 Hz, 1H, ArH);

13

C NMR: δ 118.4 (ArCq), 121.3 (ArCH), 122.2 (ArCH), 122.4

(ArCH), 126.4 (ArCH), 128.6 (ArCq), 129.2 (ArCH), 130.1 (ArCH), 130.6 (ArCH),
132.8 (ArCH), 136.9 (ArCq), 142.0 (ArCq).

NO2

NO2

OH

Further elution with 50% EtOAc:hexanes to

OH
Cl

I
OH

OH

100% EtOAc gave a mixture of products (24
mg) assigned by MS analysis as diols ±-121

‡

and ±-122. MS (ES−): 372 (72, 121+Cl), 280 (100%, 122+Cl).
Further elution with EtOAc afforded heterocycle 114136 (14 mg, 8% based
NO
NO

on 2-iodonitrobenzene) as a brown solid. 1H NMR: δ 7.77-7.81 (m, 4H,
4xH), 8.39-8.43 (m, 2H, 2xArH), 8.48-8.52 (m, 2H, 2xArH);

13

C NMR: δ

119.3 (2xArCH), 120.7 (2xArCq), 122.4 (2xArCH), 130.1 (2xArCH), 131.0
(2xArCH), 136.4 (2xArCq).
Method 2 using CuCN·2LiCl: This reaction followed General Procedure 3 using THF

soluble CuCN·2LiCl for transmetallation. Therefore, a solution of CuCN (157 mg, 1.75
mmol) and LiCl (148 mg, 3.49 mmol) in THF (2 mL) was transferred to the Grignard
solution at -40 oC before addition of bioxirane ±-87 (39 mg, 0.45 mmol). The same
quantities of all other reagents and solvents were used. Following work-up, the crude
residue was subjected to column chromatography (10% EtOAc:hexanes) affording
biphenyl 113 (92 mg, 43% based on 2-iodonitrobenzene).
Further elution with 20% to 25% EtOAc:hexanes gave a mixture of

OH
Cl

Cl
OH

diol ±-118 (22.5 mg, 31%) and heterocycle 115 (20.5 mg, 12% based
on 2-iodonitrobenzene). Data for ±-118: 1H NMR: δ 2.45 (bs, 2H,

2xOH), 3.54-3.65 (m, 4H, H1, H4), 3.86-3.92 (m, 2H, H2, H3); 13C NMR: δ 45.8 (C1,
C4), 71.1 (C2, C3).
Further elution with 50% EtOAc:hexanes to 100% EtOAc gave a trace quantity of
heterocycle 114 (<1%).
‡

Both anions exhibited the expected isotopic pattern however only the highest intensity peak of each
isotope set is reported. The mass spectrum is provided in Appendix 2.
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Method 3 without Cu: This reaction followed General Procedure 3 without the

presence of a Cu salt. Therefore, a solution of bioxirane ±-87 (40 mg, 0.46 mmol) in
THF (1 mL) was added directly to the Grignard solution at -40 oC. The same quantities
of all other reagents and solvents were used. Following work-up, the crude residue was
subjected to column chromatography (12.5% EtOAc:hexanes) affording biphenyl 113
(27 mg, 13% based on 2-iodonitrobenzene). Further elution with 30% EtOAc:hexanes
gave diol ±-118 (55 mg, 75%) as a light brown solid.

9.6.4 Towards the Synthesis of Racemic 2,2'-Biindoline
±-1,4-Di(2-methoxyphenyl)-2,3-butanediol 2,3-Dimethanesulfonate (130)
OMe

General Procedure 4 for mesylation: To a solution of diol ±-

OMs

89 (70 mg, 0.23 mmol) and NEt3 (49 mg, 0.49 mmol) in
OMs

OMe

CH2Cl2 (2 mL) at 0 oC was added dropwise MsCl (38 µL, 0.49

mmol) and the mixture was allowed to warm to RT and stirred in air for 1 h. The
solution was diluted with EtOAc (20 mL) and washed with 5% CuSO4 (10 mL), sat.
NaHCO3 (10 mL) and brine (10 mL). The aq. layers were combined and extracted with
CH2Cl2 (2 x 15 mL). The combined organic layers were dried and concentrated to give
dimesylate ±-130 (106 mg, 100%) as a white solid, m.p. 98-100 oC. 1H NMR: δ 2.35 (s,
6H, 2xSCH3), 2.90-2.95 (m, 2H, H1a, H4a), 3.31-3.34 (m, 2H, H1b, H4b), 3.82 (s, 6H,
2xOCH3), 5.15-5.17 (m, 2H, H2, H3), 6.86-6.91 (m, 4H, 2xArH3, 2xArH5), 7.22-7.27
(m, 4H, 2xArH4, 2xArH6); 13C NMR: δ 31.9 (C1, C4), 37.4 (2xSCH3), 55.3 (2xOCH3),
81.6 (C2, C3), 110.4 (2xArC3), 120.4 (2xArC5), 124.4 (2xArC1), 128.8 (2xArC4),
131.9 (2xArC6), 157.7 (2xArC2); FTIR v 2923 (w), 1497 (w), 1370 (m), 1349 (m),
1246 (m), 1172 (s), 1110 (w), 1033 (w), 922 (s), 876 (s), 827 (m), 765 (s); MS (EI+):
458 (13, M+), 241 (47), 145 (100%); HRMS (EI+) calcd for C20H26O8S2 458.1069,
found 458.1066.

±-1,4-Di(2-bromophenyl)-2,3-butanediol 2,3-Dimethanesulfonate (131)
Br

This reaction followed General Procedure 4 using diol ±-105

OMs

(67 mg, 0.17 mmol), NEt3 (37 mg, 0.37 mmol), CH2Cl2 (3 mL),
OMs

Br

MsCl (28 µL, 0.37 mmol) and a 30 min reaction time. The

solution was diluted with CH2Cl2 (20 mL) and washed with 5% CuSO4 (10 mL), sat.
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NaHCO3 (10 mL) and brine (10 mL). The aq. layers were combined and extracted with
CH2Cl2 (2 x 10 mL). The combined organic layers were dried and concentrated to give
dimesylate ±-131 (83 mg, 89%) as a white solid, m.p. 172-175 oC. 1H NMR: δ 2.39 (s,
6H, 2xCH3), 3.21 (dd, J = 10.5, 14.1 Hz, 2H, H1a, H4a), 3.44 (d, J = 14.1 Hz, 2H, H1b,
H4b), 5.23 (d, J = 10.5 Hz, 2H, H2, H3), 7.18 (t, J = 7.8 Hz, 2H, 2xArH4), 7.26-7.39
(m, 4H, 2xArH5, 2xArH6), 7.61 (d, J = 7.8 Hz, 2H, 2xArH3);

13

C NMR: δ 36.5 (C1,

C4), 37.4 (2xCH3), 80.9 (C2, C3), 125.0 (2xArC2), 127.7 (2xArC5), 129.4 (2xArC4),
132.7 (2xArC6), 133.3 (2xArC3), 135.4 (2xArC1); FTIR v 2972 (w), 1468 (w), 1356
(s), 1320 (w), 1175 (s), 1022 (m), 967 (m), 954 (m), 895 (s), 809 (m), 762 (m), 754 (m);
MS (ES+, HCOOH): 622 (60, M+Na+CH3CN, 81Br, 81Br), 620 (100%, M+Na+CH3CN,
81

Br,

79

Br), 618 (52, M+Na+CH3CN,

M+Na,
81

81

Br,

79

79

Br,

Br), 577 (52, M+Na,

79

Br), 581 (56, M+Na, 81Br, 81Br), 579 (93,

79

79

Br,

Br); HRMS (ES+) calcd for

79

C18H20 Br BrO6S2+Na 578.8945, found 578.8950.
±-(1E)-3-Azido-1,4-di(2-methoxyphenyl)-1-butene
phenyl)-2,3-butanediazide

(135)

and

(134),

±-1,4-Di(2-methoxy

±-(2R,3S)/(2S,3R)-3-Azido-1,4-di(2-

methoxyphenyl)-2-butanol 2-Methanesulfonate (136)
General Procedure 5 for azidation: A mixture of dimesylate ±-130 (104 mg, 0.23

mmol) and NaN3 (59 mg, 0.91 mmol) in DMF (1 mL) was heated at 80 oC for 109 h.
H2O (5 mL) was added and the mixture was extracted with CH2Cl2 (3 x 10 mL). The
combined extracts were dried, concentrated and subjected to column chromatography
(1.5% EtOAc:hexanes) giving a mixture of alkene ±-134 (4.7 mg, 7%) and diazide ±135 (7.3 mg, 9%).

OMe'
2'

1'

Data for ±-134: 1H NMR: δ 2.92-2.98 (m, 2H, H4), 3.83 (s,

N3
1''

2''

OMe''

3H, CH3' or CH3''), 3.84 (s, 3H, CH3' or CH3''), 4.36 (q, J = 7.8
Hz, 1H, H3), 6.20 (dd, J = 7.8, 15.6 Hz, 1H, H2), 6.79-6.92

(m, 5H, H1, 4xArH), 7.14-7.26 (m, 3H, 3xArH), 7.41 (dd, J = 1.4, 7.7 Hz, 1H, ArH);
13

C NMR: δ 36.2 (C4), 55.3 (CH3' or CH3''), 55.5 (CH3' or CH3''), 64.6 (C3), 110.3

(ArCH), 110.9 (ArCH), 120.4 (ArCH), 120.6 (ArCH), 125.2 (C1'), 125.7 (C1''), 127.0
(ArCH), 127.68 (C2), 127.72 (C1), 128.1 (ArCH), 129.0 (ArCH), 131.3 (ArCH), 156.9
(C2' or C2''), 157.6 (C2' or C2''); MS (EI+): 309 (5, M+), 188 (68), 145 (87), 105
(100%).
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Further elution gave a second portion of diazide ±-135 (20.4

N3

mg, 26%) as a viscous pale yellow oil to give a total overall
N3

yield of 27.7 mg, 35%. 1H NMR: δ 3.00 (d, J = 6.6 Hz, 4H, H1,

OMe

H4), 3.62 (t, J = 6.6 Hz, 2H, H2, H3), 3.68 (s, 6H, 2xCH3), 6.80 (d, J = 7.8 Hz, 2H,
2xArH3), 6.89 (t, J = 7.8 Hz, 2H, 2xArH5), 7.15 (d, J = 7.8 Hz, 2H, 2xArH6), 7.23 (t, J
= 7.8 Hz, 2H, 2xArH4); 13C NMR: δ 33.2 (C1, C4), 55.0 (2xCH3), 62.8 (C2, C3), 110.2
(2xArC3), 120.6 (2xArC5), 125.2 (2xArC1), 128.3 (2xArC4), 131.2 (2xArC6), 157.4
(2xArC2); FTIR v 2097 (s), 1493 (m), 1464 (w), 1246 (s), 1028 (w), 753 (s); MS (ES+):
375 (100%, M+Na), 368 (33, M+NH4).
5''

OMe'
2'
3'

1'
6'

4'

N3

1''

OMs

4''

Further elution with 15% EtOAc:hexanes afforded azide ±-

3''

136 (18.6 mg, 20%) as a pale yellow solid, m.p. 82-84 oC. 1H

OMe''

NMR: δ 2.39 (s, 3H, SCH3), 2.84 (dd, J = 9.3, 13.8 Hz, 1H,

6''
2''

5'

H4a), 2.95-3.09 (m, 2H, H1a, H4b), 3.20 (dd, J = 3.8, 14.0 Hz, 1H, H1b), 3.82 (s, 3H,
OCH3' or OCH3''), 3.84 (s, 3H, OCH3' or OCH3''), 4.19-4.25 (m, 1H, H3), 4.98-5.04 (m,
1H, H2), 6.85-6.96 (m, 4H, H3', H3'', H5', H5''), 7.17-7.31 (m, 4H, H4', H4'', H6', H6'');
13

C NMR: δ 31.3 (C1), 32.2 (C4), 37.4 (SCH3), 55.2 (OCH3' or OCH3''), 55.3 (OCH3' or

OCH3''), 64.6 (C3), 83.6 (C2), 110.4 (C3', C3''), 120.50 (C5' or C5''), 120.52 (C5' or
C5''), 124.5 (C1' or C1''), 124.8 (C1' or C1''), 128.6 (C4' or C4''), 128.8 (C4' or C4''),
131.2 (C6' or C6''), 132.0 (C6' or C6''), 157.61 (C2' or C2''), 157.64 (C2' or C2''); FTIR v
2915 (w), 2849 (w), 2105 (w), 1489 (w), 1464 (w), 1348 (m), 1246 (m), 1180 (m), 1024
(m), 956 (m), 913 (s), 901 (m), 760 (s); MS (ES+): 428 (100%, M+Na); HRMS (EI+)
calcd for C19H23N3O5S 405.1358, found 405.1351.
Further elution with 25% EtOAc:hexanes recovered dimesylate ±-130 (24.4 mg, 23%).

±-(1E)-3-Azido-1,4-di(2-bromophenyl)-1-butene (137) and ±-1,4-Di(2bromophenyl)
-2,3-butanediazide (138)

This reaction followed General Procedure 5 using dimesylate ±-131 (84 mg, 0.15
mmol), NaN3 (39 mg, 0.60 mmol), DMF (1 mL) and a 120 h reaction time. The crude
residue was subjected to column chromatography (0.5% EtOAc:hexanes) giving a
mixture of alkene ±-137 (9 mg, 15%) and diazide ±-138 (31 mg, 46%).
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Data for ±-137: 1H NMR: δ 3.06-3.22 (m, 2H, H4), 4.45 (q, J =
Br
2'

N3
1'

1''

7.8 Hz, 1H, H3), 6.11 (dd, J = 7.8, 15.6 Hz, 1H, H2), 6.90 (d, J
2''

Br

= 15.6 Hz, 1H, H1), 7.09-7.18 (m, 2H, 2xArH), 7.25-7.30 (m,

3H, 3xArH), 7.48-7.58 (m, 3H, 3xArH); 13C NMR: δ 41.3 (C4), 63.8 (C3), 123.7 (C2' or
C2''), 124.7 (C2' or C2''), 127.3 (ArCH), 127.47 (ArCH), 127.52 (ArCH), 128.7
(ArCH), 129.2 (ArCH), 129.4 (C2), 132.0 (ArCH), 132.4 (C1), 132.9 (ArCH), 133.0
(ArCH), 136.0 (C1' or C1''), 136.4 (C1' or C1'').
A sample of the above mixture containing alkene ±-137 (7.0
Br

N3

mg, 17.2 µmol) and diazide ±-138 (24.6 mg, 54.7 µmol) was
Br

N3

dissolved in THF (1 mL) and a solution of KMnO4 (5 mg, 32

µmol) in H2O (1 mL) was added. After stirring in air for 30 h, the mixture was diluted
with CH2Cl2 (10 mL) and H2O (10 mL). The organic layer was separated and the aq.
layer extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried,
concentrated and vacuum filtered through silica (2% EtOAc:hexanes) recovering
diazide ±-138 (22.3 mg, 91%) as a viscous pale yellow oil. 1H NMR: δ 3.06-3.22 (m,
4H, H1, H4), 3.74 (t, J = 6.0 Hz, 2H, H2, H3), 7.09-7.18 (m, 2H, 2xArH4), 7.25-7.30
(m, 4H, 2xArH5, 2xArH6), 7.54 (d, J = 8.4 Hz, 2H, 2xArH3);

13

C NMR: δ 38.5 (C1,

C4), 63.2 (C2, C3), 124.5 (2xArC2), 127.8 (2xArC5), 129.0 (2xArC4), 131.8 (2xArC6),
133.1 (2xArC3), 136.1 (2xArC1); FTIR v 2105 (s), 1476 (w), 1443 (w), 1259 (w), 1024
(m), 749 (s); MS (EI+):‡ 169 (100%).

±-1,4-Di(2-bromophenyl)-2,3-butanediamine (143)
Br

To a solution of diazide ±-138 (22.0 mg, 48.9 µmol) in THF (1

NH2

mL) was added polymer supported PPh3 (49 mg, 3.0 mmol/g
NH2

Br

loading, 0.15 mmol of PPh3) and the mixture was stirred for 3.5

h. H2O (3 drops) was added from a pasteur pipette and the mixture was heated at reflux
for 14 h. The mixture was diluted with CH2Cl2 (5 mL) and vacuum filtered. The filtrate
was dried and concentrated and the residue was taken up in CH2Cl2 (10 mL) and
extracted with 10% HCl (2 x 10 mL). The combined aq. layers were alkalified with
KOH pellets and extracted with CH2Cl2 (2 x 10 mL). The combined organic extracts
were dried and concentrated to give diamine ±-143 (14.0 mg, 72%) as a viscous pale
‡

No molecular ion was detected. Attempts to detect any characteristic ions by ES MS analysis also failed.
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brown oil. 1H NMR: δ 1.83 (bs, 4H, 2xNH2), 2.80 (dd, J = 8.1, 13.5 Hz, 2H, H1a, H4a),
3.00 (d, J = 13.5 Hz, 2H, H1b, H4b), 3.34-3.42 (m, 2H, H2, H3), 7.06 (t, J = 7.8 Hz, 2H,
2xArH4), 7.20-7.31 (m, 4H, 2xArH5, 2xArH6), 7.52 (d, J = 7.8 Hz, 2H, 2xArH3); 13C
NMR: δ 41.1 (C1, C4), 64.1 (C2, C3), 124.6 (2xArC2), 127.5 (2xArC5), 128.0
(2xArC4), 131.3 (2xArC6), 132.8 (2xArC3), 138.8 (2xArC1); MS (ES+, HCOOH): 401
(48, M+H, 81Br, 81Br), 399 (100%, M+H, 81Br, 79Br), 397 (47, M+H, 79Br, 79Br); HRMS
(ES+) calcd for C16H1981Br79BrN2 398.9894, found 398.9889.

±-2,2'-Biindoline (38)
5
6

4

General Procedure 6 for Pd catalysed microwave cyclisation:

3
2

7
8

9

N
H

A mixture of Pd(OAc)2 (1.7 mg, 7.6 µmol), ±-BINAP (9.3 mg,

N
H

14.9 µmol) and toluene (0.5 mL) in a microwave vessel was

stirred for 30 min to give a yellow solution. A solution of diamine ±-143 (13.0 mg, 32.7
µmol) in toluene (0.5 mL) was added, followed by NaOt-Bu (9.4 mg, 97.8 µmol), and
the burgundy solution was heated in a microwave at 120 oC for 4 h. The mixture was
diluted with toluene (15 mL) and vacuum filtered through Celite. The filtrate was
concentrated and subjected to column chromatography (5% to 10% EtOAc:hexanes)
giving biindoline ±-38106 (3.5 mg, 45%) as a light brown solid, m.p. 150-152 oC.‡ 1H
NMR: δ 2.71 (dd, J = 8.1, 15.6 Hz, 2H, H3a, H3'a), 3.17 (dd, J = 8.7, 15.6 Hz, 2H, H3b,
H3'b), 3.82-3.92 (m, 2H, H2, H2'), 4.20 (bs, 2H, 2xNH), 6.59 (d, J = 7.5 Hz, 2H, H8,
H8'), 6.71 (t, J = 7.5 Hz, 2H, H6, H6'), 7.01 (t, J = 7.5 Hz, 2H, H7, H7'), 7.07 (d, J = 7.5
Hz, 2H, H5, H5');

13

C NMR: δ 33.3 (C3, C3'), 64.9 (C2, C2'), 109.5 (C8, C8'), 119.0

(C6, C6'), 124.7 (C5, C5'), 127.4 (C7, C7'), 128.6 (C4, C4'), 150.7 (C9, C9'); FTIR v
3360 (w), 2843 (w), 1603 (m), 1481 (m), 1460 (m), 1238 (s), 1066 (m), 745 (s); MS
(ES+, HCOOH): 237 (100%, M+H); MS (EI+): 236 (5, M+), 119 (74), 118 (100%), 117
(45); HRMS (EI+) calcd for C16H16N2 236.1313, found 236.1312.

‡

A much higher m.p. of 211-220 oC is reported in reference 106, however it is not specified within
whether the sample was the racemate, the meso compound or a mixture of the diastereomers. No spectral
data was reported.
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9.6.5 Synthesis of (2S,2'S)-2,2'-Biindoline
2,3-O-Isopropylidene-D-threitol 1,4-Dimethanesulfonate (157)108

This
O

OMs
OMs

O

reaction

followed

General

Procedure

4

using

2,3-O-

‡

isopropylidene-D-threitol (6.87 g, 42.36 mmol), NEt3 (15.92 mL 0.11
mol), CH2Cl2 (75 mL), MsCl (8.84 mL, 0.11 mol) and a 2 h reaction

time. The mixture was diluted with CH2Cl2 (50 mL) and washed with 5% CuSO4 (50
mL), sat. NaHCO3 (2 x 50 mL) and brine (50 mL). The organic layer was dried,
concentrated and subjected to column chromatography (50% to 75% EtOAc:hexanes)
giving dimesylate (R,R)-157 (8.23 g, 61%) as a white solid. 1H NMR: δ 1.44 (s, 6H,
2xC(CH3)), 3.09 (s, 6H, 2xSCH3), 4.17-4.21 (m, 2H, H2, H3), 4.32-4.41 (m, 4H, H1,
H4); 13C NMR: δ 26.8 (2xC(CH3)), 37.7 (2xSCH3), 67.9 (C1, C4), 75.1 (C2, C3), 110.9
(C(CH3)2).
D-Threitol 1,4-Dimethanesulfonate (158)108

A solution of dimesylate (R,R)-157 (8.20 g, 25.75 mmol) and

OH
OMs

MsO
OH

MsOH (42 µL, 0.64 mmol) in 95% EtOH (50 mL) was heated at
reflux in air for 20 h. After standing in a freezer for 48 h, the

mixture was vacuum filtered and the precipitate washed with chilled EtOH (5 mL) and
hexanes (10 mL) giving diol (R,R)-158 (6.19 g, 86%) as a white solid. [α]24
D +5.9 (c
1
5.08, acetone); Lit.252 [α]20
D +5.5 (c 2, acetone); H NMR [(CD3)2CO]: δ 3.13 (s, 6H,

2xCH3), 3.99-4.07 (m, 2H, H2, H3), 4.25-4.40 (m, 4H, H1, H4); 13C NMR [(CD3)2CO]:
δ 37.2 (2xCH3), 69.7 (C1, C4), 71.7 (C2, C3).
(2R,2'R)-2,2'-Bioxirane (87)108
O
O

To a solution of diol (R,R)-158 (1.98 g, 7.11 mmol) in Et2O (25 mL) was
added dropwise a solution of KOH (917 mg, 16.34 mmol) in H2O (6 mL)

and the mixture was stirred in air for 2 h. The Et2O layer was separated and the aq.
solution extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried
and carefully concentrated at ≥200 mbar (40 oC) to give bioxirane (R,R)-87 (466 mg,

‡

This compound was prepared from D-tartaric acid as previously described108,110 and is also
commercially available from Sigma-Aldrich.
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253
76%) as a colourless liquid. [α]24
[α]26
D -21.2 (c 1.91, CHCl3); Lit.
D -29.5 (c 2.27,

CHCl3); 1H NMR: δ 2.70-2.92 (m, 6H, H1, H2, H3, H4);

13

C NMR: δ 44.2 (C2, C3),

52.0 (C1, C4).

(2R,3R)-1,4-Di(2-bromophenyl)-2,3-butanediol (105)
Br

To a solution of 2-bromoiodobenzene (854 mg, 3.02 mmol) in

OH

THF (6 mL) at -40 oC was added i-PrMgCl (1.82 mL, 1.66 M*
OH

Br

in THF, 3.02 mmol) and the mixture was allowed to warm to

o

-25 C over 2 h. The solution was cooled to -40 oC and added to a suspension of CuI (29
mg, 0.15 mmol) in THF (1 mL) at -40 oC. After 10 min, a solution of bioxirane (R,R)-87
(98 mg, 1.14 mmol) in THF (2 mL) was added dropwise and the mixture was allowed to
warm to -10 oC and maintained at this temp for 5 h. Sat. NH4Cl (3 mL) was added
slowly then the mixture was diluted with H2O (3 mL) and EtOAc (15 mL), shaken and
allowed to settle. The clear organic layer was decanted from the slurry and the process
was twice repeated with EtOAc (2 x 15 mL). The combined organic layers were dried
and concentrated to give a white solid (347 mg). Successive recrystallisations from
EtOH (5 mL) provided two precipitate crops which were combined to give diol (R,R)105 (194 mg, 43%) with minor impurities. A further recrystallisation from EtOH (5 mL)

provided the pure diol (R,R)-105 (142 mg, 31%) as a white solid spectroscopically
identical to diol ±-105. [α]20
D +21.1 (c 0.98, EtOH).

(2R,3R)-1,4-Di(2-bromophenyl)-2,3-butanediol 2,3-Dimethanesulfonate (131)
Br

This reaction followed General Procedure 4 using diol (R,R)-

OMs

105 (139 mg, 0.35 mmol), NEt3 (88 mg, 0.87 mmol), CH2Cl2 (5
OMs

Br

mL), a solution of MsCl (88 mg, 0.77 mmol) in CH2Cl2 (1 mL)

and a 3 h reaction time. The solution was diluted with CH2Cl2 (10 mL), washed with
5% CuSO4 (15 mL) and sat. NaHCO3 (15 mL), then dried and concentrated to give
dimesylate (R,R)-131 (162 mg, 84%) as a white solid spectroscopically identical to
dimesylate ±-131. [α]25
D +32.9 (c 4.00, CH2Cl2).
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(1E,3S)-3-Azido-1,4-di(2-bromophenyl)-1-butene (137) and (2S,3S)-1,4-Di(2-bromo
phenyl)-2,3-butanediazide (138)
Br

This reaction followed General Procedure 5 using dimesylate

N3

(R,R)-131 (159 mg, 0.29 mmol), NaN3 (111 mg, 1.71 mmol),
Br

Br

crude

N3
Br

N3

DMF (1 mL) and a 264 h reaction time giving after work-up a
mixture

of

alkene

(S)-137

(~30

mg,

~25%)

(spectroscopically identical to alkene ±-137) and diazide (S,S)138 (~81 mg, ~63%). This was dissolved in THF (3 mL), then a

solution of KMnO4 in H2O (3 mL) was added and the mixture was stirred in air for 12 h.
The brown slurry was diluted with CH2Cl2 (15 mL) and H2O (10 mL), then 10% HCl (5
mL) and 10% Na2SO3 (1 mL) were added. The organic layer was separated and the aq.
solution extracted with CH2Cl2 (10 mL). The combined organic layers were dried,
concentrated and subjected to column chromatography (1% EtOAc:hexanes) giving
diazide (S,S)-138 (60 mg, 47% overall) as a viscous pale yellow oil spectroscopically
identical to diazide ±-138. [α]22
D -28.5 (c 3.00, CH2Cl2).
(2S,3S)-1,4-Di(2-bromophenyl)-2,3-butanediamine (143)
Br

A solution of diazide (S,S)-138 (45.6 mg, 0.10 mmol) and PPh3

NH2

(58 mg, 0.22 mmol) in THF (1 mL) was stirred for 2 h. H2O (2
NH2

Br

drops) was added from a pasteur pipette and the solution was

heated at reflux for 13 h. The mixture was diluted with CH2Cl2 (20 mL), washed with
H2O (5 mL), dried and concentrated to give a white solid (96 mg). This was dissolved in
10% EtOAc:Et2O (5 mL), then HCl (1 mL, 2.0 M in Et2O) was added dropwise,
forming a white precipitate. After stirring for 2 h, the suspension was vacuum filtered
and the precipitate washed with Et2O (4 x 5 mL) to give a pale yellow solid (49 mg)
which was dissolved in a biphase of 15% NaOH (3 mL) and CH2Cl2 (3 mL). The
mixture was diluted with H2O (5 mL) and CH2Cl2 (15 mL), then the organic layer was
separated, dried and concentrated to give a viscous colourless oil containing PPh3O (8.6
mg) and diamine (S,S)-143 (28.6 mg, 71%) (spectroscopically identical to diamine ±143) which was used directly in the subsequent cyclisation.

167

CHAPTER 9

Experimental

(2S,2'S)-2,2'-Biindoline (38)

This reaction followed General Procedure 6 using Pd(OAc)2 (3.2
mg, 14.4 µmol), ±-BINAP (17.9 mg, 28.7 µmol), toluene (0.5
N
H

N
H

mL), a solution of diamine (S,S)-143 (28.6 mg, 71.8 µmol) and

PPh3O (8.6 mg) in toluene (0.5 mL) and NaOt-Bu (20.7 mg, 0.22 mmol) giving
biindoline (S,S)-38‡ (9.7 mg, 57%) as a light brown solid spectroscopically identical to
biindoline ±-38.

(2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biindoline (82)
5
6
7
8

4
9

General Procedure 7 for Boc protection of biindoline (S,S)-

3
2

N
Boc

38: To a solution of biindoline (S,S)-38 (6.4 mg, 27.1 µmol) and

N
Boc

NEt3 (6.0 mg, 59.6 µmol) in THF (0.5 mL) was added a solution

of Boc2O (12.4 mg, 56.9 µmol) in THF (0.5 mL) and the mixture was stirred in air for
144 h, during which time three additional portions of Boc2O (3 x ~15 mg) were added
(after 3, 27 and 52 h). The mixture was diluted with CH2Cl2 (10 mL) and H2O (5 mL),
then the organic layer was separated, dried, concentrated and subjected to column
chromatography (hexanes to 4% EtOAc:hexanes) to give biindoline (S,S)-82 (9.0 mg,
76%) as a white solid, mp. 182-184 oC. [α]21
D -91.4 (c 0.45, CH2Cl2); HPLC analysis
(2.5% i-PrOH:hexane, retention time: 10.5 min) showed the ee of biindoline (S,S)-82
was >99%; 1H NMR: δ 1.54 (s, 18H, 6xCH3), 2.72 (d, J = 16.8 Hz, 2H, H3a, H3'a), 3.16
(dd, J = 9.6, 16.8 Hz, 2H, H3b, H3'b), 4.96-5.04 (m, 2H, H2, H2'), 6.91 (t, J = 7.5 Hz,
2H, H6, H6'), 7.01 (d, J = 7.5 Hz, 2H, H5, H5'), 7.16 (t, J = 7.5 Hz, 2H, H7, H7'), 7.70
(bs, 2H, H8, H8');

13

C NMR: δ 28.4 (6xCH3), 29.2 (C3, C3'), 60.0 (C2, C2'), 81.3

(2xC(CH3)3), 115.5 (C8, C8'), 122.5 (C6, C6'), 124.5 (C5, C5'), 127.3 (C7, C7'), 130.2
(C4, C4'), 143.2 (C9, C9'), 152.6 (2xC=O); FTIR v 2966 (w), 2919 (w), 2848 (w), 1696
(s), 1485 (m), 1390 (s), 1373 (m), 1341 (s), 1161 (m), 1021 (m), 752 (s); MS (EI+): 436
(17, M+), 118 (100%); HRMS (EI+) calcd for C26H32N2O4 436.2362, found 436.2345.

‡

The quantity obtained was insufficient to obtain a precise optical rotation as readings were close to zero
and variable. See the specific rotation of biindoline (S,S)-38 synthesised from biaziridine (S,S)-183
(Section 9.7.4).

168

CHAPTER 9

Experimental

9.6.6 Ring Opening with Lithium tert-Butoxycarbonyl(2-lithiophenyl)amide
2-Phenylcarbamoyl-N-tert-butoxycarbonylaniline

(164),

2-(2-Phenylcarbamoyl)

phenylcarbamoyl-N-tert-butoxycarbonylaniline (165) and 1,4-Di(2-N-tert-butoxy
carbonylaniline)-2,3-butanediol (81)
Method 1 using CuCN·LiCl in THF: To a solution of N-Boc aniline (718 mg, 3.72

mmol) in THF (6 mL) at -40 oC was added t-BuLi (4.38 mL, 1.7 M in pentane, 7.44
mmol) and the yellow solution was allowed to warm to -20 oC over 2 h. The mixture
was cooled to -50 oC (liquid N2/CH3CN/EtOAc slush bath) and a solution of CuCN
(167 mg, 1.86 mmol) and LiCl (79 mg, 1.86 mmol) in THF (5 mL) was added dropwise.
After 10 min, a solution of bioxirane ±-87 (40 mg, 0.46 mmol) in THF (1 mL) was
added and the mixture was allowed to warm to -10 oC over 2 h. Sat. NH4Cl (5 mL) was
added slowly, followed by H2O (5 mL), and the mixture was extracted with CH2Cl2 (2 x
15 mL). The combined extracts were dried, concentrated and subjected to column
chromatography (3% to 15% EtOAc:hexanes) recovering N-Boc aniline (305 mg, 42%).
Further elution yielded amide 164 (111 mg, 19% based on N-

5'

BocHN
1
6

2

N
H

3

5

4'

6'

O

1'

Boc aniline) as a white solid, m.p. 165-168 oC. 1H NMR: δ 1.54

3'
2'

(s, 9H, 3xCH3), 6.92 (t, J = 7.5 Hz, 1H, H4), 7.18 (t, J = 7.5 Hz,

4

1H, H4'), 7.29 (t, J = 7.5 Hz, 1H, H5), 7.40 (t, J = 7.5 Hz, 2H,

H3', H5'), 7.45 (d, J = 7.5 Hz, 1H, H3), 7.66 (d, J = 7.5 Hz, 2H, H2', H6'), 8.15 (d, J =
8.4 Hz, 1H, H6), 8.60 (bs, 1H, NHBoc), 9.61 (bs, 1H, NHCOAr);

13

C NMR: δ 28.3

(3xCH3), 80.5 (C(CH3)3), 120.3 (C6), 120.5 (C2', C6'), 121.0 (C2), 121.6 (C4), 124.7
(C4'), 127.1 (C3), 129.1 (C3', C5'), 132.1 (C5) 137.8 (C1'), 139.4 (C1), 153.4 (tBuOC=O), 167.3 (ArC=O); FTIR v 3305 (w), 2968 (w), 1698 (m), 1653 (m), 1518 (s),
1439 (m), 1328 (m), 1254 (m), 1156 (s), 1053 (m), 761 (s), 728 (m); MS (ES+,
HCOOH): 313 (100%, M+H); HRMS (EI+) calcd for C18H20N2O3 312.1474, found
312.1467.

BocHN
1
6

5''

2

7

3

5
4

Further elution gave diamide 165 (25 mg, 5% based on

O
1'
6'

5'

2'
3'

4'

7'

4''

6''

NH O
N
H

1''

3''
2''

N-Boc aniline) as a white solid, m.p. 220-222 oC. 1H

NMR: δ 1.51 (3xCH3), 7.07-7.24 (m, 3H, H4, H4', H4''),
7.38-7.67 (m, 7H, H2'', H3', H3'', H5, H5', H5'', H6''),
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7.77 (d, J = 7.5 Hz, 1H, H3), 8.11 (bs, 1H, NHBoc), 8.41 (d, J = 8.4 Hz, 1H, H6), 8.60
(d, J = 8.4 Hz, 1H, H6'), 10.33 (bs, 1H, NHCOAr), 11.66 (bs, 1H, NHCOAr);

13

C

NMR: δ 28.3 (3xCH3), 80.3 (C(CH3)3), 119.7 (C2), 119.9 (C6), 120.7 (C2'), 120.8 (C2'',
C6''), 122.0 (C4), 122.4 (C6'), 123.6 (C4'), 125.3 (C4''), 126.8 (C3'), 127.4 (C3), 129.2
(C3'', C5''), 132.8 (C5), 133.0 (C5'), 137.1 (C1''), 139.2 (C1'), 141.0 (C1), 153.0 (tBuOC=O), 167.3 (C7'), 167.8 (C7); FTIR v 3305 (m), 2976 (w), 2923 (w), 1723 (m),
1649 (s), 1542 (m), 1518 (m), 1439 (m), 1324 (m), 1246 (m), 1156 (s), 757 (s); MS
(ES+, HCOOH): 432 (100%, M+H); HRMS (ES+) calcd for C25H26N3O4 432.1923,
found 432.1939.

NHBoc

Further elution with 20% to 50% EtOAc:hexanes afforded a

OH

mixture of compounds (105 mg) found to contain diol ±-81
OH
107

sample.

NHBoc

by comparison of the NMR spectra with that of an authentic

Data for ±-81: m.p.107 142-143 oC; 1H NMR: δ 1.49 (s, 18H, 6xCH3), 2.80-

2.94 (m, 4H, H1, H4), 3.26 (bs, 2H, 2xOH), 3.65-3.73 (m, 2H, H2, H3), 7.06 (t, J = 7.5
Hz, 2H, 2xArH5), 7.12 (d, J = 7.5 Hz, 2H, 2xArH6), 7.22 (t, J = 7.5 Hz, 2H, 2xArH4),
7.62 (d, J = 7.5 Hz, 2H, 2xArH3), 7.67 (s, 2H, 2xNH); 13C NMR: δ 28.4 (6xCH3), 35.4
(C1, C4), 74.9 (C2, C3) 80.3 (2xC(CH3)3), 123.9 (2xArC3), 124.6 (2xArC5), 127.4
(2xArC4), 129.9 (2xArC1), 130.5 (2xArC6) 137.0 (2xArC2), 154.2 (2xC=O); MS
(ES+, HCOOH): 495 (100%, M+Na), 473 (45, M+H); HRMS (EI+) calcd for
C26H36N2O6 472.2573, found 472.2568.
±-N,N'-Di-tert-butoxycarbonyl-2,2'-biindoline (82)

The mixture containing diol ±-81 from Method 1 (see directly
N
Boc

N
Boc

above) was dissolved in a solution of NEt3 (142 mg, 1.40 mmol)
in CH2Cl2 (2 mL) at 0 oC and a solution of MsCl (161 mg, 1.41

mmol) in CH2Cl2 (1 mL) was added dropwise. After warming to RT and stirring in air
for 48 h, the solution was diluted with CH2Cl2 (20 mL) and washed with 5% CuSO4 (10
mL), sat. NaHCO3 (10 mL) and brine (10 mL). The aq. layers were combined and
extracted with CH2Cl2 (2 x 10 mL) and the combined organic layers were dried and
concentrated. The residue (115 mg) was dissolved in dry THF (2 mL) and the solution
added over 10 min to a suspension of NaH (56 mg, 60% suspension, 1.40 mmol) in
THF (0.5 mL) at 0 oC. After allowing to warm to RT over 43 h, H2O (5 mL) was slowly
added and the mixture was extracted with CH2Cl2 (3 x 10 mL). The combined extracts
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were dried, concentrated and subjected to column chromatography (3% EtOAc:hexanes)
yielding biindoline ±-82 (18 mg, 9% overall from bioxirane ±-87) as a white solid
spectroscopically identical to biindoline (S,S)-82.
Method 2 using CuCN in Et2O: To a suspension of N-Boc aniline (808 mg, 4.18

mmol) in Et2O (8 mL) at -30 oC was added t-BuLi (5.50 mL, 1.52 M* in pentane, 8.36
mmol) and the yellow solution was maintained at -10 oC for 3 h. The cloudy solution
was cooled to -40 oC and added to a suspension of CuCN (187 mg, 2.09 mmol) in THF
(5 mL) at -78 oC. After 30 min, a solution of bioxirane ±-87 (59 mg, 0.69 mmol) in THF
(1 mL) was added and the yellow/brown slurry was allowed to warm to 0 oC over 1 h
and became homogenous. Sat. NH4Cl (3 mL) was added slowly then the mixture was
diluted with H2O (3 mL), shaken and allowed to settle. The clear organic layer was
decanted from the slurry and the process was thrice repeated with EtOAc (3 x 15 mL).
The combined organic layers were dried, concentrated and subjected to column
chromatography (3% to 9% EtOAc:hexanes) recovering N-Boc aniline (156 mg, 19%).
Further elution with 10% to 20% EtOAc:hexanes afforded amide 164 (164 mg, 25%),
followed by a mixture of amide 164 (45 mg, 7%) and diamide 165 (29 mg, 5%) to give
a total yield of amide 164 of 209 mg, 32% (based on N-Boc aniline). Further elution
afforded a second portion of diamide 165 (6 mg, 1%) to give a total yield of diamide
165 of 35 mg, 6% (based on N-Boc aniline).

Further elution with 21% to 30% EtOAc:hexanes gave a mixture of compounds (65 mg)
found to contain diol ±-81 by comparison of the spectra with that of an authentic
sample.107

2-(2-Aminobenzoyl)-N-tert-butoxycarbonylaniline (166) and 2-(2-(2-Aminobenzoyl)
phenylcarbamoyl)-N-tert-butoxycarbonylaniline (167)
Method 3 without Cu: To a suspension of N-Boc aniline (808 mg, 4.18 mmol) in Et2O

(8 mL) at -30 oC was added t-BuLi (5.50 mL, 1.52 M* in pentane, 8.36 mmol) and the
yellow solution was maintained at -10 oC for 3 h and became cloudy. After cooling to
-78 oC, a solution of bioxirane ±-87 (47 mg, 0.55 mmol) in Et2O (2 mL) was added
dropwise and the mixture was allowed to warm to 0 oC over 1 h, maintained at this temp
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for 1 h, then allowed to warm to RT and stirred for 8 h. Sat. NH4Cl (3 mL) was added
slowly, then the mixture was diluted with H2O (20 mL) and CH2Cl2 (40 mL). The
organic layer was separated and the aq. solution extracted with CH2Cl2 (30 mL). The
combined organic layers were dried, concentrated and subjected to column
chromatography (4% to 7% EtOAc:hexanes) recovering N-Boc aniline (247 mg, 31%).

BocHN
1
6

O
2

2'

1'

3

5

Further elution with 8% to 16% EtOAc:hexanes afforded aniline

NH2
3'
4'

6'

4

5'

166 (117 mg, 18% based on N-Boc aniline) as a yellow solid, m.p.

154 oC. 1H NMR: δ 1.50 (s, 9H, 3xCH3), 5.90 (bs, 2H, NH2), 6.60

(t, J = 7.2 Hz, 1H, H5'), 6.73 (d, J = 8.4 Hz, 1H, H3'), 7.01 (t, J = 7.5 Hz, 1H, H4), 7.27
(d, J = 8.4 Hz, 1H, H6'), 7.33-7.39 (m, 2H, H3, H4'), 7.47 (t, J = 7.8 Hz, 1H, H5), 8.27
(d, J = 8.4 Hz, 1H, H6), 8.93 (bs, 1H, NH); 13C NMR: δ 28.3 (3xCH3), 80.5 (C(CH3)3),
115.7 (C5'), 117.0 (C3'), 119.1 (C1'), 120.4 (C6), 121.0 (C4), 126.3 (C2), 131.8 (C3),
132.3 (C5), 134.36 (C4' or C6'), 134.38 (C4' or C6'), 139.2 (C1), 150.8 (C2'), 152.9 (tBuOC=O), 200.0 (Ar2C=O); FTIR v 3458 (w), 3359 (w), 3347 (w), 1702 (m), 1613 (m),
1581 (m), 1513 (m), 1447 (m), 1245 (s), 1156 (s), 932 (m), 749 (s); MS (ES+,
HCOOH): 313 (100%, M+H); HRMS (ES+) calcd for C18H21N2O3 313.1552, found
313.1555.
Further elution gave amide 164 (35 mg, 5% based on N-Boc aniline).

BocHN
1
6

2 7
3

5
4

Further elution with 18% to 20% EtOAc:hexanes provided

O
NH
1'
6'

O

2'
3'

5'
4'

7' 1''

NH2
2''
3''
4''

6''
5''

a fraction containing aniline 167 in high purity (5 mg, 1%
based on N-Boc aniline) as a yellow/brown solid. 1H NMR:
δ 1.51 (s, 9H, 3xCH3), 5.91 (bs, 2H, NH2), 6.63 (t, J = 7.5

Hz, 1H, H5''), 6.73 (d, J = 8.1 Hz, 1H, H3''), 7.07 (t, J = 7.5 Hz, 1H, H4), 7.17 (t, J = 7.5
Hz, 1H, H4'), 7.31 (t, J = 7.8 Hz, 1H, H4''), 7.39 (d, J = 7.8 Hz, 1H, H6''), 7.43-7.53 (m,
2H, H3', H5), 7.58 (t, J = 7.8 Hz, 1H, H5'), 7.67 (d, J = 8.1 Hz, 1H, H3), 8.41 (d, J = 8.4
Hz, 1H, H6), 8.52 (d, J = 8.1 Hz, 1H, H6'), 10.21 (bs, 1H, NHBoc), 10.77 (bs, 1H,
NHCOAr); 13C NMR: δ 28.3 (3xCH3), 80.3 (C(CH3)3), 115.8 (C5''), 117.2 (C3''), 118.8
(C1''), 120.0 (C6), 121.1 (C2), 121.7 (C4), 122.4 (C6'), 122.9 (C4'), 127.0 (C3), 127.4
(C2'), 132.4 (C3'), 132.6 (C5'), 133.0 (C5), 134.3 (C6''), 134.7 (C4''), 138.3 (C1'), 141.0
(C1), 151.0 (C2''), 153.0 (t-BuOC=O), 167.5 (C7), 200.2 (C7'); FTIR v 2913 (w), 2850
(w), 1729 (w), 1582 (m), 1519 (m), 1445 (m), 1295 (m), 1245 (m), 1156 (s), 1050 (w),
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932 (w), 752 (s); MS (ES+, HCOOH): 432 (100%, M+H); HRMS (ES+) calcd for
C25H26N3O4 432.1923, found 432.1917.

9.7 Synthesis of 2,2'-Biindoline from 2,2'-Biaziridine
9.7.1 Synthesis of (2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biaziridine
(2R,3R)-1,4-Diazido-2,3-butanediol (180)177

This reaction followed General Procedure 5 using D-threitol 1,4-

OH
N3

N3
OH

dimethanesulfonate† (2.00 g, 7.19 mmol), NaN3 (1.40 g, 21.58 mmol),
DMF (7.5 mL) and a 48 h reaction time affording diol (R,R)-180 (1.05

g, 85%) as a colourless oil. 1H NMR: δ 2.71 (bs, 2H, 2xOH), 3.46 (d, J = 5.4 Hz, 4H,
H1, H4), 3.73-3.79 (m, 2H, H2, H3); 13C NMR: δ 53.8 (C1, C4), 70.5 (C2, C3).
(2R,3R)-1,4-Di(N-tert-butoxycarbonylamino)-2,3-butanediol (181)171

A vessel containing a mixture of diol (R,R)-180 (818 mg, 4.75

OH
NHBoc

BocHN
OH

mmol) and Pd/C (506 mg, wet, 10% dry wt. Pd, ~0.48 mmol of
Pd) in EtOH (8 mL) was cautiously evacuated. The vacuum

was released with a H2(g) balloon then the mixture was stirred at RT for 23 h. The vessel
was opened to the atmosphere and a solution of Boc2O (2.05 g, 9.50 mmol) in EtOH (3
mL) was added over 10 min, then stirring continued in air for 28 h. The mixture was
vacuum filtered and the filter cake washed with CH2Cl2 (20 mL). The filtrate was
concentrated and subjected to column chromatography (20% to 90% EtOAc:hexanes)
giving diol (R,R)-181 (1.27 g, 83%) as a white solid.‡ 1H NMR: δ 1.43 (s, 18H, 6xCH3),
3.15-3.25 (m, 2H, H1a, H4a), 3.25-3.37 (m, 2H, H1b, H4b), 3.59-3.66 (m, 2H, H2, H3),
4.33 (bs, 2H, 2xOH), 5.68 (bs, 2H, 2xNH);

13

C NMR: δ 28.2 (6xCH3) 43.0 (C1, C4),

70.8 (C2, C3), 79.4 (2xC(CH3)3), 156.9 (2xC=O).

†
‡

This compound was prepared from D-tartaric acid as described in Section 9.6.5.
No physical or spectral data reported in reference 171.
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(2R,3R)-1,4-Di(N-tert-butoxycarbonylamino)-2,3-butanediol
2,3-Dimethanesulfonate (182)171

This reaction followed General Procedure 4 using diol (R,R)-

OMs
NHBoc

BocHN
OMs

181 (1.27 g, 3.95 mmol), NEt3 (879 mg, 8.68 mmol), CH2Cl2

(20 mL), MsCl (994 mg, 8.68 mmol) and a 24 h reaction time.

The solution was diluted with CH2Cl2 (20 mL) and washed with 5% CuSO4 (20 mL),
sat. NaHCO3 (20 mL) and brine (20 mL). The aq. layers were combined and extracted
with CH2Cl2 (2 x 20 mL). The combined organic layers were dried and concentrated to
give dimesylate (R,R)-182 (1.79 g, 95%) as a white solid, m.p. 118-120 oC.† 1H NMR: δ
1.43 (s, 18H, 6xC(CH3)), 3.17 (s, 6H, 2xSCH3), 3.40-3.50 (m, 2H, H1a, H4a), 3.50-3.61
(m, 2H, H1b, H4b), 4.80-4.87 (m, 2H, H2, H3), 5.16 (bs, 2H, 2xNH); 13C NMR: δ 28.3
(6xC(CH3)) 38.5 (2xSCH3), 40.8 (C1, C4), 76.9 (C2, C3), 80.3 (2xC(CH3)3), 156.0
(2xC=O); FTIR v 3347 (w), 2925 (w), 1690 (s), 1538 (m), 1354 (m), 1334 (m), 1289
(m), 1177 (s), 1163 (s), 909 (s), 890 (m), 782 (w); MS (ES+, HCOOH): 499 (85,
M+Na), 477 (100%, M+H); HRMS (ES+) calcd for C16H33N2O10S2 477.1577, found
477.1577.
(2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biaziridine (183)171
NBoc
BocN

To a suspension of NaH (376 mg, 60% suspension, 9.39 mmol) in
THF (5 mL) at 0 oC was added over 20 min a solution of dimesylate

(R,R)-182 (1.79 g, 3.76 mmol) in THF (25 mL) and the mixture was allowed to warm to
RT and stirred for 14 h. H2O (5 mL) was slowly added and the mixture was extracted
with CH2Cl2 (3 x 10 mL). The combined extracts were dried and concentrated to give
biaziridine (S,S)-183 (1.01 g, 94%) as a white solid. [α]23
D -145.2 (c 1.93, MeOH); Lit.
‡ 1
H NMR: δ 1.40 (s, 18H, 6xCH3), 2.10 (d, J =
(R,R)-183171 [α]20
D +175 (c 4.4, MeOH);

2.4 Hz, 2H, H3a, H3'a), 2.24 (d, J = 6.0 Hz, 2H, H3b, H3'b), 2.65-2.68 (m, 2H, H2, H2');
13

C NMR: δ 27.8 (6xCH3) 29.4 (C3, C3'), 35.5 (C2, C2'), 81.3 (2xC(CH3)3), 161.8

(2xC=O); MS (ES+, HCOOH): 285 (100%, M+H).

†

No physical or spectral data reported in reference 171.
Although both enantiomers of biaziridine 183 were reported in reference 171, only the specific rotation
of the (R,R)-isomer is given. This reference also reported a mixture of rotamers in the 13C spectrum. We
observed only a single peak for each (non-equivalent) carbon atom.

‡
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9.7.2 Ring Opening of (2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biaziridine
(4S,5S)-2,7-Dimethyl-4,5-di(N-tert-butoxycarbonylamino)octane (188) and (4S,5S)4,5-Diisobutyl-1-tert-butoxycarbonyl-2-imidazolidinone (189)

3

2

1a

1b

4

To a suspension of CuBr·SMe2 (146 mg, 0.71 mmol) and

8b

BocHN
5

7

6

8a

biaziridine (S,S)-183 (224 mg, 0.79 mmol) in THF (4 mL) at -40
o

NHBoc

C was added a cooled solution (-40 oC) of i-PrMgCl (2.36 mL,

2.0 M in THF, 4.72 mmol) and the solution was allowed to warm to -10 oC over 3 h.
H2O (5 mL) was added slowly and the mixture was extracted with EtOAc (3 x 10 mL).
The combined extracts were dried, concentrated and subjected to column
chromatography (4% EtOAc:hexanes to 100% EtOAc) yielding dicarbamate (S,S)-188
1
(66 mg, 22%) as a pale yellow solid, m.p. 147 oC. [α]21
D -65.9 (c 2.77, CH2Cl2); H

NMR: δ 0.91 (d, J = 6.6 Hz, 12H, H1a, H1b, H8a, H8b), 1.22-1.35 (m, 4H, H3, H6), 1.43
(s, 18H, 6xC(CH3)), 1.61-1.75 (m, 2H, H2, H7), 3.49-3.60 (m, 2H, H4, H5), 4.49 (bs,
2H, 2xNH);

13

C NMR: δ 21.9 (C1a, C8a), 23.4 (C1b, C8b), 24.8 (C2, C7), 28.4

(6xC(CH3)), 42.4 (C3, C6), 52.9 (C4, C5), 79.0 (2xC(CH3)3), 156.3 (2xC=O); FTIR v
3351 (w), 2949 (w), 1685 (s), 1534 (s), 1362 (w), 1291 (w), 1179 (m), 1011 (w); MS
(ES+, HCOOH): 373 (76, M+H), 217 (100%, M+H+HCOOH-2Boc); HRMS (EI+):
calcd for C20H40N2O4 372.2988, found 372.3001.

3''a

2'' 1''

1' 2'

3'a

4 5
3''b

HN

2

O

NBoc

3'b

Further elution gave imidazolidinone (S,S)-189 (148 mg, 63%) as a
1
yellow syrup. [α]21
D -5.4 (c 4.23, CH2Cl2); H NMR: δ 0.91-0.97 (m,

12H, H3'a, H3''a, H3'b, H3''b), 1.22-1.30 (m, 1H, H1''a), 1.32-1.74
(m, 5H, H1', H1''b, H2', H2''), 1.53 (s, 9H, 3xC(CH3)), 3.26 (t, J =

7.2 Hz, 1H, H4), 3.76 (t, J = 7.2 Hz, 1H, H5), 6.90 (bs, 1H, NH);

13

C NMR: δ 21.4

(C3'a, C3''a, C3'b or C3''b), 21.9 (C3'a, C3''a, C3'b or C3''b), 22.8 (C3'a, C3''a, C3'b or C3''b),
23.8 (C3'a, C3''a, C3'b or C3''b), 24.0 (C2' or C2''), 24.1 (C2' or C2''), 28.0 (3xC(CH3)),
42.3 (C1'), 45.3 (C1''), 52.0 (C4), 59.3 (C5), 81.8 (C(CH3)3), 150.3 (t-BuOC=O), 155.9
(C2); FTIR v 3289 (w), 2952 (m), 2866 (w), 1787 (s), 1711 (m), 1370 (m) 1336 (s),
1254 (m), 1164 (s), 1131 (m), 1102 (w), 778 (m). MS (ES+, HCOOH): 299 (15, M+H),
243 (100%, M+HCOOH-Boc); HRMS (EI+): calcd for C16H30N2O3 298.2256, found
298.2259.
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(2S,3S)-2,3-Di(N-tert-butoxycarbonylamino)-1,4-di(2-methoxyphenyl)butane (191),
(4S,5S)-4,5-Di(2-methoxybenzyl)-1-tert-butoxycarbonyl-2-imidazolidinone (192)
and (4S,5S)-4,5-Di(2-methoxybenzyl)-2-imidazolidinone (193)
MeO

To a suspension of Mg (26 mg, 1.07 mmol) in THF (2 mL)

BocHN

was added o-bromoanisole (200 mg, 1.07 mmol) and the
NHBoc

mixture was heated at 40 oC for 30 min. The dark brown

OMe

solution was cooled to RT and added dropwise to a suspension of CuBr.SMe2 (33 mg,
0.16 mmol) and biaziridine (S,S)-183 (40 mg, 0.14 mmol) in THF (5 mL) at -40 oC. The
solution was allowed to warm to -10 oC over 2 h, then H2O (5 mL) was added slowly
and the mixture was extracted with CH2Cl2 (3 x 10 mL). The combined extracts were
dried, concentrated and subjected to column chromatography (4% to 10%
EtOAc:hexanes) yielding dicarbamate (S,S)-191 (12 mg, 17%) as a white solid, m.p.
135 oC. 1H NMR: δ 1.30 (s, 18H, 6xC(CH3)), 2.73-2.94 (m, 4H, H1, H4), 3.81 (s, 6H,
2xOCH3), 3.78-3.90 (m, 2H, H2, H3), 4.93 (bs, 2H, 2xNH), 6.81-6.89 (m, 4H, 2xArH3,
2xArH5), 7.12-7.20 (m, 4H, 2xArH4, 2xArH6);

13

C NMR: δ 28.3 (6xC(CH3)), 33.4

(C1, C4), 55.21 (2xOCH3), 55.24 (C2, C3), 78.7 (2xC(CH3)3), 110.2 (2xArC3), 120.5
(2xArC5), 126.9 (2xArC1), 127.6 (2xArC4), 131.0 (2xArC6), 156.3 (2xC=O), 157.6
(2xArC2); FTIR v 3355 (w), 2972 (w), 1683 (s), 1526 (w), 1366 (w), 1240 (m), 1175
(m), 1054 (m), 1026 (w), 751 (s); MS (ES+): 501 (100%, M+H); HRMS (ES+) calcd
for C28H40N2O6+Na 523.2784, found 523.2813.

OMe''

Further elution with 50% to 60% EtOAc:hexanes gave

Me'O

2''

3''

7' 1'

1'' 7''

2' 3'

4 5

4''
5''

6''

HN

6'

2

O

imidazolidinone (S,S)-192 (30 mg, 50%) as a white solid,
4'

NBoc

5'

1
m.p. 136-138 oC. [α]21
D -18.0 (c 0.61, CH2Cl2); H NMR: δ

1.56 (s, 9H, 3xC(CH3)), 2.50-2.73 (m, 3H, H7'a, H7''), 3.20

(dd, J = 3.9, 12.9 Hz, 1H, H7'b), 3.53-3.58 (m, 1H, H4), 3.58 (s, 3H, OCH3' or OCH3''),
3.66 (s, 3H, OCH3' or OCH3''), 4.28 (dd, J = 3.9, 10.2 Hz, 1H, H5), 5.61 (bs, 1H, NH),
6.62-6.69 (m, 2H, H3', H3''), 6.75-6.88 (m, 3H, H5', H5'', (H6' or H6'')), 6.98 (d, J = 7.2
Hz, 1H, H6' or H6''), 7.09-7.18 (m, 2H, H4', H4''); 13C NMR: δ 28.1 (3xC(CH3)), 34.1
(C7'), 37.0 (C7''), 51.5 (C4), 54.8 (OCH3' or OCH3''), 54.9 (OCH3' or OCH3''), 58.7
(C5), 81.9 (C(CH3)3), 110.1 (C3', C3''), 120.2 (C5', C5''), 124.4 (C1' or C1''), 124.5 (C1'
or C1''), 127.9 (C4' or C4''), 128.0 (C4' or C4''), 130.9 (C6' or C6''), 131.4 (C6' or C6''),
150.4 (t-BuOC=O), 155.6 (C2), 157.2 (C2' or C2''), 157.5 (C2' or C2''); FTIR v 2921
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(w), 1776 (s), 1492 (w), 1351 (m), 1250 (s), 1153 (m), 1117 (w), 1026 (w), 754 (s); MS
(ES+, HCOOH): 427 (8, M+H), 371 (100%, M+HCOOH-Boc), 327 (75, M+2H-Boc);
HRMS (EI+) calcd for C24H30N2O5 426.2155, found 426.2163.

OMe

MeO

2'

3'

1'

193 (4.1 mg, 9%) as a white solid, m.p. 74-76 oC. 1H NMR: δ

7'
4 5

4'
5'

6'

HN

2

Further elution with EtOAc afforded imidazolidinone (S,S)2.69-2.84 (m, 4H, 2xH7'), 3.73-3.77 (m, 2H, H4, H5), 3.77 (s,

NH

6H, 2xCH3), 4.44 (bs, 2H, 2xNH), 6.78-6.89 (m, 4H, 2xH3',

O

2xH5'), 7.06 (d, J = 7.2 Hz, 2H, 2xH6'), 7.21 (t, J = 7.5 Hz, 2H, 2xH4');

13

C NMR: δ

36.6 (2xC7'), 55.2 (2xCH3), 57.5 (C4, C5), 110.3 (2xC3'), 120.5 (2xC5'), 125.4 (2xC1'),
128.2 (2xC4'), 131.1 (2xC6'), 157.4 (2xC2'), 162.0 (C2); FTIR v 3221 (w), 2921 (w),
1696 (s), 1494 (m), 1464 (w), 1247 (s), 1052 (w), 748 (s); MS (ES+): 327 (100%,
M+H); HRMS (EI+) calcd for C19H22N2O3 326.1630, found 326.1639.
(2S,3S)-1,4-Di(2-bromophenyl)-2,3-di(N-tert-butoxycarbonylamino)butane (194)
and (4S,5S)-4,5-Di(2-bromobenzyl)-1-tert-butoxycarbonyl-2-imidazolidinone (195)
Br

General Procedure 8 for ring opening of biaziridine (S,S)-183

BocHN

with o-BrPhMgCl: To a solution of 2-bromoiodobenzene (1.09
NHBoc

Br

g, 3.86 mmol) in THF (4 mL) at -40 oC was added i-PrMgCl

(1.61 mL, 2.0 M in THF, 3.22 mmol) and the mixture was allowed to warm to -25 oC
over 2.5 h. The solution was cooled to -40 oC and added dropwise to a suspension of
CuBr·SMe2 (99 mg, 0.48 mmol) and biaziridine (S,S)-183 (183 mg, 0.64 mmol) in THF
(2 mL) at -40 oC. The solution was allowed to warm to -10 oC over 6 h, then sat. NH4Cl
(2 mL) was added slowly, followed by H2O (5 mL) and the mixture was extracted with
EtOAc (3 x 10 mL). The combined extracts were dried, concentrated and subjected to
column chromatography (5% to 10% EtOAc:hexanes) affording dicarbamate (S,S)-194
1
(94 mg, 24%) as a white solid, m.p. 172 oC. [α]21
D -61.7 (c 1.97, CH2Cl2); H NMR: δ

1.33 (s, 18H, 6xCH3), 2.75-3.18 (m, 4H, H1, H4), 4.01-4.19 (m, 2H, H2, H3), 4.88 (bs,
2H, 2xNH), 7.02-7.14 (m, 2H, 2xArH4), 7.15-7.26 (m, 4H, 2xArH5, 2xArH6), 7.52 (d,
J = 7.8 Hz, 2H, 2xArH3); 13C NMR: δ 28.3 (6xCH3), 39.3 (C1, C4), 54.5 (C2, C3), 79.3

(2xC(CH3)3), 125.2 (2xArC2), 127.3 (2xArC5), 128.1 (2xArC4), 131.4 (2xArC6), 132.7
(2xArC3), 137.7 (2xArC1), 155.9 (2xC=O); FTIR v 3359 (w), 2972 (w), 1681 (s), 1525
(m), 1370 (w), 1299 (w), 1250 (w), 1167 (m), 1022 (w), 752 (m); MS (ES+, HCOOH):
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601 (24, M+H, 81Br, 81Br), 599 (45, M+H,
(48, M+H+HCOOH-2Boc,
441

(50,

81

81

Br,

79

Br), 597 (22, M+H, 79Br,

Br, 81Br), 443 (100%, M+H+HCOOH-2Boc,

M+H+HCOOH-2Boc,

79

79

Br,

Br);

HRMS

(ES+)

79

81

Br), 445

Br,

calcd

79

Br),
for

79

C26H34 Br2N2O4+Na 619.0783, found 619.0812.
Br

7' 1'

1'' 7''

2' 3'

4 5

4''
5''

6''

Further elution with 12% EtOAc:hexanes to 100% EtOAc

Br

2''

3''

HN

4'
6'

NBoc

2

yielded imidazolidinone (S,S)-195 (141 mg, 42%) as a pale
1
yellow syrup. [α]21
D -33.8 (c 4.50, CH2Cl2); H NMR: δ 1.50

5'

O

(s, 9H, 3xCH3), 2.85-2.93 (m, 3H, H7'a, H7''), 3.24 (dd, J =

5.4, 13.2 Hz, 1H, H7'b), 3.63 (t, J = 6.9 Hz, 1H, H4), 4.40 (dd, J = 5.4, 9.3 Hz, 1H, H5),
6.84 (bs, 1H, NH), 6.93-7.14 (m, 6H, H4', H4'', H5', H5'', H6', H6''), 7.36-7.43 (m, 2H,
H3', H3''); 13C NMR: δ 28.0 (3xCH3), 38.9 (C7'), 40.9 (C7''), 52.1 (C4), 58.0 (C5), 82.4
(C(CH3)3), 124.5 (C2' or C2''), 124.6 (C2' or C2''), 127.4 (C5' or C5''), 127.5 (C5' or
C5''), 128.26 (C4' or C4''), 128.30 (C4' or C4''), 131.0 (C6' or C6''), 131.6 (C6' or C6''),
132.8 (C3' or C3''), 132.9 (C3' or C3''), 135.1 (C1' or C1''), 135.6 (C1' or C1''), 150.0 (tBuOC=O), 155.6 (C2); FTIR v 3350 (m), 1768 (s), 1345 (m), 1242 (w), 1152 (m), 741
(s); MS (ES+, HCOOH): 527 (9, M+H, 81Br, 81Br), 525 (18, M+H, 81Br, 79Br), 523 (8,
M+H, 79Br, 79Br), 471 (48, M+HCOOH-Boc, 81Br, 81Br), 469 (100%, M+HCOOH-Boc,
81

Br,

79

Br), 467 (48, M+HCOOH-Boc,

79

Br,

79

Br); HRMS (ES+) calcd for

C22H2479Br2N2O3+Na 545.0051, found 545.0075.

9.7.3 Hydrolysis/Deprotection of N-Boc-2-Imidazolidinones
(4S,5S)-4,5-Di(2-bromobenzyl)-2-imidazolidinone (196)
Br

To a solution of imidazolidinone (S,S)-195 (23.7 mg, 45.2

Br

2'

3'

1'

µmol) in Et2O (2mL) was added 32% HCl (1 mL) and the

7'
4 5

4'
5'

6'

HN

2

mixture was stirred in air for 75 h, alkalified with 15% NaOH

NH

(5 mL) and extracted with CH2Cl2 (2 x 10 mL). The

O

combined extracts were dried and concentrated to give imidazolidinone (S,S)-196 (18.6
mg, 97%) as a white solid, m.p. 116-117 oC. 1H NMR: δ 2.90 (dd, J = 8.1, 13.5 Hz, 2H,
2xH7'a), 3.03 (dd, J = 5.4, 13.5 Hz, 2H, 2xH7'b), 3.85 (t, J = 5.4 Hz, 2H, H4, H5), 4.74
(bs, 2H, 2xNH), 7.06-7.12 (m, 2H, 2xH4'), 7.16-7.26 (m, 4H, 2xH5', 2xH6'), 7.51 (d, J
= 8.1 Hz, 2H, 2xH3');
178
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C NMR: δ 41.8 (2xC7'), 57.0 (C4, C5), 124.5 (2xC2'), 127.7
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(2xC5'), 128.7 (2xC4'), 131.6 (2xC6'), 133.2 (2xC3'), 136.1 (2xC1'), 161.6 (C2); FTIR v
3201 (w), 2925 (w), 1702 (s), 1470 (w), 1441 (w), 1025 (m), 747 (m); MS (ES+): 468
(51, M+H+CH3CN,
79

81

Br,

Br), 466 (100%, M+H+CH3CN,

79

Br,

79

81

81

81

Br,

79

Br), 464 (51,

M+H+CH3CN, Br, Br), 427 (43, M+H, Br, Br), 425 (86, M+H, Br, 79Br), 423
(44, M+H,

79

81

81

Br); HRMS (ES+) calcd for C17H1781Br79BrN2O 424.9687, found

424.9694.

(4S,5S)-4,5-Diisobutyl-2-imidazolidinone (190)
3'a

A mixture of imidazolidinone (S,S)-189 (27.0 mg, 90.5 µmol) and
2' 1'

Ba(OH)2.8H2O (143 mg, 0.45 mmol) in 80% EtOH (3.4 mL) was

4 5
3'b

HN

2

NH

O

heated at reflux in air for 36 h. The mixture was diluted sequentially
with CH2Cl2 (10 mL) and 10% HCl (2 mL), stirred for 10 min, then

alkalified with 15% NaOH (10 mL). The organic layer was separated and the aq. layer
extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried and
concentrated to give imidazolidinone (S,S)-190 (17.6 mg, 98%) as a white solid, m.p.
1
98-100 oC. [α]22
D -76.2 (c 0.85, CH2Cl2); H NMR: δ 0.88-0.94 (m, 12H, 2xH3'a,

2xH3'b), 1.24-1.34 (m, 2H, 2xH1'a), 1.42-1.52 (m, 2H, 2xH1'b), 1.57-1.71 (m, 2H, H2'),
3.31-3.38 (m, 2H, H4, H5), 5.33 (bs, 2H, 2xNH);

13

C NMR: δ 21.8 (2xC3'a), 23.3

(2xC3'b), 24.9 (2xC2'), 44.8 (2xC1'), 57.2 (C4, C5), 163.1 (C2); FTIR v 3193 (w), 2928
(w), 1704 (s), 1465 (m), 1368 (w), 1278 (w), 1244 (w), 706 (m); MS (ES+, HCOOH):
240 (100%, M+H+CH3CN), 199 (43, M+H); HRMS (EI+) calcd for C11H22N2O
198.1732, found 198.1723.

(4S,5S)-2,7-Dimethyl-4,5-octanediamine (201)
NH2

A suspension of imidazolidinone (S,S)-190 (10.0 mg, 50.4 µmol) in
32% HCl (3 mL) was heated at 110 oC in a microwave under air for

NH2

10 h. The bright green solution was diluted with H2O (7 mL),

washed with CH2Cl2 (2 x 5 mL), alkalified with 15% NaOH (15 mL) and extracted with
CH2Cl2 (3 x 10 mL). The combined extracts were dried and concentrated to give a tan
solid assigned by MS analysis as diamine (S,S)-201 (6.3 mg, 72%).‡ MS (ES+): 173
(100%, M+H).
‡

This compound degraded before further spectal data could be obtained. The enantiomer (R,R)-201 has
been reported in the form of its dihydrochloride salt.254
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(2S,3S)-1,4-Di(2-bromophenyl)-2,3-butanediamine (143)
Br

A suspension of imidazolidinone (S,S)-195 (19.6 mg, 37.4

NH2
NH2

µmol) in 32% HCl (3 mL) was heated at 110 oC in a microwave
Br

under air for 12 h. The dark green suspension was vacuum

filtered and the grey/brown solid was washed with H2O (5 mL) and Et2O (25 mL), then
dissolved in a biphase of 15% NaOH (10 mL) and CH2Cl2 (10 mL). The acidic aq. layer
from the earlier filtration was separated and added, maintaining alkalinity. The organic
layer was separated and the aq. solution extracted with CH2Cl2 (10 mL). The combined
organic layers were dried and concentrated to give diamine (S,S)-143 (13.3 mg, 89%) as
a viscous brown oil spectroscopically identical to diamine (S,S)-143 synthesised from
bioxirane (R,R)-87.

9.7.4 Synthesis of (2S,2'S)-2,2'-Biindoline
(2S,3S)-1,4-Di(2-bromophenyl)-2,3-di(N-tert-butoxycarbonylamino)butane (194)
and (4S,5S)-4,5-Di(2-bromobenzyl)-1-tert-butoxycarbonyl-2-imidazolidinone (195)
Br

This reaction followed General Procedure 8 using 2-

BocHN

bromoiodobenzene (4.77 g, 16.86 mmol), THF (5 mL), iNHBoc

Br

PrMgCl (7.81 mL, 1.80 M* in THF, 14.05 mmol) and a

suspension of CuBr·SMe2 (433 mg, 2.11 mmol) and biaziridine (S,S)-183 (799 mg, 2.81
mmol) in THF (5 mL). After addition of the Grignard, the pale green cloudy mixture
was allowed to warm to -10 oC over 9 h, then quenched with sat. NH4Cl (4 mL). The
mixture was diluted with H2O (10 mL) and EtOAc (25 mL), shaken and allowed to
settle. The clear organic layer was decanted from the slurry and the process was twice
repeated with EtOAc (2 x 25 mL). The combined organic layers were washed with H2O
(2 x 20 mL), dried, concentrated and subjected to column chromatography (25%
EtOAc:hexanes) yielding the partially pure dicarbamate (S,S)-194 (84 mg, 5%) as a
white solid.
Br

Br

Further elution with 25% to 50% EtOAc:hexanes gave
HN

NBoc
O
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imidazolidinone (S,S)-195 (715 mg, 49%) as a pale yellow
syrup. [α]23
D -38.5 (c 1.32, CH2Cl2).
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(2S,3S)-1,4-Di(2-bromophenyl)-2,3-butanediamine

(143)

and

(4S,5S)-4,5-Di(2-

bromobenzyl)-2-imidazolidinone (196)
Br

A suspension of imidazolidinone (S,S)-195 (617 mg, 1.18

NH2

mmol) in EtOH (0.5 mL) and 32% HCl (3 mL) was heated at
NH2

Br

Br

Br

110 oC in a microwave under air for 18 h. Et2O (5 mL) was
added to the slurry and the vessel was shaken and allowed to
settle, then the supernatant liquid was decanted. This process

HN

NH

was twice repeated with Et2O (2 x 5 mL), then the remaining

O

sticky solids were stirred vigorously for 1 h in 30%

CH2Cl2:Et2O (7 mL). The suspension was vacuum filtered and the collected solid (~300
mg) was dried in a 110 oC oven for 30 min before being dissolved in a biphase of 5 M
NaOH (3 mL) and CH2Cl2 (3 mL). The mixture was diluted with 5 M NaOH (20 mL)
and CH2Cl2 (30 mL), then the acidic aq. layer from the earlier decanting was separated
and added, maintaining alkalinity. The organic layer was separated and the aq. layer
extracted with CH2Cl2 (15 mL). The combined organic layers were dried and
concentrated to give a viscous brown oil containing diamine (S,S)-143 (188 mg, 40%)
and imidazolidinone (S,S)-196 (94 mg, 19%) which was used directly in the subsequent
cyclisation.
(5aS,11aS)-5,5a,6,11,11a,12-Hexahydrodibenzo[b,g][1,5]naphthyridine (151),
1H,1'H-2,2'-Biindole

(202),

(2S)-2,3-Dihydro-1H,1'H-2,2'-Biindole

(203)

and

(2S,2'S)-2,2'-Biindoline (38)

This reaction followed General Procedure 6 using Pd(OAc)2 (7.4 mg, 33.0 µmol), ±BINAP (41 mg, 65.8 µmol), toluene (2 mL), a solution of diamine (S,S)-143 (175 mg,
0.44 mmol) with imidazolidinone (S,S)-196 (88 mg, 0.21 mmol) in toluene (2 mL),
NaOt-Bu (190 mg, 1.98 mmol) and a 12 h reaction time. The crude mixture was
subjected to column chromatography (5% to 10% EtOAc:hexanes) giving naphthyridine
(S,S)-151 (3.0 mg, 3%) as a brown solid. 1H NMR: δ 2.75 (dd, J = 3.6, 16.8 Hz, 2H,
H6x, H12x), 3.16 (dd, J = 4.2, 16.8 Hz, 2H, H6y, H12y), 3.51 (bs, 2H, 2xNH), 3.79 (t, J
= 3.0 Hz, 2H, H5a, H11a), 6.44 (d, J = 7.8 Hz, 2H, H4, H10),
7
8
9
10

6a

6

5a

10a N 11a

H

H
N
12

4a
12a

6.63 (t, J = 7.5 Hz, 2H, H2, H8), 6.93-7.00 (m, 4H, H1, H3, H7,

4
3
2
1

H9); 13C NMR: δ 33.5 (C6, C12), 46.8 (C5a, C11a), 114.5 (C4,
C10), 117.2 (C6a, C12a), 117.3 (C2, C8), 127.1 (C3, C9), 129.9
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(C1, C7), 143.6 (C4a, C10a); MS (ES+, HCOOH): 237 (100%, M+H); HRMS (EI+)
calcd for C16H16N2 236.1313, found 236.1308.
Further elution gave a white solid (4.3
N
H

N
H

N
H
255

mixture of biindole 202

N
H

mg) assigned by MS analysis as a

and indoline (S)-203256 (<5% conversion combined). MS

(ES−): 231 (100%, 202−H); MS (ES+, HCOOH): 235 (100%, 203+H).
Further elution provided biindoline (S,S)-38 (82 mg, 79%) as a
N
H

light brown solid spectroscopically identical to the product

N
H

synthesised from bioxirane (R,R)-87.‡ [α]23
D +10.9 (c 3.84, CH2Cl2). A sample (~15 mg)
was dissolved in 50% CH2Cl2:MeOH (1 mL) and slow evaporation in an NMR tube
provided colourless crystalline needles/rods suitable for X-ray analysis.
(2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-biindoline (82)

This reaction followed General Procedure 7 using biindoline
N
Boc

(S,S)-38 (6.6 mg, 27.9 µmol), NEt3 (6.2 mg, 61.4 µmol), THF

N
Boc

(0.5 mL), a solution of Boc2O (12.8 mg, 58.7 µmol) in THF (0.5

mL) and three additional portions of Boc2O (3 x ~15 mg) affording biindoline (S,S)-82
(9.0 mg, 74%) as a white solid spectroscopically identical to biindoline (S,S)-82
synthesised from bioxirane (R,R)-87. [α]22
D -88.6 (c 0.45, CH2Cl2); HPLC analysis
(2.5% i-PrOH:hexane, retention time: 11.3 min) showed the ee of biindoline (S,S)-82
was >99%.

9.8 Synthesis of 2,2'-Bipyrrolidine from 2,2'-Bioxirane
9.8.1 Ring Opening with Lithioacetonitrile
±-4,5-Dihydroxyoctanedinitrile (205)
N

OH

‡

General Procedure 9 for ring opening of bioxirane 87 with

OH
N

lithioacetonitrile: To a solution of i-Pr2NH (517 mg, 5.11

See Appendix 3 for the 1H and 13C NMR spectra.
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mmol) in THF (5 mL) at -78 oC was added n-BuLi (3.19 ml, 1.6 M in hexanes, 5.10
mmol) and the mixture was maintained at -78 oC for 45 min, before a solution of
CH3CN (210 mg, 5.12 mmol) in THF (3 mL) was added dropwise, forming a white
precipitate. After stirring the slurry at -78 oC for 45 min, a cooled solution (-40 oC) of
bioxirane ±-87 (196 mg, 2.28 mmol) in THF (3 mL) was added dropwise and the
mixture was maintained at -78 oC for 1 h before being allowed to warm to 0 oC over 1.5
h. Sat. NH4Cl (2 mL) was added slowly then the mixture was diluted with H2O (3 mL)
and extracted with EtOAc (6 x 10 mL). The combined extracts were dried, concentrated
and subjected to column chromatography (50% EtOAc:hexanes to 100% EtOAc)
yielding dinitrile ±-205 (207 mg, 54%) as a white solid, m.p. 44-45 oC. 1H NMR: δ 1.83
(q, J = 6.6 Hz, 4H, H3, H6), 2.56 (t, J = 6.9 Hz, 4H, H2, H7), 2.72-2.92 (bs, 2H, 2xOH),
3.57-3.60 (m, 2H, H4, H5); 13C NMR: δ 13.8 (C3, C6), 29.0 (C2, C7), 71.9 (C4, C5),
119.8 (C1, C8); FTIR v 3444 (m), 3353 (s), 2242 (w), 1444 (m), 1421 (m), 1121 (s),
1056 (m), 939 (s), 916 (m), 885 (m), 701 (m); MS (ES−): 167 (100%, M−H); HRMS
(EI+) calcd for C8H12N2O2 168.0899, found 168.0892.

9.8.2 Reduction of Racemic 4,5-Dihydroxyoctanedinitrile
±-1,8-Diamino-4,5-octanediol (206)
Method 1 using BH3·SMe2: A flask fitted with a vigreaux

OH
NH2

H2N
OH

column and side arm condenser was charged with
BH3·SMe2 (0.49 mL, 2.0 M in THF, 0.98 mmol) and the

solution was heated at reflux before a solution of dinitrile ±-205 (47 mg, 0.28 mmol) in
THF (0.5 mL) was added over 45 min. After heating at reflux for a further 8 h, the
solvent was evaporated and 32% HCl (0.36 mL) was added dropwise. After stirring for
10 min, the mixture was alkalified with KOH pellets, then saturated with K2CO3 and
extracted with CH2Cl2 (3 x 10 mL). The combined extracts were dried and concentrated
to afford diol ±-206257 (14 mg, 28%) as a viscous colourless oil.‡ 1H NMR (CD3OD): δ
1.44-1.69 (m, 8H, H2, H3, H6, H7), 2.68 (bs, 4H, 2xNH2), 3.39-3.42 (m, 2H, H4, H5),
3.54-3.59 (m, 4H, H1, H8); 13C NMR (CD3OD): δ 30.2 (C2, C7), 31.3 (C3, C6), 62.8
(C1, C8), 75.1 (C4, C5); MS (ES+, HCOOH): 177 (100%, M+H); HRMS (ES+): calcd
for C8H21N2O2 177.1603, found 177.1609.
‡

No physical or spectral data reported in reference 257.
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±-1,8-Di(N-tert-butoxycarbonylamino)-4,5-octanediol (207) and ±-(4R,5R)/(4S,5S)8-N-tert-Butoxycarbonylamino-4,5-dihydroxyoctanenitrile (209)
Method 2 using NiCl2/NaBH4: To a solution of

OH
NHBoc

BocHN

0.50 mmol) and NiCl2·6H2O (6 mg, 0.025 mmol) in

OH
OH
BocHN
OH

dinitrile ±-205 (21 mg, 0.12 mmol), Boc2O (109 mg,
MeOH (2 mL) at 0 oC was added NaBH4 (66 mg, 1.74

N

mmol) portion-wise over 30 min and the mixture was

allowed to warm to RT and stirred for 72 h. The mixture was diluted with MeOH (10
mL), then a solution of ethylenediamine (23 mg, 0.38 mmol) in MeOH (1 mL) was
added and the pale purple solution was stirred for 1 h. The solvent was evaporated and
the residue was dissolved in EtOAc (20 mL), washed with sat. NaHCO3 (2 x 20 mL),
then dried and concentrated to give a viscous colourless oil (22 mg) as a mixture of
products assigned by MS and NMR analysis as diols ±-207 and ±-209 (molar ratio
~1:1). MS (ES+, HCOOH): 377 (100%, 207+H), 273 (23, 209+H). This mixture was resubjected to the reaction conditions and work-up just described, using the same
quantities of reagents and solvents, providing full conversion to diol ±-207‡ (29 mg,
62%) as a viscous colourless oil spectroscopically identical to that reported for diol
(R,R)-207.196 1H NMR: δ 1.44 (s, 18H, 6xCH3), 1.45-1.69 (m, 8H, H2, H3, H6, H7),
3.06-3.23 (m, 6H, H1, H8, 2xOH), 3.38-3.45 (m, 2H, H4, H5), 4.81 (t, J = 6.0 Hz, 2H,
2xNH);

13

C NMR: δ 26.4 (C2, C7), 28.4 (6xCH3), 30.3 (C3, C6), 40.3 (C1, C8), 74.1

(C4, C5), 79.3 (2xC(CH3)3), 156.3 (2xC=O).
Method 3 using Raney Ni/KBH4 (General Procedure 10 for reduction/Boc protection
of dinitrile 205): To a suspension of Raney Ni (17 mg, 0.29 mmol) and KBH4 (61 mg,

1.13 mmol) in EtOH (0.5 mL) was added a solution of dinitrile ±-205 (24 mg, 0.14
mmol) in EtOH (0.5 mL) and the mixture was stirred for 3 h before being vacuum
filtered. The filter cake was washed with EtOH (5 mL), then the filtrate was treated with
a solution of Boc2O (61 mg, 0.28 mmol) in EtOH (2 mL) and the mixture was stirred in
air for 17 h. The solvent was evaporated, then CH2Cl2 (15 mL) and H2O (5 mL) were
added. The organic layer was separated and the aq. solution extracted with CH2Cl2 (15
mL). The combined organic layers were dried and concentrated to give diol ±-207‡ (51
mg, 97%) as a viscous colourless oil.
‡

Peak broadening in the NMR spectra was observed, presumably due to the presence of residual Ni.
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9.8.3 Synthesis of (2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-bipyrrolidine
(4R,5R)-4,5-Dihydroxyoctanedinitrile (205)
N

This reaction followed General Procedure 9 using i-Pr2NH

OH

(764 mg, 7.55 mmol), THF (8 mL), n-BuLi (3.51 ml, 2.15 M*
N

OH

in hexanes, 7.55 mmol), a solution of CH3CN (310 mg, 7.55

mmol) in THF (3 mL) and a solution of bioxirane (R,R)-87‡ (260 mg, 3.02 mmol) in
THF (4 mL). After quenching with sat. NH4Cl (3 mL), the mixture was extracted with
CH2Cl2 (2 x 25 mL). The combined extracts were dried, concentrated and subjected to
column chromatography (50% EtOAc:hexanes to 80% EtOAc) yielding dinitrile (R,R)205 (242 mg, 48%) as a white solid spectroscopically identical to dinitrile ±-205. [α]22
D

+69.5 (c 4.18, EtOH).

(4R,5R)-1,8-Di(N-tert-butoxycarbonylamino)-4,5-octanediol (207)

This reaction followed General Procedure 10 using

OH
NHBoc

BocHN

Raney Ni (170 mg, 2.90 mmol), KBH4 (616 mg,
11.42 mmol), EtOH (3 mL), a solution of dinitrile

OH

(R,R)-205 (240 mg, 1.43 mmol) in EtOH (8 mL), a solution of Boc2O (654 mg, 3.00
mmol) in EtOH (2 mL) and an 8 h reduction time (prior to filtration and treatment with
Boc2O). The combined organic layers after work-up and extraction were washed with
brine (30 mL), dried, concentrated and subjected to column chromatography (60% to
80% EtOAc:hexanes) to give diol (R,R)-207196 (286 mg, 53%) as a viscous colourless
196
[α]20
oil spectroscopically identical to diol ±-207. [α]23
D +15.7 (c 4.11, CHCl3); Lit.
D

+14.61 (c 0.96, CHCl3).
(4R,5R)-1,8-Di(N-tert-butoxycarbonylamino)-4,5-octanediol
4,5-Dimethanesulfonate (208)

To a solution of MsCl (162 mg, 1.46 mmol) in

OMs
NHBoc

BocHN
OMs

CH2Cl2 (3 mL) at 0 oC was added a solution of NEt3
(168 mg, 1.66 mmol) in CH2Cl2 (1 mL) and the

mixture was stirred in air for 5 min before a solution of diol (R,R)-207 (250 mg, 0.66
‡

This compound was prepared from D-tartaric acid as described in Section 9.6.5.
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mmol) in CH2Cl2 (6 mL) was added. The mixture was stirred at 0 oC for 10 min then
allowed to warm to RT and stirred for 20 min before further aliquots of NEt3 (0.23 mL,
1.66 mmol) and MsCl (0.11 mL, 1.46 mmol) were sequentially added. After stirring in
air for 10 min, the mixture was diluted with CH2Cl2 (10 mL) and washed with sat.
NaHCO3 (20 mL), H2O (20 mL) and brine (20 mL). The organic layer was dried,
concentrated and subjected to column chromatography (40% EtOAc:hexanes) affording
dimesylate (R,R)-208 (239 mg, 68%) as a white solid, m.p. 84 oC. [α]23
D +11.32 (c 2.65,
CH2Cl2); 1H NMR: δ 1.44 (s, 18H, 6xC(CH3)), 1.60-1.90 (m, 8H, H2, H3, H6, H7), 3.11
(s, 6H, 2xSCH3), 3.13-3.19 (m, 4H, H1, H8), 4.70-4.85 (m, 4H, H4, H5, 2xNH);

13

C

NMR: δ 25.4 (C2, C7), 27.6 (C3, C6), 28.4 (6xC(CH3)), 38.7 (2xSCH3), 39.7 (C1, C8),
79.3 (2xC(CH3)3), 80.1 (C4, C5), 156.1 (2xC=O); FTIR v 3383 (w), 2972 (w), 1681
(m), 1522 (m), 1343 (m), 1332 (m), 1177 (s), 1160 (s), 911 (m), 893 (m); MS (ES+,
HCOOH): 533 (100%, M+H); HRMS (ES+) calcd for C20H41N2O10S2 533.2203, found
533.2181.

(2S,2'S)-N,N'-Di-tert-butoxycarbonyl-2,2'-bipyrrolidine (43)

To a suspension of NaH (53 mg, 60% suspension, 1.32 mmol) in THF (2
N
Boc

N
Boc

mL) at 0 oC was added dropwise a solution of dimesylate (R,R)-208 (234
mg, 0.44 mmol) in THF (6 mL) and the mixture was allowed to warm to

RT and stirred for 22 h. The supernatant liquid was syringed into a fresh batch of NaH
(neat, >>2 eq.) and the remaining residue was rinsed with fresh THF (5 mL) providing a
second aliquot to the fresh NaH. The resulting suspension was heated at reflux for 22 h,
then H2O (10 mL) was slowly added and the mixture was extracted with Et2O (3 x 20
mL). The combined extracts were washed with brine (20 mL), dried, concentrated and
subjected to column chromatography (10% to 20% EtOAc:hexanes) affording
bipyrrolidine (S,S)-4358,105 (28.5 mg, 19%) as a viscous colourless oil. [α]21
D -52.1 (c
1
1.43, CHCl3); Lit.58 [α]27
D -40.6 (c 0.31, CHCl3); H NMR: δ 1.44 (s, 9H, 3xCH3), 1.47

(s, 9H, 3xCH3), 1.55-1.63 (m, 2H, H3a, H3'a), 1.83-1.86 (m, 6H, H3b, H3'b, H4, H4'),
3.30-3.54 (m, 4H, H5, H5'), 3.80-3.90 (m, 2H, H2, H2'); 13C NMR:‡ δ 22.4, 22.8, 23.3
(C4, C4'), 28.4 (6xCH3), 28.9, 29.2 (C3, C3'), 46.4, 46.5, 47.0 (C5, C5'), 58.7, 59.0,
59.4, 59.6 (C2, C2'), 78.4, 78.8, 79.2 (2xC(CH3)3), 154.8 (2xC=O).
‡

The 13C NMR spectra clearly indicated the presence of rotamers with multiple signals observed for each
(non-equivalent) carbon atom. This is consistent with the data previously reported.61,198
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9.8.4 Alternative Synthesis of 2,2'-Bipyrrolidine
±-4,5-Dihydroxyoctanedinitrile 4,5-Dimethanesulfonate (215)

This reaction followed General Procedure 4 using dinitrile ±-

OMs

N

205 (33 mg, 0.20 mmol), NEt3 (50 mg, 0.49 mmol), CH2Cl2
N

OMs

(0.5 mL), a solution of MsCl (49 mg, 0.43 mmol) in CH2Cl2

(0.5 mL) and a 30 min reaction time. The mixture was diluted with EtOAc (15 mL),
washed with 5% CuSO4 (10 mL), sat. NaHCO3 (10 mL) and brine (10 mL), then dried
and concentrated to give dimesylate ±-215 (63 mg, 99%) as a colourless syrup that
crystallised upon addition of EtOH, m.p. 102 oC. 1H NMR: δ 2.00-2.22 (m, 4H, H3,
H6), 2.59 (t, J = 6.9 Hz, 4H, H2, H7), 3.18 (s, 6H, 2xCH3), 4.87-4.90 (m, 2H, H4, H5);
13

C NMR: δ 13.7 (C3, C6), 26.1 (C2, C7), 38.4 (2xCH3) 77.1 (C4, C5), 118.8 (C1, C8);

FTIR v 2246 (w), 1361 (s), 1169 (s), 975 (m), 920 (s), 912 (s), 850 (m), 821 (m); MS
(ES+, HCOOH): 343 (100%, M+H+H2O), 342 (88, M+NH4), 325 (19, M+H); HRMS
(ES+) calcd for C10H17N2O6S2 325.0528, found 325.0543.
9.8.4.1 Attempted Reductive Cyclisation
±-1,8-Di(N-tert-butoxycarbonylamino)-4,5-octanediol 4,5-Dimethanesulfonate (208)
Method 1 using LiAlH4: To a suspension of LiAlH4

OMs
NHBoc

BocHN
OMs

(8 mg, 0.21 mmol) in THF (0.5 mL) at 0 oC was
added over 30 min a solution of dimesylate ±-215 (34

mg, 0.10 mmol) in THF (1 mL) and the mixture was allowed to warm to RT and stirred
for 2 h. After cooling to 0 oC, the reaction was quenched with sat. Na2SO4 (4 drops from
a pasteur pipette) and the mixture was stirred for 10 min. A solution of Boc2O (46 mg,
0.21 mmol) in THF (1 mL) was added dropwise and the mixture was allowed to warm
to RT and stirred for 10 h. H2O (5 mL) was added and the mixture was extracted with
CH2Cl2 (2 x 10 mL). The combined extracts were dried, concentrated and subjected to
column chromatography (25% EtOAc:hexanes to 100% EtOAc) yielding dimesylate ±208 (13 mg, 23%) as a viscous colourless oil spectroscopically identical to dimesylate

(R,R)-208.
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±-(5'R,6'R)/(5'S,6'S)-3-(1-Azabicyclo[3.1.0]hexan-6-yl)-1-(N-tert-butoxycarbonyl
amino)propane (217)
Method 2 using Raney Ni/KBH4: To a suspension of Raney Ni (7 mg, 0.12 mmol) and

KBH4 (25 mg, 0.46 mmol) in EtOH (1 mL) was added dimesylate ±-215 (18.8 mg, 57.9
µmol) and the mixture was stirred for 13 h, diluted with EtOH (1 mL) and stirred for an
additional 4 h. Following vacuum filtration, the filter cake was washed with EtOH (8
mL),‡ then the filtrate was treated with a solution of Boc2O (26 mg, 0.12 mmol) in
EtOH (1 mL) and the mixture was stirred for 20 h. The solvent was evaporated before
the addition of CH2Cl2 (15 mL) and H2O (5 mL), then the organic layer was separated
and the aq. solution extracted with CH2Cl2 (15 mL). The combined organic layers were
dried, concentrated and subjected to column chromatography (25% EtOAc:hexanes to
100% EtOAc) yielding dimesylate ±-208 (2.0 mg, 6%).
2'

6'

N

3'

1

3
2

NHBoc

5'

Further elution with 10% NEt3:EtOAc gave the bicyclic amine
±-217 (4.6 mg, 33%) as a viscous pale brown oil. 1H NMR

4'

(500 MHz): δ 1.29-1.86 (m, 8H, H2, H3, H3', H5', H4'a), 1.44 (s, 9H, 3xCH3), 2.05 (dd,
J = 8.5, 13.0 Hz, 1H, H4'b), 2.09-2.13 (m, 1H, H6'), 2.83-2.89 (m, 1H, H2'a), 2.95-2.99

(m, 1H, H2'b), 3.08-3.21 (m, 2H, H1), 4.90 (bs, 1H, NH); 13C NMR: δ 21.0 (C2), 25.9
(C4'), 27.7 (C3'), 28.4 (3xCH3), 29.5 (C3), 37.4 (C5'), 40.2 (C1), 46.1 (C6'), 52.5 (C2'),
78.9 (C(CH3)3), 156.0 (C=O); MS (ES+, HCOOH): 241 (100%, M+H); HRMS (ES+):
calcd for C13H25N2O2 241.1916, found 241.1925.

9.9 Towards the Phosphorus and Arsenic Analogues
9.9.1 Synthesis of 1-Phenylphospholane 1-Oxide
1,4-Di(bromomagnesio)butane (238)220
BrMg

MgBr

General Procedure 11 for preparation of diGrignard 238: A

suspension of Mg and 1,4-dibromobutane in THF was stirred at

o

30 C for 1 h. The dark grey solution of diGrignard 238 was cooled to RT before direct
use in subsequent reactions.
‡

Further washing of the filter cake with CH2Cl2 (20 mL) and concentrating the resulting filtrate
recovered dimesylate ±-215 (5.9 mg, 31%).
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1-Phenylphospholane 1-Oxide (234)

To a solution of PhPOCl2 (1.00 g, 5.13 mmol) in THF (15 mL) at 0 oC was
P
O

added diGrignard 238 {prepared by General Procedure 11 using 1,4Ph

dibromobutane (0.61 mL, 5.13 mmol), Mg (312 mg, 12.83 mmol) and THF

(10 mL)} over 20 min and the mixture was allowed to warm to RT and stirred for 24 h.
H2O (10 mL) was slowly added and the mixture was extracted with EtOAc (3 x 15 mL).
The combined extracts were dried, concentrated and subjected to column
chromatography (2.5% NEt3:EtOAc) yielding phospholane 234213,214 (216 mg, 23%) as
a yellow oil. 1H NMR: δ 1.80-2.18 (m, 8H, H2, H3, H4, H5), 7.33-7.44 (m, 3H, ArH2,
ArH4, ArH6), 7.60-7.69 (m, 2H, ArH3, ArH5);

13

C NMR: δ 24.8 (d, J = 8.1 Hz, C3,

C4), 29.1 (d, J = 67.7 Hz, C2, C5), 128.2 (d, J = 11.8 Hz, ArC3, ArC5), 129.4 (d, J =
9.7 Hz, ArC2, ArC6), 131.2 (d, J = 2.6 Hz, ArC4), 133.7 (d, J = 90.1 Hz, ArC1).

9.9.2 Synthesis of Racemic Benzophospholane Derivatives
1-Bromo-2-(2-chloroethyl)benzene (250)224,258
3
4

2

1'

Cl
2'

5
6

1

Br

A mixture of 2-(2-bromophenyl)ethanol (500 mg, 2.49 mmol) and PCl5
(778 mg, 3.74 mmol) in CHCl3 was heated at reflux for 40 h. H2O (5
mL) was added dropwise, then the mixture was diluted with CH2Cl2 (20

mL). The organic layer was separated and the aq. layer extracted with CH2Cl2 (2 x 15
mL). The combined organic layers were washed with sat. NaHCO3 (15 mL), dried,
concentrated and subjected to column chromatography (hexanes) giving dihalide 250
(356 mg, 65%) as a colourless oil. 1H NMR (500 MHz): δ 3.21 (t, J = 7.0 Hz, 2H, H1'),
3.74 (t, J = 7.0 Hz, 2H, H2'), 7.10-7.14 (m, 1H, H5), 7.25-7.28 (m, 2H, H3, H4), 7.55
(d, J = 8.0 Hz, 1H, H6);

13

C NMR (125 MHz): δ 39.3 (C1'), 43.1 (C2'), 124.4 (C1),

127.5 (C4), 128.7 (C5), 131.3 (C3), 133.0 (C6), 137.3 (C2).
1-Bromomagnesio-2-(2-(chloromagnesio)ethyl)benzene (251)224
MgCl
MgBr

General Procedure 12 for preparation of diGrignard 251: A

suspension of Mg and dihalide 250 in THF was heated at reflux for 12
h. The dark grey/brown solution of diGrignard 251 was cooled to RT

before direct use in subsequent reactions.
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±-1-Phenylbenzophospholane 1-Oxide (235)
5
6

4

3

9

P

To a solution of PhPOCl2 (638 mg, 3.27 mmol) in THF (20 mL) at 78 oC was added diGrignard 251 {prepared by General Procedure

2
7
8

1'

6'
5'

O

4'

2'
3'

12 using dihalide 250 (817 mg, 3.72 mmol), Mg (185 mg, 7.63

mmol) and THF (15 mL)} over 40 min, then the solution was

maintained below -45 oC for 1 h before being allowed to warm to RT and stirred for 24
h. H2O (10 mL) was slowly added and the mixture was extracted with CH2Cl2 (3 x 15
mL). The combined extracts were dried, concentrated and subjected to column
chromatography (70% EtOAc:hexanes to 100% EtOAc, then 2.5% to 5% NEt3:EtOAc)
giving benzophospholane ±-235215-217 (340 mg, 46%) as a pale yellow solid. 1H NMR: δ
2.42-2.52 (m, 2H, H2), 3.11-3.26 (m, 1H, H3a), 3.35-3.50 (m, 1H, H3b), 7.32-7.68 (m,
9H, H5-H8, H2'-H6'); 13C NMR:‡ δ 27.9 (d, J = 70.8 Hz, C2), 28.1 (d, J = 4.1 Hz, C3),
126.3 (d, J = 11.2 Hz, ArCH), 127.7 (d, J = 10.3 Hz, ArCH), 128.4 (d, J = 12.1 Hz, C3',
C5'), 128.9 (d, J = 9.5 Hz, ArCH), 130.4 (d, J = 10.3 Hz, C2', C6'), 131.7 (d, J = 2.9 Hz,
C4'), 132.6 (d, J = 2.3 Hz, ArCH), 132.7 (d, J = 103.3 Hz, C1' or C9), 133.3 (d, J = 97.6
Hz, C1' or C9), 147.4 (d, J = 30.8 Hz, C4).

±-1-Phenylbenzophospholane (255)
4

3

9

P

A solution of phosphine oxide ±-235 (494 mg, 2.16 mmol) and SiPhH3
2

(0.40 mL, 3.24 mmol) in toluene (5 mL) was heated at reflux for 15 h.

1'

After cooling to RT, the mixture was subjected to column
chromatography (hexanes) affording phosphine ±-255229 (430 mg, 94%)

as a cloudy oil. 1H NMR (500 MHz): δ 2.07-2.12 (m, 1H, H2a), 2.27-2.38 (m, 1H, H2b),
3.08-3.23 (m, 2H, H3), 7.17-7.37 (m, 8H, 8xArH), 7.62-7.66 (m, 1H, ArH); 13C NMR
(125 MHz): δ 27.6 (d, J = 8.2 Hz, C2), 34.3 (d, J = 5.8 Hz, C3), 124.9 (d, J = 1.9 Hz,
ArCH), 126.7 (d, J = 7.2 Hz, ArCH), 128.0 (ArCH), 128.2 (d, J = 5.8 Hz, ArCH), 129.0
(ArCH), 131.2 (ArCH), 131.36 (ArCH), 139.6 (d, J = 22.5 Hz, C9), 140.0 (d, J = 6.8
Hz, C1'), 149.4 (d, J = 2.4 Hz, C4).

‡

No 13C NMR data reported in references 215-217.
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±-1-Phenylbenzophospholane-borane (256)229

To a solution of phosphine ±-255 (430 mg, 2.03 mmol) in THF (5

3

4

mL) at 0 oC was added dropwise BH3·SMe2 (1.52 mL, 2.0 M in THF,

2
6'

P
H3B

5'
2'
3'

3.04 mmol) and the mixture was allowed to warm to RT and stirred
for 20 min. The mixture was quenched by the slow addition of H2O

(20 mL) before extraction with CH2Cl2 (2 x 25 mL). The combined extracts were
washed with brine (20 mL), dried, concentrated and subjected to column
chromatography (3% EtOAc:hexanes) affording benzophospholane-borane ±-256 (417
mg, 91%) as a colourless oil. 1H NMR: δ 0.47-1.60 (m, 3H, BH3), 2.20-2.54 (m, 2H,
H2), 3.28-3.38 (m, 2H, H3), 7.33-7.54 (m, 8H, 8xArH), 7.61 (t, J = 7.5 Hz, ArH); 13C
NMR: δ 25.9 (d, J = 38.5 Hz, C2), 31.7 (d, J = 3.4 Hz, C3), 125.6 (d, J = 8.1 Hz,
ArCH), 128.0 (d, J = 9.8 Hz, ArCH), 128.8 (d, J = 10.0 Hz, C3', C5'), 130.2 (d, J = 12.4
Hz, ArCH), 130.9 (d, J = 6.9 Hz, ArCq), 131.2 (d, J = 2.6 Hz, ArCH), 131.3 (d, J = 44.7
Hz, ArCq), 131.67 (d, J = 2.3 Hz, ArCH), 131.68 (d, J = 9.8 Hz, C2', C6'), 148.4 (d, J =
15.0 Hz, C4).

±-1-Dimethylaminobenzophospholane 1-Oxide (257)
5
6
7
8

4
9

O

To a solution of NMe2POCl2 (211 mg, 1.30 mmol) in THF (5 mL) at

3

P

2

-78 oC was added diGrignard 251 {prepared by General Procedure 12

NMe2

using dihalide 250 (329 mg, 1.50 mmol), Mg (73 mg, 3.00 mmol) and

THF (5 mL)} over 10 min, then the solution was maintained at -78 oC for 2 h before
being allowed to warm to RT and stirred for 48 h. H2O (5 mL) was slowly added and
the mixture was extracted with CH2Cl2 (3 x 10 mL). The combined extracts were dried,
concentrated and subjected to column chromatography (75% EtOAc:hexanes to 100%
EtOAc, then 5% NEt3:EtOAc) giving a brown oil assigned by NMR analysis as
benzophospholane ±-257 (152 mg, 60%). 1H NMR: δ 2.07-2.17 (m, 2H, H2), 2.58 (s,
3H, CH3), 2.62 (s, 3H, CH3), 2.98-3.14 (m, 1H, H3a), 3.14-3.30 (m, 1H, H3b), 7.29-7.38
(m, 2H, H5, H8), 7.49 (t, J = 7.8 Hz, 1H, H6 or H7), 7.64 (t, J = 7.8 Hz, 1H, H6 or H7);
13

C NMR: δ 22.2 (d, J = 85.0 Hz, C2), 26.9 (d, J = 5.7 Hz, C3), 35.66 (CH3), 35.71

(CH3), 126.7 (d, J = 12.3 Hz, ArCH), 127.4 (d, J = 10.4 Hz, ArCH), 127.9 (d, J = 8.6
Hz, ArCH), 130.7 (d, J = 120.9 Hz, C9), 132.4 (d, J = 2.6 Hz, ArCH), 147.0 (d, J = 34.7
Hz, C4). This compound hydrolysed upon standing in air quantitatively to ±-1hydroxybenzophospholane 1-oxide (258).217
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9.9.3 Synthesis of 1-Phenylarsolane and Racemic 1-Phenylbenzoarsolane
1-Phenylarsolane (259)

To a solution of PhAsO (168 mg, 1.00 mmol) in THF (5 mL) at 0 oC was added
diGrignard 238 {prepared by General Procedure 11 using 1,4-dibromobutane

As
Ph

(0.18 mL, 1.50 mmol), Mg (73 mg, 3.00 mmol) and THF (5 mL)} over 20 min,

then the mixture was allowed to warm to RT and stirred for 20 h. H2O (10 mL) was
slowly added and the mixture was extracted with CH2Cl2 (3 x 15 mL). The combined
extracts were dried, concentrated and subjected to column chromatography (hexanes)
giving arsolane 259230 (25 mg, 12%) as a colourless oil. 1H NMR: δ 1.70-1.98 (m, 8H,
H2, H3, H4, H5), 7.22-7.32 (m, 3H, ArH2, ArH4, ArH6), 7.39-7.44 (m, 2H, ArH3,
ArH5); 13C NMR: δ 27.4 (C3, C4), 30.4 (C2, C5), 127.3 (ArC4), 128.2 (ArC2, ArC6),
131.4 (ArC3, ArC5), 143.2 (ArC1).

±-1-Phenylbenzoarsolane (263)
5
6

To a solution of PhAsO (168 mg, 1.00 mmol) in THF (7 mL) at -78 oC

4

3

9

As

was added diGrignard 251 {prepared by General Procedure 12 using

2

7
8

1'

6'

2'
3'

5'
4'

dihalide 250 (329 mg, 1.50 mmol), Mg (73 mg, 3.00 mmol) and THF
(4 mL)} over 20 min, then the solution was maintained at -78 oC for 30
min before being allowed to warm to RT and stirred for 21 h. H2O (10

mL) was slowly added and the mixture was extracted with Et2O (3 x 15 mL). The
combined extracts were dried, concentrated and subjected to column chromatography
(hexanes) giving benzoarsolane ±-263219 (51 mg, 20%) as a colourless oil.‡ 1H NMR: δ
2.08-2.26 (m, 2H, H2), 3.15-3.35 (m, 2H, H3), 7.19-7.21 (m, 5H, H2'-H6'), 7.20-7.36
(m, 3H, H6, H7, H8), 7.65 (d, J = 6.6 Hz, 1H, H5); 13C NMR: δ 26.7 (C2), 36.4 (C3),
125.0 (C6), 126.5 (C8), 127.7 (C4'), 128.3 (C2', C6'), 128.6 (C7), 131.8 (C3', C5'),
131.9 (C5), 140.9 (C1'), 142.7 (C9), 150.8 (C4); FTIR v 3384 (w), 3046 (w), 2360 (w),
1435 (w), 872 (m), 765 (m), 733 (s), 696 (m); MS (EI+): 256 (77, M+), 227 (40), 179
(100%).

‡

No spectral data reported in reference 219.
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9.10 Synthesis and Application of Catalysts
Di-μ-hydroxo-bis[(N,N,N',N'-tetramethylethylenediamine)copper(II)]
Iodide (269)235

A vessel containing a mixture of TMEDA (232 mg, 2.00 mmol) and
Me2N

NMe2

CuI (381 mg, 2.00 mmol) in 95% EtOH (5 mL) was cautiously

Cu
OH 2I
Cu
Me2N
NMe2
HO

evacuated. The vacuum was released with an O2(g) balloon (Caution:
ensure that the tap to the vacuum line is closed before releasing with
O2!) then the mixture was stirred at RT for 16 h. The suspension was

vacuum filtered and the precipitate washed with 95% EtOH (5 mL) before drying under
high vacuum at 60 oC for 2 h to give complex 269 (605 mg, 93%) as a dark brown/grey
powder.‡ MS (ES+): 147 (16, 65Cu+.(CH3CN)2), 145 (34, 65Cu+.(CH3CN)2), 117 (100%,
TMEDA+H).
μ-Hydroxo-[{(2S,2'S)-2,2'-bipyrrolidine}copper(II)] Iodide (270)

To a solution of bipyrrolidine (S,S)-43 (28.5 mg, 83.7 µmol) in
N
N
H Cu H
HO

nI
n

CH2Cl2 (5 mL) was added TFA (64 µL, 0.84 mmol) and the solution
was stirred in air for 4 h, after which time a second aliquot of TFA
(0.10 mL, 1.30 mmol) was added. After a further 20 h, aliquots of

TFA (0.50 mL, 6.49 mmol) and 32% HCl (0.10 mL) were added and the solution was
stirred for 9 h before being diluted with CH2Cl2 (5 mL) and alkalified with 5 M NaOH
(3 mL). The organic layer was separated and added to a suspension of CuI (15.9 mg,
83.5 µmol) in 95% EtOH (5 mL) and the resulting dark blue mixture was stirred in air
for 60 h. The mixture was concentrated to give a dark blue/aqua powder (28.8 mg)
assumed to be complex (S,S)-270 ([Cu.(S,S)-37.OH]nIn, n = 2 or 3, 99% yield based on
assumed structure). MS (ES+): 147 (14,

65

Cu+.(CH3CN)2), 145 (30,

65

Cu+.(CH3CN)2),

141 (100%, (S,S)-37+H).

‡

No spectral data reported in reference 235.
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±-3,3'-Dicarbomethoxy-2,2'-dihydroxy-1,1'-binaphthyl (268)
CO2Me
OH
OH
CO2Me

Method 1 using TMEDA/Cu(II) complex 269 (General
Procedure 13 for oxidative homo-coupling): A vessel containing

TMEDA/Cu(II) complex 269 (200 mg, 0.62 mmol based on
monomeric unit) and methyl 3-hydroxy-2-naphthoate (1.25 g, 6.18

mmol) was cautiously evacuated. The vacuum was released with an O2(g) balloon
(Caution: ensure that the tap to the vacuum line is closed before releasing with O2!)
then (CH2Cl)2 (62 mL) was added and the mixture was heated at 40 oC for 22 h. The
mixture was diluted sequentially with 10% NH3 (25 mL), CH2Cl2 (30 mL) and H2O (20
mL). The organic layer was separated, washed with 5% HCl (30 mL), dried,
concentrated and subjected to column chromatography (30% CH2Cl2:hexanes to 100%
CH2Cl2) giving binaphthyl ±-268238 (819 mg, 66%) as a yellow solid. 1H NMR: δ 4.04
(s, 6H, 2xCH3), 7.13-7.18 (m, 2H, 2xArH), 7.31-7.37 (m, 4H, 4xArH), 7.89-7.94 (m,
2H, 2xArH), 8.68 (s, 2H, H4, H4'), 10.71 (s, 2H, 2xOH);

13

C NMR: δ 52.7 (2xCH3),

114.1 (2xArCq), 117.0 (2xArCq), 123.9 (2xArCH), 124.6 (2xArCH), 127.2 (2xArCq),
129.4 (2xArCH), 129.8 (2xArCH), 132.9 (2xArCH), 137.2 (2xArCq), 154.0 (C2, C2'),
170.5 (2xC=O).
Method 2 using bipyrrolidine/Cu(II) complex (S,S)-270:† This reaction followed
General Procedure 13 using bipyrrolidine/Cu(II) complex (S,S)-270 (4.8 mg, 13.8 µmol

based on monomeric unit), 3-hydroxy-2-naphthoate (27.9 mg, 0.138 mmol), (CH2Cl)2
(1.5 mL) and a 216 h reaction time. Work-up and purification by column
chromatography afforded racemic‡ binaphthyl 268 (7.9 mg, 28%) as a yellow solid.
238
[α]D +170.5 (c 1.1, THF)}.
{ [α]23
D +3.5 (c 0.40, THF); Lit. (M)-268

(2S,2'S)-2,2'-Biindolinepalladium(II) Dichloride (274)

To a solution of biindoline (S,S)-38 (9.3 mg, 39.4 µmol) in
4

3
2

9

N
N
H Pd H
Cl
Cl

CH2Cl2 (1 mL) was added a solution of Pd(CH3CN)2Cl2 (10.2
mg, 39.4 µmol) in CH2Cl2 (3 mL) and a yellow/orange
precipitate formed. After stirring in air for 2 h, the mixture was

allowed to stand in a freezer for 1 h before vacuum filtration. The precipitate was
†
‡

The structure of this complex was not able to be confirmed with an X-ray structure.
The specific rotation was considered to be negligible in comparison to that reported.
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dissolved in 50% acetone:MeOH (15 mL) and gravity filtered. The filtrate was dried
and concentrated to give Pd complex (S,S)-274 (15.4 mg, 95%) as a yellow/orange
powder. 1H NMR [(CD3)2CO]: δ 3.15-3.32 (m, 4H, H3, H3'), 3.96-4.04 (m, 2H, H2,
H2'), 7.24-7.30 (m, 4H, 4xArH), 7.33-7.37 (m, 2H, 2xArH), 7.46 (bs, 2H, 2xNH), 8.088.12 (m, 2H, 2xArH);

13

C NMR [(CD3)2CO]: δ 33.6 (C3, C3'), 69.3 (C2, C2'), 122.9

(2xArCH), 126.2 (2xArCH), 127.9 (2xArCH), 128.3 (2xArCH), 134.0 (2xC4), 146.4
(2xC9). Slow evaporation of a sat. solution of the complex in CH3CN (~1 mg/mL) in an
open NMR tube provided orange crystals suitable for X-ray analysis.
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APPENDIX 1: HPLC Traces of 1,8-Di(benzyloxy)-4,5-octanediol

All traces were obtained using a Daicel Chiralcel OD-H column with a UV detector
(254 nm) and a gradient elution system of 10% to 40% i-PrOH:hexane (flow rate 0.5
mL/min).
1) (4S,5S)-1,8-Di(benzyloxy)-4,5-octanediol:
OH
OBn

BnO
OH
(S,S)-73

1. (R,R)-73 (minor)
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2. meso-73 (minor)

3. (S,S)-73 (major)
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2) (4R,5R)-1,8-Di(benzyloxy)-4,5-octanediol:
OH
OBn

BnO
OH
(R,R)-73

1. (R,R)-73 (major) 2. meso-73 (minor)

3. (S,S)-73 (minor)
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HPLC Traces

3) (4R,5R)- and (4S,5S)-1,8-Di(benzyloxy)-4,5-octanediol (combined injection):
OH

OH
OBn

BnO

+

OH
(R,R)-73

1. (R,R)-73 (major)
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OBn

BnO
OH
(S,S)-73

2. meso-73 (minor)

3. (S,S)-73 (major)

APPENDIX 2: ES− Mass Spectra of Diol Mixtures

1) ±-(2R,3S)/(2S,3R)-1-(2-Bromophenyl)-4-chloro-2,3-butanediol, ±-(2R,3S)/(2S,3R)-1(2-Bromophenyl)-4-iodo-2,3-butanediol and ±-1,4-Di(2-bromophenyl)-2,3-butanediol:
Br

OH

Br
Cl

Br

OH
I

+

OH

+

OH
107
[M+Cl]

OH
106
[M+Cl]

OH
105
[M+Cl]

Br

m/z 313, 315

m/z 405, 407

m/z 433, 435, 437

Note: I− = m/z 127
[105+HCOO]− = m/z 445
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ES- Mass Spectra

2) ±-1,4-Dichloro-2,3-butanediol, ±-(2R,3R)/(2S,3S)-4-Chloro-1-iodo-2,3-butanediol
and ±-1,4-Diiodo-2,3-butanediol:
OH

OH
Cl

Cl

OH
I

Cl

+

I

I

OH
118
[M+Cl]

OH
117
[M+Cl]

OH
116
[M+Cl]

m/z 193, 195

m/z 285, 287

m/z 377, 379

Note: I− = m/z 127
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ES- Mass Spectra

3) ±-(2R,3S)/(2S,3R)-4-Chloro-1-(2-nitrophenyl)-2,3-butanediol and ±-(2R,3S)/ (2S,3R)4-Iodo-1-(2-nitrophenyl)-2,3-butanediol:
NO2

OH

NO2
Cl

OH

OH
I

+

122
[M+Cl]

OH
121
[M+Cl]

m/z 280, 282

m/z 372, 374
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APPENDIX 3: NMR Spectra of (2S,2'S)-2,2'-Biindoline
1) 1H NMR:
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NMR Spectra of Biindoline

2) 13C NMR:
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APPENDIX 4: Crystal Data for (2S,2'S)-2,2'-Biindoline
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Crystal Data for Biindoline
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Crystal Data for Biindoline
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Crystal Data for Biindoline

APPENDIX 5: Crystal Data for (2S,2'S)-2,2'-Biindolinepalladium(II)
Dichloride
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